 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
1995
Population and fertility by age and sex for 195 countries and 
territories, 1950–2017: a systematic analysis for the Global 
Burden of Disease Study 2017
GBD 2017 Population and Fertility Collaborators*
Summary
Background Population estimates underpin demographic and epidemiological research and are used to track progress 
on numerous international indicators of health and development. To date, internationally available estimates of 
population and fertility, although useful, have not been produced with transparent and replicable methods and do not 
use standardised estimates of mortality. We present single-calendar year and single-year of age estimates of fertility 
and population by sex with standardised and replicable methods.
Methods We estimated population in 195 locations by single year of age and single calendar year from 1950 to 2017 
with standardised and replicable methods. We based the estimates on the demographic balancing equation, with 
inputs of fertility, mortality, population, and migration data. Fertility data came from 7817 location-years of vital 
registration data, 429 surveys reporting complete birth histories, and 977 surveys and censuses reporting summary 
birth histories. We estimated age-specific fertility rates (ASFRs; the annual number of livebirths to women of a 
specified age group per 1000 women in that age group) by use of spatiotemporal Gaussian process regression and used 
the ASFRs to estimate total fertility rates (TFRs; the average number of children a woman would bear if she survived 
through the end of the reproductive age span [age 10–54 years] and experienced at each age a particular set of ASFRs 
observed in the year of interest). Because of sparse data, fertility at ages 10–14 years and 50–54 years was estimated 
from data on fertility in women aged 15–19 years and 45–49 years, through use of linear regression. Age-specific 
mortality data came from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 estimates. Data 
on population came from 1257 censuses and 761 population registry location-years and were adjusted for 
underenumeration and age misreporting with standard demographic methods. Migration was estimated with the 
GBD Bayesian demographic balancing model, after incorporating information about refugee migration into the model 
prior. Final population estimates used the cohort-component method of population projection, with inputs of fertility, 
mortality, and migration data. Population uncertainty was estimated by use of out-of-sample predictive validity testing. 
With these data, we estimated the trends in population by age and sex and in fertility by age between 1950 and 2017 in 
195 countries and territories.
Findings From 1950 to 2017, TFRs decreased by 49·4% (95% uncertainty interval [UI] 46·4–52·0). The TFR decreased 
from 4·7 livebirths (4·5–4·9) to 2·4 livebirths (2·2–2·5), and the ASFR of mothers aged 10–19 years decreased from 
37 livebirths (34–40) to 22 livebirths (19–24) per 1000 women. Despite reductions in the TFR, the global population 
has been increasing by an average of 83·8 million people per year since 1985. The global population increased by 
197·2% (193·3–200·8) since 1950, from 2·6 billion (2·5–2·6) to 7·6 billion (7·4–7·9) people in 2017; much of this 
increase was in the proportion of the global population in south Asia and sub-Saharan Africa. The global annual rate 
of population growth increased between 1950 and 1964, when it peaked at 2·0%; this rate then remained nearly 
constant until 1970 and then decreased to 1·1% in 2017. Population growth rates in the southeast Asia, east Asia, and 
Oceania GBD super-region decreased from 2·5% in 1963 to 0·7% in 2017, whereas in sub-Saharan Africa, population 
growth rates were almost at the highest reported levels ever in 2017, when they were at 2·7%. The global average age 
increased from 26·6 years in 1950 to 32·1 years in 2017, and the proportion of the population that is of working age 
(age 15–64 years) increased from 59·9% to 65·3%. At the national level, the TFR decreased in all countries and 
territories between 1950 and 2017; in 2017, TFRs ranged from a low of 1·0 livebirths (95% UI 0·9–1·2) in Cyprus to a 
high of 7·1 livebirths (6·8–7·4) in Niger. The TFR under age 25 years (TFU25; number of livebirths expected by age 
25 years for a hypothetical woman who survived the age group and was exposed to current ASFRs) in 2017 ranged 
from 0·08 livebirths (0·07–0·09) in South Korea to 2·4 livebirths (2·2–2·6) in Niger, and the TFR over age 30 years 
(TFO30; number of livebirths expected for a hypothetical woman ageing from 30 to 54 years who survived the age 
group and was exposed to current ASFRs) ranged from a low of 0·3 livebirths (0·3–0·4) in Puerto Rico to a high of 
3·1 livebirths (3·0–3·2) in Niger. TFO30 was higher than TFU25 in 145 countries and territories in 2017. 33 countries 
had a negative population growth rate from 2010 to 2017, most of which were located in central, eastern, and western 
Europe, whereas population growth rates of more than 2·0% were seen in 33 of 46 countries in sub-Saharan Africa. 
In 2017, less than 65% of the national population was of working age in 12 of 34 high-income countries, and less than 
50% of the national population was of working age in Mali, Chad, and Niger.
Lancet 2018; 392: 1995–2051
*Collaborators listed at the end 
of the paper
Correspondence to: 
Prof Christopher J L Murray, 
Institute for Health Metrics and 
Evaluation, Seattle, WA 98121, 
USA 
cjlm@uw.edu
 Global Health Metrics
1996 
www.thelancet.com   Vol 392   November 10, 2018
Introduction
Age-sex-specific estimates of population are a bedrock of 
epidemiological and economic analyses, and they are 
integral to planning across several sectors of society. As 
the denominator for most indicators, such estimates 
permeate every aspect of our understanding of health 
and development. Errors in population estimates affect 
national and international target tracking and time-series 
and cross-country analyses of development outcomes. 
The impor 
tance of accurate population estimates for 
government planning cannot be overstated: population 
size, age, and composition dictate the national need for 
infrastructure, housing, education, employment, health 
care, care of older people, electoral representation, 
provision of public health and services, food supply, and 
security.1 Similarly, fertility rates, both by maternal age 
and overall, are key drivers of population growth and 
important social outcomes in their own right.
Many governments typically produce national popu-
lation estimates by age and sex for planning purposes. 
Most international studies and comparative indicators, 
including the Millennium Development Goals and the 
Sustainable Development Goals, rely on the estimates 
generated by the UN Population Division at the 
Department of Economics and Social Affairs (UNPOP) 
for population denomi 
nators,2,3 although it is not well 
documented how often these estimates are used by 
national governments. The UNPOP has produced 
population estimates since 1951, and it uses a de-
centralised approach to estimation.4 For example, the 
Latin American and Caribbean Demographic Centre 
produces estimates for Latin America, whereas estimates 
for all other groups of countries are developed by analysts 
in New York. Although the UNPOP describes a general 
approach of examining data on fertility, mortality, 
migration, and population and searching for consistency,5 
replicable statistical methods are not used. Decisions on 
how to deal with inconsistency between the compo-
nents of fertility, mortality, and migration within 
population counts are left to individual analysts, leading 
to considerable hetero 
geneity in approaches across 
countries. Accordingly, discrepancies between UNPOP 
and nationally produced estimates—for instance, in 
2015, the population estimates for Mexico by UNPOP 
were 4·6 million more than those of Mexico’s National 
Population Council (125·9 million by UNPOP vs 
Interpretation Population trends create demographic dividends and headwinds (ie, economic benefits and detriments) 
that affect national economies and determine national planning needs. Although TFRs are decreasing, the global 
population continues to grow as mortality declines, with diverse patterns at the national level and across age groups. 
To our knowledge, this is the first study to provide transparent and replicable estimates of population and fertility, 
which can be used to inform decision making and to monitor progress.
Funding Bill & Melinda Gates Foundation.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Research in context
Evidence before this study
Population estimates by age and sex are extensively used in all 
forms of epidemiological and demographic analysis. National 
estimates of population and fertility for age and sex groups 
have been produced by the UN Population Division since 1951. 
The US Census Bureau produces revised demographic estimates 
for 15 to 30 countries each year. Several national authorities 
produce their own population estimates, particularly those in 
high and middle Socio-demographic Index countries. These 
efforts are all based on the cohort-component method of 
population projection, namely that population in an age group 
at a given time t must equal the population in that cohort at 
the start of the time period (t–1) plus new entrants and minus 
people exiting the population because of migration and death. 
Although these estimates are based on the demographic 
balancing equation, estimates are not based on standardised, 
transparent, or replicable statistical methods.
Added value of this study
To our knowledge, this study presents the first estimates of 
population by location from 1950 to 2017 that are based on 
transparent data and replicable analytical code, applying a 
standardised approach to the estimation of population for each 
single year of age for each calendar year from 1950 to 2017 for 
195 countries and territories and for the globe. This study 
provides improved population estimates that are internally 
consistent with the Global Burden of Diseases, Injuries, and Risk 
Factors Study’s assessment of fertility and mortality, which are 
important inputs to other epidemiological research and 
government planning. 
Implications of all the available evidence
Population counts by age and sex that are produced with a 
transparent and empirical approach will be useful for 
epidemiological and demographic analyses. The production of 
annual estimates will also facilitate timely tracking of progress 
on global indicators, including the Sustainable Development 
Goals. In the future, the methods applied here can be used to 
enhance population estimation at the subnational level. 
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
1997
121·3 million by National Population Council)—cannot 
currently be resolved.4,6
The US Census Bureau’s International Division 
periodically releases detailed population analyses for 
selected countries, with new revisions produced for 
15 to 30 countries per year.7 Other organisations, such as 
the Population Reference Bureau,8 the World Bank,9 
the Wittgenstein Centre,10 and Gapminder Foundation11 
also release population estimates, but these are largely 
combinations of national estimates with selected UNPOP 
or US Census Bureau analyses. Many of the organi-
sations who estimate or report on population also 
provide fertility estimates, which, in addition to affecting 
population trends, are used to monitor reproductive 
health service delivery in many locations. To our 
knowledge, global estimates of annual population by age 
and sex with underlying primary data and replicable 
computer code and statistical modelling details are not 
available from any source.
The Global Burden of Diseases, Injuries, and Risk 
Factors Study (GBD) is committed to the Guidelines on 
Accurate and Transparent Health Estimates Reporting 
(GATHER).12 Continued use of the UNPOP population 
estimates in GBD is not compatible with GATHER 
because the methods used for UNPOP estimation are 
not transparent and uncertainty intervals are not 
estimated for populations.4 Moreover, UNPOP population 
esti 
mates, especially in years between or after a census, 
are inconsistent with GBD estimates because there is a 
marked difference between UNPOP and GBD estimates 
of age-specific mortality in many instances.13,14 For this 
GBD 2017 paper, we sought to produce population 
estimates 
and 
associated 
fertility 
estimates 
for 
195 countries and territories from 1950 to 2017 that were 
based on the available census or population registry data 
and survey and census data on age-specific fertility rates 
(ASFR; ie, the annual number of livebirths to women of a 
specified age group per 1000 women in that age group) 
by use of replicable methods, leveraging the previous 
GBD work that estimated age-sex-specific mortality 
rates.15 To achieve this goal, we aimed to conduct 
systematic analyses of available sources that could 
inform ASFR estimation and to systematically identify 
and extract census and population registry data.
Methods
Overview
As with all population estimation, the underlying 
equation used for GBD is based on the demographic 
balancing equation16
where N (T) is the population at a given time, N (0) is the 
population at the start of the interval, B (0,T) is livebirths 
during the interval, D (0,T) is deaths during the interval, 
and G (0,T) is net migration during the interval.
The cohort-component method of population pro 
jection 
extends this demographic balancing equation to estimate 
internally consistent age-sex-specific popu 
lations. The 
method requires estimates of ASFRs, sex ratio at birth, 
age-sex-specific net migration, and age-sex-specific mor-
tality rates that are consistent with observed population 
counts that have been corrected for underenumeration or 
overenumeration. GBD provides a consistent set of age-
sex-specific mortality rates with standardised methods;15 in 
this analysis, we estimated the sex ratio at birth, ASFR, and 
age-sex-specific migration rates consistent with the 
available population data to create a full time series of 
population estimates by age and sex.
These estimates comply with GATHER (appendix 1 
section 5). Analyses were done with R version 3.3.2, Python 
version 2.7
.14, or Stata version 13.1. Data and statistical 
code for all analyses are publicly available online. 
Geographical units and time periods
We produced single calendar-year and single year-of-
age population estimates for 195 countries and territories 
that were grouped into 21 regions and seven super-
regions. The seven super-regions are central Europe, 
eastern Europe, and central Asia; high income; 
Latin America and the Caribbean; north Africa and the 
Middle East; south Asia; southeast Asia, east Asia, and 
Oceania; and sub-Saharan Africa. Each year, GBD includes 
sub 
national analyses for a few new countries and 
continues to provide subnational estimates for countries 
that were added in previous cycles. Subnational estimation 
in GBD 2017 includes five new countries (Ethiopia, Iran, 
New Zealand, Norway, Russia) and countries previously 
estimated at subnational levels (GBD 2013: China, Mexico, 
and the UK [regional level]; GBD 2015: Brazil, India, 
Japan, Kenya, South Africa, Sweden, and the USA; GBD 
2016: Indonesia and the UK [local government authority 
level]). All analyses are at the first level of administrative 
organisation within each country except for New Zealand 
(by Māori ethnicity), Sweden (by Stockholm and non-
Stockholm), and the UK (by local government authorities). 
All subnational estimates for these countries were 
incorporated into model development and evaluation as 
part of GBD 2017
. To meet data use requirements, in this 
publication we present all subnational estimates excluding 
those pending publication (Brazil, India, Japan, Kenya, 
Mexico, Sweden, the UK, and the USA); given space 
constraints, these results are presented in appendix 2 
instead of the main text. Subnational estimates for 
countries with populations of more than 200 million 
people (assessed by use of our most recent year of 
published estimates) that have not yet been published 
elsewhere are presented wherever estimates are illus-
trated with maps but are not included in tables. Estimates 
were produced for the years 1950–2017
. 1950 was selected 
as the start year for the analysis because we were unable to 
locate sufficient data on ASFR, mortality, and population 
before 1950.
N(T)=N(0) + B(0,T) – D(0,T) + G(0,T)
See Online for appendix 1
For the statistical code see 
http://ghdx.healthdata.org/gbd-
2017
See Online for appendix 2
 Global Health Metrics
1998 
www.thelancet.com   Vol 392   November 10, 2018
Fertility
Fertility data are obtained from vital registration systems, 
complete birth histories, or summary birth histories. 
Complete birth histories include the date of birth and, if 
applicable, the dates of death of all children ever born 
alive to each woman that is interviewed, whereas 
summary birth histories include the total number of 
children ever born alive to each mother and the total 
number of those children born alive to each mother that 
have died. In countries with complete birth registration, 
vital registration systems typically provide tabulations of 
births by age of the mother. From 1890,17 some censuses 
asked about the number of children ever born to a 
woman, and this question has been widely asked in 
censuses and many household surveys in the past 
70 years. From the 1970s, fertility information has also 
been collected through complete birth histories, 
beginning with the World Fertility Survey, then the 
Demographic and Health Surveys, and, in some 
countries, the Multiple Indicator Cluster Surveys, 
sponsored by the UN Children’s Fund. We identified 
977 censuses and household surveys that had summary 
birth history data, 429 household surveys that had 
complete birth history data, and 7817 country-years of 
birth registration systems through searches of national 
statistical sources and the Demographic Yearbooks 
produced by the UN Statistics Division from 1948 to 
present.18 The number and type of sources for each 
location are provided in appendix 1 (section 5). The 
Global Health Data Exchange provides the metadata for 
all these sources.
Given the hetergeneous nature of the data (vital 
registration, summary birth histories, complete birth 
histories), we used a two-stage approach to modelling the 
ASFR for the age groups 15–19 years, 20–24 years, 
25–29 years, 30–34 years, 35–39 years, 40–44 years, and 
45–49 years. The two-stage approach was designed to take 
advantage of the greater availability of some summary 
birth history data for the period 1950 to 1975 and to help 
to compensate for the lower availability of complete birth 
history data in some low-income countries. For the 
fertility rates in those aged 10–14 years and 50–54 years, 
which are much lower than in other age groups and for 
which only vital registration data were available, we used 
a separate, simpler approach, described later in this 
section.
In the first stage of our analysis, we used spatio 
temporal 
Gaussian process regression to analyse vital registration 
and complete birth history data.15,19 For spatiotemporal 
Gaussian process regression, the prior was estimated 
separately for women aged 20–24 years, with average years 
of schooling in women aged 20–24 years as the covariate. 
For all other age groups, the prior was estimated with a 
spline on the estimated ASFR for women aged 20–24 years 
and with the average years of schooling for the age group 
of interest. The prior for GBD locations in the high-
income super-region did not include average years of 
schooling as a covariate. Spline knots were selected by 
inspection of the data to identify where there was a 
reversal in trend. The purpose of this approach was to 
capture an increase in fertility rates in women aged 
30 years or older while the ASFR for women aged 
20–24 years decreased below a specific threshold. Given 
that the point of inflection for the ASFR for women aged 
30 years or older relative to the ASFR for women 
aged 20–24 years varied by super-region, we fit the models 
separately for some GBD super-regions (high income; 
sub-Saharan Africa; and central Europe, eastern Europe, 
and central Asia) and modelled the rest of the super-
regions together. The first step of the model also included 
location-and-source-specific random effects to correct bias 
from non-sampling error in different source types, such 
as incomplete vital registration. Hyperparameters for the 
model were selected on the basis of a measure of data 
density. Further details on this process are provided in 
appendix 1 (section 2).
In the second stage of the analysis, we used the 
ASFR estimates from the first stage to process and 
incorporate several forms of aggregated data. First, we 
split cumulative cohort fertility data (ie, children ever 
born) from summary birth history into period ASFR data. 
For this split, we computed the ratio between reported 
children ever born alive from each 5-year cohort of women 
represented in a given data source and the total fertility for 
each of these cohorts that was implied by the first-stage 
estimates of ASFR by location and year. This ratio 
was applied as a scaling factor to our estimated cohort 
ASFR at 5-year intervals (when all members of the cohort 
all belong to a single 5-year GBD age group), to distribute 
experienced fertility (ie, from age 10 years until the date of 
the survey in women interviewed from the cohorts 
specified in the original data) back across age and time. 
Additionally, we used the estimated age proportion of 
livebirths from the first stage to distribute total reported 
livebirths by the age of the mother. Lastly, for historical 
location aggregates for which we had registry data (eg, the 
Soviet Union), we used the estimated proportions of age-
specific livebirths in constituent locations from the first 
stage to allocate births back in time to their current 
GBD geographies. This new set of methods allowed us to 
supplement the model with a substantial amount of 
additional information about the overall fertility. We then 
re-estimated ASFR as described, with all vital registration, 
complete birth history, and split data to produce final 
fertility estimates for women aged 15–49 years.
In both the first and second stage, data were adjusted in 
the mixed-effects model on the basis of random 
effects values (appendix 1 section 2) by selecting a 
reference or benchmark source. In locations with 
complete child death registration (see previous GBD 
analyses),15,20 vital registration was typically the benchmark 
or reference source. In other locations, Demographic and 
Health Survey complete birth history data were used as 
the reference source. If neither vital registration nor 
For the Global Health Data 
Exchange see http://ghdx.
healthdata.org/
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
1999
Demographic and Health Survey complete birth histories 
were available, other complete birth history sources were 
used as the reference. If no vital registration or complete 
birth history data were used, then the average of all 
remaining summary birth history sources were used as 
reference. 
Where 
sources 
were 
inconsistent 
or 
implausible time trends were identified, some reference 
source designations were modified; the final choice of 
reference sources for each location are provided in the 
appendix 1 (section 5).
Many household surveys on fertility excluded women in 
the age groups 10–14 years and 50–54 years, and 
these data were limited to 3947 country-years of vital 
registration data. To estimate fertility in girls aged 
10–14 years, we used a linear regression of the log of the 
ratio of the ASFR of girls aged 10–14 years to the ASFR for 
girls aged 15–19 years as a function of the ASFR for girls 
aged 15–19 years. For women aged 50–54 years, we found 
no covariates that predicted variation in the ratio of ASFR 
for women aged 50–54 years to the ASFR for those aged 
45–49 years. In this case, we assumed the ratio of ASFR 
for women aged 50–54 years to ASFR for women aged 
45–49 years was constant across locations and over time.
Our analysis generated a full set of ASFRs for each 
location and year from 1950 to 2017; we used these ASFRs 
to compute the total fertility rate (TFR), which is the 
average number of children a woman would bear if she 
survived through the end of the reproductive age span 
(age 10–54 years) and experienced at each age a particular 
set of ASFRs observed in the year of interest. We also 
estimated the total fertility rate under age 25 years 
(TFU25; number of livebirths expected by age 25 years for 
a hypothetical woman who survived the age group and 
was exposed to current ASFRs) and the total fertility in 
women older than 30 years (TFO30; number of livebirths 
expected for a hypothetical woman ageing from 30 to 
54 years who survived the age group and was exposed to 
current ASFRs). These age ranges were computed 
because nearly all locations show decreases in the TFU25 
over time, with few or no reversals. In women aged 30 
years or older, there is a clear U-shaped curve, with 
decreases followed by sustained increases; in women 
aged 25–29 years, the pattern is less consistent. The 
fertility rate in girls aged 10–19 years is a Sustainable 
Development Goal (SDG) indicator for goal 3, target 3.7: 
ensure universal access to sexual and reproductive health-
care services, including for family planning, information 
and education, and the integration of reproductive health 
into national strategies and programmes.21
We estimated the sex ratio at birth with 4690 unique 
location-years of registered livebirths by sex, 1756 location-
years of census and population registry counts that 
included children younger than 1 year and younger than 
5 years by sex, and 2490 location-years of the proportion 
of live-born males from complete birth history. These 
data informed a spatiotemporal Gaussian process 
regression model of the proportion of live-born males, 
assuming a time-invariant prior for the mean because, in 
the absence of sex-selective abortion, we would not expect 
the sex ratio at birth to deviate significantly from its 
natural equili 
brium. Hyperparameters for spatiotemporal 
smoothing and Gaussian process regression were chosen 
on the basis of data-density scores, taking into account 
both the quantity and quality of available data. Our 
analysis only produced national estimates of sex ratio at 
birth—including for Hong Kong and Macau—for all 
years from 1950 to 2017; thus, we assume that subnational 
sex ratio at birth equals the national sex ratio at birth. 
With additional data seeking and extraction, we will 
extend the analysis to all GBD locations in the next GBD 
study. Further details regarding sex ratio at birth 
estimation are shown in appendix 1 (section 2).
Population
To determine national and subnational populations, we 
searched the Integrated Public Use Microdata Series 
questionnaires, the UN Demographic Yearbook, the UN 
census programme census dates, and the International 
Population Census Biography to identify all censuses 
conducted between 1950 and 2017 and available popu-
lation registers.22–25 We included 1233 censuses and 
26 population registers that contained 730 location-years 
of census or population registry data. In some cases, 
the same census was reported by different sources 
in different years. We resolved these incon 
sistencies 
through a review of available documentation. A list of 
all confirmed censuses is shown in the appendix 1 
(section 5). We obtained population counts that were age-
sex-specific from 1171 censuses and only by sex from 
62 censuses. We sought to identify whether the counts in 
each census were de facto (allocated to the place of 
enumeration) or de jure (allocated to the place of regular 
or legal residence). Our basis for population estimation 
is the de-facto population and, where both counts were 
available, we used de-facto counts. Where only de-jure 
counts were available—typically in lower Socio-
demographic Index (SDI) countries—we assumed that 
de-jure and de-facto populations were similar. The main 
difference between the counts at the national level is the 
exclusion of some migrant workers in some de-jure 
counts; where migrant workers are known to be an 
important fraction of the population and de-facto counts 
were not available, we searched directly for data on 
documented migration.
In several cases, the UN does not recognise admin-
istrative splits in territories, including Kosovo and 
Serbia, Transnistria and Moldova, and the so-called 
Turkish Republic of Northern Cyprus and Cyprus.26 
In these cases, we obtained census counts for the 
components and interpolated to generate census counts 
for the full territory. For east and west Germany before 
unification, as the input to the model, we used census 
counts for each component and interpolation to 
generate estimates of joint census counts in years 
 Global Health Metrics
2000 
www.thelancet.com   Vol 392   November 10, 2018
closest to the censuses in both locations. We were able 
to obtain census counts for five of the six constituent 
components that made up Yugoslavia; for Serbia we 
split aggregate Yugoslavia census data with previous 
population estimates. For Singapore, we estimated the 
population for residents and non-resident workers 
combined (appendix 1 section 2). Of the 1963 location-
years 
of 
census 
or 
population 
registry 
data, 
72 lo 
cation-years were identified as outliers that were 
inconsistent with adjacent data, model analysis, or 
excluded subpopulations.
Census counts are typically undercounts of the actual 
population, although there are known cases in which 
censuses have overcounted the population.27–29 Post-
enumeration surveys (PESs) aim to identify instances of 
overcounts or undercounts by comparing data. Many, if 
not most, PESs are not published or are only reported in 
government releases, presentations, or online reports. 
PESs themselves are subject to considerable error, whether 
they use a direct or indirect method of estimating census 
completeness. We searched for all available PES results 
and supple 
mented these results with publications or 
presentations that provided summaries of other PESs.30–34 
We identified 165 PESs, although it is likely that many 
more were done that did not publicly report their results. 
We analysed the 165 PESs to generate a general model of 
census com 
pleteness as a function of SDI. Because of 
variable quality of PESs, we assumed that, in aggregate, 
the 165 PESs provided an unbiased view of the association 
between enumeration completeness and SDI, so we 
adjusted census counts by the predictions from this model. 
We used nationally reported PES results to adjust census 
counts in high SDI countries and used the estimated 
census completeness to adjust data in other settings. 
To account for systematic age variation in census 
enumeration, we input age-sex-specific PES results into 
DisMod-MR 2.1, a Bayesian meta-regression tool, to 
estimate a global age pattern of enumeration. This age 
pattern was then used to adjust the overall predicted 
enumeration to vary by age (appendix 1 section 2).
As has been extensively noted in the demographic 
literature, census counts have several common problems: 
undercounts (particularly of children younger than 
5 years), a tendency to exaggerate age at older ages, and 
age heaping (reporting ages rounded to the nearest 
5 or 10 years).35–38 The population counts from 
four different censuses, illustrating the different types of 
age heaping and undercounts, are shown in figure 1. We 
evaluated the age structure and consistency of census 
data by calculating sex and age ratios for each census. 
These ratios were then used to calculate sex and age ratio 
scores, which were combined into a joint score. The joint 
score was used to determine whether to apply a correction 
to the census counts or not. For census counts available 
in 1-year age groups, we used the Feeney correction; 
for counts available in 5-year or 10-year age groups, we 
used either the Arriaga or Arriaga strong correction.39,40 
More details on the age-heaping corrections are shown in 
appendix 1 (section 2). For all censuses in low and middle 
SDI countries, we did not use the census count of 
children younger than 5 years in our model estimation. 
In other words, population estimates in these age groups 
were driven by fertility and mortality estimates and 
consistency with the later census counts for the same 
cohort. Systematic over 
estimation of age, particularly in 
some countries in sub-Saharan Africa and Latin America, 
was apparent in the data; for example, census counts 
could only be explained by large immigration of 
populations at older ages, which appears implausible. 
We were unable to correct the data for these issues and 
used the modelling strategy that is subsequently 
described to deal with these challenges.
Our approach requires an estimate of the population 
in 1950 in all locations for detailed age and sex groups; 
only 54 countries had a census count in 1950. For 
most other locations, we used backwards application of 
the cohort-component method of population projection by 
use of the oldest available census and the reverse 
application of estimated mortality rates and an assumption 
of zero net migration (appendix 1 section 2). As sub-
sequently noted, in our GBD Bayesian demographic 
balancing modelling framework, the base 
line population 
is assumed to be measured with substantial error, and 
the model produced posterior estimates that varied 
considerably from this initial baseline.
We used the estimates of population by location and 
year for each single year of age to generate other 
summary measures, including population growth rates 
that assumed logarithmic growth and the proportion 
of the population that was of working age, which is 
defined by the Organisation for Economic Co-operation 
and Development and the World Bank as those aged 
15–64 years.41,42
Mortality
The GBD mortality process produced annual abridged life 
tables that comprised 24 age groups: younger than 1 year, 
1–4 years, and then 5-year age groups up to age 110 years 
or older.13 To project populations forwards in time with the 
cohort-component method of population projection, we 
needed annual period life tables with single-year age 
groups up to 95 years or older. For ages 15–99 years, we 
interpolated abridged lx values (the number of people still 
alive at age x for a hypothetical cohort in a period life table) 
by use of a monotone cubic spline with Hyman filtering.43,44 
For people younger than 15 years and older than 100 years, 
we applied regression coeffi 
cients to predict single-year 
age group probability of death values. The Human 
Mortality Database provided 4557 empirical full-period life 
tables for 48 locations. We excluded 1280 of the life tables 
because they were identified by the Human Mortality 
Database as proble 
matic or occurred during time periods 
with extremely high mortality, such as World War 2 or 
the 1918 influenza pandemic. To predict probability of 
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2001
death qx at age x for single-year age groups, we fit the 
following separate linear regression by single-year age 
group between ages zero and 110: 
where 1qxf is the single-year age group qx value from the full-
period life table, β0 is the coefficient for the intercept, β1 is 
the coefficient for the slope, εxf is the error term, and 5qxa is 
the correponding abridged life-table age group’s qx value. 
These predicted 1qxf values were scaled to the GBD abridged 
life-table 5qx values for consis 
tency. 
For those aged 15–99 years, the non-parametric spline 
approach did not require rescaling to match the abridged 
5qx values and, consequently, produced smooth steps 
in mortality across single-year ages and between 5-year 
age groups. The regression coefficients were applied to 
children younger than 15 years because of the unique 
patterns of single-year mortality younger than 15 years 
and to adults older than 100 years because of instability 
caused by low lx values at older ages. To mitigate instability 
caused by spikes in mortality due to fatal discontinuities 
such as wars and natural disasters, full-period life tables 
were first generated based on abridged life tables without 
fatal discontinuities, and then fatal discontinuities were 
added to nmx (the death rate in age group x to x + 1 for a 
hypothetical cohort in a period life table) assuming a 
constant death rate for fatal discontinuities within each 
age group. To produce full life tables with the complete 
set of single-year age group 1qx values, we assumed 1ax (the 
average number of years lived in age group x to x + 1 by 
people who died during the interval for a hypothetical 
log(1qx )=
β
0 + 
β
1log(5qx
f
) + 
ε
x
a
f
Model posterior
Datapoints
Source
PES-corrected data
Un-age-heaped data
Raw data
Data processing step
0
500 000
1 000 000
1 500 000
2 000 000
Population count/age group interval length
A
0
1 000 000
2 000 000
3 000 000
B
0
10
20
40
60
80
30
50
70
90
100
0
100 000
200 000
300 000
Population count/age group interval length
Middle of age group (years)
C
0
10
20
40
60
80
30
50
70
90
100
0
500 000
1 000 000
1 500 000
Middle of age group (years)
D
Figure 1: Census age patterns for females in 1970 in the USA (A), males in 2001 in Bangladesh (B), females in 1979 in Afghanistan (C), and males in 2010 in Russia (D)
Lines show the model posterior and datapoints. Data processing steps are indicated by symbols. The 95% uncertainty interval is shown by light blue shading around the model posterior. 
PES=post-enumeration survey.
 Global Health Metrics
2002 
www.thelancet.com   Vol 392   November 10, 2018
cohort in a period life table) was 0·5 in all age groups 
except for those younger than 1 year and older than 
110 years; these groups were assumed to be identical to 
the abridged life-table 1ax values.
Migration
Real data on age-specific net migration are more difficult 
to obtain than data on fertility, population, and mortality. 
Net migration includes any change in the de-facto 
population that is not accounted for by births or deaths; 
this number would include refugees and temporary 
workers. For most country-years, documented net 
migration data are not reported and undocumented net 
migration is not estimated. For some high-SDI countries, 
net migration is tracked and reported,45 and the UN High 
Commission for Refugees (UNHCR) reports the stock of 
refugees (the count of people not born in the country that 
they currently live in) in each country by country of origin 
at the end of year. In more recent census rounds, census 
questions on the number of foreign-born individuals 
living in a country have been used, as have assumptions 
on differential survival to estimate when migration 
occurred;46 however, these approaches, especially for the 
period before 2000, have considerable uncertainty 
associated with them and are heavily dependent on 
fertility and mortality assum 
ptions for migrants.
We developed and applied the GBD Bayesian demo-
graphic balancing model to estimate net migration by 
single year of age and single calendar year, consistent 
with our estimates of age-sex-specific mortality and 
ASFR and the observed population data. Our model was 
developed on the basis of the work of Wheldon and 
colleagues47–49 but includes important modifications, such 
as correlation of migration rates across ages and over 
time and single-year, single-age estimation. Details on 
our GBD Bayesian demographic balancing model, 
developed in Template Model Builder, an open-source 
statistical package for R,50 are shown in the appendix 1 
(section 2).
In applying the model, we dealt with known issues of 
age misreporting by including larger input data variance 
for population counts at the youngest ages and input 
variance that steadily increases after age 45 years. The 
choice of data variance was based on testing of a range of 
variance assumptions; variance assumptions only change 
the point estimates of the results in settings where there 
is substantial inconsistency between adjacent census 
counts or between census counts (or both) and in the 
key inputs. To address age misreporting in the oldest 
ages, we ran several model versions for each location. For 
each model version, we excluded census counts above a 
given maximum age from the model fitting process 
(appendix 1 section 5). We then selected the best model 
version by prioritising versions that used the highest 
maximum age, predicted low absolute values of migration 
in the age groups older than 55 years, and had good 
in-sample fits. In high-income locations, the selection 
algorithm often chose the model version that did not 
exclude any of the census data for older ages but, in other 
regions, the population estimates at older ages were 
driven by the census counts for younger ages and the 
mortality estimates that aged those people forwards in 
time (appendix 1 section 2).
An example of the fit to the available population data for 
the eight largest populations in 2017 is shown in figure 2. 
Overall, the in-sample fit of the model for age-sex-specific 
population log space had an R² value of 0·99. These fits 
show that the model closely tracks the available corrected 
census counts for all ages combined and by age. Code 
for the GBD Bayesian demographic balancing model 
is available at the Global Health Data Exchange. The 
population estimates and census and registry data for all 
195 countries and territories are shown in appendix 2.
The cohort-component method of population 
projection and uncertainty
We produced final population estimates by single year and 
by single-year age groups with the cohort-component 
method of population projection.16 The population in 
each single-year age group in each year was estimated 
on the basis of the estimated starting population and 
single-year, single-age rates of migration, fertility, and 
mortality. Uncertainty in population estimates comes 
from two fundamental sources: uncertainty about the 
complete 
ness of a census count in a census year and 
uncertainty between censuses due to errors in estimates 
of migration, fertility, and mortality. Uncertainty in the 
counts was estimated by sampling the variance-covariance 
matrix of the model that predicted census completeness. 
We estimated the uncertainty between counts by use 
of out-of-sample predictive validity. We held out data 
and estimated the error in estimates as a function of 
the minimum of the number of years to the next 
or previous census. We combined these two sources of 
uncertainty and generated 1000 draws of percentage error 
in the population for each location-year. The 1000 draws of 
percentage error in the population and the population 
mean, generated by the GBD Bayesian demographic 
balancing model, were then combined to create 1000 draws 
of population by age, sex, location, and year. 95% uncer-
tainty intervals (UIs) were calculated with the 2·5th and 
97·5th percentiles. Details of this out-of-sample estimation 
of uncertainty are shown in appendix 1 (section 2). Out-of-
sample estimates of uncertainty yielded larger uncertainty 
than in-sample methods because of the nearly perfect 
inverse correlation between migration and death rates, 
which was conditional on census counts with low error. 
A dot plot comparison of our total population counts by 
country for different age groups in 2017 with UNPOP 
estimates is shown in appendix 2.
SDI
GBD 2015 developed the SDI as a composite measure of 
TFR in a population, lag-distributed income per capita, 
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2003
1950 1960
1980
2000
2020
0
50
100
150
Population (millions)
Year
G Males
1950 1960
1980
2000
2020
Year
Females
1950 1960
1980
2000
2020
0
30
90
120
Population (millions)
Year
H Males
1950 1960
1980
2000
2020
60
Year
Females
0
60
90
120
Population (millions)
E Males
30
Females
0
25
100
125
Population (millions)
F Males
75
50
Females
0
90
150
180
Population (millions)
C Males
120
Females
0
90
120
180
Population (millions)
D Males
60
150
Females
0
400
600
800
Population (millions)
A Males
Females
0
400
600
800
Population (millions)
B Males
200
Females
�
�
�
�
�
�
�
�
�
�
�
�
�
�
Zero migration prior
Model posterior
Datapoints
Source
��
�
�
�
�
�
�
��
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
��
�
�
�
�
�
��
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
��
�
�
�
�
�
�
��
�
�
�
�
�
�
Figure 2: Fit of the GBD Bayesian demographic balancing model for the total population of males and females, from 1950 to 2017, in mainland China (A), India (B), the USA (C), Indonesia (D), 
Pakistan (E), Brazil (F), Nigeria (G), and Bangladesh (H)
The 95% uncertainty interval is shown by light blue shading around the model posterior line. Mainland China excludes Hong Kong and Macao. GBD=Global Burden of Diseases, Injuries, and Risk Factors 
Study.
 Global Health Metrics
2004 
www.thelancet.com   Vol 392   November 10, 2018
and average years of education in the population older 
than 15 years.15,20 Each component was rescaled to a value 
between 0 and 1, and the SDI was derived from their 
geometric mean. The TFR was used in this overall 
measure of development as a proxy for the status of 
women in society; other plausible measures capturing 
the status of women are not available for all countries 
over a long time period. Our analysis of detailed ASFR 
0
0·5
1·0
1·5
2·0
2·5
3·0
3·5
4·0
4·5
5·0
Total fertility rate (livebirths per woman)
A
1950
1955
1960
1965
1970
1975
1980
1985
1990
1995
2000
2005
2010
2015 2017
0
20
40
60
80
100
120
140
Livebirths (millions)
Year
B
Age group (years)
50−54
45−49
40−44
35−39
30−34
25−29
20−24
15−19
10−14
GBD super-region
Central Europe, eastern Europe, and central Asia
High income
Latin America and Caribbean
North Africa and Middle East
South Asia
Southeast Asia, east Asia, and Oceania
Sub-Saharan Africa
Figure 3: Global total fertility rate distributed by maternal age group (A) and number of livebirths by GBD super-region, for both sexes combined (B), 1950–2017
Total fertility rate is the number of births expected per woman in each age group if she were to survive through the reproductive years (10–54 years) under the age-specific fertility rates at that 
timepoint. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2005
revealed in many countries that, through the process of 
development the TFO30 generally decreased and then 
increased. For example, in the USA, the TFO30 has 
increased steadily from 1975. In exploratory analysis, we 
found that the TFU25 did not show this U-shaped pattern 
as countries develop. For GBD 2017, we have recalculated 
the SDI by use of the TFU25 as a better proxy for the 
status of women in society. The TFU25 not only does 
not show a U-shaped pattern with development but 
also remains highly correlated with under-5 mortality 
(Pearson correlation coefficient r=0·873) and other 
mortality measures. The revised method for computing 
SDI compared with the GBD 2016 method is correlated 
with the GBD 2017 method (r=0·992). Detailed 
comparisons of the GBD 2015 and GBD 2016 methods 
compared with the approach we used are shown in 
appendix 1 (section 3).
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. All authors had full access to all the data in the 
study and had final responsibility for the decision to 
submit for publication.
Results
Global
The global TFR by maternal age group from 1950 to 2017 
is shown in figure 3. In 1950, the TFR was 4·7 livebirths 
(95% UI 4·5–4·9) and, by 2017, the TFR had decreased by 
49·4% (46·4–52·0) to 2·4 livebirths (2·2–2·5). From 1950 
to 1995, the TFR within all 5-year maternal age groups 
decreased: the greatest decrease in terms of contribution 
to TFR was in women aged 20–24 years (who showed a 
decrease of 0·42 livebirths), 25–29 years (0·52 livebirths), 
and 30–34 years (0·38 livebirths). Since 1995, decreases in 
the contribution to TFR from women aged 30–34 years, 
35–39 years, and 40–44 years effectively plateaued at the 
global level, whereas decreases in women at younger ages 
continued. This slowing trend in reductions in the 
number of livebirths per woman in these age groups 
masks marked heterogeneity across countries, as we 
subsequently discuss. Of the total livebirths globally in 
2017, 9·4% occurred in teenage mothers, which is a 
reduction from 9·9% of livebirths to teenage mothers in 
1950. The age-specific fertility rate per 1000 women aged 
10–19 years decreased from 37 livebirths (34–40) per 
1000 women in 1950 to 22 livebirths (19–24) per 1000 
women in 2017
. The number of livebirths globally 
increased from 92·6 million livebirths (88·9–96·4 
million) in 1950 to a peak of 141·7 million livebirths 
(135·8–147·3 million) in 2012. Over the past 35 years, the 
number of livebirths annually has varied within a 
relatively narrow range of 133·2 million (130·1–136·2) 
livebirths to 141·7 million (135·8–147·3) livebirths.
The trend in world population from 1950 to 2017 by 
GBD super-region is shown in figure 4. From 1950 to 
1980, the global population increased exponentially at an 
annualised rate of 1·9% (95% UI 1·88–1·92). From 
1981 to 2017, however, the pace of the global popu-
lation increase has been largely linear, increasing by 
83·6 million (79·8–87·5) people per year. Over the past 
10 years (2007–17), the average annual increase in 
population has been by 87·2 million (80·8–93·2) people, 
compared with 81·5 million (79·0–84·5) people per year 
in the previous 10 years (1997–2007). The global 
population increased by 197·2% (95% UI 193·3–200·8), 
from 2·6 billion (2·5–2·6) people in 1950 to 7·6 billion 
(7·4–7·9) people in 2017
. Over this period, the 
composition 
of 
the 
world’s 
population 
changed 
substantially. In 1950, the high-income, central Europe, 
eastern Europe, and central Asia GBD super-regions 
accounted for 35·2% of the global population but, in 
2017, the populations of these countries accounted for 
19·5% of the global population. Large increases occurred 
in the proportion of the world’s population living in 
south Asia, sub-Saharan Africa, Latin America and 
the Caribbean, and north Africa and the Middle East.
The annual population growth rate between 1950 and 
2017, globally and for the GBD super-regions, is shown 
in figure 4. Growth of the global population increased 
in the 1950s and reached 2·0% per year in 1964, then 
slowly decreased to 1·1% in 2017
. The slow shift in the 
global population growth rate is determined by 
markedly different trends by super-region. Growth of 
the popu 
lation in north Africa and the Middle East 
increased until the 1970s, and it has remained quite 
high, at 1·7% in 2017
. Population growth rates in sub-
Saharan Africa increased from 1950 to 1985, decreased 
during 1985–1993, increased again until 1997, and then 
plateaued; at 2·7% in 2017, population growth rates 
were almost the highest rates ever recorded in this 
region. The most substantial changes to population 
growth rates were in the southeast Asia, east Asia, and 
Oceania super-region, where the population growth 
rate decreased from 2·5% in 1963 to 0·7% in 2017
. The 
large reduction in the population growth rate for this 
super-region around 1960 was due to the Great Leap 
Forward in China. In central Europe, eastern Europe, 
and central Asia, the population growth rate dropped 
rapidly after 1987 and was negative from 1993 to 2008. 
Growth rates in the high-income super-region have 
changed the least, starting at 1·2% in 1950 and reaching 
0·4% in 2017
.
Global population pyramids in 1950, 1975, 2000, and 
2017 are shown in figure 5. As the world’s population 
has grown, not only has the distribution of the global 
population shifted toward sub-Saharan Africa and 
south Asia, but the age structure of the global population 
has also changed considerably. In 1950, the global mean 
age of a person was 26·6 years, decreasing to 26·0 years, 
in 1975, then increasing to 29·0 years in 2000 and 
32·1 years in 2017
. Demographic change has economic 
consequences, and the proportion of the population that 
 Global Health Metrics
2006 
www.thelancet.com   Vol 392   November 10, 2018
is of working age (15–64 years) decreased from 59·9% in 
1950 to 57·1% in 1975, then increased to 62·9% in 2000 
and 65·3% in 2017
. Another dimension of the global 
population is the proportion of the population that is 
female, which decreased from 50·1% to 49·8% over the 
67-year period.
1950
1955
1960
1965
1970
1975
1980
1985
1990
1995
2000
2005
2010
2015 2017
0
1
2
4
3
Population growth rate (%)
Year
B
0
0·1
0·2
0·3
0·4
0·5
0·6
0·7
0·8
0·9
1·0
Proportion of the global population (%)
A
GBD super-region
Central Europe, eastern Europe, and central Asia
High income
Latin America and Caribbean
North Africa and Middle East
South Asia
Southeast Asia, east Asia, and Oceania
Sub-Saharan Africa
GBD super-region
Central Europe, eastern Europe, and central Asia
High income
Latin America and Caribbean
North Africa and Middle East
South Asia
Southeast Asia, east Asia, and Oceania
Sub-Saharan Africa
Global
Figure 4: Proportion of the global population accounted for by the GBD super-regions (A) and the annual population growth rates, globally and for the super-regions (B)
Data are shown for both sexes combined, from 1950 to 2017. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2007
National
Fertility rates vary substantially across countries and 
over time (table 1; appendix 2). In 1950, TFR ranged 
from a low of 1·7 livebirths (95% UI 1·4–2·0) in Andorra 
to a high of 8·9 livebirths (8·7–9·0) in Jordan. The TFR 
decreased in all 195 countries and territories between 
1950 and 2017, and 102 countries and territories showed 
a decrease of more than 50%. By 2017, the TFR ranged 
from a low of 1·0 livebirths (0·9–1·2) in Cyprus to a 
high of 7·1 livebirths (6·8–7·4) in Niger. Although a 
useful summary, the TFR masks variation in trends in 
fertility at different ages in many countries. The global 
decrease in median ASFRs from 1950 to 2017 was 
43·4% in women aged 15–19 years and 49·4% in women 
aged 20–24 years, which contrasts with the observed 
decreases in the median ASFR in older age groups of 
mothers of 59·4% in women aged 40–44 years, 65·6% in 
women aged 45–49 years, and 68·7% in women aged 
50–54 years.
In 2017, the TFU25 ranged from 0·08 livebirths 
(95% UI 0·07–0·09) in South Korea to 2·4 livebirths 
(2·2–2·6) in Niger (figure 6), which is 31 times higher. 
Countries and territories where the TFU25 was 
less than 0·25 livebirths included many in western 
Europe, Japan, South Korea, and Taiwan (province of 
China). TFU25 exceeded 1·5 livebirths in many parts 
of western, eastern, and central sub-Saharan Africa and 
in Afghanistan. Trends in TFO30 are more complex; 
decreases in fertility rate are observed at earlier stages of 
development, and there are sustained increases in 
fertility rate at higher levels of development due to 
women delaying childbearing. TFO30 ranged from a 
low of 0·3 livebirths (0·3–0·4) in Puerto Rico to a high 
of 3·1 livebirths (3·0–3·2) in Niger. In 2017, 145 countries 
showed higher fertility in women older than 30 years 
than in women younger than 25 years. The geographical 
pattern shows low fertility in women older than 30 years 
in disparate settings: central and eastern Europe, China, 
India, many parts of Latin America, and in some parts 
of the Middle East. North America, western Europe, 
central Europe, eastern Europe, Australasia, and high-
income Asia Pacific had a higher TFO30 in 2017 than 
in 1975, with a mean of 60·2% higher TFO30 in 
these regions.
Figure 7 shows the areas where the TFO30 has 
been increasing since 1975; increases of more than 
Females
Males
Female mean
Female median
Male mean
Male median
Age
Sex
400
300
200
100
0
100
200
300
400
0
25
50
75
100
Age (years)
Population (millions)
400
300
200
100
0
100
200
300
400
Population (millions)
2000
2017
0
25
50
75
100
Age (years)
1950
1975
Figure 5: Global population pyramids for females and males by age, in 1950, 1975, 2000, and 2017
 Global Health Metrics
2008 
www.thelancet.com   Vol 392   November 10, 2018
50% have been observed in most of western Europe, 
high-income North America, Australasia, and high-
income Asia Pacific. The correlation of the ASFR over 
maternal age groups is shown in appendix 2. In 2017, 
169 countries had a sex ratio of less than 1·07 males 
per female at birth. Countries with higher sex ratios at 
birth varied geographically (figure 7). For example, 
Greenland, Tunisia, and Afghanistan had sex ratios 
between 1·07 and 1·10 males per female at birth, and 
India had a sex ratio at birth of 1·10 males per female. 
Three countries had higher sex ratios at birth: Armenia 
(1·14 males per female), Azerbaijan (1·15 males per 
female), and China (1·17 males per female). High sex 
ratios at birth lower the effective net reproductive rate 
(the number of female livebirths expected per woman, 
given observed age-specific death and fertility rates) 
even more than the TFR. Estimates of the net 
reproductive rate are shown in table 1. Net reproductive 
rate in 2017 ranged from 0·48 female livebirths 
(0·42–0·56) expected per woman in Cyprus to 
3·00 female livebirths (2·90–3·10) expected per woman 
in Niger. 95 countries had a net reproductive rate of less 
than 1 meaning that, without changes in fertility, death 
rates, or net immigration, populations in those 
countries will eventually decrease.
The population growth rate from 2010 to 2017 is shown 
in figure 8. 33 countries had a negative population 
growth rate, most of which were located in central, 
eastern, and western Europe and the Caribbean. 
Outside Europe, negative growth rates were observed 
in 14 countries, and the largest negative growth rates 
were observed in Syria, the Northern Mariana Islands, 
Georgia, Puerto Rico, and the Virgin Islands. Cyprus 
(which has a growth rate of 1·7%), Israel (1·9%), and 
Luxembourg (2·3%) are notable in the GBD western 
Europe region because they are the only countries with a 
growth rate greater than 1·2%. Population growth rates 
in North America, Latin America, and the Caribbean 
ranged from –0·5% in Puerto Rico to 2·6% in Belize. 
Population growth rates of more than 2·0% were 
seen in 33 of 46 countries in sub-Saharan Africa. 
The Persian Gulf states, with the exception of the 
United Arab Emirates, all had growth rates of more than 
2·2%, mostly due to the migration of workers, not 
fertility rates. Australia is of note among the GBD 
high-income super-region in the southern hemisphere, 
with a high population growth rate of 1·5%.
Even when countries have a TFR of less than the 
replacement value (the TFR at which a population 
replaces itself from generation to generation, assuming 
no migration; generally estimated to be 2·05),51 popu-
lations can continue to grow because of population 
momentum: the phenomenon by which the past growth 
of birth cohorts leads to more women of childbearing 
age and increased births relative to deaths, even though 
the TFR for a time period is less than the replacement 
value.52 Populations can also grow due to immigration, 
as observed in many Persian Gulf nations. A comparison 
of the 2017 population growth rate versus the TFR is 
shown in figure 9, which highlights countries in which 
the TFR is less than the replacement value but where 
the population is still growing. The countries where the 
population is declining are also shown. Countries fall 
into four quadrants, defined as a TFR of more than 
or less than the replacement value and a population 
growth rate of more than or less than zero. Divergence 
between these two measures, as noted, is a function of 
lags between period TFR and growth rate (population 
momentum) or net migration.
Population estimates by country since 1950 are shown 
in table 2. Age-sex-specific detail for these same years is 
provided in appendix 2. Single-year, single-age population 
estimates for the entire period of 1950–2017 are available 
from the Global Health Data Exchange.
The proportion of the population that was of working 
age from 1950 to 2017 by GBD super-region is shown in 
figure 10. Studies of economic growth have identified 
the potential for a demographic dividend when the 
proportion of the population that is of working age 
reaches more than 65%.53 In high-income countries, the 
proportion of the population that is of working age 
increased from the 1960s, crossed the 65% threshold in 
the late 1970s, and was relatively constant during 
the 1980s and 1990s. In 2005, this proportion began to 
decrease and was only just more than the 65% threshold 
in 2017
. 12 of 34 high-income countries now have a 
proportion of the population of working age that is less 
than 65%, and Japan has a working-age proportion of 
less than 60%. Other than sub-Saharan Africa and high-
income countries, the GBD super-regions have had a 
substantially increasing proportion of the population of 
working age from the mid-1960s to the present day; in 
2017, Latin American and the Caribbean, north Africa 
and the Middle East, south Asia, and central Europe, 
eastern Europe, and central Asia all had proportions of 
the population that are of working age between 64% and 
71%. The most pronounced increase in the working-age 
population occurred in southeast Asia, east Asia, and 
Oceania, which increased from 54·2% of the population 
in 1965 to 72·2% in 2011. Sub-Saharan Africa is the clear 
outlier among GBD super-regions; the proportion of the 
population of working age in this region has remained 
at or less than 55% during the entire time period, 
although this proportion has more recently increased. 
In sub-Saharan Africa, the proportion of the population 
that is of working age was less than 50% in Mali 
(49·7%), Chad (46·6%), and Niger (46·1%) in 2017
.
Discussion
Main findings
To our knowledge, this study presents the first estimates 
of population by location from 1950 to 2017 that are 
based on transparent data and replicable analytical 
code. Annual population estimates are provided for 
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2009
Age-specific fertility rate (livebirths per 1000 women annually)
Total 
fertility 
rate
Total 
fertility rate 
under age 
25 years
Total fertility 
rate from ages 
30 to 54 years 
Number of 
livebirths 
Net 
reproductive 
rate
10–14 
years
15–19 
years
20–24 
years
25–29 
years
30–34 
years
35–39 
years
40–44 
years
45–49 
years
50–54 
years
Global
0·81 
(0·35–
1·69)
42·9 
(38·6–
48·0)
129·4 
(117·8–
142·7)
131·9 
(125·9–
138·7)
96·8 
(91·4–
102·9)
52·4 
(47·7–
57·5)
17·2 
(15·4–
19·2)
3·4 
(3·1–
3·8)
0·06 
(0·06–
0·06)
2·4 
(2·2–2·5)
0·87 
(0·78–0·96)
0·85 
(0·79–0·92)
138 810 622 
(129 960 385–
149 058 367)
1·08 
(1·02–1·16)
Low SDI
1·4 
(0·6–
2·9)
71·9 
(65·0–
80·0)
202·6 
(181·7–
225·9)
188·4 
(177·3–
200·9)
147·0 
(136·9–
158·2)
93·4 
(83·6–
103·5)
44·6 
(39·5–
49·9)
15·1 
(13·7–
16·7)
0·29 
(0·28–
0·3)
3·8 
(3·6–4·1)
1·4 
(1·2–1·5)
1·5 
(1·4–1·6)
37 891 965 
(35 159 071–
41 108 482)
1·68 
(1·58–1·81)
Low-middle SDI
0·88 
(0·39–
1·85)
51·7 
(45·5–
59·3)
156·6 
(141·0–
174·3)
152·0 
(143·4–
161·4)
112·4 
(104·4–
121·8)
63·8 
(57·0–
72·0)
24·1 
(21·0–
27·7)
6·4 
(5·5–
7·5)
0·12 
(0·11–
0·12)
2·8 
(2·6–3·1)
1·0 
(0·9–1·2)
1·0 
(0·9–1·1)
40 394 490 
(37 088 216–
44 296 344)
1·28 
(1·18–1·4)
Middle SDI
0·61 
(0·27–
1·27)
33·5 
(30·1–
37·6)
112·4 
(100·6–
125·9)
120·1 
(113·3–
127·9)
79·2 
(73·7–
85·3)
39·0 
(34·4–
44·2)
11·3 
(9·9–
13·1)
1·4 
(1·1–
1·6)
0·03 
(0·03–
0·03)
2·0 
(1·8–2·2)
0·73 
(0·66–0·82)
0·65 
(0·6–0·72)
26 502 966 
(24 536 281–
28 871 941)
0·83 
(0·77–0·9)
High-middle SDI
0·42 
(0·18–
0·86)
19·8 
(18·3–
21·6)
84·2 
(79·0–
89·9)
107·0 
(103·4–
110·7)
69·4 
(65·8–
73·1)
32·1 
(29·2–
35·3)
8·0 
(7·2–
8·8)
0·63 
(0·53–
0·74)
0·01 
(0·01–
0·01)
1·6 
(1·5–1·7)
0·52 
(0·49–0·56)
0·55 
(0·51–0·59)
22 028 156 
(20 983 021–
23 184 413)
0·86 
(0·81–0·9)
High SDI
0·25 
(0·11–
0·5)
12·5 
(11·3–
14·0)
49·6 
(44·4–
55·7)
89·5 
(84·3–
95·2)
98·6 
(91·2–
106·8)
51·8 
(45·2–
59·4)
11·1 
(9·4–
13·2)
0·63 
(0·55–
0·72)
0·01 
(0·01–
0·01)
1·6 
(1·4–1·7)
0·31 
(0·28–0·35)
0·81 
(0·73–0·9)
11 638 396 
(10 631 265–
12 780 564)
0·76 
(0·69–0·83)
Central 
Europe, eastern 
Europe, and 
central Asia
0·08 
(0·03–
0·15)
27·0 
(23·5–
31·2)
102·9 
(89·3–
118·2)
110·0 
(102·9–
117·7)
77·0 
(70·1–
84·8)
32·6 
(27·8–
38·2)
6·3 
(5·3–
7·5)
0·29 
(0·24–
0·35)
0·01 
(0·01–
0·01)
1·8 
(1·6–2·0)
0·65 
(0·56–0·75)
0·58 
(0·52–0·66)
5 224 690 
(4 687 984–
5 805 610)
0·84 
(0·76–0·94)
Central Asia
0·05 
(0·02–
0·1)
35·8 
(30·7–
41·8)
172·3 
(151·6–
195·2)
145·6 
(137·2–
154·7)
91·2 
(82·3–
102·1)
39·3 
(33·4–
47·0)
9·6 
(7·8–
12·0)
0·53 
(0·37–
0·79)
0·01 
(0·01–
0·01)
2·5 
(2·3–2·7)
1·0 
(0·9–1·2)
0·7 
(0·62–0·81)
1 910 928 
(1 754 242–
2 076 808)
1·15 
(1·05–1·25)
Armenia
0·04 
(0·02–
0·09)
24·8 
(21·3–
28·8)
113·7 
(99·3–
129·9)
103·4 
(95·0–
113·6)
50·3 
(44·0–
58·1)
20·5 
(16·9–
24·9)
3·7 
(2·9–
4·6)
0·2 
(0·13–
0·31)
0·0 
(0·0–
0·0)
1·6 
(1·4–1·7)
0·69 
(0·6–0·79)
0·37 
(0·33–0·42)
38 128 
(34 976–
41 387)
0·73 
(0·67–0·8)
Azerbaijan
0·01 
(0·0–
0·02)
44·1 
(37·4–
52·0)
148·3 
(128·8–
169·9)
118·6 
(108·9–
129·2)
55·6 
(48·9–
63·2)
21·0 
(17·5–
25·2)
4·5 
(3·6–
5·5)
0·46 
(0·31–
0·72)
0·01 
(0·01–
0·01)
2·0 
(1·7–2·2)
0·96 
(0·83–1·11)
0·41 
(0·35–0·47)
173 728 
(153 488–
196 430)
0·87 
(0·77–0·99)
Georgia
0·26 
(0·11–
0·54)
46·3 
(39·3–
54·6)
126·8 
(109·2–
146·5)
119·8 
(109·9–
131·5)
71·1 
(62·7–
81·3)
35·8 
(29·6–
43·9)
9·0 
(7·3–
11·3)
0·89 
(0·67–
1·21)
0·02 
(0·02–
0·02)
2·0 
(1·9–2·2)
0·87 
(0·74–1·01)
0·58 
(0·5–0·69)
50 298 
(45 798–
55 247)
0·97 
(0·88–1·07)
Kazakhstan
0·05 
(0·02–
0·1)
30·1 
(26·5–
34·4)
140·1 
(120·0–
162·7)
149·2 
(137·1–
162·3)
93·7 
(81·5–
108·8)
52·5 
(41·6–
66·6)
12·4 
(9·3–
16·8)
0·5 
(0·31–
0·81)
0·01 
(0·01–
0·01)
2·4 
(2·2–2·6)
0·85 
(0·73–0·99)
0·8 
(0·66–0·97)
347 980 
(315 168–
381 856)
1·13 
(1·03–1·25)
Kyrgyzstan
0·01 
(0·01–
0·03)
38·2 
(32·6–
44·7)
151·2 
(132·1–
172·4)
171·9 
(159·8–
186·0)
119·1 
(107·2–
131·6)
57·0 
(48·0–
66·9)
18·0 
(14·6–
22·0)
0·26 
(0·16–
0·39)
0·0 
(0·0–
0·01)
2·8 
(2·6–3·0)
0·95 
(0·82–1·09)
0·97 
(0·85–1·1)
151 035 
(141 013–
161 162)
1·31 
(1·22–1·4)
Mongolia
0·21 
(0·09–
0·43)
27·2 
(23·9–
30·8)
147·3 
(130·5–
165·0)
159·7 
(148·4–
171·4)
114·5 
(103·9–
125·6)
69·6 
(60·3–
79·7)
20·1 
(16·6–
24·1)
1·5 
(1·0–
2·1)
0·03 
(0·03–
0·03)
2·7 
(2·5–2·9)
0·87 
(0·77–0·98)
1·0 
(0·9–1·2)
75 835 
(70 120–
81 639)
1·27 
(1·17–1·37)
Tajikistan
0·06 
(0·03–
0·13)
55·7 
(47·3–
65·4)
226·8 
(199·4–
255·5)
208·3 
(193·6–
223·8)
128·9 
(112·4–
148·6)
68·3 
(53·5–
87·5)
19·2 
(14·0–
26·4)
2·1 
(1·4–
3·4)
0·04 
(0·04–
0·04)
3·5 
(3·2–3·9)
1·4 
(1·2–1·6)
1·1 
(0·9–1·3)
285 161 
(259 803–
310 494)
1·62 
(1·47–1·77)
Turkmenistan
0·04 
(0·02–
0·07)
19·2 
(16·4–
22·5)
156·1 
(135·1–
181·5)
190·9 
(176·5–
207·5)
125·8 
(113·3–
140·8)
49·1 
(41·1–
59·4)
10·4 
(8·3–
13·2)
0·01 
(0·01–
0·01)
0·0 
(0·0–
0·0)
2·8 
(2·5–3·1)
0·88 
(0·77–1·0)
0·93 
(0·81–1·07)
109 634 
(98 243–
123 307)
1·29 
(1·15–1·45)
Uzbekistan
0·03 
(0·01–
0·06)
32·3 
(27·4–
38·0)
194·3 
(169·4–
221·0)
127·8 
(115·6–
142·5)
85·2 
(74·9–
97·8)
25·4 
(20·8–
31·5)
5·1 
(3·9–
6·7)
0·2 
(0·13–
0·31)
0·0 
(0·0–
0·0)
2·4 
(2·1–2·6)
1·1 
(1·0–1·3)
0·58 
(0·5–0·68)
679 125 
(619 142–
740 880)
1·09 
(1·0–1·19)
Central Europe
0·19 
(0·08–
0·39)
19·5 
(17·5–
21·6)
57·2 
(49·7–
66·0)
93·1 
(86·7–
99·8)
78·0 
(70·9–
86·2)
31·9 
(27·0–
37·8)
5·5 
(4·8–
6·4)
0·24 
(0·2–
0·28)
0·0 
(0·0–
0·0)
1·4 
(1·3–1·6)
0·38 
(0·34–0·44)
0·58 
(0·52–0·65)
1 066 904 
(960 814–
1 187 258)
0·69 
(0·62–0·76)
(Table 1 continues on next page)
 Global Health Metrics
2010 
www.thelancet.com   Vol 392   November 10, 2018
Age-specific fertility rate (livebirths per 1000 women annually)
Total 
fertility 
rate
Total 
fertility rate 
under age 
25 years
Total fertility 
rate from ages 
30 to 54 years 
Number of 
livebirths 
Net 
reproductive 
rate
10–14 
years
15–19 
years
20–24 
years
25–29 
years
30–34 
years
35–39 
years
40–44 
years
45–49 
years
50–54 
years
(Continued from previous page)
Albania
0·07 
(0·03–
0·13)
19·0 
(15·9–
22·7)
104·0 
(86·8–
123·8)
144·9 
(132·5–
158·3)
73·8 
(63·5–
85·5)
28·4 
(21·9–
36·5)
5·9 
(4·2–
8·1)
0·37 
(0·26–
0·52)
0·01 
(0·01–
0·01)
1·9 
(1·6–2·2)
0·62 
(0·51–0·73)
0·54 
(0·45–0·65)
37 047 
(32 029–
42 830)
0·88 
(0·76–1·02)
Bosnia and 
Herzegovina
0·05 
(0·02–
0·11)
10·1 
(8·6–
11·7)
48·3 
(42·7–
54·6)
87·1 
(81·7–
92·8)
74·0 
(67·7–
80·7)
27·3 
(23·2–
31·9)
4·8 
(3·9–
5·9)
0·32 
(0·23–
0·45)
0·01 
(0·01–
0·01)
1·3 
(1·2–1·4)
0·29 
(0·26–0·33)
0·53 
(0·49–0·58)
27 688 
(25 627–
29 913)
0·6 
(0·56–0·65)
Bulgaria
0·74 
(0·33–
1·54)
39·3 
(34·2–
45·4)
72·2 
(61·9–
84·0)
87·0 
(79·8–
94·9)
65·4 
(57·6–
74·1)
25·7 
(20·8–
31·7)
3·9 
(3·0–
4·9)
0·2 
(0·14–
0·27)
0·0 
(0·0–
0·0)
1·5 
(1·3–1·7)
0·56 
(0·48–0·65)
0·48 
(0·41–0·55)
58 874 
(51 873–
66 693)
0·71 
(0·62–0·8)
Croatia
0·06 
(0·03–
0·12)
9·8 
(8·5–
11·6)
45·6 
(40·5–
51·3)
87·7 
(82·7–
93·0)
85·9 
(79·4–
92·6)
38·4 
(33·5–
43·8)
6·4 
(5·2–
7·7)
0·32 
(0·23–
0·44)
0·01 
(0·01–
0·01)
1·4 
(1·3–1·4)
0·28 
(0·25–0·31)
0·66 
(0·59–0·72)
36 549 
(34 544–
38 688)
0·66 
(0·63–0·7)
Czech Republic
0·03 
(0·01–
0·06)
12·6 
(10·7–
14·8)
51·1 
(44·9–
58·2)
99·4 
(93·5–
105·9)
103·0 
(95·5–
111·2)
43·4 
(37·6–
50·0)
6·2 
(4·7–
7·9)
0·2 
(0·12–
0·32)
0·0 
(0·0–
0·0)
1·6 
(1·4–1·7)
0·32 
(0·28–0·37)
0·76 
(0·7–0·84)
104 681 
(95 942–
114 456)
0·76 
(0·7–0·84)
Hungary
0·28 
(0·12–
0·56)
21·7 
(18·7–
25·3)
47·0 
(40·0–
55·3)
82·4 
(75·7–
89·7)
86·4 
(77·5–
96·4)
39·9 
(33·2–
47·7)
7·2 
(5·6–
9·5)
0·22 
(0·15–
0·3)
0·0 
(0·0–
0·0)
1·4 
(1·3–1·6)
0·35 
(0·29–0·4)
0·67 
(0·59–0·76)
86 143 
(76 294–
97 319)
0·69 
(0·61–0·78)
Macedonia
0·27 
(0·12–
0·54)
15·9 
(13·7–
18·5)
64·9 
(58·5–
71·7)
104·8 
(99·2–
110·7)
81·5 
(75·4–
87·9)
29·4 
(25·1–
34·1)
4·2 
(3·1–
5·6)
0·26 
(0·17–
0·38)
0·01 
(0·0–
0·01)
1·5 
(1·4–1·6)
0·41 
(0·37–0·44)
0·58 
(0·54–0·62)
23 593 
(22 076–
25 167)
0·71 
(0·67–0·76)
Montenegro
0·12 
(0·05–
0·24)
11·3 
(9·6–
13·5)
63·3 
(56·4–
71·9)
112·5 
(106·2–
119·1)
95·1 
(88·3–
102·2)
42·9 
(37·2–
49·4)
8·8 
(6·9–
11·4)
0·45 
(0·29–
0·69)
0·01 
(0·01–
0·01)
1·7 
(1·6–1·8)
0·37 
(0·33–0·43)
0·74 
(0·69–0·79)
7069 
(6742–7432)
0·79 
(0·76–0·84)
Poland
0·05 
(0·02–
0·11)
12·7 
(10·9–
14·9)
49·8 
(42·6–
58·2)
89·9 
(83·1–
97·3)
73·5 
(65·7–
82·2)
29·7 
(24·5–
35·8)
5·7 
(4·5–
7·1)
0·23 
(0·17–
0·31)
0·0 
(0·0–
0·0)
1·3 
(1·2–1·5)
0·31 
(0·27–0·37)
0·55 
(0·47–0·63)
355 970 
(315 476–
402 395)
0·63 
(0·56–0·71)
Romania
0·38 
(0·17–
0·79)
34·9 
(30·5–
40·6)
71·9 
(61·9–
83·5)
97·4 
(90·0–
105·5)
73·7 
(65·7–
82·8)
28·9 
(23·6–
35·3)
4·7 
(3·6–
6·1)
0·22 
(0·16–
0·29)
0·0 
(0·0–
0·0)
1·6 
(1·4–1·7)
0·54 
(0·48–0·6)
0·54 
(0·47–0·62)
177 010 
(158 216–
198 220)
0·75 
(0·67–0·84)
Serbia
0·2 
(0·09–
0·4)
15·4 
(13·3–
18·0)
60·1 
(51·0–
70·7)
90·8 
(83·4–
99·0)
74·7 
(66·3–
84·2)
28·5 
(23·4–
34·6)
4·4 
(3·4–
5·7)
0·32 
(0·22–
0·45)
0·01 
(0·01–
0·01)
1·4 
(1·2–1·6)
0·38 
(0·32–0·44)
0·54 
(0·47–0·62)
80 547 
(71 021–
91 372)
0·66 
(0·58–0·75)
Slovakia
0·13 
(0·06–
0·27)
23·1 
(20·2–
26·5)
54·5 
(46·4–
63·9)
87·0 
(79·9–
94·8)
76·7 
(68·2–
86·3)
31·8 
(26·1–
38·6)
5·3 
(4·1–
6·7)
0·21 
(0·15–
0·28)
0·0 
(0·0–
0·0)
1·4 
(1·2–1·6)
0·39 
(0·33–0·45)
0·57 
(0·5–0·65)
52 596 
(46 603–
59 441)
0·67 
(0·59–0·76)
Slovenia
0·03 
(0·01–
0·07)
5·0 
(4·1–
6·0)
41·5 
(34·9–
49·4)
108·1 
(100·3–
117·2)
103·0 
(93·7–
114·0)
39·7 
(33·0–
48·5)
5·9 
(4·3–
8·0)
0·23 
(0·14–
0·36)
0·0 
(0·0–
0·0)
1·5 
(1·4–1·7)
0·23 
(0·2–0·28)
0·74 
(0·66–0·84)
19 132 
(17 463–
21 101)
0·73 
(0·67–0·8)
Eastern Europe
0·03 
(0·01–
0·07)
25·3 
(21·8–
29·4)
80·1 
(68·1–
94·0)
98·6 
(90·2–
107·8)
70·6 
(61·7–
80·6)
30·4 
(24·2–
37·8)
5·6 
(4·3–
7·3)
0·23 
(0·17–
0·3)
0·0 
(0·0–
0·0)
1·6 
(1·4–1·8)
0·53 
(0·45–0·62)
0·53 
(0·45–0·63)
2 246 857 
(1 958 844–
2 577 202)
0·74 
(0·64–0·85)
Belarus
0·02 
(0·01–
0·03)
19·2 
(16·5–
22·2)
84·7 
(74·5–
96·3)
104·3 
(95·9–
113·6)
72·3 
(64·1–
81·4)
29·3 
(24·3–
35·3)
4·8 
(3·8–
6·1)
0·16 
(0·11–
0·23)
0·0 
(0·0–
0·0)
1·6 
(1·4–1·8)
0·52 
(0·46–0·59)
0·53 
(0·46–0·62)
101 939 
(90 523–
114 916)
0·75 
(0·67–0·85)
Estonia
0·04 
(0·02–
0·07)
14·1 
(11·8–
16·9)
52·8 
(44·6–
62·5)
98·6 
(91·1–
106·9)
90·7 
(81·6–
100·8)
46·9 
(38·9–
56·2)
10·1 
(7·5–
13·5)
0·3 
(0·18–
0·46)
0·01 
(0·01–
0·01)
1·6 
(1·4–1·8)
0·33 
(0·28–0·4)
0·74 
(0·64–0·85)
13 446 
(11 863–
15 268)
0·75 
(0·66–0·86)
Latvia
0·03 
(0·01–
0·06)
18·7 
(15·9–
22·0)
62·8 
(53·0–
74·2)
100·2 
(92·2–
109·0)
84·4 
(74·8–
95·1)
41·2 
(33·8–
50·0)
8·2 
(6·4–
10·3)
0·32 
(0·22–
0·43)
0·01 
(0·01–
0·01)
1·6 
(1·4–1·8)
0·41 
(0·34–0·48)
0·67 
(0·59–0·77)
19 399 
(17 182–
21 920)
0·76 
(0·67–0·86)
Lithuania
0·03 
(0·02–
0·07)
15·8 
(13·6–
18·5)
61·1 
(51·8–
72·0)
114·5 
(105·7–
124·2)
89·8 
(80·0–
100·8)
36·2 
(29·7–
43·8)
6·3 
(5·0–
7·7)
0·24 
(0·17–
0·31)
0·0 
(0·0–
0·0)
1·6 
(1·4–1·8)
0·39 
(0·33–0·45)
0·66 
(0·58–0·75)
29 108 
(25 844–
32 717)
0·78 
(0·69–0·88)
(Table 1 continues on next page)
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2011
Age-specific fertility rate (livebirths per 1000 women annually)
Total 
fertility 
rate
Total 
fertility rate 
under age 
25 years
Total fertility 
rate from ages 
30 to 54 years 
Number of 
livebirths 
Net 
reproductive 
rate
10–14 
years
15–19 
years
20–24 
years
25–29 
years
30–34 
years
35–39 
years
40–44 
years
45–49 
years
50–54 
years
(Continued from previous page)
Moldova
0·05 
(0·02–
0·1)
23·5 
(20·3–
27·3)
75·7 
(65·1–
89·2)
82·2 
(74·9–
91·0)
53·7 
(47·3–
61·6)
21·6 
(17·9–
26·5)
4·1 
(3·4–
5·2)
0·13 
(0·09–
0·2)
0·0 
(0·0–
0·0)
1·3 
(1·2–1·5)
0·5 
(0·44–0·56)
0·4 
(0·34–0·47)
35 612 
(31 581–
40 581)
0·62 
(0·55–0·71)
Russia
0·03 
(0·01–
0·07)
25·6 
(22·0–
29·9)
81·7 
(68·9–
96·4)
101·1 
(92·5–
110·7)
74·1 
(64·7–
84·8)
32·3 
(25·6–
40·5)
6·0 
(4·4–
7·9)
0·23 
(0·15–
0·33)
0·0 
(0·0–
0·0)
1·6 
(1·4–1·9)
0·54 
(0·46–0·63)
0·56 
(0·48–0·67)
1 622 870 
(1 410 393–
1 868 353)
0·77 
(0·66–0·88)
Ukraine
0·03 
(0·01–
0·06)
26·8 
(23·3–
30·9)
77·7 
(66·2–
90·9)
89·4 
(81·5–
98·1)
57·8 
(50·3–
66·5)
23·7 
(19·0–
29·5)
4·6 
(3·5–
5·8)
0·24 
(0·17–
0·34)
0·0 
(0·0–
0·0)
1·4 
(1·2–1·6)
0·52 
(0·45–0·61)
0·43 
(0·37–0·51)
424 480 
(369 821–
487 645)
0·66 
(0·58–0·76)
High income
0·36 
(0·16–
0·73)
16·2 
(14·8–
17·8)
53·5 
(47·9–
60·1)
91·0 
(85·6–
96·9)
104·4 
(95·9–
113·6)
56·1 
(48·6–
64·8)
11·6 
(9·6–
14·1)
0·65 
(0·57–
0·75)
0·01 
(0·01–
0·01)
1·7 
(1·5–1·8)
0·35 
(0·32–0·39)
0·86 
(0·77–0·97)
11 470 352 
(10 419 059–
12 658 766)
0·81 
(0·73–0·89)
Australasia
0·22 
(0·1–
0·45)
14·5 
(12·8–
16·5)
51·9 
(45·4–
59·2)
101·1 
(94·5–
108·1)
125·9 
(116·1–
136·3)
69·8 
(60·6–
80·0)
14·4 
(11·7–
17·8)
0·81 
(0·51–
1·31)
0·02 
(0·01–
0·02)
1·9 
(1·7–2·1)
0·33 
(0·29–0·38)
1·1 
(0·9–1·2)
373 680 
(338 110–
413 048)
0·91 
(0·83–1·01)
Australia
0·15 
(0·06–
0·3)
13·3 
(11·3–
15·6)
49·2 
(41·8–
57·8)
98·9 
(91·5–
107·1)
125·0 
(113·8–
137·1)
69·4 
(58·9–
81·4)
14·4 
(11·1–
18·4)
0·82 
(0·51–
1·33)
0·02 
(0·02–
0·02)
1·9 
(1·6–2·1)
0·31 
(0·27–0·37)
1·0 
(0·9–1·2)
313 630 
(278 661–
353 002)
0·89 
(0·79–1·01)
New Zealand
0·59 
(0·25–
1·2)
20·1 
(17·2–
23·9)
66·4 
(58·4–
76·4)
114·1 
(106·9–
122·5)
131·7 
(122·3–
142·7)
72·0 
(63·0–
83·0)
14·9 
(11·7–
18·6)
0·74 
(0·46–
1·2)
0·01 
(0·01–
0·01)
2·1 
(1·9–2·3)
0·44 
(0·38–0·5)
1·1 
(1·0–1·2)
60 050 
(54 692–
66 222)
1·01 
(0·92–1·12)
High-income Asia 
Pacific
0·01 
(0·01–
0·03)
3·4 
(2·9–
4·0)
23·8 
(19·5–
29·1)
74·1 
(67·8–
80·8)
103·3 
(93·5–
114·1)
47·4 
(39·7–
56·5)
7·5 
(5·8–
9·8)
0·22 
(0·15–
0·31)
0·0 
(0·0–
0·0)
1·3 
(1·2–1·5)
0·14 
(0·11–0·17)
0·79 
(0·69–0·9)
1 427 130 
(1 260 959–
1 623 740)
0·63 
(0·56–0·71)
Brunei
0·28 
(0·12–
0·57)
12·4 
(10·3–
14·9)
53·7 
(43·8–
65·4)
107·4 
(97·8–
117·5)
111·8 
(98·6–
125·8)
70·1 
(56·8–
87·0)
19·8 
(14·6–
26·3)
0·55 
(0·34–
0·86)
0·01 
(0·01–
0·01)
1·9 
(1·7–2·0)
0·33 
(0·27–0·4)
1·0 
(0·9–1·1)
7093 
(6568–7631)
0·89 
(0·82–0·96)
Japan
0·01 
(0·0–
0·01)
4·0 
(3·3–
4·9)
29·6 
(23·1–
37·6)
81·9 
(72·7–
92·2)
96·7 
(82·6–
112·5)
46·3 
(35·2–
59·9)
8·0 
(5·6–
11·1)
0·21 
(0·13–
0·31)
0·0 
(0·0–
0·0)
1·3 
(1·1–1·6)
0·17 
(0·13–0·21)
0·76 
(0·62–0·92)
922 225 
(767 131–
1 106 046)
0·65 
(0·54–0·77)
Singapore
0·08 
(0·03–
0·16)
4·4 
(3·6–
5·3)
20·4 
(15·8–
26·0)
65·0 
(57·4–
73·7)
101·4 
(86·9–
117·8)
51·7 
(39·5–
66·5)
9·6 
(6·8–
13·3)
0·37 
(0·23–
0·6)
0·01 
(0·01–
0·01)
1·3 
(1·1–1·5)
0·12 
(0·1–0·16)
0·82 
(0·67–0·99)
64 836 
(54 182–
77 378)
0·61 
(0·51–0·73)
South Korea
0·02 
(0·01–
0·04)
1·7 
(1·4–
2·1)
13·5 
(11·7–
15·5)
60·6 
(57·3–
64·1)
117·4 
(111·6–
123·3)
48·9 
(44·2–
53·8)
6·1 
(4·9–
7·4)
0·24 
(0·15–
0·39)
0·0 
(0·0–
0·0)
1·2 
(1·2–1·3)
0·08 
(0·07–0·09)
0·86 
(0·81–0·92)
432 974 
(412 109–
453 553)
0·6 
(0·57–0·63)
High-income North 
America
0·55 
(0·24–
1·11)
20·7 
(18·8–
22·7)
70·7 
(64·2–
77·9)
99·4 
(94·4–
104·8)
103·3 
(96·4–
110·8)
52·5 
(46·5–
59·2)
11·0 
(9·3–
13·1)
0·74 
(0·55–
0·99)
0·01 
(0·01–
0·01)
1·8 
(1·7–1·9)
0·46 
(0·42–0·51)
0·84 
(0·76–0·92)
4 314 373 
(3 982 175–
4 683 089)
0·86 
(0·8–0·94)
Canada
0·15 
(0·07–
0·31)
12·8 
(10·7–
15·3)
46·8 
(37·8–
57·7)
99·2 
(89·7–
109·7)
111·9 
(98·2–
127·0)
51·8 
(40·8–
64·8)
9·5 
(7·0–
12·7)
0·42 
(0·28–
0·62)
0·01 
(0·01–
0·01)
1·7 
(1·4–1·9)
0·3 
(0·24–0·37)
0·87 
(0·73–1·02)
390 262 
(334 379–
455 010)
0·8 
(0·69–0·94)
Greenland
0·62 
(0·27–
1·28)
42·5 
(35·8–
51·1)
104·5 
(87·6–
123·9)
119·1 
(107·8–
132·7)
87·0 
(74·8–
100·8)
42·9 
(33·6–
54·2)
6·5 
(4·6–
9·2)
0·05 
(0·03–
0·08)
0·0 
(0·0–
0·0)
2·0 
(1·8–2·3)
0·74 
(0·65–0·84)
0·68 
(0·57–0·81)
817 
(728–910)
0·94 
(0·84–1·06)
USA
0·58 
(0·25–
1·19)
21·4 
(19·6–
23·4)
73·1 
(66·9–
80·0)
99·4 
(94·9–
104·3)
102·3 
(96·2–
108·9)
52·5 
(47·2–
58·5)
11·2 
(9·6–
13·2)
0·78 
(0·56–
1·05)
0·01 
(0·01–
0·02)
1·8 
(1·7–1·9)
0·48 
(0·43–0·52)
0·83 
(0·77–0·91)
3 923 218 
(3 646 761–
4 226 835)
0·87 
(0·81–0·94)
Southern Latin 
America
1·5 
(0·7–
3·2)
53·7 
(49·0–
59·3)
92·0 
(82·4–
102·6)
96·7 
(91·3–
102·8)
90·6 
(81·3–
100·9)
61·8 
(52·1–
72·9)
15·6 
(12·2–
19·8)
0·99 
(0·64–
1·49)
0·02 
(0·02–
0·02)
2·1 
(1·9–2·2)
0·74 
(0·68–0·79)
0·84 
(0·73–0·98)
1 041 669 
(958 720–
1 130 812)
1·0 
(0·91–1·08)
Argentina
1·7 
(0·7–
3·5)
58·2 
(51·9–
66·0)
100·2 
(87·8–
113·6)
101·3 
(93·9–
110·2)
92·0 
(82·7–
102·2)
63·8 
(54·1–
75·0)
15·8 
(12·4–
19·8)
1·0 
(0·7–
1·6)
0·02 
(0·02–
0·02)
2·2 
(2·0–2·3)
0·8 
(0·73–0·88)
0·86 
(0·75–0·99)
747 539 
(695 353–
801 816)
1·04 
(0·97–1·12)
(Table 1 continues on next page)
 Global Health Metrics
2012 
www.thelancet.com   Vol 392   November 10, 2018
Age-specific fertility rate (livebirths per 1000 women annually)
Total 
fertility 
rate
Total 
fertility rate 
under age 
25 years
Total fertility 
rate from ages 
30 to 54 years 
Number of 
livebirths 
Net 
reproductive 
rate
10–14 
years
15–19 
years
20–24 
years
25–29 
years
30–34 
years
35–39 
years
40–44 
years
45–49 
years
50–54 
years
(Continued from previous page)
Chile
1·2 
(0·5–
2·4)
40·9 
(35·9–
46·6)
72·3 
(62·3–
83·9)
86·3 
(79·5–
93·9)
87·5 
(78·2–
97·8)
57·4 
(48·0–
68·3)
15·6 
(12·1–
19·9)
0·88 
(0·55–
1·36)
0·02 
(0·02–
0·02)
1·8 
(1·6–2·1)
0·57 
(0·5–0·66)
0·81 
(0·69–0·94)
245 912 
(215 928–
279 946)
0·88 
(0·77–1·0)
Uruguay
1·2 
(0·5–
2·6)
53·9 
(47·1–
61·6)
86·9 
(74·5–
101·2)
93·6 
(85·6–
102·5)
87·8 
(77·7–
99·2)
56·1 
(46·0–
67·9)
14·1 
(10·5–
18·6)
1·0 
(0·7–
1·5)
0·02 
(0·02–
0·02)
2·0 
(1·7–2·3)
0·71 
(0·61–0·82)
0·8 
(0·68–0·93)
48 170 
(41 869–
55 322)
0·95 
(0·82–1·09)
Western Europe
0·05 
(0·02–
0·1)
8·7 
(7·5–
10·0)
40·6 
(35·0–
47·2)
87·8 
(81·6–
94·5)
106·6 
(97·6–
116·6)
61·2 
(52·7–
70·8)
13·3 
(11·1–
15·8)
0·73 
(0·64–
0·82)
0·01 
(0·01–
0·01)
1·6 
(1·4–1·8)
0·25 
(0·21–0·29)
0·91 
(0·81–1·02)
4 313 498 
(3 871 044–
4 807 568)
0·77 
(0·69–0·86)
Andorra
0·22 
(0·09–
0·45)
4·9 
(4·2–
5·6)
26·7 
(22·6–
31·3)
57·2 
(52·2–
62·6)
85·1 
(76·5–
94·1)
52·1 
(45·5–
59·3)
12·6 
(10·4–
15·1)
0·96 
(0·59–
1·45)
0·02 
(0·02–
0·02)
1·2 
(1·1–1·3)
0·16 
(0·13–0·19)
0·75 
(0·67–0·85)
642 
(567–724)
0·58 
(0·51–0·65)
Austria
0·05 
(0·02–
0·11)
9·1 
(7·7–
10·6)
42·8 
(37·4–
49·0)
87·4 
(81·8–
93·4)
99·3 
(91·8–
107·5)
53·5 
(46·7–
61·2)
10·1 
(8·2–
12·4)
0·46 
(0·32–
0·63)
0·01 
(0·01–
0·01)
1·5 
(1·4–1·7)
0·26 
(0·23–0·3)
0·82 
(0·75–0·9)
86 756 
(79 382–
94 860)
0·73 
(0·67–0·8)
Belgium
0·04 
(0·02–
0·07)
7·6 
(6·4–
9·1)
43·6 
(36·9–
51·5)
114·3 
(106·5–
122·7)
111·8 
(101·9–
122·7)
49·7 
(41·7–
59·0)
9·7 
(7·8–
12·0)
0·51 
(0·36–
0·71)
0·01 
(0·01–
0·01)
1·7 
(1·5–1·9)
0·26 
(0·22–0·3)
0·86 
(0·77–0·96)
121 588 
(109 546–
134 907)
0·82 
(0·74–0·91)
Cyprus
0·03 
(0·01–
0·06)
4·0 
(3·3–
4·8)
24·5 
(19·6–
30·6)
58·8 
(52·8–
65·5)
68·3 
(59·7–
78·1)
35·9 
(28·7–
44·6)
9·3 
(6·9–
12·6)
1·1 
(0·7–
1·6)
0·02 
(0·02–
0·02)
1·0 
(0·9–1·2)
0·14 
(0·11–0·18)
0·57 
(0·49–0·67)
10 788 
(9310–12 496)
0·48 
(0·42–0·56)
Denmark
0·01 
(0·01–
0·03)
4·6 
(3·9–
5·6)
35·7 
(29·6–
43·0)
111·4 
(103·0–
120·6)
128·2 
(116·8–
140·5)
58·3 
(49·4–
68·6)
11·0 
(8·8–
13·6)
0·49 
(0·33–
0·7)
0·01 
(0·01–
0·01)
1·7 
(1·6–1·9)
0·2 
(0·17–0·24)
0·99 
(0·89–1·1)
60 724 
(54 681–
67 563)
0·84 
(0·76–0·94)
Finland
0·02 
(0·01–
0·03)
7·0 
(5·9–
8·3)
45·0 
(38·5–
52·6)
95·5 
(88·2–
103·5)
109·9 
(99·5–
121·3)
57·1 
(48·1–
67·3)
12·8 
(10·3–
15·8)
0·69 
(0·51–
0·93)
0·01 
(0·01–
0·01)
1·6 
(1·5–1·8)
0·26 
(0·22–0·3)
0·9 
(0·81–1·01)
55 235 
(49 589–
61 618)
0·8 
(0·71–0·89)
France
0·03 
(0·01–
0·06)
7·6 
(6·6–
8·8)
47·4 
(41·0–
54·8)
117·2 
(109·7–
125·4)
120·6 
(110·6–
131·4)
61·5 
(52·6–
71·7)
13·8 
(11·1–
17·1)
0·77 
(0·55–
1·03)
0·01 
(0·01–
0·02)
1·8 
(1·7–2·0)
0·28 
(0·24–0·32)
0·98 
(0·88–1·1)
737 405 
(664 102–
819 651)
0·89 
(0·81–0·99)
Germany
0·04 
(0·02–
0·07)
8·0 
(6·9–
9·3)
34·3 
(29·4–
40·1)
75·2 
(69·5–
81·5)
97·3 
(88·5–
107·1)
53·6 
(45·4–
63·0)
9·9 
(7·9–
12·3)
0·4 
(0·28–
0·53)
0·01 
(0·01–
0·01)
1·4 
(1·2–1·6)
0·21 
(0·18–0·25)
0·81 
(0·71–0·91)
710 634 
(633 455–
798 663)
0·67 
(0·6–0·76)
Greece
0·14 
(0·06–
0·29)
9·1 
(7·9–
10·6)
32·1 
(27·0–
38·2)
74·5 
(68·4–
81·1)
100·8 
(91·0–
111·5)
55·6 
(46·7–
65·8)
11·2 
(8·6–
14·6)
1·3 
(0·9–
1·9)
0·03 
(0·02–
0·03)
1·4 
(1·3–1·6)
0·21 
(0·18–0·24)
0·84 
(0·75–0·95)
89 713 
(79 740–
100 854)
0·69 
(0·61–0·77)
Iceland
0·07 
(0·03–
0·14)
9·6 
(8·1–
11·3)
54·5 
(46·5–
63·9)
109·1 
(100·9–
118·1)
112·7 
(102·0–
124·6)
64·9 
(55·2–
75·5)
15·3 
(12·2–
19·2)
0·5 
(0·31–
0·81)
0·01 
(0·01–
0·01)
1·8 
(1·7–2·0)
0·32 
(0·28–0·37)
0·97 
(0·88–1·05)
4250 
(3897–4639)
0·89 
(0·82–0·98)
Ireland
0·05 
(0·02–
0·09)
10·6 
(9·2–
12·6)
40·5 
(34·4–
47·6)
77·1 
(71·0–
84·0)
123·4 
(112·4–
135·4)
93·4 
(80·9–
107·2)
22·0 
(17·6–
27·2)
1·2 
(0·8–
1·7)
0·02 
(0·02–
0·02)
1·8 
(1·6–2·1)
0·26 
(0·22–0·29)
1·2 
(1·1–1·4)
64 902 
(57 702–
72 962)
0·89 
(0·79–1·0)
Israel
0·03 
(0·01–
0·06)
11·3 
(9·6–
13·5)
101·1 
(88·1–
115·8)
171·3 
(161·6–
181·8)
169·7 
(157·9–
182·1)
100·8 
(88·7–
114·0)
24·1 
(19·8–
29·1)
1·7 
(1·2–
2·3)
0·03 
(0·03–
0·03)
2·9 
(2·6–3·2)
0·56 
(0·49–0·65)
1·5 
(1·3–1·6)
177 148 
(161 025–
194 812)
1·4 
(1·27–1·54)
Italy
0·02 
(0·01–
0·03)
5·6 
(4·7–
6·6)
28·4 
(24·3–
33·2)
66·2 
(61·0–
71·9)
91·6 
(83·0–
101·1)
58·5 
(49·8–
68·5)
14·9 
(12·0–
18·5)
0·92 
(0·64–
1·27)
0·02 
(0·02–
0·02)
1·3 
(1·2–1·5)
0·17 
(0·15–0·2)
0·83 
(0·73–0·94)
464 442 
(410 461–
526 027)
0·64 
(0·57–0·73)
Luxembourg
0·08 
(0·04–
0·17)
6·2 
(5·1–
7·4)
34·4 
(28·3–
41·8)
75·7 
(69·3–
82·8)
103·8 
(94·0–
114·6)
62·2 
(52·7–
72·6)
13·4 
(10·5–
17·0)
0·61 
(0·38–
0·92)
0·01 
(0·01–
0·01)
1·5 
(1·4–1·6)
0·2 
(0·17–0·24)
0·9 
(0·83–0·97)
6407 
(5861–6965)
0·72 
(0·65–0·78)
Malta
0·19 
(0·08–
0·39)
12·6 
(10·9–
14·4)
38·1 
(32·2–
45·2)
89·2 
(82·0–
97·0)
101·3 
(90·6–
113·2)
47·0 
(38·6–
56·9)
9·0 
(7·0–
11·5)
0·44 
(0·3–
0·65)
0·01 
(0·01–
0·01)
1·5 
(1·3–1·7)
0·25 
(0·22–0·29)
0·79 
(0·68–0·91)
4311 
(3812–4880)
0·71 
(0·63–0·81)
(Table 1 continues on next page)
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2013
Age-specific fertility rate (livebirths per 1000 women annually)
Total 
fertility 
rate
Total 
fertility rate 
under age 
25 years
Total fertility 
rate from ages 
30 to 54 years 
Number of 
livebirths 
Net 
reproductive 
rate
10–14 
years
15–19 
years
20–24 
years
25–29 
years
30–34 
years
35–39 
years
40–44 
years
45–49 
years
50–54 
years
(Continued from previous page)
Netherlands
0·02 
(0·01–
0·05)
4·1 
(3·4–
4·9)
30·0 
(25·1–
35·7)
98·2 
(91·1–
105·9)
129·2 
(118·1–
141·3)
60·5 
(51·0–
71·4)
9·7 
(7·5–
12·9)
0·43 
(0·29–
0·59)
0·01 
(0·01–
0·01)
1·7 
(1·5–1·8)
0·17 
(0·14–0·2)
1·0 
(0·9–1·11)
172 472 
(155 190–
191 686)
0·8 
(0·72–0·89)
Norway
0·01 
(0·01–
0·03)
5·7 
(4·7–
6·9)
42·2 
(36·3–
49·0)
106·9 
(100·2–
114·1)
120·4 
(111·6–
129·9)
59·9 
(51·9–
68·9)
12·0 
(9·2–
15·4)
0·64 
(0·4–
0·98)
0·01 
(0·01–
0·01)
1·7 
(1·6–1·9)
0·24 
(0·21–0·28)
0·96 
(0·88–1·05)
60 329 
(55 230–
66 015)
0·84 
(0·77–0·92)
Portugal
0·12 
(0·05–
0·25)
10·2 
(8·7–
12·0)
31·2 
(26·0–
37·3)
64·2 
(58·8–
70·2)
89·9 
(80·9–
99·9)
51·5 
(43·2–
61·2)
11·1 
(8·8–
14·0)
0·65 
(0·45–
0·88)
0·01 
(0·01–
0·01)
1·3 
(1·1–1·5)
0·21 
(0·17–0·25)
0·77 
(0·67–0·88)
85 589 
(74 860–
97 921)
0·63 
(0·55–0·72)
Spain
0·08 
(0·04–
0·17)
8·3 
(7·0–
9·8)
26·0 
(22·7–
29·8)
57·8 
(54·1–
61·9)
95·1 
(88·7–
102·1)
66·5 
(59·8–
73·9)
15·7 
(13·2–
18·6)
0·87 
(0·6–
1·23)
0·02 
(0·02–
0·02)
1·4 
(1·2–1·5)
0·17 
(0·15–0·2)
0·89 
(0·81–0·98)
407 088 
(370 674–
447 913)
0·65 
(0·59–0·72)
Sweden
0·02 
(0·01–
0·04)
5·2 
(4·4–
6·3)
43·6 
(38·1–
49·9)
108·8 
(102·7–
115·5)
125·7 
(117·3–
134·7)
68·7 
(60·7–
77·6)
14·4 
(11·4–
17·8)
0·73 
(0·46–
1·09)
0·01 
(0·01–
0·01)
1·8 
(1·7–2·0)
0·24 
(0·21–0·28)
1·0 
(1·0–1·1)
118 087 
(109 169–
127 819)
0·88 
(0·82–0·96)
Switzerland
0·01 
(0·01–
0·03)
3·4 
(2·8–
4·1)
28·3 
(23·3–
34·3)
77·0 
(70·4–
84·3)
111·8 
(101·6–
123·0)
65·1 
(55·4–
76·2)
13·1 
(10·6–
16·1)
0·64 
(0·45–
0·85)
0·01 
(0·01–
0·01)
1·5 
(1·3–1·7)
0·16 
(0·13–0·19)
0·95 
(0·85–1·06)
87 282 
(78 003–
97 459)
0·72 
(0·64–0·81)
UK
0·11 
(0·05–
0·21)
15·3 
(13·5–
17·4)
54·1 
(46·8–
62·4)
91·0 
(84·7–
97·9)
107·1 
(97·8–
117·3)
64·7 
(55·9–
74·7)
13·5 
(11·0–
16·5)
0·8 
(0·58–
1·07)
0·02 
(0·01–
0·02)
1·7 
(1·6–1·9)
0·35 
(0·3–0·4)
0·93 
(0·83–1·05)
783 225 
(703 221–
873 164)
0·84 
(0·75–0·93)
England
0·1 
(0·05–
0·21)
14·9 
(13·1–
17·0)
54·7 
(47·5–
63·0)
92·4 
(86·2–
99·3)
108·5 
(99·2–
118·7)
66·1 
(57·2–
76·2)
14·0 
(11·2–
17·2)
0·82 
(0·61–
1·09)
0·02 
(0·02–
0·02)
1·8 
(1·6–2·0)
0·35 
(0·3–0·4)
0·95 
(0·84–1·06)
672 857 
(604 801–
749 278)
0·85 
(0·76–0·95)
Northern 
Ireland
0·13 
(0·06–
0·27)
15·2 
(13·1–
17·6)
53·4 
(44·9–
63·4)
95·7 
(87·9–
104·3)
114·6 
(103·4–
126·9)
67·3 
(56·7–
79·4)
13·0 
(9·7–
16·9)
0·59 
(0·31–
1·04)
0·01 
(0·01–
0·01)
1·8 
(1·6–2·0)
0·34 
(0·29–0·41)
0·98 
(0·85–1·12)
23 589 
(20 766–
26 808)
0·87 
(0·76–0·99)
Scotland
0·11 
(0·05–
0·22)
18·9 
(16·9–
21·2)
44·8 
(38·8–
51·8)
72·1 
(66·9–
77·8)
93·1 
(84·6–
102·5)
55·4 
(47·8–
64·0)
10·1 
(8·1–
12·4)
0·62 
(0·31–
1·16)
0·01 
(0·01–
0·01)
1·5 
(1·3–1·6)
0·32 
(0·28–0·37)
0·8 
(0·72–0·88)
53 451 
(48 281–
59 123)
0·71 
(0·64–0·79)
Wales
0·11 
(0·05–
0·22)
16·1 
(14·2–
18·3)
59·8 
(51·0–
70·0)
96·1 
(88·7–
104·2)
100·2 
(90·1–
111·4)
52·4 
(43·9–
62·3)
10·0 
(7·8–
12·6)
0·76 
(0·47–
1·16)
0·01 
(0·01–
0·02)
1·7 
(1·5–1·9)
0·38 
(0·33–0·44)
0·82 
(0·71–0·94)
33 470 
(29 639–
37 854)
0·81 
(0·72–0·92)
Latin America and 
Caribbean
2·0 
(0·9–
4·2)
63·5 
(57·1–
71·0)
112·9 
(100·1–
127·8)
104·2 
(96·7–
112·6)
85·7 
(79·2–
92·9)
51·5 
(45·2–
58·3)
15·5 
(13·2–
18·1)
1·3 
(1·1–
1·5)
0·02 
(0·02–
0·02)
2·2 
(2·0–2·4)
0·89 
(0·8–1·0)
0·77 
(0·69–0·85)
10 393 604 
(9 469 048–
11 430 456)
1·04 
(0·95–1·14)
Andean Latin 
America
1·4 
(0·6–
2·9)
71·4 
(63·9–
79·5)
138·2 
(121·6–
157·2)
132·8 
(123·2–
143·6)
114·3 
(102·9–
127·4)
76·8 
(65·8–
88·4)
27·0 
(22·1–
32·5)
2·7 
(2·1–
3·4)
0·05 
(0·05–
0·05)
2·8 
(2·6–3·1)
1·1 
(0·9–1·2)
1·1 
(1·0–1·2)
1 386 395 
(1 260 285–
1 526 533)
1·34 
(1·22–1·47)
Bolivia
2·2 
(1·0–
4·6)
71·9 
(61·8–
83·4)
156·2 
(132·9–
184·4)
154·6 
(141·1–
170·5)
136·2 
(119·8–
155·6)
92·4 
(75·8–
111·0)
30·9 
(23·9–
39·4)
4·3 
(2·9–
6·3)
0·08 
(0·08–
0·09)
3·2 
(2·9–3·6)
1·2 
(1·0–1·3)
1·3 
(1·2–1·5)
301 119 
(271 239–
334 416)
1·52 
(1·37–1·69)
Ecuador
0·76 
(0·33–
1·58)
60·5 
(51·5–
70·9)
134·3 
(112·3–
159·1)
112·9 
(101·6–
125·3)
86·2 
(73·8–
100·2)
46·3 
(36·0–
58·7)
12·5 
(9·3–
16·6)
1·2 
(0·8–
1·8)
0·02 
(0·02–
0·02)
2·3 
(1·9–2·7)
0·98 
(0·82–1·15)
0·73 
(0·6–0·89)
315 984 
(268 796–
370 024)
1·08 
(0·92–1·26)
Peru
1·5 
(0·6–
3·1)
78·0 
(67·0–
91·9)
133·5 
(113·1–
158·8)
135·0 
(123·0–
149·3)
120·9 
(106·5–
138·2)
87·0 
(72·2–
103·1)
32·9 
(25·8–
41·0)
3·0 
(2·0–
4·2)
0·06 
(0·05–
0·06)
3·0 
(2·6–3·3)
1·1 
(0·9–1·3)
1·2 
(1·1–1·4)
769 292 
(687 072–
866 600)
1·42 
(1·26–1·59)
Caribbean
1·2 
(0·5–
2·5)
58·1 
(51·1–
66·0)
119·3 
(108·3–
131·3)
112·8 
(105·8–
120·1)
86·0 
(78·5–
93·7)
52·7 
(46·0–
60·0)
15·3 
(12·6–
18·1)
1·9 
(1·5–
2·3)
0·03 
(0·03–
0·03)
2·2 
(2·0–2·4)
0·89 
(0·81–0·99)
0·78 
(0·7–0·86)
815 882 
(746 824–
889 894)
1·04 
(0·95–1·13)
Antigua and 
Barbuda
2·5 
(1·1–
5·1)
50·1 
(43·2–
58·2)
81·5 
(67·2–
98·3)
75·7 
(67·8–
84·6)
57·8 
(49·2–
67·8)
27·5 
(21·1–
35·5)
6·9 
(5·1–
9·3)
0·08 
(0·05–
0·13)
0·0 
(0·0–
0·0)
1·5 
(1·3–1·8)
0·67 
(0·56–0·79)
0·46 
(0·38–0·56)
1071 
(905–1261)
0·73 
(0·62–0·86)
(Table 1 continues on next page)
 Global Health Metrics
2014 
www.thelancet.com   Vol 392   November 10, 2018
Age-specific fertility rate (livebirths per 1000 women annually)
Total 
fertility 
rate
Total 
fertility rate 
under age 
25 years
Total fertility 
rate from ages 
30 to 54 years 
Number of 
livebirths 
Net 
reproductive 
rate
10–14 
years
15–19 
years
20–24 
years
25–29 
years
30–34 
years
35–39 
years
40–44 
years
45–49 
years
50–54 
years
(Continued from previous page)
The Bahamas
0·76 
(0·33–
1·56)
33·5 
(28·2–
39·9)
73·4 
(59·3–
90·2)
82·4 
(73·3–
92·6)
65·8 
(55·4–
77·8)
41·5 
(31·7–
53·5)
10·8 
(7·9–
14·6)
0·37 
(0·24–
0·56)
0·01 
(0·01–
0·01)
1·5 
(1·3–1·9)
0·54 
(0·44–0·65)
0·59 
(0·48–0·73)
4679 
(3895–5611)
0·74 
(0·62–0·88)
Barbados
1·2 
(0·5–
2·4)
40·2 
(34·3–
47·1)
75·6 
(61·9–
91·8)
74·7 
(66·6–
83·7)
58·2 
(49·2–
68·7)
27·9 
(21·2–
36·2)
8·6 
(6·3–
11·6)
0·17 
(0·11–
0·25)
0·0 
(0·0–
0·0)
1·4 
(1·2–1·7)
0·58 
(0·48–0·7)
0·47 
(0·38–0·58)
2850 
(2393–3388)
0·68 
(0·58–0·81)
Belize
1·1 
(0·5–
2·3)
59·0 
(51·1–
68·2)
132·5 
(115·2–
151·8)
112·5 
(102·9–
123·1)
81·3 
(72·5–
91·2)
46·8 
(39·2–
55·6)
11·3 
(9·4–
13·5)
1·3 
(1·1–
1·5)
0·03 
(0·02–
0·03)
2·2 
(2·0–2·5)
0·96 
(0·83–1·1)
0·7 
(0·61–0·81)
7843 
(6904–8895)
1·06 
(0·94–1·2)
Bermuda
0·42 
(0·18–
0·86)
8·5 
(7·3–
9·8)
34·9 
(30·0–
40·6)
58·6 
(53·5–
64·4)
83·0 
(74·8–
92·2)
58·1 
(49·8–
67·6)
16·1 
(13·3–
19·7)
0·96 
(0·61–
1·47)
0·02 
(0·02–
0·02)
1·3 
(1·2–1·5)
0·22 
(0·19–0·25)
0·79 
(0·71–0·89)
562 
(502–631)
0·63 
(0·57–0·71)
Cuba
1·6 
(0·7–
3·3)
45·5 
(41·1–
51·0)
91·2 
(82·5–
100·4)
84·1 
(78·8–
90·4)
52·7 
(47·5–
58·4)
23·3 
(19·3–
28·0)
4·1 
(3·1–
5·5)
0·15 
(0·1–
0·24)
0·0 
(0·0–
0·0)
1·5 
(1·4–1·6)
0·69 
(0·64–0·75)
0·4 
(0·35–0·46)
109 664 
(103 731–
116 193)
0·72 
(0·68–0·77)
Dominica
1·4 
(0·6–
3·0)
44·6 
(38·0–
53·2)
84·3 
(68·6–
104·7)
79·4 
(70·7–
90·2)
66·6 
(56·4–
79·5)
34·5 
(27·7–
43·3)
8·0 
(6·0–
10·6)
0·23 
(0·15–
0·36)
0·0 
(0·0–
0·0)
1·6 
(1·3–1·9)
0·65 
(0·54–0·8)
0·55 
(0·45–0·67)
801 
(677–960)
0·75 
(0·63–0·89)
Dominican 
Republic
0·91 
(0·4–
1·92)
90·9 
(78·3–
105·1)
153·6 
(131·2–
178·5)
123·0 
(111·4–
135·8)
69·6 
(58·8–
82·1)
29·5 
(22·5–
38·3)
6·2 
(4·5–
8·4)
0·65 
(0·44–
0·92)
0·01 
(0·01–
0·01)
2·4 
(2·0–2·7)
1·2 
(1·1–1·4)
0·53 
(0·43–0·65)
216 514 
(186 677–
250 296)
1·12 
(0·96–1·29)
Grenada
0·92 
(0·41–
1·91)
48·2 
(41·8–
55·7)
88·0 
(72·1–
106·7)
84·3 
(75·2–
94·6)
85·3 
(73·2–
99·2)
53·3 
(41·7–
67·1)
16·1 
(12·2–
21·1)
0·69 
(0·43–
1·06)
0·01 
(0·01–
0·01)
1·9 
(1·6–2·2)
0·69 
(0·57–0·82)
0·78 
(0·64–0·94)
1514 
(1279–1786)
0·9 
(0·76–1·06)
Guyana
1·9 
(0·8–
3·9)
67·3 
(58·2–
77·8)
153·7 
(131·8–
178·1)
126·2 
(114·6–
138·9)
89·6 
(77·8–
102·8)
47·9 
(38·4–
59·1)
12·4 
(9·6–
15·9)
1·2 
(0·8–
1·7)
0·02 
(0·02–
0·02)
2·5 
(2·2–2·9)
1·1 
(1·0–1·3)
0·76 
(0·63–0·9)
15 719 
(13 597–
18 087)
1·18 
(1·02–1·35)
Haiti
1·3 
(0·6–
2·6)
49·9 
(42·6–
58·3)
128·6 
(108·7–
153·2)
147·9 
(135·1–
163·1)
139·7 
(123·9–
158·4)
107·9 
(90·8–
128·2)
43·5 
(34·9–
53·0)
8·3 
(6·3–
10·7)
0·16 
(0·15–
0·17)
3·1 
(2·8–3·5)
0·9 
(0·79–1·02)
1·5 
(1·3–1·7)
325 281 
(290 528–
365 513)
1·41 
(1·25–1·59)
Jamaica
1·1 
(0·5–
2·2)
41·0 
(35·9–
46·9)
81·8 
(70·6–
94·5)
75·7 
(69·2–
82·9)
62·7 
(55·5–
70·9)
39·2 
(33·7–
45·5)
12·8 
(10·6–
15·5)
0·93 
(0·7–
1·22)
0·02 
(0·02–
0·02)
1·6 
(1·4–1·8)
0·62 
(0·54–0·71)
0·58 
(0·5–0·67)
38 063 
(33 491–
43 222)
0·76 
(0·67–0·86)
Puerto Rico
0·74 
(0·32–
1·51)
30·9 
(26·9–
35·5)
75·5 
(66·6–
86·5)
65·2 
(59·9–
71·2)
43·5 
(38·1–
49·6)
21·0 
(16·8–
26·2)
4·7 
(3·4–
6·4)
0·15 
(0·1–
0·21)
0·0 
(0·0–
0·0)
1·2 
(1·1–1·3)
0·54 
(0·49–0·59)
0·35 
(0·29–0·41)
29 896 
(27 172–
32 946)
0·57 
(0·52–0·63)
Saint Lucia
0·94 
(0·41–
1·95)
44·5 
(37·8–
52·3)
84·2 
(68·5–
102·8)
71·9 
(63·8–
81·0)
60·4 
(51·0–
71·2)
34·6 
(26·7–
44·4)
10·3 
(7·5–
14·0)
0·52 
(0·35–
0·77)
0·01 
(0·01–
0·01)
1·5 
(1·3–1·8)
0·65 
(0·53–0·78)
0·53 
(0·43–0·65)
2102 
(1753–2513)
0·74 
(0·62–0·88)
Saint Vincent and 
the Grenadines
1·5 
(0·6–
3·1)
60·1 
(51·4–
70·3)
94·6 
(77·7–
114·3)
88·9 
(79·4–
99·5)
70·6 
(59·8–
83·1)
43·4 
(33·3–
55·8)
11·2 
(8·4–
14·7)
0·81 
(0·5–
1·3)
0·02 
(0·01–
0·02)
1·9 
(1·6–2·2)
0·78 
(0·65–0·93)
0·63 
(0·51–0·77)
1551 
(1302–1838)
0·88 
(0·74–1·05)
Suriname
3·4 
(1·5–
7·1)
55·6 
(48·1–
64·1)
112·7 
(95·7–
132·1)
115·0 
(104·8–
126·2)
91·2 
(80·1–
103·6)
49·7 
(40·5–
60·6)
12·3 
(9·5–
15·8)
0·84 
(0·68–
1·03)
0·02 
(0·02–
0·02)
2·2 
(1·9–2·5)
0·86 
(0·73–1·0)
0·77 
(0·65–0·9)
9614 
(8337–11 018)
1·04 
(0·9–1·18)
Trinidad and 
Tobago
0·74 
(0·33–
1·54)
39·4 
(34·2–
45·3)
96·7 
(82·8–
112·5)
92·3 
(84·3–
101·1)
68·8 
(61·0–
77·5)
34·6 
(28·8–
41·4)
7·9 
(6·4–
9·6)
0·49 
(0·37–
0·65)
0·01 
(0·01–
0·01)
1·7 
(1·5–1·9)
0·68 
(0·59–0·79)
0·56 
(0·48–0·64)
17 521 
(15 376–
19 960)
0·81 
(0·71–0·92)
Virgin Islands
1·6 
(0·7–
3·4)
52·8 
(44·9–
62·0)
121·5 
(100·8–
145·1)
113·0 
(101·8–
125·3)
77·3 
(66·0–
90·1)
36·3 
(27·9–
46·7)
4·8 
(3·6–
6·3)
0·07 
(0·04–
0·1)
0·0 
(0·0–
0·0)
2·0 
(1·7–2·4)
0·88 
(0·73–1·04)
0·59 
(0·49–0·71)
1287 
(1097–1507)
0·98 
(0·84–1·15)
Central Latin 
America
1·8 
(0·8–
3·7)
72·5 
(65·4–
80·4)
129·6 
(115·3–
145·5)
118·0 
(110·1–
126·5)
87·4 
(78·9–
97·1)
47·9 
(40·7–
56·2)
12·3 
(10·0–
15·1)
1·4 
(1·0–
1·7)
0·03 
(0·02–
0·03)
2·4 
(2·1–2·6)
1·0 
(0·9–1·1)
0·75 
(0·65–0·85)
5 004 522 
(4 502 598–
5 583 565)
1·12 
(1·01–1·25)
(Table 1 continues on next page)
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2015
Age-specific fertility rate (livebirths per 1000 women annually)
Total 
fertility 
rate
Total 
fertility rate 
under age 
25 years
Total fertility 
rate from ages 
30 to 54 years 
Number of 
livebirths 
Net 
reproductive 
rate
10–14 
years
15–19 
years
20–24 
years
25–29 
years
30–34 
years
35–39 
years
40–44 
years
45–49 
years
50–54 
years
(Continued from previous page)
Colombia
1·2 
(0·5–
2·5)
64·1 
(55·2–
74·4)
114·6 
(97·0–
134·7)
104·7 
(94·9–
115·7)
80·9 
(70·3–
92·9)
45·4 
(36·7–
55·9)
10·9 
(8·4–
14·0)
1·3 
(0·9–
1·8)
0·02 
(0·02–
0·03)
2·1 
(1·8–2·5)
0·9 
(0·77–1·05)
0·69 
(0·58–0·82)
851 115 
(733 293–
985 161)
1·01 
(0·87–1·17)
Costa Rica
1·3 
(0·6–
2·6)
53·8 
(48·4–
60·5)
92·1 
(82·7–
103·5)
86·6 
(80·7–
93·7)
69·7 
(63·0–
77·8)
37·0 
(31·1–
43·9)
9·6 
(7·2–
12·6)
0·71 
(0·51–
0·99)
0·01 
(0·01–
0·01)
1·8 
(1·6–1·9)
0·74 
(0·66–0·83)
0·58 
(0·53–0·64)
69 820 
(64 085–
76 591)
0·85 
(0·78–0·93)
El Salvador
1·1 
(0·5–
2·2)
63·6 
(55·9–
72·3)
105·5 
(90·6–
122·3)
93·7 
(85·4–
103·0)
72·4 
(64·1–
81·7)
40·1 
(33·2–
48·2)
11·7 
(9·5–
14·4)
1·0 
(0·72–
1·36)
0·02 
(0·02–
0·02)
1·9 
(1·7–2·2)
0·85 
(0·74–0·98)
0·63 
(0·54–0·73)
107 660 
(94 215–
122 854)
0·93 
(0·81–1·06)
Guatemala
1·5 
(0·7–
3·2)
75·9 
(65·7–
87·5)
138·9 
(118·3–
161·9)
134·4 
(122·4–
147·5)
105·7 
(92·1–
120·9)
72·4 
(58·5–
88·4)
26·4 
(20·7–
33·3)
4·7 
(3·3–
6·6)
0·09 
(0·09–
0·09)
2·8 
(2·4–3·2)
1·1 
(0·9–1·3)
1·0 
(0·9–1·2)
430 775 
(372 362–
496 213)
1·33 
(1·15–1·53)
Honduras
2·8 
(1·2–
6·0)
86·7 
(75·5–
100·7)
148·5 
(127·8–
173·7)
130·7 
(119·4–
144·2)
109·0 
(95·7–
125·1)
72·8 
(59·4–
89·5)
25·1 
(19·6–
32·3)
3·3 
(2·3–
4·7)
0·06 
(0·06–
0·07)
2·9 
(2·5–3·4)
1·2 
(1·0–1·4)
1·1 
(0·9–1·3)
244 568 
(212 956–
283 074)
1·37 
(1·19–1·59)
Mexico
1·7 
(0·8–
3·6)
70·0 
(59·9–
82·8)
137·1 
(115·2–
164·1)
125·9 
(113·7–
140·5)
90·0 
(77·1–
105·9)
46·9 
(36·5–
60·7)
11·0 
(7·9–
15·4)
1·1 
(0·8–
1·5)
0·02 
(0·02–
0·02)
2·4 
(2·1–2·9)
1·0 
(0·9–1·2)
0·74 
(0·61–0·91)
2 518 031 
(2 153 263–
2 972 894)
1·16 
(0·99–1·37)
Nicaragua
1·5 
(0·6–
3·0)
82·8 
(71·5–
95·6)
129·6 
(108·9–
153·1)
113·9 
(102·7–
126·3)
96·6 
(83·1–
111·8)
53·5 
(41·8–
67·5)
13·1 
(9·7–
17·5)
1·5 
(1·0–
2·2)
0·03 
(0·03–
0·03)
2·5 
(2·1–2·9)
1·1 
(0·9–1·2)
0·82 
(0·68–1·0)
137 802 
(117 837–
160 442)
1·18 
(1·01–1·37)
Panama
2·4 
(1·1–
5·1)
77·1 
(66·1–
89·7)
126·4 
(105·5–
150·2)
113·5 
(102·8–
125·4)
85·3 
(73·8–
98·2)
44·7 
(35·5–
55·7)
11·3 
(8·6–
14·7)
0·78 
(0·54–
1·11)
0·01 
(0·01–
0·02)
2·3 
(2·0–2·7)
1·0 
(0·9–1·2)
0·71 
(0·59–0·85)
69 684 
(59 588–
81 021)
1·1 
(0·94–1·27)
Venezuela
2·7 
(1·2–
5·8)
92·1 
(83·1–
102·1)
122·2 
(107·4–
138·7)
105·2 
(97·4–
113·7)
75·2 
(66·8–
84·5)
38·8 
(31·9–
47·1)
10·7 
(8·2–
13·9)
1·1 
(0·8–
1·7)
0·02 
(0·02–
0·02)
2·2 
(2·0–2·5)
1·1 
(1·0–1·2)
0·63 
(0·54–0·74)
575 062 
(511 153–
645 003)
1·06 
(0·95–1·19)
Tropical Latin 
America
2·8 
(1·2–
5·8)
50·4 
(43·8–
58·9)
82·8 
(70·9–
98·1)
78·0 
(70·8–
86·7)
76·7 
(67·2–
87·2)
48·9 
(39·5–
59·9)
16·2 
(12·7–
20·3)
0·73 
(0·54–
0·96)
0·01 
(0·01–
0·01)
1·8 
(1·6–2·0)
0·68 
(0·59–0·8)
0·71 
(0·6–0·84)
3 186 804 
(2 886 839–
3 554 625)
0·85 
(0·77–0·95)
Brazil
2·9 
(1·3–
6·0)
49·9 
(43·0–
58·6)
81·6 
(69·2–
97·4)
76·4 
(69·0–
85·4)
75·7 
(66·0–
86·2)
48·3 
(38·7–
59·4)
16·1 
(12·5–
20·2)
0·72 
(0·53–
0·97)
0·01 
(0·01–
0·01)
1·8 
(1·6–2·0)
0·67 
(0·57–0·79)
0·7 
(0·59–0·83)
3 040 969 
(2 742 060–
3 409 928)
0·84 
(0·75–0·94)
Paraguay
0·7 
(0·31–
1·45)
64·1 
(54·8–
74·8)
115·4 
(96·9–
136·6)
124·0 
(112·3–
137·0)
110·9 
(96·6–
126·8)
70·8 
(57·1–
86·8)
22·2 
(16·9–
28·8)
0·99 
(0·65–
1·47)
0·02 
(0·02–
0·02)
2·5 
(2·2–3·0)
0·9 
(0·76–1·06)
1·0 
(0·9–1·2)
145 834 
(125 161–
169 315)
1·2 
(1·03–1·4)
North Africa and 
Middle East
0·28 
(0·13–
0·59)
47·3 
(42·3–
53·0)
131·6 
(121·0–
143·2)
138·9 
(131·4–
147·7)
117·7 
(108·3–
128·6)
72·7 
(63·1–
83·1)
28·2 
(25·1–
31·8)
5·1 
(4·4–
5·9)
0·09 
(0·09–
0·09)
2·7 
(2·5–2·9)
0·9 
(0·82–0·98)
1·1 
(1·0–1·2)
13 008 474 
(12 060 286–
14 103 277)
1·26 
(1·17–1·37)
Afghanistan
0·38 
(0·16–
0·8)
97·5 
(84·5–
113·6)
279·2 
(255·7–
302·0)
314·6 
(304·2–
324·5)
248·6 
(234·8–
261·8)
166·7 
(150·2–
182·4)
70·9 
(61·0–
80·8)
24·0 
(20·1–
27·9)
0·46 
(0·44–
0·48)
6·0 
(5·7–6·3)
1·9 
(1·7–2·0)
2·6 
(2·4–2·7)
1 376 280 
(1 303 953–
1 448 446)
2·64 
(2·52–2·76)
Algeria
0·05 
(0·02–
0·09)
9·8 
(8·2–
11·6)
70·9 
(59·1–
84·3)
121·3 
(109·5–
133·9)
162·4 
(145·4–
179·9)
132·8 
(115·8–
149·9)
58·4 
(49·7–
67·4)
5·3 
(4·3–
6·5)
0·1 
(0·1–
0·11)
2·8 
(2·5–3·1)
0·4 
(0·34–0·48)
1·8 
(1·6–2·0)
963 291 
(855 732–
1 073 343)
1·32 
(1·17–1·47)
Bahrain
0·2 
(0·09–
0·4)
15·1 
(12·7–
18·4)
95·6 
(83·7–
108·6)
127·7 
(118·9–
136·8)
87·0 
(78·0–
96·6)
59·9 
(50·6–
70·2)
20·6 
(16·2–
25·7)
3·2 
(2·3–
4·4)
0·06 
(0·06–
0·06)
2·0 
(1·9–2·2)
0·55 
(0·49–0·62)
0·85 
(0·76–0·95)
19 881 
(18 264–
21 611)
0·99 
(0·9–1·07)
Egypt
0·3 
(0·13–
0·62)
61·8 
(52·7–
72·3)
171·9 
(147·3–
198·8)
136·6 
(124·0–
151·6)
102·0 
(88·2–
118·9)
46·7 
(37·0–
57·8)
11·0 
(8·3–
14·8)
2·0 
(1·4–
2·8)
0·04 
(0·04–
0·04)
2·7 
(2·4–2·9)
1·2 
(1·0–1·4)
0·81 
(0·71–0·93)
2 127 960 
(1 940 392–
2 330 506)
1·26 
(1·15–1·37)
Iran
0·52 
(0·22–
1·06)
26·4 
(22·1–
32·0)
77·0 
(62·4–
93·6)
100·2 
(89·8–
111·3)
79·9 
(68·1–
92·8)
46·2 
(36·0–
58·1)
14·3 
(10·7–
18·7)
1·2 
(0·8–
1·7)
0·02 
(0·02–
0·02)
1·7 
(1·5–2·0)
0·52 
(0·44–0·61)
0·71 
(0·58–0·86)
1 274 094 
(1 085 203–
1 494 227)
0·82 
(0·7–0·96)
(Table 1 continues on next page)
 Global Health Metrics
2016 
www.thelancet.com   Vol 392   November 10, 2018
Age-specific fertility rate (livebirths per 1000 women annually)
Total 
fertility 
rate
Total 
fertility rate 
under age 
25 years
Total fertility 
rate from ages 
30 to 54 years 
Number of 
livebirths 
Net 
reproductive 
rate
10–14 
years
15–19 
years
20–24 
years
25–29 
years
30–34 
years
35–39 
years
40–44 
years
45–49 
years
50–54 
years
(Continued from previous page)
Iraq
0·29 
(0·13–
0·61)
59·7 
(50·8–
71·0)
173·8 
(149·3–
203·1)
186·2 
(172·4–
202·2)
175·3 
(159·5–
193·5)
113·3 
(97·7–
129·5)
37·4 
(30·6–
44·9)
5·5 
(4·0–
7·2)
0·1 
(0·1–
0·11)
3·8 
(3·4–4·1)
1·2 
(1·0–1·4)
1·7 
(1·5–1·8)
1 255 056 
(1 135 149–
1 393 958)
1·75 
(1·59–1·93)
Jordan
0·09 
(0·04–
0·18)
26·1 
(21·9–
31·2)
126·5 
(106·5–
151·4)
180·3 
(165·9–
197·0)
157·5 
(140·7–
174·8)
96·7 
(81·0–
113·4)
22·1 
(16·7–
28·6)
1·5 
(1·0–
2·1)
0·03 
(0·03–
0·03)
3·1 
(2·8–3·4)
0·76 
(0·66–0·89)
1·4 
(1·2–1·6)
243 217 
(223 920–
266 880)
1·46 
(1·34–1·6)
Kuwait
0·03 
(0·01–
0·06)
8·3 
(6·9–
10·2)
62·3 
(52·6–
73·2)
78·4 
(71·8–
85·5)
68·9 
(60·6–
78·0)
44·8 
(36·4–
54·3)
18·8 
(14·3–
24·0)
2·8 
(1·8–
4·1)
0·05 
(0·05–
0·06)
1·4 
(1·3–1·6)
0·35 
(0·3–0·41)
0·68 
(0·59–0·77)
60 885 
(55 064–
67 021)
0·68 
(0·62–0·75)
Lebanon
0·29 
(0·13–
0·6)
57·6 
(48·9–
68·8)
117·0 
(96·9–
142·3)
138·8 
(125·9–
154·1)
106·1 
(91·9–
123·3)
51·1 
(40·5–
64·9)
7·2 
(5·6–
9·2)
1·3 
(0·9–
1·7)
0·02 
(0·02–
0·03)
2·4 
(2·1–2·8)
0·87 
(0·73–1·06)
0·83 
(0·7–0·98)
186 159 
(160 797–
217 399)
1·15 
(0·99–1·34)
Libya
0·13 
(0·06–
0·27)
13·3 
(11·0–
16·3)
50·8 
(40·2–
65·0)
114·5 
(102·8–
128·6)
122·3 
(106·1–
141·8)
77·7 
(61·4–
98·4)
36·8 
(28·1–
48·1)
8·0 
(5·4–
11·7)
0·15 
(0·15–
0·16)
2·1 
(1·8–2·6)
0·32 
(0·26–0·41)
1·2 
(1·0–1·5)
122 256 
(102 820–
146 859)
0·99 
(0·84–1·19)
Morocco
0·2 
(0·09–
0·42)
20·0 
(16·6–
24·0)
73·3 
(58·9–
90·4)
97·3 
(86·9–
108·8)
106·8 
(91·8–
125·1)
80·8 
(64·1–
101·8)
43·3 
(33·6–
55·7)
6·2 
(4·1–
9·5)
0·12 
(0·12–
0·12)
2·1 
(1·9–2·4)
0·47 
(0·38–0·57)
1·2 
(1·0–1·5)
601 214 
(528 391–
683 943)
1·01 
(0·89–1·15)
Oman
0·12 
(0·05–
0·25)
12·4 
(10·7–
14·3)
83·3 
(69·6–
98·7)
142·8 
(131·2–
154·8)
133·3 
(118·8–
148·4)
92·6 
(78·5–
107·8)
39·1 
(31·7–
47·2)
6·1 
(4·8–
7·5)
0·12 
(0·11–
0·12)
2·5 
(2·3–2·8)
0·48 
(0·41–0·56)
1·4 
(1·2–1·5)
80 314 
(72 628–
88 378)
1·23 
(1·11–1·35)
Palestine
0·05 
(0·02–
0·11)
77·9 
(67·5–
91·0)
201·0 
(176·8–
226·0)
184·9 
(171·1–
199·0)
131·4 
(116·6–
146·9)
75·8 
(63·4–
89·4)
25·6 
(21·2–
30·6)
2·0 
(1·5–
2·5)
0·04 
(0·04–
0·04)
3·5 
(3·2–3·9)
1·4 
(1·3–1·5)
1·2 
(1·0–1·3)
138 165 
(125 084–
152 033)
1·66 
(1·51–1·83)
Qatar
0·18 
(0·08–
0·37)
11·2 
(9·5–
13·1)
75·5 
(64·1–
88·1)
118·4 
(109·1–
128·1)
108·6 
(97·6–
120·1)
66·8 
(57·6–
76·8)
24·9 
(20·3–
30·0)
2·4 
(1·8–
3·2)
0·05 
(0·04–
0·05)
2·0 
(1·9–2·2)
0·43 
(0·38–0·5)
1·0 
(0·9–1·1)
30 253 
(27 787–
32 803)
0·99 
(0·9–1·07)
Saudi Arabia
0·11 
(0·05–
0·23)
9·7 
(8·1–
11·4)
59·6 
(48·8–
72·1)
82·9 
(75·5–
90·8)
85·4 
(74·4–
97·2)
63·0 
(50·5–
77·0)
29·6 
(23·3–
36·9)
3·5 
(2·4–
4·9)
0·07 
(0·06–
0·07)
1·7 
(1·5–1·9)
0·35 
(0·29–0·42)
0·91 
(0·78–1·05)
502 343 
(444 354–
565 465)
0·8 
(0·7–0·9)
Sudan
0·35 
(0·15–
0·74)
85·5 
(74·2–
99·7)
185·2 
(162·3–
212·3)
204·6 
(190·7–
220·6)
186·7 
(170·1–
205·5)
116·6 
(99·2–
134·6)
52·1 
(42·9–
62·0)
11·7 
(8·6–
15·4)
0·23 
(0·22–
0·23)
4·2 
(3·9–4·6)
1·4 
(1·2–1·6)
1·8 
(1·7–2·0)
1 336 735 
(1 216 996–
1 472 638)
1·93 
(1·78–2·1)
Syria
0·22 
(0·1–
0·46)
35·2 
(29·9–
42·0)
98·7 
(82·1–
117·2)
113·6 
(103·1–
124·7)
103·5 
(90·2–
117·7)
60·3 
(47·9–
74·5)
19·1 
(14·3–
24·9)
3·8 
(2·5–
5·9)
0·07 
(0·07–
0·08)
2·2 
(1·9–2·5)
0·67 
(0·58–0·77)
0·93 
(0·78–1·11)
276 298 
(239 261–
317 552)
0·99 
(0·85–1·14)
Tunisia
0·44 
(0·19–
0·91)
5·9 
(4·9–
7·3)
47·2 
(37·8–
59·8)
97·8 
(87·8–
109·8)
106·5 
(93·5–
122·3)
72·0 
(59·7–
87·5)
22·8 
(18·2–
28·7)
1·6 
(1·2–
2·3)
0·03 
(0·03–
0·03)
1·8 
(1·5–2·1)
0·27 
(0·22–0·34)
1·0 
(0·9–1·2)
167 745 
(144 002–
197 624)
0·84 
(0·72–0·99)
Turkey
0·19 
(0·08–
0·38)
25·9 
(21·9–
30·6)
90·4 
(76·2–
108·5)
106·3 
(96·4–
118·2)
81·1 
(71·3–
93·1)
42·0 
(35·1–
49·7)
11·0 
(8·9–
13·5)
1·1 
(0·8–
1·4)
0·02 
(0·02–
0·02)
1·8 
(1·6–2·0)
0·58 
(0·51–0·67)
0·68 
(0·61–0·75)
1 116 714 
(1 004 994–
1 245 930)
0·85 
(0·77–0·95)
United Arab 
Emirates
0·44 
(0·19–
0·89)
12·1 
(10·2–
14·7)
58·5 
(46·9–
73·9)
70·2 
(62·1–
80·2)
66·5 
(56·6–
77·3)
36·8 
(29·6–
45·1)
16·3 
(12·9–
20·3)
1·6 
(1·1–
2·1)
0·03 
(0·03–
0·03)
1·3 
(1·2–1·5)
0·36 
(0·29–0·45)
0·61 
(0·52–0·7)
71 039 
(62 614–
80 613)
0·63 
(0·56–0·71)
Yemen
0·35 
(0·15–
0·73)
82·1 
(71·0–
96·0)
205·3 
(180·0–
234·7)
221·3 
(206·8–
237·8)
177·9 
(160·4–
197·8)
124·5 
(105·8–
143·5)
64·9 
(54·4–
75·7)
29·0 
(24·1–
33·7)
0·56 
(0·54–
0·58)
4·5 
(4·2–5·0)
1·4 
(1·3–1·7)
2·0 
(1·8–2·2)
1 046 417 
(953 260–
1 151 663)
2·05 
(1·89–2·23)
South Asia
0·43 
(0·19–
0·88)
32·6 
(28·4–
37·8)
159·3 
(137·3–
185·9)
138·0 
(126·3–
151·8)
78·0 
(69·5–
87·4)
32·9 
(27·6–
39·4)
9·8 
(7·4–
12·8)
3·4 
(2·5–
4·6)
0·06 
(0·06–
0·07)
2·3 
(2·0–2·5)
0·96 
(0·83–1·12)
0·62 
(0·54–0·72)
33 968 926 
(30 525 169–
38 074 532)
1·01 
(0·92–1·13)
Bangladesh
0·97 
(0·42–
2·02)
70·9 
(60·8–
82·0)
133·1 
(115·0–
155·3)
99·5 
(90·3–
110·5)
56·2 
(48·6–
64·6)
28·2 
(22·2–
35·3)
6·9 
(5·2–
9·0)
3·4 
(2·3–
4·7)
0·06 
(0·06–
0·07)
2·0 
(1·8–2·2)
1·0 
(0·9–1·1)
0·47 
(0·39–0·57)
2 858 475 
(2 598 018–
3 180 667)
0·93 
(0·84–1·04)
(Table 1 continues on next page)
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2017
Age-specific fertility rate (livebirths per 1000 women annually)
Total 
fertility 
rate
Total 
fertility rate 
under age 
25 years
Total fertility 
rate from ages 
30 to 54 years 
Number of 
livebirths 
Net 
reproductive 
rate
10–14 
years
15–19 
years
20–24 
years
25–29 
years
30–34 
years
35–39 
years
40–44 
years
45–49 
years
50–54 
years
(Continued from previous page)
Bhutan
0·44 
(0·2–
0·92)
35·4 
(29·6–
42·9)
125·3 
(103·6–
152·4)
113·5 
(101·8–
127·6)
71·1 
(59·9–
83·5)
38·4 
(29·1–
49·6)
9·6 
(6·8–
13·1)
3·1 
(2·0–
4·6)
0·06 
(0·06–
0·06)
2·0 
(1·8–2·3)
0·81 
(0·67–0·98)
0·61 
(0·49–0·75)
17 338 
(15 394–
19 757)
0·93 
(0·82–1·06)
India
0·37 
(0·16–
0·76)
25·4 
(21·2–
30·8)
162·3 
(140·1–
189·1)
133·7 
(122·1–
147·4)
70·0 
(60·5–
80·3)
26·3 
(20·7–
32·8)
8·0 
(5·9–
10·4)
2·6 
(1·9–
3·6)
0·05 
(0·05–
0·05)
2·1 
(1·9–2·4)
0·94 
(0·81–1·1)
0·53 
(0·45–0·63)
24 568 864 
(22 072 577–
27 481 958)
0·96 
(0·87–1·06)
Nepal
0·58 
(0·25–
1·21)
59·0 
(50·7–
68·5)
156·9 
(134·6–
183·9)
114·0 
(102·9–
127·4)
67·7 
(57·7–
80·3)
30·8 
(24·1–
39·9)
9·9 
(7·5–
12·8)
3·3 
(2·3–
4·6)
0·06 
(0·06–
0·07)
2·2 
(2·0–2·5)
1·1 
(1·0–1·2)
0·56 
(0·48–0·67)
632 646 
(560 875–
717 437)
1·03 
(0·91–1·17)
Pakistan
0·34 
(0·15–
0·71)
43·6 
(36·8–
52·4)
161·5 
(137·5–
190·5)
200·4 
(185·8–
217·2)
152·9 
(135·6–
173·1)
85·5 
(69·1–
105·8)
26·2 
(19·7–
33·8)
9·7 
(6·7–
14·0)
0·19 
(0·18–
0·19)
3·4 
(3·0–3·9)
1·0 
(0·9–1·2)
1·4 
(1·2–1·6)
5 891 600 
(5 173 076–
6 733 145)
1·48 
(1·3–1·69)
Southeast Asia, 
east Asia, and 
Oceania
0·15 
(0·07–
0·31)
18·9 
(17·3–
20·8)
93·6 
(86·4–
101·6)
117·7 
(113·6–
121·9)
71·9 
(68·4–
75·9)
32·1 
(29·5–
35·3)
9·0 
(8·1–
10·1)
1·1 
(0·9–
1·3)
0·02 
(0·02–
0·02)
1·7 
(1·6–1·8)
0·56 
(0·52–0·61)
0·57 
(0·54–0·61)
28 562 870 
(27 037 176–
30 297 827)
0·79 
(0·75–0·84)
East Asia
0·1 
(0·04–
0·21)
8·7 
(8·0–
9·4)
89·4 
(82·8–
96·2)
116·8 
(112·3–
121·4)
61·8 
(57·9–
65·7)
20·5 
(18·4–
22·7)
5·5 
(4·8–
6·2)
0·8 
(0·61–
1·07)
0·02 
(0·01–
0·02)
1·5 
(1·4–1·6)
0·49 
(0·45–0·53)
0·44 
(0·41–0·48)
17 180 872 
(16 167 753–
18 210 317)
0·69 
(0·65–0·73)
China
0·1 
(0·05–
0·21)
8·9 
(8·2–
9·7)
91·5 
(84·5–
98·6)
117·6 
(112·9–
122·2)
61·4 
(57·4–
65·4)
20·2 
(18·0–
22·5)
5·5 
(4·8–
6·3)
0·82 
(0·62–
1·1)
0·02 
(0·02–
0·02)
1·5 
(1·4–1·6)
0·5 
(0·46–0·54)
0·44 
(0·4–0·48)
16 469 641 
(15 475 992–
17 488 048)
0·69 
(0·65–0·74)
North Korea
0·05 
(0·02–
0·09)
1·8 
(1·5–
2·3)
49·2 
(39·0–
61·3)
112·8 
(101·2–
126·9)
71·8 
(60·5–
84·4)
23·3 
(17·2–
30·7)
5·4 
(3·8–
7·8)
0·43 
(0·26–
0·7)
0·01 
(0·01–
0·01)
1·3 
(1·2–1·5)
0·26 
(0·2–0·32)
0·5 
(0·42–0·61)
258 789 
(228 429–
295 066)
0·62 
(0·55–0·71)
Taiwan (province 
of China)
0·08 
(0·03–
0·17)
4·0 
(3·4–
4·9)
23·5 
(19·4–
28·4)
63·5 
(58·0–
69·7)
78·8 
(70·3–
88·2)
34·1 
(28·0–
41·5)
4·4 
(3·2–
6·0)
0·03 
(0·02–
0·04)
0·0 
(0·0–
0·0)
1·0 
(0·9–1·2)
0·14 
(0·11–0·17)
0·59 
(0·51–0·67)
175 666 
(154 235–
200 219)
0·5 
(0·44–0·57)
Oceania
0·54 
(0·24–
1·13)
56·3 
(48·0–
65·8)
194·1 
(170·4–
219·3)
194·9 
(182·0–
208·4)
171·6 
(155·8–
189·1)
123·9 
(106·5–
143·3)
49·6 
(40·7–
60·2)
12·4 
(9·1–
16·7)
0·23 
(0·22–
0·24)
4·0 
(3·7–4·4)
1·3 
(1·1–1·4)
1·8 
(1·6–2·0)
398 611 
(364 718–
433 764)
1·77 
(1·62–1·93)
American Samoa
0·72 
(0·32–
1·49)
35·3 
(29·7–
41·9)
142·8 
(122·6–
165·4)
171·4 
(157·9–
185·8)
136·3 
(120·1–
153·8)
80·4 
(65·8–
97·0)
16·1 
(12·1–
21·0)
0·91 
(0·57–
1·4)
0·02 
(0·02–
0·02)
2·9 
(2·5–3·3)
0·89 
(0·76–1·04)
1·2 
(1·0–1·4)
1134 
(987–1298)
1·37 
(1·2–1·57)
Federated States 
of Micronesia
1·8 
(0·8–
3·6)
36·0 
(30·5–
42·6)
127·9 
(106·5–
154·5)
146·1 
(133·0–
161·7)
127·2 
(110·9–
146·9)
82·6 
(66·6–
100·1)
18·0 
(13·1–
24·9)
4·3 
(2·7–
6·7)
0·08 
(0·08–
0·09)
2·7 
(2·4–3·1)
0·83 
(0·72–0·96)
1·2 
(1·0–1·3)
2118 
(1891–2392)
1·26 
(1·12–1·43)
Fiji
0·07 
(0·03–
0·14)
34·4 
(29·2–
40·4)
149·8 
(129·9–
172·0)
156·6 
(144·6–
169·6)
110·6 
(98·2–
124·4)
57·2 
(47·9–
67·9)
12·5 
(9·8–
15·9)
1·2 
(0·9–
1·6)
0·02 
(0·02–
0·02)
2·6 
(2·3–3·0)
0·92 
(0·8–1·06)
0·91 
(0·78–1·05)
18 373 
(16 204–
20 801)
1·21 
(1·07–1·37)
Guam
0·65 
(0·29–
1·35)
44·8 
(38·1–
52·7)
146·7 
(128·8–
166·5)
165·2 
(153·0–
179·3)
141·2 
(127·1–
156·5)
74·3 
(61·0–
91·1)
15·5 
(11·5–
20·3)
0·56 
(0·36–
0·85)
0·01 
(0·01–
0·01)
2·9 
(2·7–3·2)
0·96 
(0·84–1·1)
1·2 
(1·1–1·3)
3350 
(3080–3638)
1·38 
(1·28–1·5)
Kiribati
0·33 
(0·15–
0·68)
38·8 
(32·8–
45·7)
188·0 
(162·6–
215·5)
184·8 
(170·7–
199·9)
175·3 
(158·1–
193·3)
117·1 
(98·6–
136·9)
29·9 
(23·3–
37·8)
7·6 
(5·5–
10·4)
0·15 
(0·14–
0·15)
3·7 
(3·3–4·2)
1·1 
(1·0–1·3)
1·7 
(1·4–1·9)
3544 
(3124–4001)
1·66 
(1·46–1·86)
Marshall Islands
0·82 
(0·36–
1·71)
66·1 
(57·8–
76·5)
177·1 
(154·4–
201·0)
148·8 
(136·4–
161·7)
109·1 
(96·0–
123·1)
55·0 
(44·7–
66·6)
14·9 
(11·5–
18·8)
1·1 
(0·7–
1·6)
0·02 
(0·02–
0·02)
2·9 
(2·5–3·2)
1·2 
(1·1–1·4)
0·9 
(0·76–1·05)
1298 
(1159–1448)
1·32 
(1·17–1·47)
Northern Mariana 
Islands
0·91 
(0·4–
1·89)
38·5 
(33·6–
44·0)
102·3 
(85·3–
121·1)
107·1 
(96·4–
118·4)
104·8 
(91·1–
119·6)
49·5 
(40·3–
60·0)
9·2 
(6·7–
12·3)
0·11 
(0·07–
0·17)
0·0 
(0·0–
0·0)
2·1 
(1·8–2·3)
0·71 
(0·61–0·81)
0·82 
(0·72–0·92)
547 
(483–612)
0·98 
(0·86–1·09)
Papua New 
Guinea
0·57 
(0·25–
1·2)
59·4 
(50·4–
70·0)
200·1 
(173·1–
229·1)
198·5 
(183·9–
213·9)
178·4 
(160·3–
199·0)
133·2 
(113·1–
156·0)
56·1 
(45·0–
69·5)
14·9 
(10·6–
20·5)
0·29 
(0·28–
0·3)
4·2 
(3·8–4·6)
1·3 
(1·1–1·5)
1·9 
(1·6–2·2)
309 184 
(282 124–
336 719)
1·83 
(1·67–2·0)
(Table 1 continues on next page)
 Global Health Metrics
2018 
www.thelancet.com   Vol 392   November 10, 2018
Age-specific fertility rate (livebirths per 1000 women annually)
Total 
fertility 
rate
Total 
fertility rate 
under age 
25 years
Total fertility 
rate from ages 
30 to 54 years 
Number of 
livebirths 
Net 
reproductive 
rate
10–14 
years
15–19 
years
20–24 
years
25–29 
years
30–34 
years
35–39 
years
40–44 
years
45–49 
years
50–54 
years
(Continued from previous page)
Samoa
0·17 
(0·07–
0·35)
42·9 
(36·5–
51·1)
207·9 
(182·2–
237·7)
244·8 
(230·5–
260·6)
222·1 
(205·2–
240·2)
153·5 
(134·7–
173·9)
56·0 
(46·0–
68·0)
11·0 
(8·1–
14·4)
0·21 
(0·2–
0·22)
4·7 
(4·2–5·2)
1·3 
(1·1–1·4)
2·2 
(2·0–2·5)
6070 
(5464–6756)
2·18 
(1·96–2·42)
Solomon Islands
0·59 
(0·26–
1·22)
62·2 
(52·9–
72·9)
207·0 
(180·4–
237·8)
211·7 
(196·9–
228·6)
176·0 
(158·0–
196·6)
124·1 
(104·4–
146·7)
46·9 
(37·0–
57·7)
11·1 
(7·7–
15·4)
0·21 
(0·21–
0·22)
4·2 
(3·8–4·6)
1·3 
(1·2–1·5)
1·8 
(1·6–2·0)
20 410 
(18 459–
22 554)
1·91 
(1·72–2·12)
Tonga
0·4 
(0·17–
0·8)
17·1 
(14·3–
20·5)
108·3 
(89·8–
129·6)
176·1 
(162·2–
191·1)
170·7 
(153·8–
188·6)
121·8 
(103·5–
141·3)
36·6 
(28·7–
45·9)
2·8 
(2·0–
3·8)
0·05 
(0·05–
0·05)
3·2 
(2·8–3·6)
0·63 
(0·52–0·75)
1·7 
(1·4–1·9)
2184 
(1908–2489)
1·49 
(1·3–1·68)
Vanuatu
0·53 
(0·23–
1·1)
51·2 
(43·4–
61·2)
190·1 
(164·6–
220·0)
187·2 
(172·7–
204·0)
158·8 
(141·5–
176·7)
109·5 
(91·1–
128·8)
41·3 
(32·3–
51·3)
8·0 
(5·3–
11·3)
0·15 
(0·15–
0·16)
3·7 
(3·4–4·1)
1·2 
(1·0–1·4)
1·6 
(1·4–1·8)
8428 
(7704–9314)
1·71 
(1·56–1·88)
Southeast Asia
0·21 
(0·09–
0·43)
32·0 
(28·5–
36·3)
98·6 
(83·7–
117·5)
118·2 
(111·0–
127·0)
94·0 
(86·3–
103·2)
54·1 
(47·9–
61·5)
17·1 
(14·8–
19·9)
1·8 
(1·4–
2·2)
0·03 
(0·03–
0·03)
2·1 
(1·9–2·3)
0·65 
(0·56–0·77)
0·84 
(0·75–0·93)
10 983 387 
(9 949 746–
12 233 978)
0·97 
(0·88–1·08)
Cambodia
0·34 
(0·15–
0·7)
43·6 
(37·0–
52·2)
133·8 
(114·2–
157·9)
150·7 
(138·2–
165·5)
118·5 
(104·6–
133·2)
75·4 
(61·4–
90·7)
20·4 
(16·0–
25·5)
4·1 
(2·9–
5·6)
0·08 
(0·08–
0·08)
2·7 
(2·5–3·0)
0·89 
(0·76–1·05)
1·1 
(0·9–1·3)
377 406 
(343 642–
419 172)
1·28 
(1·17–1·42)
Indonesia
0·15 
(0·06–
0·3)
27·7 
(23·5–
32·6)
92·8 
(76·9–
113·1)
113·7 
(103·0–
126·6)
89·5 
(77·7–
104·1)
51·7 
(41·7–
64·8)
16·4 
(12·7–
21·5)
1·8 
(1·2–
2·5)
0·03 
(0·03–
0·04)
2·0 
(1·7–2·3)
0·6 
(0·52–0·7)
0·8 
(0·67–0·96)
4 032 914 
(3 491 800–
4 705 431)
0·92 
(0·8–1·08)
Laos
0·41 
(0·18–
0·85)
62·9 
(54·0–
74·2)
164·6 
(143·4–
190·0)
147·0 
(135·4–
159·0)
109·1 
(96·9–
122·1)
65·9 
(54·4–
78·6)
23·1 
(18·1–
29·0)
7·7 
(5·4–
10·5)
0·15 
(0·14–
0·15)
2·9 
(2·6–3·2)
1·1 
(1·0–1·3)
1·0 
(0·9–1·2)
176 836 
(161 828–
194 522)
1·32 
(1·21–1·45)
Malaysia
0·22 
(0·09–
0·44)
11·1 
(9·4–
13·1)
51·7 
(44·2–
60·2)
122·2 
(113·9–
130·8)
125·1 
(114·1–
136·6)
72·6 
(61·9–
84·2)
20·7 
(16·4–
25·6)
1·4 
(0·9–
2·2)
0·03 
(0·03–
0·03)
2·0 
(1·8–2·3)
0·32 
(0·28–0·36)
1·1 
(1·0–1·2)
508 960 
(457 674–
566 097)
0·96 
(0·86–1·07)
Maldives
0·12 
(0·05–
0·24)
17·6 
(14·7–
21·0)
96·6 
(83·8–
110·2)
112·9 
(104·0–
121·9)
83·1 
(73·3–
93·7)
46·0 
(36·9–
58·1)
15·8 
(11·7–
21·1)
1·9 
(1·2–
2·9)
0·04 
(0·04–
0·04)
1·9 
(1·7–2·0)
0·57 
(0·5–0·64)
0·73 
(0·66–0·82)
6844 
(6312–7356)
0·9 
(0·83–0·97)
Mauritius
0·46 
(0·2–
0·93)
23·0 
(19·6–
26·9)
61·0 
(52·3–
70·6)
82·1 
(75·2–
90·5)
63·0 
(55·5–
72·2)
28·0 
(22·4–
34·8)
6·8 
(4·9–
9·4)
0·31 
(0·19–
0·49)
0·01 
(0·01–
0·01)
1·3 
(1·2–1·4)
0·42 
(0·36–0·49)
0·49 
(0·43–0·55)
12 416 
(11 454–
13 507)
0·64 
(0·59–0·69)
Myanmar
0·25 
(0·11–
0·51)
24·8 
(20·9–
29·8)
84·7 
(70·9–
102·3)
105·4 
(95·7–
115·6)
94·6 
(83·1–
106·9)
65·3 
(53·9–
77·9)
25·5 
(20·1–
31·8)
3·0 
(2·1–
4·1)
0·06 
(0·06–
0·06)
2·0 
(1·9–2·2)
0·55 
(0·46–0·66)
0·94 
(0·84–1·06)
876 249 
(804 806–
959 636)
0·92 
(0·85–1·01)
Philippines
0·22 
(0·1–
0·47)
54·2 
(46·1–
64·6)
137·3 
(116·6–
162·7)
162·4 
(149·5–
177·5)
141·5 
(126·5–
157·0)
92·2 
(77·4–
107·9)
32·2 
(26·0–
39·1)
3·5 
(2·5–
4·7)
0·07 
(0·06–
0·07)
3·1 
(2·8–3·4)
0·96 
(0·81–1·14)
1·3 
(1·2–1·5)
2 526 359 
(2 304 451–
2 800 024)
1·44 
(1·31–1·59)
Sri Lanka
0·13 
(0·06–
0·27)
18·5 
(15·4–
22·2)
67·3 
(54·0–
83·3)
109·6 
(98·6–
121·7)
97·2 
(84·2–
111·8)
51·3 
(40·9–
63·7)
14·3 
(10·9–
18·6)
0·81 
(0·56–
1·17)
0·02 
(0·02–
0·02)
1·8 
(1·5–2·1)
0·43 
(0·35–0·53)
0·82 
(0·68–0·98)
292 833 
(248 351–
344 723)
0·86 
(0·73–1·01)
Seychelles
1·1 
(0·5–
2·4)
58·0 
(50·5–
66·6)
114·4 
(98·8–
132·0)
111·8 
(102·4–
122·0)
81·8 
(73·8–
90·7)
48·8 
(42·0–
56·6)
13·6 
(11·1–
16·7)
0·5 
(0·31–
0·78)
0·01 
(0·01–
0·01)
2·1 
(1·9–2·4)
0·87 
(0·75–1·0)
0·72 
(0·64–0·82)
1497 
(1322–1693)
1·03 
(0·91–1·16)
Thailand
0·36 
(0·16–
0·73)
32·4 
(27·1–
39·3)
64·6 
(52·1–
81·1)
66·0 
(58·6–
74·0)
48·6 
(41·2–
57·0)
21·8 
(16·8–
27·7)
7·6 
(5·8–
9·9)
0·49 
(0·34–
0·69)
0·01 
(0·01–
0·01)
1·2 
(1·1–1·4)
0·49 
(0·4–0·6)
0·39 
(0·32–0·48)
613 237 
(539 713–
701 506)
0·58 
(0·51–0·66)
Timor-Leste
0·4 
(0·18–
0·84)
61·1 
(51·9–
71·8)
176·0 
(150·4–
204·0)
209·8 
(195·1–
225·2)
194·0 
(176·2–
212·3)
123·2 
(103·5–
144·2)
52·5 
(41·9–
64·4)
10·7 
(7·4–
14·8)
0·21 
(0·2–
0·21)
4·1 
(3·6–4·7)
1·2 
(1·0–1·4)
1·9 
(1·6–2·2)
38 826 
(34 156–
43 904)
1·92 
(1·69–2·17)
Vietnam
0·25 
(0·11–
0·51)
24·7 
(20·9–
29·6)
107·8 
(91·8–
127·8)
114·7 
(105·5–
124·5)
77·0 
(67·9–
86·8)
36·7 
(30·4–
43·9)
8·8 
(7·0–
10·8)
0·48 
(0·34–
0·65)
0·01 
(0·01–
0·01)
1·9 
(1·7–2·0)
0·66 
(0·56–0·79)
0·61 
(0·53–0·71)
1 504 552 
(1 372 351–
1 660 292)
0·88 
(0·8–0·97)
Sub-Saharan Africa
2·1 
(0·9–
4·3)
93·7 
(84·2–
105·2)
199·0 
(184·9–
215·8)
206·3 
(198·2–
215·8)
190·1 
(179·9–
201·1)
137·5 
(125·6–
149·2)
71·2 
(64·2–
78·1)
23·3 
(21·2–
25·3)
0·44 
(0·43–
0·46)
4·6 
(4·3–4·9)
1·5 
(1·4–1·6)
2·1 
(2·0–2·3)
36 181 702 
(34 016 504–
38 650 498)
2·02 
(1·91–2·14)
(Table 1 continues on next page)
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2019
Age-specific fertility rate (livebirths per 1000 women annually)
Total 
fertility 
rate
Total 
fertility rate 
under age 
25 years
Total fertility 
rate from ages 
30 to 54 years 
Number of 
livebirths 
Net 
reproductive 
rate
10–14 
years
15–19 
years
20–24 
years
25–29 
years
30–34 
years
35–39 
years
40–44 
years
45–49 
years
50–54 
years
(Continued from previous page)
Central sub-Saharan 
Africa
1·5 
(0·6–
3·1)
94·1 
(85·6–
103·0)
195·3 
(178·9–
212·1)
209·5 
(199·7–
219·6)
214·4 
(202·8–
225·9)
159·2 
(147·9–
169·6)
81·9 
(75·8–
87·8)
19·0 
(16·3–
21·9)
0·37 
(0·35–
0·38)
4·9 
(4·6–5·1)
1·5 
(1·3–1·6)
2·4 
(2·3–2·5)
4 318 103 
(4 060 044–
4 568 273)
2·14 
(2·04–2·23)
Angola
1·7 
(0·7–
3·5)
120·6 
(105·7–
137·3)
206·1 
(179·5–
234·4)
212·7 
(198·1–
228·0)
209·3 
(192·1–
226·9)
162·3 
(143·3–
182·6)
91·6 
(81·2–
102·5)
20·0 
(16·0–
24·9)
0·39 
(0·37–
0·4)
5·1 
(4·7–5·5)
1·6 
(1·4–1·9)
2·4 
(2·2–2·6)
1 052 695 
(962 954–
1 146 611)
2·27 
(2·09–2·46)
Central African 
Republic
1·4 
(0·6–
3·0)
87·9 
(75·6–
101·8)
162·5 
(137·3–
192·9)
127·3 
(114·8–
142·3)
150·2 
(132·6–
170·9)
104·0 
(85·0–
126·8)
55·9 
(45·0–
67·4)
22·9 
(17·9–
28·1)
0·44 
(0·42–
0·46)
3·6 
(3·2–4·0)
1·3 
(1·1–1·4)
1·7 
(1·5–1·9)
133 353 
(119 271–
149 763)
1·44 
(1·31–1·58)
Congo 
(Brazzaville)
1·2 
(0·5–
2·6)
69·8 
(60·5–
81·5)
130·4 
(111·1–
154·2)
137·4 
(125·8–
151·2)
157·4 
(142·7–
172·5)
111·7 
(92·5–
131·7)
41·4 
(32·2–
51·6)
11·0 
(7·8–
14·9)
0·21 
(0·2–
0·22)
3·3 
(3·0–3·7)
1·0 
(0·9–1·2)
1·6 
(1·4–1·9)
131 030 
(119 585–
145 001)
1·48 
(1·35–1·63)
Democratic 
Republic of the 
Congo
1·4 
(0·6–
2·9)
87·4 
(77·7–
97·9)
200·0 
(178·9–
221·6)
221·3 
(208·0–
234·6)
227·4 
(213·0–
241·5)
168·1 
(153·2–
182·2)
85·1 
(76·9–
93·1)
19·5 
(15·8–
23·5)
0·38 
(0·36–
0·39)
5·1 
(4·7–5·4)
1·4 
(1·3–1·6)
2·5 
(2·4–2·6)
2 920 848 
(2 712 396–
3 123 108)
2·21 
(2·09–2·32)
Equatorial Guinea
1·6 
(0·7–
3·3)
107·7 
(93·4–
123·7)
167·1 
(141·7–
195·1)
157·1 
(143·3–
172·0)
161·5 
(143·6–
180·4)
108·8 
(89·5–
129·8)
58·0 
(46·8–
70·2)
13·7 
(9·7–
19·0)
0·26 
(0·25–
0·27)
3·9 
(3·4–4·4)
1·4 
(1·2–1·6)
1·7 
(1·5–2·0)
39 049 
(33 922–
44 596)
1·74 
(1·51–1·98)
Gabon
1·2 
(0·5–
2·5)
62·9 
(53·4–
75·0)
112·7 
(92·5–
138·4)
123·9 
(111·6–
138·7)
131·1 
(114·4–
151·2)
91·4 
(73·7–
110·5)
30·0 
(22·6–
38·6)
4·8 
(3·2–
7·0)
0·09 
(0·09–
0·1)
2·8 
(2·5–3·2)
0·88 
(0·73–1·07)
1·3 
(1·1–1·5)
41 125 
(36 192–
47 105)
1·3 
(1·15–1·48)
Eastern 
sub-Saharan Africa
1·9 
(0·8–
4·0)
92·8 
(82·2–
105·6)
209·7 
(192·1–
229·6)
203·1 
(193·6–
213·9)
186·7 
(176·0–
198·8)
138·2 
(125·4–
151·0)
73·1 
(65·6–
80·2)
23·9 
(21·4–
26·2)
0·46 
(0·44–
0·47)
4·6 
(4·4–5·0)
1·5 
(1·4–1·7)
2·1 
(2·0–2·3)
13 995 648 
(13 041 912–
15 084 874)
2·07 
(1·95–2·2)
Burundi
1·4 
(0·6–
2·9)
52·6 
(45·0–
62·2)
206·7 
(184·8–
232·0)
238·1 
(224·9–
253·1)
243·2 
(228·8–
258·6)
198·9 
(185·5–
211·0)
96·7 
(88·1–
104·7)
23·0 
(18·9–
27·1)
0·44 
(0·43–
0·46)
5·3 
(5·0–5·6)
1·3 
(1·2–1·5)
2·8 
(2·7–2·9)
406 276 
(379 690–
436 338)
2·32 
(2·2–2·46)
Comoros
1·3 
(0·6–
2·7)
43·7 
(37·0–
51·6)
123·3 
(102·5–
147·0)
144·1 
(131·0–
158·4)
169·2 
(151·5–
187·9)
120·1 
(100·7–
140·8)
49·5 
(39·4–
60·9)
25·5 
(20·4–
30·8)
0·49 
(0·47–
0·51)
3·4 
(2·9–3·9)
0·84 
(0·7–1·0)
1·8 
(1·6–2·1)
18 191 
(15 712–
20 908)
1·54 
(1·34–1·77)
Djibouti
1·4 
(0·6–
2·8)
49·0 
(41·3–
58·0)
135·0 
(112·3–
160·8)
147·7 
(134·3–
162·3)
200·5 
(182·8–
218·7)
128·1 
(108·0–
149·3)
61·0 
(49·6–
73·4)
39·8 
(36·6–
42·5)
0·77 
(0·74–
0·79)
3·8 
(3·3–4·3)
0·93 
(0·77–1·1)
2·2 
(1·9–2·4)
34 700 
(30 383–
39 346)
1·72 
(1·5–1·95)
Eritrea
1·3 
(0·6–
2·8)
48·2 
(40·6–
58·1)
146·7 
(122·7–
176·3)
128·6 
(116·0–
143·7)
185·8 
(167·6–
206·4)
167·4 
(148·5–
187·4)
82·5 
(70·8–
95·1)
43·8 
(41·8–
45·5)
0·84 
(0·81–
0·88)
4·0 
(3·6–4·6)
0·98 
(0·82–1·18)
2·4 
(2·1–2·7)
177 412 
(155 541–
203 011)
1·82 
(1·61–2·04)
Ethiopia
1·9 
(0·8–
3·9)
89·0 
(77·4–
103·5)
202·7 
(178·6–
230·7)
207·2 
(193·0–
223·4)
200·2 
(183·4–
218·9)
151·3 
(133·3–
168·9)
75·3 
(65·7–
84·9)
29·4 
(25·1–
33·4)
0·57 
(0·54–
0·59)
4·8 
(4·4–5·2)
1·5 
(1·3–1·7)
2·3 
(2·1–2·5)
3 714 299 
(3 402 189–
4 069 663)
2·15 
(2·0–2·32)
Kenya
1·5 
(0·6–
3·1)
70·9 
(60·6–
83·9)
184·0 
(158·3–
211·0)
153·7 
(140·2–
167·8)
139·0 
(122·1–
156·5)
85·0 
(68·2–
103·3)
35·2 
(27·0–
44·6)
6·4 
(4·3–
8·9)
0·12 
(0·12–
0·13)
3·4 
(3·0–3·8)
1·3 
(1·1–1·4)
1·3 
(1·1–1·6)
1 365 160 
(1 208 543–
1 535 478)
1·54 
(1·34–1·75)
Madagascar
2·4 
(1·0–
5·0)
128·0 
(113·1–
144·4)
230·2 
(204·3–
257·3)
215·6 
(201·2–
230·7)
175·1 
(157·7–
193·5)
134·5 
(115·5–
154·3)
75·9 
(65·5–
86·6)
16·8 
(13·2–
21·0)
0·32 
(0·31–
0·34)
4·9 
(4·4–5·5)
1·8 
(1·6–2·0)
2·0 
(1·8–2·3)
975 570 
(871 322–
1 083 828)
2·16 
(1·93–2·4)
Malawi
2·7 
(1·2–
5·6)
110·3 
(98·7–
124·4)
220·2 
(199·4–
244·0)
191·9 
(179·5–
206·2)
154·1 
(140·3–
168·2)
107·7 
(93·9–
122·2)
69·9 
(60·9–
78·9)
33·9 
(30·3–
37·2)
0·65 
(0·63–
0·68)
4·5 
(4·2–4·8)
1·7 
(1·5–1·9)
1·8 
(1·6–2·0)
612 862 
(571 079–
660 504)
1·99 
(1·86–2·12)
Mozambique
2·0 
(0·8–
4·1)
98·2 
(87·6–
111·0)
187·4 
(167·5–
208·0)
160·7 
(149·2–
172·6)
157·7 
(143·6–
172·0)
114·7 
(99·8–
130·2)
74·4 
(65·4–
83·3)
36·5 
(33·0–
39·6)
0·7 
(0·68–
0·73)
4·2 
(3·8–4·5)
1·4 
(1·3–1·6)
1·9 
(1·8–2·1)
988 056 
(912 263–
1 068 141)
1·78 
(1·66–1·91)
Rwanda
1·1 
(0·5–
2·2)
30·1 
(25·5–
36·2)
167·6 
(143·9–
196·1)
205·2 
(190·6–
222·0)
219·1 
(202·2–
237·6)
158·4 
(139·9–
178·5)
83·4 
(72·8–
93·5)
20·9 
(16·1–
26·7)
0·4 
(0·39–
0·42)
4·4 
(4·0–4·9)
0·99 
(0·85–1·17)
2·4 
(2·2–2·6)
423 424 
(381 994–
470 006)
2·03 
(1·85–2·24)
Somalia
1·9 
(0·8–
4·1)
96·4 
(83·1–
112·9)
248·7 
(221·2–
279·3)
273·3 
(259·9–
288·1)
251·7 
(236·9–
267·4)
202·6 
(188·7–
214·9)
101·6 
(92·0–
110·1)
42·3 
(39·8–
44·3)
0·81 
(0·78–
0·85)
6·1 
(5·7–6·5)
1·7 
(1·5–2·0)
3·0 
(2·8–3·1)
685 515 
(638 214–
737 921)
2·56 
(2·44–2·69)
(Table 1 continues on next page)
 Global Health Metrics
2020 
www.thelancet.com   Vol 392   November 10, 2018
Age-specific fertility rate (livebirths per 1000 women annually)
Total 
fertility 
rate
Total 
fertility rate 
under age 
25 years
Total fertility 
rate from ages 
30 to 54 years 
Number of 
livebirths 
Net 
reproductive 
rate
10–14 
years
15–19 
years
20–24 
years
25–29 
years
30–34 
years
35–39 
years
40–44 
years
45–49 
years
50–54 
years
(Continued from previous page)
South Sudan
2·3 
(1·0–
4·8)
129·6 
(113·5–
149·1)
271·7 
(245·0–
300·8)
262·4 
(248·5–
277·7)
251·7 
(237·0–
265·6)
163·5 
(144·6–
181·5)
78·4 
(66·6–
90·0)
25·7 
(20·4–
31·2)
0·49 
(0·48–
0·51)
5·9 
(5·6–6·3)
2·0 
(1·8–2·3)
2·6 
(2·3–2·8)
413 783 
(387 551–
444 396)
2·5 
(2·36–2·66)
Tanzania
2·0 
(0·9–
4·1)
99·2 
(87·4–
113·8)
220·7 
(197·7–
247·1)
211·7 
(198·2–
227·1)
183·2 
(167·3–
201·4)
138·7 
(122·5–
155·0)
79·4 
(71·0–
87·8)
21·9 
(17·9–
26·0)
0·42 
(0·41–
0·44)
4·8 
(4·4–5·2)
1·6 
(1·4–1·8)
2·1 
(2·0–2·3)
1 986 281 
(1 828 505–
2 163 767)
2·16 
(2·02–2·32)
Uganda
2·1 
(0·9–
4·4)
108·5 
(97·4–
121·9)
246·8 
(226·3–
269·9)
246·1 
(234·2–
257·9)
198·9 
(185·1–
212·7)
146·0 
(131·7–
160·0)
80·2 
(73·0–
87·4)
19·2 
(15·7–
23·0)
0·37 
(0·36–
0·38)
5·2 
(5·0–5·5)
1·8 
(1·6–2·0)
2·2 
(2·1–2·4)
1 550 366 
(1 471 798–
1 638 382)
2·37 
(2·26–2·48)
Zambia
2·0 
(0·9–
4·3)
104·8 
(91·1–
121·6)
206·2 
(180·0–
236·7)
199·3 
(184·8–
216·1)
183·5 
(165·8–
203·6)
136·6 
(116·9–
158·8)
81·0 
(69·8–
91·8)
23·1 
(18·0–
28·3)
0·44 
(0·43–
0·46)
4·7 
(4·2–5·2)
1·6 
(1·4–1·8)
2·1 
(1·9–2·3)
634 965 
(568 251–
710 865)
2·1 
(1·9–2·31)
Southern 
sub-Saharan Africa
0·77 
(0·34–
1·61)
69·2 
(59·8–
81·1)
124·3 
(109·2–
143·1)
137·5 
(127·6–
149·0)
100·3 
(88·0–
113·7)
66·1 
(54·1–
79·6)
22·8 
(18·7–
27·5)
2·9 
(2·1–
3·8)
0·05 
(0·05–
0·06)
2·6 
(2·4–2·9)
0·97 
(0·85–1·12)
0·96 
(0·82–1·12)
1 748 266 
(1 595 640–
1 938 810)
1·19 
(1·09–1·32)
Botswana
0·5 
(0·22–
1·03)
45·8 
(39·3–
54·0)
115·1 
(102·5–
130·6)
119·0 
(111·2–
127·2)
95·3 
(87·3–
103·8)
66·5 
(58·7–
74·8)
24·9 
(21·5–
28·7)
4·3 
(3·3–
5·5)
0·08 
(0·08–
0·09)
2·4 
(2·2–2·5)
0·81 
(0·71–0·92)
0·96 
(0·87–1·04)
48 644 
(45 386–
52 258)
1·1 
(1·03–1·19)
Lesotho
1·1 
(0·5–
2·2)
70·2 
(61·2–
81·3)
150·9 
(132·5–
173·1)
123·4 
(113·2–
135·7)
108·8 
(97·0–
121·3)
73·9 
(61·8–
87·2)
38·4 
(32·1–
45·3)
6·5 
(4·5–
8·9)
0·12 
(0·12–
0·13)
2·9 
(2·6–3·2)
1·1 
(1·0–1·3)
1·1 
(1·0–1·3)
48 751 
(44 699–
53 717)
1·23 
(1·12–1·36)
Namibia
3·1 
(1·4–
6·4)
54·5 
(47·6–
63·1)
129·4 
(114·1–
147·9)
146·9 
(136·8–
157·4)
128·9 
(116·4–
142·0)
95·5 
(82·0–
109·8)
37·3 
(30·6–
44·8)
7·0 
(4·9–
9·8)
0·14 
(0·13–
0·14)
3·0 
(2·8–3·3)
0·93 
(0·82–1·07)
1·3 
(1·2–1·5)
59 520 
(54 862–
64 829)
1·4 
(1·28–1·52)
South Africa
0·59 
(0·26–
1·24)
59·3 
(50·2–
70·9)
102·9 
(84·1–
126·9)
129·6 
(117·0–
144·8)
89·0 
(76·0–
103·3)
56·7 
(44·2–
71·1)
18·1 
(13·4–
23·7)
1·9 
(1·3–
2·8)
0·04 
(0·04–
0·04)
2·3 
(2·0–2·6)
0·81 
(0·67–0·99)
0·83 
(0·68–1·0)
1 091 574 
(976 081–
1 238 233)
1·05 
(0·94–1·19)
Swaziland 
(eSwatini)
1·2 
(0·5–
2·4)
73·3 
(63·7–
85·2)
153·0 
(133·0–
177·1)
129·3 
(117·9–
143·0)
125·5 
(111·1–
142·7)
83·8 
(69·3–
101·8)
35·8 
(28·4–
45·3)
6·5 
(4·4–
9·1)
0·12 
(0·12–
0·13)
3·0 
(2·7–3·5)
1·1 
(1·0–1·3)
1·3 
(1·1–1·5)
30 680 
(26 863–
35 270)
1·36 
(1·18–1·56)
Zimbabwe
0·86 
(0·38–
1·82)
100·7 
(89·6–
114·2)
192·2 
(176·1–
208·8)
176·1 
(166·7–
185·8)
143·4 
(132·6–
154·6)
98·3 
(87·1–
109·9)
39·0 
(32·7–
45·8)
6·1 
(4·8–
7·8)
0·12 
(0·11–
0·12)
3·8 
(3·5–4·0)
1·5 
(1·4–1·6)
1·4 
(1·3–1·6)
469 094 
(438 268–
501 128)
1·7 
(1·6–1·81)
Western 
sub-Saharan Africa
2·5 
(1·1–
5·3)
98·0 
(86·9–
111·6)
203·0 
(187·9–
219·9)
222·8 
(214·1–
232·4)
207·2 
(196·6–
218·2)
147·2 
(133·7–
160·6)
78·0 
(69·4–
86·6)
29·1 
(26·2–
31·8)
0·56 
(0·54–
0·58)
4·9 
(4·6–5·3)
1·5 
(1·4–1·7)
2·3 
(2·1–2·5)
16 119 684 
(15 142 476–
17 204 806)
2·12 
(2·01–2·25)
Benin
6·2 
(2·7–
12·9)
79·3 
(69·3–
91·6)
204·3 
(182·9–
229·0)
224·2 
(210·5–
239·8)
203·1 
(186·6–
221·6)
134·7 
(116·5–
153·0)
74·0 
(63·7–
84·3)
28·9 
(23·9–
33·7)
0·56 
(0·54–
0·58)
4·8 
(4·4–5·2)
1·4 
(1·3–1·6)
2·2 
(2·0–2·4)
420 926 
(387 743–
457 500)
2·09 
(1·96–2·24)
Burkina Faso
2·4 
(1·0–
5·0)
98·0 
(86·9–
111·5)
235·6 
(214·1–
260·0)
247·3 
(234·4–
261·7)
217·2 
(201·6–
234·4)
164·4 
(148·0–
180·2)
85·9 
(76·6–
94·9)
29·0 
(25·1–
32·7)
0·56 
(0·54–
0·58)
5·4 
(5·1–5·8)
1·7 
(1·5–1·9)
2·5 
(2·3–2·7)
850 128 
(792 781–
913 615)
2·31 
(2·2–2·44)
Cameroon
2·3 
(1·0–
4·9)
91·9 
(80·0–
106·7)
172·9 
(150·4–
199·7)
164·5 
(151·4–
179·8)
166·3 
(149·8–
185·4)
115·4 
(97·5–
136·4)
55·3 
(45·8–
65·5)
18·0 
(14·4–
21·9)
0·35 
(0·33–
0·36)
3·9 
(3·5–4·4)
1·3 
(1·2–1·5)
1·8 
(1·6–2·0)
860 875 
(767 156–
970 019)
1·73 
(1·54–1·94)
Cape Verde
1·4 
(0·6–
2·9)
35·3 
(29·6–
42·1)
88·8 
(71·9–
108·7)
113·3 
(101·8–
126·1)
89·1 
(75·8–
104·2)
63·4 
(49·3–
80·1)
26·2 
(19·5–
34·6)
19·4 
(14·4–
25·0)
0·37 
(0·36–
0·39)
2·2 
(1·8–2·6)
0·63 
(0·51–0·76)
0·99 
(0·8–1·22)
9895 
(8296–11 738)
1·04 
(0·86–1·24)
Chad
3·2 
(1·4–
6·9)
172·7 
(155·9–
192·3)
294·7 
(271·9–
319·2)
306·6 
(295·9–
317·0)
270·3 
(258·4–
281·4)
188·0 
(173·9–
201·0)
84·4 
(75·2–
93·3)
24·2 
(20·2–
28·2)
0·47 
(0·45–
0·48)
6·7 
(6·4–7·0)
2·4 
(2·2–2·6)
2·8 
(2·7–3·0)
716 150 
(684 354–
753 893)
2·81 
(2·71–2·92)
Côte d’Ivoire
3·1 
(1·4–
6·6)
99·1 
(87·1–
113·9)
187·7 
(163·1–
216·8)
184·2 
(169·9–
200·9)
183·6 
(166·2–
203·5)
136·2 
(117·3–
155·2)
77·9 
(67·8–
87·9)
28·1 
(23·4–
32·6)
0·54 
(0·52–
0·56)
4·5 
(4·1–4·9)
1·4 
(1·3–1·7)
2·1 
(1·9–2·3)
863 669 
(785 916–
951 705)
1·97 
(1·8–2·16)
(Table 1 continues on next page)
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2021
single calendar years and single-year age groups 
compared with previous assessments that reported 
results for 5-year age groups.4 The global population 
increased nearly three-fold between 1950 and 2017, from 
2·6 billion (2·5–2·6) people in 1950 to 7·6 billion 
(7·4–7·9) people in 2017
. Although global popu 
lation 
growth rates have declined from a peak of 2·0% in 1964 
to 1·1% in 2017, the size of the global population has 
steadily been increasing by more than 80 million people 
annually since 1985. These global estimates mask huge 
country variation, with 35 countries showing decreasing 
populations in 2017 whereas 57 countries had population 
growth at a rate higher than 2·0%. Country variation in 
population growth rates is driven to a large extent by 
wide variations in fertility rates and to a lesser extent by 
migration rates.
Of the 59 countries with a TFR of more than 
three livebirths per woman in 2017 (figure 9), 41 are in 
sub-Saharan Africa. Of the remainder, six countries are 
in north Africa and the Middle East. These continuous 
Age-specific fertility rate (livebirths per 1000 women annually)
Total 
fertility 
rate
Total 
fertility rate 
under age 
25 years
Total fertility 
rate from ages 
30 to 54 years 
Number of 
livebirths 
Net 
reproductive 
rate
10–14 
years
15–19 
years
20–24 
years
25–29 
years
30–34 
years
35–39 
years
40–44 
years
45–49 
years
50–54 
years
(Continued from previous page)
The Gambia
2·0 
(0·9–
4·3)
72·1 
(61·5–
85·5)
163·5 
(138·3–
193·9)
168·6 
(154·4–
185·4)
181·9 
(163·8–
202·5)
136·7 
(116·6–
159·4)
73·9 
(62·4–
85·5)
29·4 
(24·3–
34·3)
0·57 
(0·54–
0·59)
4·1 
(3·7–4·7)
1·2 
(1·0–1·4)
2·1 
(1·9–2·3)
68 878 
(60 884–
78 170)
1·88 
(1·68–2·09)
Ghana
1·2 
(0·5–
2·4)
49·5 
(41·8–
58·4)
131·5 
(109·5–
156·4)
160·4 
(146·5–
175·3)
160·0 
(142·4–
178·9)
111·6 
(92·4–
132·5)
55·1 
(44·2–
67·1)
25·3 
(20·2–
31·0)
0·49 
(0·47–
0·51)
3·5 
(3·0–4·0)
0·91 
(0·76–1·08)
1·8 
(1·5–2·0)
876 967 
(760 322–
1 005 644)
1·56 
(1·36–1·79)
Guinea
4·3 
(1·9–
9·0)
116·9 
(105·2–
131·1)
202·6 
(182·7–
223·0)
195·2 
(182·1–
210·2)
177·4 
(162·0–
193·0)
122·4 
(106·1–
138·9)
73·0 
(64·2–
81·8)
33·1 
(29·6–
36·3)
0·64 
(0·61–
0·66)
4·6 
(4·4–4·9)
1·6 
(1·5–1·7)
2·0 
(1·9–2·2)
434 559 
(409 818–
461 664)
1·98 
(1·88–2·08)
Guinea-Bissau
2·3 
(1·0–
4·8)
90·5 
(78·0–
104·7)
189·0 
(162·6–
217·5)
185·6 
(171·1–
201·1)
191·3 
(173·5–
209·8)
141·5 
(121·4–
163·8)
83·7 
(72·4–
96·0)
40·8 
(37·9–
43·5)
0·79 
(0·76–
0·82)
4·6 
(4·2–5·0)
1·4 
(1·2–1·6)
2·3 
(2·1–2·5)
68 623 
(62 211–
75 432)
2·01 
(1·84–2·19)
Liberia
1·3 
(0·6–
2·8)
99·9 
(87·7–
115·0)
183·5 
(160·3–
210·8)
165·9 
(152·5–
181·6)
168·1 
(151·7–
187·1)
125·4 
(107·7–
145·7)
76·0 
(65·3–
86·4)
28·5 
(23·8–
32·9)
0·55 
(0·53–
0·57)
4·2 
(3·8–4·7)
1·4 
(1·2–1·6)
2·0 
(1·8–2·2)
154 182 
(138 357–
172 510)
1·85 
(1·68–2·04)
Mali
3·1 
(1·3–
6·6)
145·8 
(132·4–
161·6)
254·1 
(232·4–
278·4)
266·1 
(253·6–
279·9)
234·7 
(220·5–
248·4)
178·5 
(164·1–
192·1)
89·6 
(81·0–
97·9)
32·1 
(28·2–
35·6)
0·62 
(0·59–
0·64)
6·0 
(5·7–6·4)
2·0 
(1·8–2·2)
2·7 
(2·5–2·9)
877 747 
(829 520–
932 043)
2·52 
(2·41–2·63)
Mauritania
2·0 
(0·9–
4·2)
69·7 
(60·1–
81·8)
155·0 
(134·5–
179·7)
164·2 
(151·4–
179·2)
192·3 
(177·0–
207·5)
146·2 
(129·5–
162·7)
68·9 
(59·8–
78·2)
32·1 
(27·8–
36·1)
0·62 
(0·59–
0·64)
4·2 
(3·8–4·5)
1·1 
(1·0–1·3)
2·2 
(2·0–2·4)
118 860 
(109 956–
129 685)
1·91 
(1·77–2·06)
Niger
3·2 
(1·4–
6·9)
174·9 
(158·1–
194·4)
303·5 
(282·6–
326·0)
315·5 
(305·2–
326·6)
278·4 
(267·0–
290·3)
201·2 
(188·6–
212·6)
101·9 
(92·9–
110·0)
37·3 
(33·7–
40·5)
0·72 
(0·69–
0·75)
7·1 
(6·8–7·4)
2·4 
(2·2–2·6)
3·1 
(3·0–3·2)
1 005 868 
(952 540–
1 063 380)
3·0 
(2·9–3·1)
Nigeria
2·3 
(1·0–
4·9)
91·5 
(80·1–
105·7)
202·4 
(179·3–
226·2)
239·9 
(226·4–
253·2)
219·2 
(204·0–
234·1)
152·4 
(136·0–
168·5)
82·5 
(73·2–
91·7)
30·4 
(26·0–
34·5)
0·58 
(0·56–
0·61)
5·1 
(4·7–5·5)
1·5 
(1·3–1·6)
2·4 
(2·2–2·6)
7 798 484 
(7 206 652–
8 409 904)
2·17 
(2·02–2·32)
São Tomé and 
Príncipe
1·0 
(0·4–
2·1)
57·3 
(49·8–
66·0)
145·8 
(126·3–
167·4)
114·6 
(103·7–
126·5)
139·2 
(123·5–
156·2)
104·1 
(88·0–
121·7)
69·1 
(58·1–
80·6)
18·6 
(14·8–
22·8)
0·36 
(0·34–
0·37)
3·3 
(2·8–3·7)
1·0 
(0·9–1·2)
1·7 
(1·4–1·9)
4948 
(4317–5639)
1·52 
(1·33–1·72)
Senegal
2·1 
(0·9–
4·4)
74·9 
(64·2–
88·4)
182·9 
(157·4–
213·2)
198·4 
(183·7–
215·2)
201·3 
(184·0–
218·4)
151·3 
(132·3–
169·9)
80·1 
(69·0–
91·0)
23·3 
(18·3–
28·4)
0·45 
(0·43–
0·47)
4·6 
(4·2–5·0)
1·3 
(1·1–1·5)
2·3 
(2·0–2·5)
496 713 
(457 701–
543 020)
2·1 
(1·94–2·27)
Sierra Leone
2·4 
(1·0–
5·0)
98·0 
(85·6–
113·3)
183·8 
(159·9–
208·7)
172·8 
(159·1–
186·9)
174·5 
(157·6–
191·7)
122·8 
(104·8–
141·3)
67·7 
(57·4–
78·2)
28·2 
(23·7–
32·5)
0·54 
(0·52–
0·56)
4·3 
(3·8–4·7)
1·4 
(1·3–1·6)
2·0 
(1·7–2·2)
269 005 
(243 337–
296 085)
1·79 
(1·64–1·95)
Togo
1·7 
(0·8–
3·6)
51·8 
(45·3–
60·1)
149·0 
(130·6–
171·3)
151·0 
(139·2–
165·0)
177·5 
(162·7–
192·5)
131·0 
(114·8–
147·2)
63·1 
(54·2–
72·3)
37·3 
(34·3–
39·9)
0·72 
(0·69–
0·75)
3·8 
(3·5–4·1)
1·0 
(0·9–1·2)
2·0 
(1·8–2·3)
223 039 
(207 346–
241 916)
1·69 
(1·58–1·81)
95% uncertainty intervals are in parentheses. Data are presented to the number of decimal places as accuracy of these data allows. Super-regions, regions, and countries are listed alphabetically. Total fertility rate is 
the number of livebirths expected per woman in each age group if she were to survive through the reproductive years (10–54 years) under the age-specific fertility rates at that timepoint. Net reproductive rate is 
the number of female livebirths expected per woman, given the observed age-specific mortality and fertility rates. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study. SDI=Socio-demographic Index.
Table 1: Age-specific fertility rates, total fertility rate, total fertility up to a maternal age of 25 years and during ages 30–54 years; the number of livebirths; and net reproductive rate, 
globally and for the SDI groups, GBD regions, super-regions, countries, and territories, 2017
 Global Health Metrics
2022 
www.thelancet.com   Vol 392   November 10, 2018
Persian Gulf
Caribbean
LCA
Dominica
ATG
TTO
Grenada
VCT
TLS
Maldives
Barbados
Seychelles
Mauritius
Comoros
West Africa
Eastern 
Mediterranean
Malta
Singapore
Balkan Peninsula
Tonga
Samoa
FSM
Fiji
Solomon Isl
Marshall Isl
Vanuatu
Kiribati
Persian Gulf
Caribbean
LCA
Dominica
ATG
TTO
Grenada
VCT
TLS
Maldives
Barbados
Seychelles
Mauritius
Comoros
West Africa
Eastern 
Mediterranean
Malta
Singapore
Balkan Peninsula
Tonga
Samoa
FSM
Fiji
Solomon Isl
Marshall Isl
Vanuatu
Kiribati
A
B
≤0·24
0·25–0·49
0·50–0·74
0·75–0·99
1·00–1·24
1·25–1·49
1·50–1·74
1·75–1·99
≥2·00
<0·50
0·50–0·99
1·00–1·49
1·50–1·74
1·75–1·99
2·00–2·24
2·25–2·49
2·50–2·99
≥3·00
Livebirths per woman
Livebirths per woman
Figure 6: Total fertility rates under age 25 years (A) and total fertility rate over age 30 years (B), in 2017, by location
Data are the number of livebirths expected for a hypothetical woman by age 25 years (A) or ageing from 30 to 54 years (B) who survived the age group and was exposed to current ASFRs. ATG=Antigua 
and Barbuda. FSM=Federated States of Micronesia. Isl=Islands. LCA=Saint Lucia. TLS=Timor-Leste. TTO=Trinidad and Tobago. VCT=Saint Vincent and the Grenadines.
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2023
A
B
Persian Gulf
Caribbean
LCA
Dominica
ATG
TTO
Grenada
VCT
TLS
Maldives
Barbados
Seychelles
Mauritius
Comoros
West Africa
Eastern 
Mediterranean
Malta
Singapore
Balkan Peninsula
Tonga
Samoa
FSM
Fiji
Solomon Isl
Marshall Isl
Vanuatu
Kiribati
Persian Gulf
Caribbean
LCA
Dominica
ATG
TTO
Grenada
VCT
TLS
Maldives
Barbados
Seychelles
Mauritius
Comoros
West Africa
Eastern 
Mediterranean
Malta
Singapore
Balkan Peninsula
Tonga
Samoa
FSM
Fiji
Solomon Isl
Marshall Isl
Vanuatu
Kiribati
<−60%
−60% to −41%
−40% to −21%
−20% to −11%
−10% to 9%
10% to 19%
20% to 39%
40% to 59%
≥60%
Change in total fertility rate
<1·07
1·07–1·09
1·10–1·12
1·13–1·15
>1·15
Ratio of males to females at birth
Figure 7: Percentage change in total fertility rates from 1975 to 2017 for women aged 30–54 years (A) and sex ratio at birth in 2017 (B), by location
Data are the number of livebirths expected for a hypothetical woman ageing from 30 to 54 years who survived the age group and was exposed to current age-specific fertility rates (A) and the ratio of males 
to females at birth (B). ATG=Antigua and Barbuda. FSM=Federated States of Micronesia. Isl=Islands. LCA=Saint Lucia. TLS=Timor-Leste. TTO=Trinidad and Tobago. VCT=Saint Vincent and the Grenadines.
 Global Health Metrics
2024 
www.thelancet.com   Vol 392   November 10, 2018
Persian Gulf
Caribbean
LCA
Dominica
ATG
TTO
Grenada
VCT
TLS
Maldives
Barbados
Seychelles
Mauritius
Comoros
West Africa
Eastern 
Mediterranean
Malta
Singapore
Balkan Peninsula
Tonga
Samoa
FSM
Fiji
Solomon Isl
Marshall Isl
Vanuatu
Kiribati
<–1·50
−1·50 to −1·0
−0·99 to −0·50
−0·49 to 0
0 to 0·49
0·50 to 0·99
1·00 to 1·49
1·50 to 1·99
≥2·00
Population growth rate (%)
Figure 8: Population growth rate from 2010 to 2017, by location
ATG=Antigua and Barbuda. FSM=Federated States of Micronesia. Isl=Islands. LCA=Saint Lucia. TLS=Timor-Leste. TTO=Trinidad and Tobago. VCT=Saint Vincent and the Grenadines.
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
Andorra
Bangladesh
Bosnia and Herzegovina
Brazil
China
Indonesia
India
Jordan
Japan
Kuwait
Luxembourg
Maldives
Northern Mariana Islands
Nigeria
Pakistan
Qatar
Russia
Saudi Arabia
South Sudan
USA
Samoa
−2
−1
0
1
2
3
4
5
1
2
3
4
5
6
7
Total fertility rate (livebirths per woman)
Population growth rate (%)
GBD super-region
Central Europe, eastern Europe, and central Asia
High income
Latin America and Caribbean
North Africa and Middle East
South Asia
Southeast Asia, east Asia, and Oceania
� Sub-Saharan Africa
Figure 9: Relationship between total fertility rates and the population growth rate, 2017
Total fertility rate is the average number of children a woman would bear if she survived through the end of the reproductive age span (age 10–54 years) and experienced at each age a particular set of 
age-specific fertility rates observed in the year of interest. Each dot represents a single country or territory. A vertical line is shown at the total fertility rate of 2·05, representing the replacement value, 
and a horizontal line is shown at a population growth rate of zero. 
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2025
1950
1960
1970
1980
1990
2000
2010
2017
Global
2 571 129 
(2 518 739–
2 623 555)
3 097 198 
(3 016 341–
3 175 666)
3 775 519 
(3 666 324–
3 878 482)
4 546 838 
(4 435 753–
4 651 568)
5 394 707 
(5 276 054–
5 506 245)
6 189 102 
(6 054 565–
6 317 018)
7 032 925 
(6 888 938–
7 176 044)
7 640 466 
(7 394 579–
7 863 850)
Low SDI
286 098 
(274 890–
297 338)
349 546 
(336 103–
363 341)
437 907 
(422 312–
454 314)
550 926 
(532 322–
569 634)
697 444 
(674 783–
720 903)
884 141 
(854 560–
913 871)
1 111 397 
(1 073 601–
1 150 583)
1 289 721 
(1 232 696–
1 350 886)
Low-middle SDI
428 432 
(409 330–
447 205)
525 533 
(502 817–
547 923)
664 708 
(640 177–
690 260)
842 355 
(812 779–
870 675)
1 044 178 
(1 009 021–
1 079 083)
1 267 751 
(1 225 483–
1 309 059)
1 512 969 
(1 462 697–
1 561 490)
1 704 731 
(1 638 487–
1 773 613)
Middle SDI
621 890 
(600 571–
645 428)
777 263 
(742 412–
812 838)
999 618 
(947 545–
1 048 416)
1 265 828 
(1 216 449–
1 313 285)
1 551 201 
(1 501 707–
1 605 269)
1 769 031 
(1 711 246–
1 829 574)
1 962 750 
(1 906 995–
2 020 809)
2 090 439 
(1 993 635–
2 188 823)
High-middle SDI
565 495 
(547 267–
585 066)
682 199 
(652 794–
713 287)
819 425 
(777 362–
859 588)
960 873 
(923 189–
999 256)
1 111 992 
(1 075 191–
1 151 041)
1 217 799 
(1 176 410–
1 260 107)
1 319 712 
(1 279 281–
1 364 508)
1 387 317 
(1 310 630–
1 462 683)
High SDI
660 034 
(642 623–
675 897)
749 699 
(733 577–
766 867)
836 408 
(818 207–
855 201)
905 978 
(885 242–
926 388)
965 963 
(945 156–
987 885)
1 024 486 
(1 001 540–
1 048 430)
1 098 420 
(1 074 557–
1 122 783)
1 139 825 
(1 098 829–
1 181 331)
Central Europe, eastern 
Europe, and central Asia
279 682 
(271 221–
287 601)
321 818 
(311 502–
331 710)
360 299 
(349 492–
370 047)
392 771 
(380 737–
404 444)
420 814 
(407 203–
433 044)
416 949 
(402 995–
430 201)
411 243 
(397 887–
423 691)
415 928 
(395 177–
435 487)
Central Asia
28 227 
(27 431–29 009)
35 702 
(34 598–36 847)
47 868 
(46 467–49 262)
58 719 
(56 970–60 513)
69 756 
(67 616–71 961)
74 835 
(71 158–78 628)
82 351 
(76 500–88 059)
90 925 
(83 164–99 015)
Armenia
1453 
(1352–1554)
1888 
(1750–2024)
2571 
(2408–2743)
3171 
(2936–3426)
3419 
(3161–3672)
3321 
(3071–3555)
3105 
(2872–3340)
3027 
(2705–3349)
Azerbaijan
3134 
(2934–3343)
3946 
(3651–4245)
5273 
(4910–5604)
6292 
(5851–6752)
7330 
(6767–7855)
8245 
(7597–8878)
9300 
(8577–9979)
10 225 
(8964–11 430)
Georgia
3698 
(3444–3957)
4225 
(3904–4523)
4807 
(4478–5152)
5171 
(4766–5548)
5508 
(5117–5908)
4691 
(4326–5071)
3971 
(3600–4344)
3691 
(3373–4045)
Kazakhstan
7859 
(7340–8388)
9966 
(9216–10 796)
13 419 
(12 438–14 356)
15 318 
(14 126–16 430)
16 843 
(15 523–18 040)
15 357 
(14 214–16 541)
16 204 
(16 114–16 287)
17 904 
(16 485–19 230)
Kyrgyzstan
1765 
(1641–1884)
2215 
(2049–2378)
3029 
(2811–3249)
3700 
(3433–3979)
4462 
(4138–4795)
5024 
(4639–5413)
5639 
(5251–6040)
6368 
(5587–7101)
Mongolia
809 
(758–860)
967 
(883–1050)
1276 
(1182–1370)
1693 
(1572–1814)
2152 
(1999–2314)
2440 
(2269–2607)
2826 
(2638–3023)
3251 
(2870–3619)
Tajikistan
1667 
(1558–1776)
2133 
(1972–2288)
3015 
(2809–3221)
4074 
(3766–4359)
5376 
(4988–5804)
6365 
(5933–6844)
7818 
(7339–8327)
9243 
(8191–10 251)
Turkmenistan
1252 
(1171–1332)
1619 
(1496–1746)
2228 
(2080–2377)
2920 
(2714–3137)
3701 
(3426–3980)
4202 
(3659–4764)
4559 
(4096–5030)
4976 
(4563–5397)
Uzbekistan
6588 
(6129–7015)
8738 
(8063–9404)
12 248 
(11 433–13 117)
16 375 
(15 242–17 475)
20 961 
(19 367–22 595)
25 186 
(21 683–28 853)
28 925 
(23 041–34 641)
32 236 
(24 584–39 887)
Central Europe
88 946 
(86 759–91 285)
101 568 
(98 788–
104 692)
110 731 
(107 678–
114 171)
120 005 
(116 244–
124 011)
124 127 
(120 615–
128 090)
121 176 
(117 460–
125 149)
117 167 
(115 229–
119 104)
114 803 
(112 042–
117 477)
Albania
1268 
(1186–1359)
1688 
(1576–1807)
2196 
(2035–2357)
2737 
(2531–2941)
3307 
(3048–3568)
3192 
(2968–3432)
2889 
(2674–3108)
2766 
(2469–3068)
Bosnia and Herzegovina
2831 
(2636–3025)
3352 
(3101–3613)
3819 
(3536–4087)
4230 
(3925–4531)
4509 
(4160–4853)
4085 
(3584–4617)
3768 
(3427–4101)
3399 
(3089–3720)
Bulgaria
7348 
(6835–7871)
8150 
(7389–8939)
8741 
(7893–9674)
9160 
(8212–10 013)
8914 
(8183–9640)
7965 
(7422–8598)
7442 
(7396–7486)
7052 
(6530–7576)
Croatia
3904 
(3625–4192)
4227 
(3905–4550)
4513 
(4143–4853)
4856 
(4497–5199)
4898 
(4527–5281)
4560 
(4235–4888)
4364 
(4058–4676)
4275 
(3838–4725)
Czech Republic
8850 
(8186–9456)
9495 
(8814–10 191)
9802 
(9168–10 485)
10 275 
(9535–11 013)
10 279 
(9458–11 050)
10 216 
(10 145–10 288)
10 470 
(10 397–10 548)
10 592 
(10 516–10 668)
Hungary
9325 
(8708–9957)
10 021 
(9354–10 715)
10 302 
(9603–11 011)
10 638 
(9973–11 385)
10 457 
(9702–11 197)
10 195 
(9432–10 949)
9930 
(9176–10 656)
9727 
(8739–10 785)
Macedonia
1311 
(1223–1406)
1434 
(1324–1541)
1666 
(1547–1788)
1943 
(1793–2083)
2010 
(1836–2200)
2021 
(1863–2186)
2130 
(1870–2379)
2174 
(1825–2523)
Montenegro
410 
(380–438)
478 
(445–510)
537 
(497–575)
592 
(549–633)
625 
(582–673)
635 
(578–693)
631 
(583–678)
626 
(558–693)
(Table 2 continues on next page)
 Global Health Metrics
2026 
www.thelancet.com   Vol 392   November 10, 2018
1950
1960
1970
1980
1990
2000
2010
2017
(Continued from previous page)
Poland
25 291 
(23 602–26 937)
30 308 
(28 285–32 322)
33 452 
(31 175–35 829)
36 651 
(33 547–39 682)
39 059 
(35 959–42 058)
38 898 
(35 689–41 955)
38 439 
(38 177–38 707)
38 393 
(38 118–38 672)
Romania
16 508 
(15 328–17 597)
18 917 
(17 237–20 689)
20 767 
(18 850–22 784)
22 690 
(20 777–24 679)
23 394 
(21 570–25 252)
22 389 
(20 571–24 271)
20 649 
(19 122–22 276)
19 433 
(17 350–21 520)
Serbia
6946 
(6491–7434)
7795 
(7188–8364)
8627 
(7948–9310)
9324 
(8636–9966)
9400 
(8633–10 120)
9642 
(8860–10 444)
9010 
(8348–9664)
8874 
(7849–9837)
Slovakia
3436 
(3420–3451)
4073 
(4055–4091)
4540 
(4518–4561)
4980 
(4956–5005)
5277 
(5248–5303)
5385 
(5352–5418)
5402 
(5364–5442)
5419 
(5006–5820)
Slovenia
1513 
(1406–1613)
1623 
(1496–1747)
1764 
(1639–1905)
1922 
(1775–2083)
1991 
(1776–2203)
1989 
(1976–2003)
2036 
(2020–2052)
2068 
(2053–2085)
Eastern Europe
162 508 
(154 850–
170 367)
184 547 
(175 249–
194 678)
201 699 
(191 753–
211 238)
214 047 
(203 174–
225 685)
226 929 
(214 331–
239 070)
220 936 
(208 467–
233 519)
211 724 
(200 353–
222 893)
210 199 
(192 574–
228 244)
Belarus
7418 
(6920–7900)
8422 
(7787–9053)
9277 
(8680–9865)
9857 
(9137–10 563)
10 455 
(9656–11 248)
10 225 
(9467–10 988)
9658 
(8899–10 409)
9491 
(8380–10 549)
Estonia
1031 
(1026–1035)
1204 
(1198–1210)
1352 
(1345–1359)
1472 
(1465–1480)
1568 
(1559–1576)
1393 
(1385–1402)
1332 
(1322–1341)
1314 
(1304–1324)
Latvia
1952 
(1817–2084)
2178 
(2014–2333)
2424 
(2256–2581)
2582 
(2393–2780)
2718 
(2518–2922)
2431 
(2250–2592)
2117 
(2103–2131)
1945 
(1931–1959)
Lithuania
2473 
(2299–2649)
2825 
(2629–3034)
3207 
(2994–3419)
3497 
(3245–3756)
3752 
(3473–4030)
3593 
(3328–3853)
3136 
(2882–3359)
2847 
(2828–2870)
Moldova
2520 
(2346–2691)
3056 
(2824–3277)
3684 
(3451–3937)
4112 
(3825–4411)
4463 
(4140–4790)
4202 
(3802–4597)
3870 
(3450–4290)
3721 
(3151–4276)
Russia
108 890 
(101 648–
116 491)
123 122 
(114 311–
132 472)
133 296 
(123 706–
142 273)
141 389 
(131 139–
152 459)
151 280 
(139 269–
162 850)
149 335 
(137 504–
161 416)
145 342 
(135 464–
155 198)
146 189 
(129 997–
162 390)
Ukraine
38 222 
(35 486–40 820)
43 737 
(40 535–46 886)
48 457 
(45 206–51 901)
51 135 
(47 072–54 769)
52 691 
(48 740–56 440)
49 754 
(46 128–53 518)
46 266 
(40 680–51 959)
44 689 
(37 188–51 843)
High income
624 261 
(607 829–
640 001)
704 358 
(687 585–
721 417)
784 499 
(765 553–
803 595)
852 184 
(830 617–
872 817)
909 777 
(888 581–
930 669)
968 090 
(945 346–
991 026)
1 036 657 
(1 012 835–
1 060 283)
1 074 889 
(1 033 559–
1 116 701)
Australasia
10 593 
(9938–11 222)
12 947 
(12 097–13 753)
15 656 
(14 634–16 627)
17 897 
(16 758–19 054)
20 271 
(18 932–21 552)
22 664 
(21 155–24 069)
25 864 
(24 172–27 407)
28 391 
(26 427–30 166)
Australia
8636 
(8016–9252)
10 511 
(9697–11 300)
12 761 
(11 805–13 698)
14 651 
(13 589–15 804)
16 854 
(15 599–18 087)
18 878 
(17 440–20 289)
21 598 
(20 005–23 097)
23 943 
(22 091–25 629)
New Zealand
1957 
(1827–2087)
2435 
(2254–2613)
2895 
(2687–3099)
3245 
(3009–3468)
3417 
(3159–3674)
3785 
(3504–4067)
4265 
(3899–4656)
4448 
(4042–4847)
High-income Asia Pacific
107 077 
(100 965–
112 694)
123 516 
(116 754–
130 199)
141 788 
(133 926–
149 440)
160 667 
(151 955–
169 179)
173 560 
(164 314–
182 570)
180 344 
(170 747–
189 636)
184 713 
(174 519–
194 370)
187 034 
(175 679–
198 805)
Brunei
62 
(58–66)
86 
(80–92)
134 
(124–144)
191 
(177–205)
258 
(239–277)
331 
(305–356)
394 
(363–424)
432 
(388–477)
Japan
85 811 
(79 862–91 233)
95 915 
(89 659–102 233)
106 925 
(99 115–114 411)
119 572 
(111 399–
127 742)
125 857 
(117 086–
134 191)
129 002 
(120 122–
137 746)
129 954 
(120 333–
138 917)
128 363 
(118 345–
139 043)
Singapore
1183 
(1104–1264)
1666 
(1517–1806)
2132 
(1985–2270)
2474 
(2319–2633)
3175 
(2972–3390)
4167 
(3873–4449)
5020 
(4674–5367)
5568 
(4906–6188)
South Korea
20 019 
(18 685–21 355)
25 848 
(24 052–27 742)
32 595 
(30 313–34 885)
38 429 
(35 734–40 903)
44 268 
(41 115–47 098)
46 842 
(43 520–49 950)
49 343 
(45 894–52 866)
52 670 
(48 472–56 781)
High-income North America
167 071 
(156 028–
177 729)
200 987 
(188 815–
213 853)
230 418 
(216 084–
244 897)
253 712 
(237 019–
269 916)
280 718 
(263 127–
298 908)
310 870 
(291 015–
330 560)
342 507 
(321 270–
364 211)
360 884 
(324 630–
398 446)
Canada
14 028 
(13 129–14 957)
18 300 
(16 943–19 638)
21 732 
(20 163–23 312)
24 473 
(22 762–26 217)
27 242 
(25 184–29 399)
30 301 
(28 135–32 397)
33 563 
(30 968–35 916)
35 982 
(33 302–38 581)
Greenland
24 
(22–25)
34 
(31–36)
47 
(44–50)
49 
(49–50)
55 
(55–55)
56 
(55–56)
56 
(56–56)
56 
(55–56)
USA
153 014 
(141 989–
163 572)
182 647 
(170 786–
195 050)
208 632 
(194 348–
222 510)
229 183 
(212 518–
245 136)
253 413 
(236 114–
271 078)
280 506 
(260 887–
299 946)
308 881 
(287 626–
330 134)
324 839 
(288 772–
362 239)
(Table 2 continues on next page)
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2027
1950
1960
1970
1980
1990
2000
2010
2017
(Continued from previous page)
Southern Latin America
25 759 
(24 521–27 013)
30 864 
(29 278–32 252)
36 133 
(34 286–37 829)
42 943 
(40 694–45 029)
49 550 
(46 839–52 051)
55 204 
(52 208–58 135)
61 228 
(58 049–64 578)
65 608 
(60 307–70 557)
Argentina
17 644 
(16 522–18 909)
20 665 
(19 199–21 994)
24 120 
(22 465–25 726)
28 791 
(26 865–30 710)
33 125 
(30 785–35 434)
36 784 
(34 178–39 630)
41 101 
(38 531–43 887)
44 265 
(39 144–49 229)
Chile
5865 
(5464–6251)
7614 
(7135–8153)
9203 
(8564–9843)
11 194 
(10 266–12 121)
13 282 
(12 242–14 355)
15 120 
(13 857–16 323)
16 762 
(14 885–18 566)
17 918 
(16 679–19 069)
Uruguay
2246 
(2088–2398)
2582 
(2353–2818)
2806 
(2530–3094)
2955 
(2663–3243)
3139 
(2824–3483)
3297 
(2988–3604)
3360 
(3106–3600)
3421 
(3059–3767)
Western Europe
313 759 
(302 436–
325 156)
336 042 
(327 368–
344 888)
360 501 
(351 707–
369 451)
376 964 
(367 690–
386 532)
385 678 
(378 299–
393 326)
399 006 
(391 457–
406 653)
422 344 
(416 202–
428 409)
432 969 
(421 014–
445 856)
Andorra
5 
(5–5)
9 
(8–10)
18 
(17–20)
34 
(31–37)
54 
(53–54)
65 
(65–66)
84 
(83–84)
79 
(79–80)
Austria
6922 
(6482–7400)
7044 
(6537–7546)
7431 
(6891–7997)
7541 
(7017–8108)
7765 
(7224–8321)
8017 
(7447–8594)
8368 
(8301–8430)
8793 
(8730–8855)
Belgium
8663 
(8082–9214)
9127 
(8464–9784)
9649 
(9004–10 304)
9832 
(9080–10 615)
9977 
(9169–10 739)
10 252 
(9503–11 028)
10 861 
(10 784–10 942)
11 319 
(11 226–11 408)
Cyprus
488 
(453–521)
590 
(550–633)
641 
(557–724)
669 
(612–726)
775 
(716–836)
915 
(848–980)
1120 
(1033–1205)
1262 
(1138–1391)
Denmark
4270 
(3976–4562)
4587 
(4281–4909)
4934 
(4585–5269)
5115 
(5080–5148)
5139 
(5101–5177)
5329 
(5288–5372)
5529 
(5483–5574)
5732 
(5682–5779)
Finland
4028 
(3743–4316)
4433 
(4132–4726)
4629 
(4605–4656)
4796 
(4764–4827)
5001 
(4969–5034)
5182 
(5146–5220)
5375 
(5335–5416)
5517 
(5474–5561)
France
43 137 
(40 160–46 060)
46 780 
(43 056–50 537)
51 885 
(47 890–56 018)
54 904 
(50 517–59 115)
57 712 
(53 593–61 378)
59 846 
(55 427–64 284)
63 693 
(59 476–67 922)
65 712 
(59 712–71 552)
Germany
71 934 
(62 172–82 007)
75 192 
(69 750–80 580)
79 263 
(73 661–84 235)
80 311 
(75 192–85 827)
80 041 
(79 562–80 550)
82 317 
(81 737–82 927)
81 692 
(81 091–82 343)
83 294 
(74 704–91 872)
Greece
7766 
(7251–8272)
8583 
(7943–9231)
8930 
(8259–9581)
9841 
(9137–10 578)
10 418 
(9642–11 205)
11 073 
(10 256–11 901)
11 034 
(10 265–11 774)
10 402 
(9301–11 460)
Iceland
141 
(140–141)
173 
(172–174)
203 
(202–204)
227 
(225–228)
253 
(252–255)
279 
(277–281)
318 
(315–320)
337 
(334–340)
Ireland
3048 
(2852–3245)
2900 
(2684–3118)
3030 
(2801–3274)
3487 
(3215–3754)
3599 
(3331–3858)
3862 
(3555–4164)
4595 
(4230–4972)
4860 
(4519–5217)
Israel
1556 
(1451–1667)
2168 
(1999–2324)
3037 
(2802–3282)
3875 
(3561–4213)
4963 
(4474–5456)
6388 
(5759–7071)
7841 
(7191–8497)
8949 
(7824–10 109)
Italy
46 697 
(43 475–49 705)
50 891 
(46 782–54 804)
53 853 
(49 819–57 792)
56 424 
(52 179–60 406)
56 799 
(52 808–60 687)
56 661 
(52 418–60 671)
60 328 
(59 854–60 768)
60 597 
(60 155–61 024)
Luxembourg
307 
(286–327)
322 
(300–343)
347 
(324–370)
368 
(339–396)
387 
(357–414)
433 
(401–466)
502 
(498–506)
590 
(585–595)
Malta
333 
(311–355)
328 
(301–357)
321 
(293–351)
339 
(306–373)
369 
(331–407)
400 
(361–440)
422 
(389–453)
434 
(392–480)
Netherlands
10 035 
(9980–10 086)
11 414 
(11 353–11 475)
12 972 
(12 903–13 048)
14 083 
(13 985–14 174)
14 914 
(14 810–15 021)
15 875 
(15 751–16 002)
16 585 
(16 442–16 731)
17 029 
(16 889–17 177)
Norway
3277 
(3060–3501)
3590 
(3344–3820)
3885 
(3621–4154)
4094 
(3840–4381)
4233 
(4205–4262)
4472 
(4439–4507)
4858 
(4821–4899)
5263 
(5219–5310)
Portugal
8749 
(8131–9348)
9189 
(8582–9837)
8894 
(8270–9519)
10 007 
(9248–10 726)
10 123 
(9342–10 866)
10 518 
(9764–11 278)
10 771 
(10 010–11 517)
10 681 
(9534–11 855)
Spain
28 823 
(26 809–30 811)
31 464 
(29 402–33 634)
35 014 
(32 739–37 502)
38 402 
(35 587–41 263)
39 659 
(37 010–42 676)
40 803 
(40 523–41 063)
46 980 
(46 656–47 300)
46 389 
(42 868–49 868)
Sweden
7038 
(6547–7532)
7500 
(7009–8008)
8046 
(8000–8089)
8304 
(8256–8355)
8575 
(8521–8630)
8892 
(8827–8957)
9404 
(9331–9468)
10 044 
(9340–10 726)
Switzerland
4812 
(4468–5149)
5536 
(5148–5914)
6374 
(5930–6794)
6494 
(6069–6939)
6971 
(6517–7430)
7401 
(6916–7870)
7950 
(7887–8009)
8593 
(7909–9209)
UK
51 455 
(48 480–54 194)
53 936 
(50 656–57 264)
56 820 
(53 576–60 255)
57 464 
(53 834–60 763)
57 567 
(53 983–61 179)
59 617 
(55 956–63 260)
63 595 
(59 545–67 590)
66 635 
(60 812–72 583)
England
42 108 
(39 171–44 851)
44 433 
(41 093–47 763)
47 051 
(43 853–50 449)
47 867 
(44 155–51 133)
47 955 
(44 409–51 589)
49 796 
(46 122–53 444)
53 318 
(49 243–57 349)
56 042 
(50 152–61 990)
(Table 2 continues on next page)
 Global Health Metrics
2028 
www.thelancet.com   Vol 392   November 10, 2018
1950
1960
1970
1980
1990
2000
2010
2017
(Continued from previous page)
Northern Ireland
1408 
(1312–1500)
1461 
(1350–1566)
1568 
(1450–1692)
1526 
(1420–1647)
1596 
(1484–1715)
1705 
(1575–1845)
1826 
(1693–1962)
1914 
(1711–2112)
Scotland
5257 
(4919–5591)
5313 
(4922–5705)
5392 
(4985–5808)
5186 
(4812–5570)
5112 
(4718–5475)
5159 
(4778–5536)
5362 
(4954–5775)
5501 
(4880–6075)
Wales
2681 
(2493–2853)
2727 
(2527–2939)
2807 
(2591–3016)
2885 
(2664–3103)
2902 
(2681–3116)
2956 
(2738–3188)
3087 
(2855–3326)
3176 
(2865–3512)
Latin America and Caribbean
141 013 
(136 721–
145 145)
187 699 
(181 895–
193 122)
249 570 
(242 059–
256 807)
320 251 
(310 191–
329 706)
391 272 
(378 561–
403 097)
465 311 
(451 038–
478 794)
534 453 
(517 913–
550 186)
581 946 
(553 278–
607 679)
Andean Latin America
13 876 
(13 314–14 475)
18 187 
(17 282–19 164)
23 910 
(22 641–25 227)
30 722 
(29 309–32 279)
38 359 
(36 434–40 371)
46 462 
(43 869–49 307)
53 990 
(51 448–56 723)
61 448 
(59 143–63 649)
Bolivia
2850 
(2648–3046)
3518 
(3079–3973)
4329 
(3849–4806)
5241 
(4767–5738)
6455 
(5906–6982)
8384 
(7758–9008)
10 124 
(9280–10 974)
11 542 
(10 295–12 716)
Ecuador
3301 
(3059–3523)
4436 
(4087–4795)
6012 
(5453–6537)
7818 
(7186–8436)
10 022 
(9345–10 688)
12 377 
(11 445–13 332)
14 906 
(13 941–15 882)
16 686 
(14 871–18 474)
Peru
7725 
(7207–8238)
10 232 
(9441–10 956)
13 568 
(12 427–14 616)
17 662 
(16 407–18 988)
21 882 
(19 972–23 707)
25 700 
(23 134–28 464)
28 959 
(26 635–31 236)
33 219 
(33 065–33 364)
Caribbean
17 715 
(17 167–18 255)
21 587 
(20 614–22 550)
26 151 
(25 327–26 952)
30 749 
(29 698–31 808)
35 316 
(33 544–37 048)
40 172 
(38 761–41 590)
43 926 
(42 256–45 624)
46 265 
(43 663–48 895)
Antigua and Barbuda
46 
(43–49)
56 
(52–60)
64 
(60–69)
60 
(52–68)
60 
(55–64)
76 
(70–82)
86 
(79–92)
88 
(79–98)
The Bahamas
79 
(74–85)
118 
(108–129)
169 
(158–180)
212 
(197–228)
257 
(239–275)
310 
(290–332)
354 
(330–380)
375 
(331–415)
Barbados
233 
(216–248)
240 
(225–256)
243 
(226–259)
251 
(234–268)
253 
(236–271)
256 
(240–273)
281 
(262–299)
295 
(264–330)
Belize
69 
(64–74)
94 
(88–100)
124 
(116–133)
150 
(140–160)
188 
(175–202)
239 
(222–256)
329 
(308–351)
394 
(348–439)
Bermuda
37 
(34–40)
44 
(41–47)
53 
(50–57)
55 
(51–59)
59 
(54–63)
63 
(59–67)
65 
(60–69)
65 
(58–73)
Cuba
5704 
(5330–6068)
6873 
(6156–7637)
8630 
(8064–9196)
9952 
(9226–10 687)
10 836 
(9518–12 097)
11 377 
(10 476–12 256)
11 435 
(10 572–12 351)
11 376 
(10 251–12 434)
Dominica
53 
(49–56)
62 
(57–66)
71 
(66–75)
75 
(69–80)
73 
(68–79)
70 
(65–75)
69 
(64–75)
68 
(61–76)
Dominican Republic
2301 
(2137–2457)
3201 
(2984–3425)
4251 
(3970–4548)
5730 
(5328–6143)
7201 
(6555–7836)
8659 
(7953–9316)
9752 
(9076–10 389)
10 451 
(9310–11 553)
Grenada
87 
(81–93)
92 
(86–97)
95 
(89–102)
94 
(87–101)
86 
(80–93)
102 
(94–110)
110 
(102–118)
110 
(98–122)
Guyana
429 
(400–457)
581 
(542–620)
728 
(678–777)
795 
(741–848)
779 
(721–831)
781 
(721–844)
752 
(695–812)
742 
(670–823)
Haiti
3282 
(3053–3521)
3906 
(3400–4444)
4455 
(4116–4804)
5063 
(4651–5478)
6376 
(5598–7140)
8203 
(7482–8886)
10 263 
(9170–11 395)
11 824 
(9880–13 736)
Jamaica
1453 
(1357–1550)
1668 
(1549–1778)
1868 
(1745–2001)
2216 
(2036–2397)
2372 
(2195–2552)
2641 
(2457–2847)
2766 
(2568–2977)
2779 
(2466–3081)
Puerto Rico
2209 
(2058–2360)
2426 
(2269–2585)
2792 
(2599–2987)
3280 
(3070–3491)
3612 
(3356–3875)
3876 
(3613–4125)
3799 
(3540–4062)
3665 
(3246–4091)
Saint Lucia
77 
(71–82)
90 
(84–96)
102 
(95–109)
118 
(110–126)
136 
(126–146)
155 
(144–166)
169 
(158–181)
176 
(156–197)
Saint Vincent and the 
Grenadines
75 
(70–80)
83 
(78–89)
89 
(83–95)
101 
(95–108)
110 
(101–118)
110 
(102–118)
112 
(103–120)
114 
(102–125)
Suriname
193 
(181–206)
287 
(259–314)
390 
(362–419)
367 
(322–409)
388 
(339–433)
449 
(418–479)
537 
(493–579)
572 
(516–627)
Trinidad and Tobago
671 
(626–715)
860 
(804–918)
969 
(904–1030)
1087 
(1012–1157)
1206 
(1124–1287)
1296 
(1208–1383)
1351 
(1246–1453)
1391 
(1241–1546)
Virgin Islands
27 
(25–29)
33 
(31–35)
66 
(62–71)
99 
(92–106)
106 
(99–112)
111 
(104–118)
108 
(101–115)
104 
(93–117)
Central Latin America
53 305 
(51 222–55 418)
72 777 
(69 750–75 647)
100 359 
(96 254–104 267)
132 448 
(126 681–
137 827)
164 144 
(157 392–
170 819)
199 489 
(191 315–
207 476)
232 490 
(223 115–
241 788)
255 488 
(238 702–
271 354)
Colombia
11 518 
(10 713–12 274)
16 035 
(14 502–17 505)
22 096 
(20 140–23 979)
26 989 
(24 200–29 733)
32 643 
(29 711–35 561)
39 822 
(35 746–43 843)
46 396 
(42 095–51 038)
50 606 
(43 109–58 074)
(Table 2 continues on next page)
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2029
1950
1960
1970
1980
1990
2000
2010
2017
(Continued from previous page)
Costa Rica
845 
(785–902)
1242 
(1134–1347)
1789 
(1639–1932)
2273 
(2057–2487)
3041 
(2732–3356)
3914 
(3646–4170)
4398 
(4093–4732)
4653 
(4190–5146)
El Salvador
1920 
(1789–2050)
2581 
(2399–2774)
3610 
(3351–3881)
4622 
(4048–5164)
5243 
(4825–5659)
5793 
(5178–6471)
5957 
(5422–6523)
6086 
(5315–6826)
Guatemala
2963 
(2763–3175)
4030 
(3679–4398)
5115 
(4688–5547)
6327 
(5859–6800)
8007 
(7215–8749)
10 939 
(10 111–11 825)
14 427 
(12 778–16 107)
16 924 
(14 243–19 628)
Honduras
1463 
(1364–1561)
1910 
(1772–2050)
2497 
(2271–2746)
3413 
(3049–3754)
4706 
(4334–5095)
6191 
(5739–6687)
7996 
(7316–8682)
9498 
(8567–10 397)
Mexico
27 378 
(25 506–29 357)
36 830 
(34 236–39 260)
51 009 
(47 429–54 370)
69 563 
(64 691–73 998)
85 439 
(79 728–91 534)
101 772 
(94 994–
108 972)
116 291 
(108 390–
123 903)
126 569 
(112 520–
141 480)
Nicaragua
1120 
(1047–1198)
1486 
(1354–1617)
1953 
(1810–2100)
2741 
(2383–3078)
3893 
(3496–4268)
4951 
(4482–5429)
5781 
(5208–6370)
6396 
(5487–7334)
Panama
815 
(762–871)
1110 
(1033–1189)
1483 
(1374–1578)
1876 
(1748–2000)
2387 
(2209–2545)
2907 
(2723–3115)
3491 
(3256–3735)
3921 
(3485–4377)
Venezuela
5280 
(4906–5656)
7550 
(6970–8118)
10 803 
(10 017–11 580)
14 640 
(13 601–15 719)
18 781 
(17 422–20 136)
23 197 
(21 380–24 971)
27 749 
(25 774–29 771)
30 831 
(27 589–34 127)
Tropical Latin America
56 114 
(52 441–59 899)
75 146 
(70 400–80 193)
99 149 
(92 501–105 855)
126 331 
(117 933–
134 844)
153 452 
(142 917–
164 089)
179 186 
(167 179–
191 447)
204 046 
(190 090–
218 128)
218 743 
(195 334–
242 050)
Brazil
54 761 
(51 039–58 521)
73 360 
(68 585–78 366)
96 804 
(90 169–103 453)
123 307 
(114 851–
131 752)
149 420 
(138 774–
159 951)
174 058 
(161 715–
186 328)
197 908 
(183 737–
211 808)
211 812 
(187 982–
234 855)
Paraguay
1353 
(1262–1446)
1786 
(1640–1921)
2345 
(2157–2533)
3024 
(2790–3260)
4031 
(3682–4369)
5128 
(4711–5564)
6138 
(5381–6897)
6931 
(5885–8046)
North Africa and Middle East
115 959 
(112 279–
119 565)
148 453 
(143 729–
153 233)
193 718 
(187 700–
199 829)
257 208 
(249 717–
264 577)
340 904 
(330 888–
350 735)
426 468 
(412 356–
440 350)
527 903 
(512 116–
544 418)
600 182 
(579 215–
621 820)
Afghanistan
7681 
(5541–9575)
9465 
(7772–11 203)
11 629 
(10 087–13 133)
12 052 
(11 180–12 917)
10 006 
(8643–11 335)
17 928 
(14 299–21 554)
26 294 
(19 416–33 390)
32 854 
(22 892–42 005)
Algeria
8799 
(8222–9375)
11 234 
(10 036–12 402)
13 781 
(12 541–15 031)
18 525 
(16 936–20 235)
25 463 
(23 280–27 514)
31 508 
(29 092–33 981)
36 293 
(33 467–39 148)
40 463 
(35 851–45 748)
Bahrain
116 
(107–124)
155 
(144–166)
216 
(199–232)
345 
(320–368)
507 
(471–545)
651 
(606–700)
1257 
(1170–1344)
1470 
(1305–1638)
Egypt
20 786 
(19 371–22 122)
27 091 
(25 383–28 856)
34 251 
(31 139–37 552)
43 063 
(39 177–46 961)
54 991 
(49 913–60 135)
66 897 
(61 131–72 575)
83 106 
(75 937–90 743)
96 484 
(90 094–102 841)
Iran
16 731 
(15 621–17 904)
21 780 
(19 732–23 814)
29 030 
(26 396–31 568)
40 335 
(36 967–44 296)
57 866 
(52 672–62 812)
67 498 
(61 587–73 597)
76 594 
(71 133–82 082)
82 176 
(75 839–88 022)
Iraq
5377 
(5048–5724)
7156 
(6535–7761)
9710 
(8716–10 707)
13 627 
(12 253–14 787)
17 444 
(15 844–19 013)
26 408 
(22 685–30 551)
34 359 
(26 137–41 960)
43 304 
(31 839–54 011)
Jordan
441 
(335–550)
736 
(602–871)
1300 
(1133–1475)
2282 
(2116–2453)
3739 
(3401–4095)
4849 
(4413–5301)
7534 
(6787–8274)
10 648 
(9754–11 559)
Kuwait
94 
(84–104)
283 
(263–305)
772 
(720–824)
1403 
(1312–1495)
1773 
(1591–1959)
1978 
(1776–2176)
3010 
(2780–3238)
4262 
(3821–4708)
Lebanon
1335 
(1243–1421)
1750 
(1538–1967)
2285 
(2128–2449)
3202 
(2787–3626)
4109 
(3347–4867)
5270 
(4041–6636)
6510 
(4425–8615)
8511 
(5685–11 791)
Libya
1070 
(994–1142)
1427 
(1294–1568)
1915 
(1742–2079)
3078 
(2787–3357)
4184 
(3769–4614)
5035 
(4540–5535)
6188 
(5601–6770)
6908 
(5974–7823)
Morocco
9176 
(8574–9848)
11 890 
(11 090–12 712)
15 497 
(14 336–16 617)
20 157 
(18 632–21 698)
25 207 
(22 885–27 584)
29 532 
(26 635–32 424)
33 167 
(30 016–36 275)
35 488 
(32 624–38 856)
Oman
442 
(290–590)
614 
(451–776)
897 
(705–1087)
1343 
(1145–1550)
1917 
(1747–2092)
2301 
(2095–2500)
2850 
(2664–3039)
4535 
(4508–4563)
Palestine
926 
(777–1083)
973 
(865–1083)
1102 
(1005–1203)
1430 
(1229–1635)
2037 
(1810–2269)
3036 
(2768–3312)
4175 
(3822–4524)
4852 
(4536–5156)
Qatar
26 
(18–33)
56 
(43–69)
131 
(109–152)
273 
(243–301)
443 
(401–483)
592 
(538–643)
1741 
(1622–1859)
2747 
(2525–2976)
(Table 2 continues on next page)
 Global Health Metrics
2030 
www.thelancet.com   Vol 392   November 10, 2018
1950
1960
1970
1980
1990
2000
2010
2017
(Continued from previous page)
Saudi Arabia
4329 
(4036–4638)
4644 
(4032–5254)
5956 
(5386–6526)
9691 
(8731–10 787)
16 386 
(14 964–17 729)
21 143 
(19 108–23 200)
28 053 
(26 153–30 133)
34 444 
(30 598–38 365)
Sudan
6013 
(5610–6390)
7146 
(6463–7843)
10 351 
(9412–11 273)
14 602 
(13 374–15 958)
20 209 
(18 414–21 941)
27 119 
(24 040–30 238)
34 285 
(31 632–37 135)
40 255 
(34 770–45 494)
Syria
3400 
(3173–3633)
4708 
(4377–5039)
6530 
(6094–6946)
9087 
(8429–9740)
12 687 
(11 444–13 866)
16 588 
(14 961–18 057)
22 738 
(20 396–25 034)
18 131 
(15 317–20 564)
Tunisia
3691 
(3431–3942)
4302 
(3922–4704)
5117 
(4656–5619)
6562 
(5955–7194)
8412 
(7628–9214)
9901 
(8986–10 817)
10 810 
(9827–11 809)
11 442 
(10 350–12 472)
Turkey
21 175 
(19 749–22 566)
27 605 
(25 702–29 512)
36 107 
(33 578–38 511)
45 410 
(42 172–48 627)
57 681 
(53 805–61 370)
65 949 
(58 509–73 185)
74 297 
(73 904–74 694)
80 456 
(80 023–80 937)
United Arab Emirates
73 
(59–86)
105 
(93–117)
250 
(229–270)
1075 
(1004–1146)
1887 
(1706–2073)
3251 
(2922–3575)
8958 
(8048–9894)
9734 
(8433–11 170)
Yemen
4254 
(2729–5807)
5291 
(3764–6756)
6804 
(5262–8251)
9499 
(8020–10 922)
13 726 
(12 427–14 966)
18 706 
(17 088–20 302)
25 182 
(22 469–27 784)
30 449 
(25 793–35 167)
South Asia
457 107 
(430 732–
483 061)
552 631 
(517 605–
586 189)
698 004 
(656 913–
739 771)
891 598 
(838 523–
941 440)
1108 770 
(1043 283–
1175 270)
1346 782 
(1265 595–
1426 290)
1605 324 
(1508 063–
1700 357)
1782 677 
(1638 317–
1941 429)
Bangladesh
41 397 
(38 577–44 053)
48 333 
(44 678–51 917)
65 862 
(59 840–71 907)
83 984 
(77 577–90 506)
108 900 
(101 213–
116 979)
128 604 
(119 080–
137 940)
145 626 
(134 711–
156 550)
156 981 
(140 228–
173 145)
Bhutan
181 
(169–194)
221 
(193–249)
293 
(237–350)
404 
(315–489)
562 
(475–649)
603 
(543–665)
789 
(715–869)
957 
(826–1094)
India
372 174 
(346 875–
397 889)
454 421 
(420 507–
487 432)
561 030 
(520 907–
600 806)
708 230 
(657 702–
757 375)
871 428 
(805 834–
934 597)
1052 960 
(971 762–
1131 565)
1249 523 
(1156 683–
1341 804)
1380 560 
(1236 095–
1534 340)
Nepal
8346 
(7781–8884)
9837 
(9139–10 572)
11 976 
(11 092–12 844)
15 574 
(14 479–16 722)
19 373 
(17 882–20 852)
23 878 
(22 183–25 498)
27 649 
(25 630–29 701)
29 891 
(26 626–32 797)
Pakistan
35 007 
(32 485–37 379)
39 815 
(36 728–42 755)
58 840 
(54 193–63 438)
83 404 
(77 107–89 378)
108 505 
(96 417–120 410)
140 735 
(129 490–
152 140)
181 734 
(161 683–
201 652)
214 287 
(199 020–
228 949)
Southeast Asia, east Asia, 
and Oceania
774 843 
(736 072–
814 983)
957 155 
(890 929–
1021 806)
1201 660 
(1101 819–
1287 271)
1460 435 
(1369 642–
1543 503)
1731 863 
(1642 563–
1818 200)
1921 127 
(1821 758–
2016 695)
2068 109 
(1975 307–
2162 325)
2158 800 
(1981 518–
2320 037)
East Asia
583 744 
(547 376–
625 484)
712 646 
(650 162–
777 420)
891 338 
(796 510–
980 025)
1073 817 
(986 653–
1157 549)
1258 648 
(1176 009–
1347 979)
1366 510 
(1275 694–
1459 970)
1439 061 
(1351 366–
1531 406)
1485 714 
(1316 627–
1646 304)
China
557 744 
(520 768–
597 524)
678 243 
(616 756–
742 010)
846 255 
(752 128–
933 401)
1019 880 
(933 340–
1101 322)
1196 979 
(1115 557–
1286 245)
1298 681 
(1208 608–
1389 466)
1367 214 
(1280 251–
1457 810)
1412 480 
(1245 008–
1569 141)
North Korea
10 681 
(7186–14 481)
12 431 
(9222–15 787)
15 201 
(12 024–18 317)
17 633 
(14 984–20 053)
20 296 
(18 578–22 146)
23 188 
(20 485–25 862)
25 160 
(23 167–27 154)
25 716 
(22 826–28 768)
Taiwan (province of China)
7575 
(7535–7617)
10 805 
(10 751–10 858)
14 617 
(14 553–14 681)
17 908 
(17 828–17 986)
20 402 
(20 294–20 517)
22 286 
(22 152–22 417)
23 191 
(23 025–23 360)
23 583 
(23 397–23 769)
Oceania
2656 
(2330–2976)
3236 
(3024–3465)
4072 
(3870–4281)
5115 
(4879–5339)
6457 
(5883–7021)
8325 
(7924–8715)
10 685 
(10 105–11 292)
12 602 
(11 585–13 653)
American Samoa
19 
(18–20)
20 
(19–22)
27 
(25–29)
33 
(30–35)
48 
(45–51)
58 
(54–62)
56 
(52–60)
55 
(49–61)
Federated States of 
Micronesia
39 
(36–41)
50 
(44–57)
65 
(52–78)
84 
(72–98)
103 
(94–114)
109 
(102–116)
105 
(98–112)
103 
(93–115)
Fiji
297 
(276–317)
408 
(372–446)
542 
(489–594)
659 
(599–722)
762 
(693–833)
818 
(741–895)
875 
(798–949)
906 
(846–970)
Guam
61 
(57–65)
69 
(65–73)
87 
(81–93)
108 
(101–115)
136 
(127–146)
159 
(148–169)
163 
(153–175)
167 
(148–186)
Kiribati
30 
(27–32)
36 
(33–40)
46 
(42–50)
62 
(57–67)
74 
(69–79)
87 
(81–94)
107 
(100–114)
118 
(108–128)
Marshall Islands
11 
(7–14)
16 
(12–20)
23 
(19–27)
34 
(30–38)
45 
(42–49)
52 
(48–56)
54 
(50–58)
56 
(50–62)
Northern Mariana Islands
4 
(4–4)
6 
(5–7)
9 
(8–10)
16 
(15–18)
45 
(42–48)
72 
(67–77)
54 
(51–58)
44 
(40–49)
(Table 2 continues on next page)
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2031
1950
1960
1970
1980
1990
2000
2010
2017
(Continued from previous page)
Papua New Guinea
1726 
(1417–2022)
2031 
(1833–2241)
2499 
(2321–2693)
3156 
(2956–3362)
4064 
(3520–4594)
5525 
(5151–5884)
7543 
(7002–8110)
9227 
(8264–10 220)
Samoa
86 
(80–92)
114 
(106–122)
147 
(136–157)
160 
(148–173)
163 
(151–175)
178 
(164–190)
192 
(178–206)
198 
(183–212)
Solomon Islands
105 
(98–112)
135 
(125–145)
170 
(159–181)
233 
(212–254)
337 
(307–369)
444 
(411–479)
552 
(509–593)
637 
(565–710)
Tonga
49 
(46–53)
66 
(59–72)
85 
(77–93)
95 
(86–104)
96 
(87–105)
100 
(91–110)
106 
(98–113)
102 
(95–110)
Vanuatu
49 
(46–53)
64 
(57–72)
88 
(80–95)
118 
(109–126)
150 
(139–161)
192 
(178–205)
247 
(229–265)
287 
(266–308)
Southeast Asia
188 442 
(182 191–
194 754)
241 272 
(232 260–
251 232)
306 249 
(295 068–
318 483)
381 501 
(369 792–
393 749)
466 758 
(451 577–
483 000)
546 290 
(515 395–
576 571)
618 362 
(598 861–
638 911)
660 484 
(625 637–
694 223)
Cambodia
4438 
(4137–4750)
5901 
(5400–6403)
7554 
(6695–8435)
7938 
(6417–9346)
10 428 
(9236–11 681)
12 634 
(11 624–13 711)
14 560 
(13 337–15 756)
16 122 
(14 157–18 177)
Indonesia
79 537 
(74 213–84 967)
98 406 
(91 399–105 742)
123 056 
(113 430–
132 056)
153 254 
(143 916–
162 920)
185 784 
(173 237–
198 423)
213 339 
(184 326–
242 359)
241 532 
(225 765–
257 592)
258 134 
(228 486–
286 754)
Laos
1694 
(1214–2166)
2107 
(1651–2593)
2632 
(2232–3062)
3302 
(2966–3630)
4136 
(3704–4539)
5330 
(4800–5868)
6360 
(5725–6943)
6970 
(6442–7469)
Malaysia
6249 
(5441–7015)
8316 
(7729–8849)
10 703 
(9952–11 389)
13 557 
(12 638–14 483)
17 639 
(16 264–18 971)
23 837 
(22 268–25 477)
28 119 
(26 310–30 148)
30 639 
(27 083–34 101)
Maldives
77 
(72–83)
92 
(85–100)
120 
(110–130)
162 
(148–176)
219 
(204–234)
278 
(259–298)
352 
(320–385)
458 
(420–497)
Mauritius
490 
(460–524)
668 
(614–723)
837 
(770–902)
991 
(902–1083)
1098 
(1028–1173)
1213 
(1128–1300)
1267 
(1176–1365)
1272 
(1147–1397)
Myanmar
19 282 
(17 833–20 583)
22 719 
(19 724–25 734)
27 646 
(25 258–30 089)
33 907 
(31 033–36 686)
40 438 
(36 067–44 754)
45 959 
(38 921–53 049)
50 146 
(45 580–55 132)
52 795 
(48 406–57 281)
Philippines
20 331 
(18 972–21 688)
28 707 
(26 687–30 602)
38 593 
(36 063–41 123)
49 864 
(46 687–52 939)
63 333 
(59 158–67 655)
79 807 
(74 205–85 456)
95 885 
(89 486–102 745)
103 470 
(94 554–111 888)
Sri Lanka
7860 
(7357–8423)
10 193 
(9265–11 080)
12 930 
(11 976–13 919)
15 187 
(14 082–16 304)
17 179 
(14 962–19 266)
18 798 
(16 243–21 314)
20 524 
(18 983–22 141)
21 596 
(19 459–23 802)
Seychelles
34 
(32–37)
43 
(40–46)
54 
(50–58)
66 
(60–72)
73 
(66–79)
81 
(74–88)
93 
(87–99)
100 
(90–112)
Thailand
20 403 
(18 913–21 794)
27 525 
(25 618–29 354)
35 509 
(33 009–37 896)
46 425 
(43 256–49 679)
57 028 
(53 286–60 983)
62 993 
(58 922–67 354)
67 779 
(63 187–72 386)
70 626 
(62 645–78 551)
Timor-Leste
413 
(360–467)
543 
(505–579)
560 
(491–630)
580 
(541–622)
781 
(726–835)
912 
(832–996)
1109 
(1034–1180)
1287 
(1188–1391)
Vietnam
27 356 
(25 495–29 238)
35 681 
(31 167–40 285)
45 566 
(39 978–51 388)
55 740 
(51 473–59 718)
67 997 
(62 530–73 389)
80 359 
(74 668–86 543)
89 793 
(83 334–96 170)
96 140 
(84 738–108 043)
Sub-Saharan Africa
178 260 
(164 732–
191 802)
225 081 
(211 487–
239 434)
287 767 
(275 293–
299 920)
372 388 
(360 384–
384 066)
491 304 
(479 290–
502 499)
644 373 
(625 722–
662 472)
849 233 
(824 168–
875 493)
1026 040 
(988 588–
1062 587)
Central sub-Saharan Africa
19 588 
(18 634–20 532)
25 453 
(23 155–27 713)
32 835 
(31 174–34 531)
41 915 
(38 838–44 872)
55 023 
(50 322–59 723)
73 396 
(65 208–82 601)
99 517 
(84 702–115 702)
121 670 
(99 121–143 192)
Angola
4393 
(4097–4705)
5152 
(4780–5526)
5934 
(5534–6338)
7508 
(6519–8450)
10 246 
(8354–12 310)
14 687 
(12 582–16 858)
21 784 
(19 754–24 078)
28 202 
(25 993–30 710)
Central African Republic
1348 
(1048–1648)
1630 
(1378–1902)
2062 
(1856–2266)
2294 
(2078–2515)
2734 
(2521–2971)
3612 
(3317–3931)
4404 
(3944–4879)
4622 
(3945–5323)
Congo (Brazzaville)
821 
(644–1015)
1034 
(878–1190)
1322 
(1198–1449)
1768 
(1598–1929)
2428 
(2157–2683)
3173 
(2811–3475)
4185 
(3840–4520)
4913 
(4244–5607)
Democratic Republic of the 
Congo
12 459 
(11 684–13 238)
16 949 
(14 650–19 201)
22 683 
(21 041–24 305)
29 288 
(26 433–32 003)
38 211 
(34 046–42 323)
50 035 
(42 266–58 951)
66 608 
(51 014–83 629)
80 884 
(57 964–102 607)
Equatorial Guinea
196 
(183–210)
217 
(189–243)
245 
(210–281)
300 
(274–328)
423 
(378–470)
653 
(543–757)
1034 
(932–1138)
1345 
(1236–1454)
Gabon
369 
(342–393)
470 
(438–501)
587 
(513–662)
754 
(645–869)
980 
(897–1076)
1233 
(1092–1376)
1500 
(1372–1624)
1702 
(1546–1857)
(Table 2 continues on next page)
 Global Health Metrics
2032 
www.thelancet.com   Vol 392   November 10, 2018
1950
1960
1970
1980
1990
2000
2010
2017
(Continued from previous page)
Eastern sub-Saharan Africa
63 017 
(57 728–68 369)
81 437 
(76 298–87 231)
107 317 
(102 585–
112 025)
142 590 
(138 124–
147 178)
191 563 
(185 668–
197 939)
248 306 
(240 183–
257 027)
326 270 
(315 878–
336 860)
393 180 
(375 866–
410 737)
Burundi
2391 
(1831–3025)
3015 
(2482–3612)
3632 
(3181–4089)
4439 
(4094–4783)
5500 
(5136–5863)
6265 
(5496–6987)
8976 
(8277–9684)
10 905 
(9535–12 329)
Comoros
158 
(132–184)
189 
(169–209)
254 
(231–277)
355 
(330–379)
462 
(429–495)
551 
(503–599)
650 
(575–731)
718 
(608–828)
Djibouti
62 
(46–76)
97 
(76–118)
156 
(132–179)
299 
(272–326)
498 
(443–553)
648 
(571–729)
902 
(838–970)
1113 
(984–1234)
Eritrea
1114 
(786–1436)
1467 
(1142–1783)
1938 
(1639–2239)
2568 
(2326–2805)
2893 
(2577–3200)
3499 
(2958–4084)
5191 
(3910–6431)
5859 
(4233–7490)
Ethiopia
17 731 
(12 350–22 674)
22 150 
(17 344–27 306)
27 867 
(23 496–32 244)
34 702 
(31 667–38 187)
51 404 
(47 067–56 618)
68 429 
(61 781–75 440)
86 259 
(78 817–93 383)
102 883 
(89 646–
116 198)
Kenya
5537 
(5181–5896)
7901 
(7298–8545)
11 965 
(11 037–12 807)
16 750 
(15 514–18 068)
23 198 
(21 587–24 928)
30 893 
(28 565–33 142)
40 694 
(37 600–43 784)
48 326 
(42 513–53 790)
Madagascar
4302 
(3997–4576)
5483 
(4766–6173)
7099 
(6407–7831)
9269 
(8376–10 167)
11 955 
(10 899–12 981)
15 858 
(14 259–17 526)
21 285 
(17 762–24 979)
26 108 
(20 426–31 770)
Malawi
2941 
(2736–3146)
3705 
(3315–4097)
4776 
(4343–5210)
6416 
(5840–6967)
9667 
(8850–10 466)
11 168 
(10 248–12 018)
14 338 
(13 150–15 501)
17 191 
(14 949–19 275)
Mozambique
6069 
(5643–6494)
7218 
(6746–7709)
9096 
(8487–9740)
12 285 
(11 388–13 163)
14 401 
(12 777–16 071)
17 315 
(15 781–18 860)
23 491 
(21 500–25 621)
30 035 
(27 827–31 998)
Rwanda
2515 
(2350–2695)
3173 
(2753–3574)
4067 
(3618–4519)
5341 
(4914–5777)
7266 
(6758–7812)
8139 
(7443–8811)
10 374 
(9574–11 208)
12 554 
(11 271–13 772)
Somalia
2336 
(2176–2488)
2906 
(2519–3290)
3829 
(3456–4206)
6424 
(5728–7071)
7175 
(6579–7781)
9738 
(8336–11 203)
13 574 
(10 638–16 499)
16 880 
(12 489–21 415)
South Sudan
2617 
(2347–2884)
3169 
(2887–3481)
3931 
(3315–4535)
4861 
(4437–5260)
5883 
(5198–6573)
7288 
(6440–8110)
9497 
(8689–10 238)
9941 
(8738–11 240)
Tanzania
7566 
(7030–8058)
10 278 
(9380–11 168)
13 870 
(12 628–15 021)
19 434 
(17 797–21 093)
25 888 
(23 767–27 993)
34 172 
(31 362–36 995)
44 584 
(41 315–47 884)
53 973 
(48 580–59 610)
Uganda
5291 
(4920–5642)
7368 
(6864–7877)
10 330 
(9552–11 147)
13 374 
(11 491–15 263)
17 349 
(16 088–18 628)
24 305 
(22 203–26 327)
32 574 
(29 492–35 541)
39 078 
(35 694–42 446)
Zambia
2368 
(2218–2525)
3285 
(2919–3697)
4463 
(4126–4793)
6010 
(5628–6376)
7919 
(7360–8483)
9881 
(9175–10 573)
13 670 
(12 838–14 542)
17 364 
(15 312–19 457)
Southern sub-Saharan Africa
17 644 
(16 546–18 863)
22 982 
(21 717–24 414)
30 803 
(29 257–32 561)
40 678 
(36 735–44 712)
52 481 
(48 570–56 500)
64 122 
(60 418–67 632)
70 987 
(67 220–74 904)
77 373 
(71 350–83 396)
Botswana
392 
(366–419)
515 
(467–562)
666 
(595–739)
920 
(850–991)
1310 
(1211–1404)
1692 
(1575–1815)
2008 
(1859–2159)
2281 
(2052–2527)
Lesotho
576 
(537–616)
762 
(688–831)
1045 
(943–1150)
1450 
(1306–1586)
1806 
(1644–1967)
1978 
(1795–2177)
1919 
(1745–2095)
1947 
(1675–2215)
Namibia
448 
(418–477)
574 
(536–612)
777 
(720–833)
1049 
(913–1188)
1415 
(1310–1523)
1844 
(1713–1972)
2118 
(1964–2275)
2353 
(2114–2595)
South Africa
13 151 
(12 211–14 119)
16 925 
(15 767–18 024)
22 606 
(21 186–24 070)
29 233 
(25 330–33 144)
36 773 
(32 941–40 675)
45 632 
(42 015–49 033)
50 861 
(47 239–54 509)
54 952 
(49 033–60 617)
Swaziland (eSwatini)
254 
(236–271)
334 
(299–369)
437 
(398–481)
587 
(533–639)
807 
(732–885)
1011 
(922–1102)
1068 
(978–1165)
1124 
(1047–1201)
Zimbabwe
2821 
(2014–3579)
3870 
(3104–4685)
5269 
(4550–5981)
7437 
(6855–8030)
10 366 
(9528–11 160)
11 961 
(10 986–12 887)
13 011 
(11 915–14 005)
14 713 
(13 330–16 032)
Western sub-Saharan Africa
78 009 
(65 663–90 262)
95 207 
(82 616–108 235)
116 810 
(105 261–
127 661)
147 204 
(137 869–
157 367)
192 235 
(184 599–
199 575)
258 547 
(245 286–
271 665)
352 458 
(336 581–
367 819)
433 815 
(413 644–
453 718)
Benin
2288 
(1723–2882)
2413 
(1926–2838)
2718 
(2400–3048)
3459 
(3209–3717)
4842 
(4456–5242)
6698 
(6148–7243)
9333 
(8506–10 124)
11 585 
(10 516–12 737)
Burkina Faso
4325 
(3282–5330)
4758 
(3933–5616)
5482 
(4907–6024)
7164 
(6481–7830)
9562 
(8610–10 525)
12 301 
(11 148–13 532)
16 868 
(15 293–18 437)
21 121 
(18 146–24 118)
Cameroon
4563 
(3495–5578)
5571 
(4638–6460)
6691 
(5980–7402)
8017 
(7253–8752)
10 355 
(9454–11 280)
14 965 
(13 507–16 519)
22 201 
(19 903–24 366)
27 769 
(23 792–31 860)
Cape Verde
155 
(145–164)
214 
(199–228)
283 
(264–303)
301 
(281–323)
351 
(326–376)
448 
(418–479)
508 
(472–542)
545 
(484–606)
(Table 2 continues on next page)
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2033
1950
1960
1970
1980
1990
2000
2010
2017
(Continued from previous page)
Chad
2559 
(1731–3399)
3093 
(2239–3948)
3703 
(2909–4507)
4621 
(3926–5314)
6037 
(5517–6569)
8267 
(7338–9195)
11 803 
(10 925–12 663)
15 222 
(13 380–17 036)
Côte d’Ivoire
3101 
(2883–3309)
4147 
(3600–4660)
5864 
(5263–6443)
8286 
(7495–9127)
12 251 
(11 216–13 262)
17 112 
(15 825–18 420)
21 621 
(19 620–23 447)
24 965 
(22 783–27 055)
The Gambia
264 
(247–280)
303 
(275–327)
456 
(418–495)
664 
(606–720)
986 
(903–1071)
1347 
(1237–1455)
1765 
(1607–1924)
2132 
(1932–2334)
Ghana
5099 
(4782–5444)
6894 
(6446–7342)
8985 
(8378–9584)
11 690 
(10 660–12 748)
14 936 
(13 332–16 513)
19 143 
(17 828–20 371)
25 227 
(23 528–26 958)
30 205 
(26 660–33 569)
Guinea
2945 
(2747–3149)
3369 
(2978–3764)
3967 
(3593–4331)
4655 
(4258–5057)
6148 
(5475–6817)
8121 
(7407–8826)
9983 
(9053–10 971)
11 819 
(10 848–12 828)
Guinea-Bissau
536 
(498–571)
570 
(531–611)
647 
(571–729)
813 
(751–869)
1009 
(936–1083)
1248 
(1085–1411)
1571 
(1450–1685)
1855 
(1636–2071)
Liberia
909 
(778–1043)
1079 
(999–1166)
1412 
(1283–1535)
1965 
(1779–2138)
1985 
(1776–2196)
2928 
(2573–3288)
4051 
(3722–4404)
4722 
(4138–5272)
Mali
3847 
(3584–4118)
4708 
(4136–5331)
5939 
(5316–6580)
7233 
(6536–7897)
8662 
(7915–9459)
11 028 
(10 142–11 941)
15 896 
(14 642–17 132)
20 253 
(17 822–22 672)
Mauritania
659 
(504–815)
874 
(720–1019)
1150 
(1019–1278)
1551 
(1408–1684)
2071 
(1903–2244)
2613 
(2437–2792)
3336 
(3058–3620)
3913 
(3560–4285)
Niger
2562 
(1964–3134)
3359 
(2785–3919)
4476 
(3984–4964)
5955 
(5447–6466)
8025 
(7371–8642)
11 245 
(10 391–12 091)
16 397 
(15 090–17 678)
21 375 
(19 349–23 648)
Nigeria
38 269 
(25 767–50 494)
46 573 
(34 104–59 648)
55 844 
(44 421–66 586)
69 128 
(60 148–79 038)
89 790 
(82 940–96 408)
121 832 
(109 542–
134 557)
166 431 
(152 067–
181 236)
206 087 
(188 405–
224 287)
São Tomé and Principe
62 
(58–66)
68 
(63–74)
76 
(71–81)
96 
(88–103)
121 
(112–130)
142 
(132–153)
174 
(160–188)
200 
(180–219)
Senegal
2529 
(1953–3162)
3397 
(2851–3959)
4523 
(4020–5024)
5860 
(5341–6380)
7624 
(7011–8229)
9910 
(9164–10 652)
12 556 
(11 482–13 626)
14 688 
(13 261–16 099)
Sierra Leone
1923 
(1640–2196)
2193 
(2009–2385)
2621 
(2378–2874)
3070 
(2770–3384)
3781 
(3413–4161)
4311 
(3917–4728)
6348 
(5717–6990)
7829 
(7207–8482)
Togo
1401 
(1245–1567)
1609 
(1477–1734)
1959 
(1823–2091)
2662 
(2483–2861)
3685 
(3262–4111)
4874 
(4289–5493)
6375 
(5963–6813)
7516 
(6726–8351)
Data are thousands of people (95% uncertainty intervals) for all ages and both sexes. Super-regions, regions, and countries are listed alphabetically. Estimates are de-facto population estimates. GBD=Global 
Burden of Diseases, Injuries, and Risk Factors Study. SDI=Socio-demographic Index.
Table 2: The global population and the populations of SDI groups, GBD regions and super-regions, countries, and territories, 1950–2017
high rates of total fertility are associated with high 
rates of population growth in sub-Saharan Africa and 
north Africa and the Middle East. The proportion of 
women whose contraceptive needs are being met 
through the provision of reproductive health services is 
46·5% (95% UI 45·2–47·6) in sub-Saharan Africa and 
69·0% (67·5–70·5) in north Africa and the Middle East.54 
Given that the economic benefits of the demographic 
dividend are estimated to occur when the working-age 
population represents more than 65% of the population,53 
government action to meet the need for family planning 
and to raise the educational attainment of women 
are two potential pathways towards faster economic 
growth. Notably, less than 55% of the population in 
sub-Saharan Africa, on average, are of working age, and 
this proportion is only slowly increasing. Fast economic 
growth in sub-Saharan Africa from 2002 to 2014 shows 
the potential for economic transition in the region; 
capitalising on the demographic dividend might add to 
this potential in the future. Policy options that focus on 
educating young girls, providing access to reproductive 
health services, and continued scale-up of effective 
interventions for child mortality are available to 
accelerate decreases in TFR and demographic change.
By contrast, 33 countries are in overall population 
decline since 2010, including Estonia, Ukraine, Belarus, 
Greece, Georgia, Bulgaria, Romania, and Spain. Many 
other countries are also likely to have decreasing 
populations as the size of their birth cohorts reduces. 
Population decline and the associated shift to an older 
population has profound cultural, economic, and social 
implications. One early measure of this trend is the 
percentage change in the number of livebirths over time; 
in 89 countries, the size of the birth cohort has decreased 
since 2000. The options in these countries to deal with 
the social and economic consequences of population 
decline include pro-natalist policies, liberal immigration 
policies, and increasing the retirement age. Pro-natalist 
policies have been pursued in more than a dozen 
countries but the effects on fertility rates have not been 
large.55–58 Liberal immigration policies have been effective 
in sustaining population numbers in several countries, 
 Global Health Metrics
2034 
www.thelancet.com   Vol 392   November 10, 2018
but such policies have been accom 
panied by social and 
political challenges in some. Dealing with population 
decline will be a central policy challenge for a substantial 
number of countries over the next few decades. 
In high-income countries, the proportion of the 
population that is of working age has also decreased in 
the past 5 years, and this trend is likely to continue 
for the foreseeable future. This demographic shift toward 
an older population has a broad range of consequences, 
from reductions in economic growth, decreasing tax 
revenue, greater use of social security with fewer 
contributors, and increasing health-care and other 
demands prompted by an ageing population.59–65 This 
shift is advanced in several high-income countries, with 
one of the earliest examples being Japan.66 Our estimates 
show that more than 20% of the population is older than 
65 years in eight countries, implying that the challenges 
of dealing effectively with ageing populations have 
already advanced in these settings. Similarly to overall 
population decline, several policy options have been 
debated and implemented, ranging from immigration, 
increasing retirement ages, pension reform, a focus on 
disease prevention, and investments in human capital, 
such as higher-level skill and knowledge building in a 
shrinking workforce.63,64 In these same regions, the effects 
of decreases in the proportion of the population aged 
15–64 years on economic productivity could be mitigated 
by individuals working far beyond age 65 years. This shift 
to later retirement is already occurring in many countries, 
including the USA, Australia, and Japan.67–72
The fertility rates in children and adolescents aged 
10–19 years is an SDG indicator for goal 3, target 3.7
. To 
our knowledge, our analysis provides the first annual 
time series of fertility rates in these age groups. Fertility 
rates in ages 15–19 years typically decrease with a 
country’s development but the trends in those aged 
10–14 years are less clear. In addition to the global 
patterns in fertility rates in children and adolescents, 
there are marked variations across countries at similar 
levels of development. Within SDI bands, the ratio of 
highest to lowest adolescent fertility rates is often more 
than an order of magnitude, highlighting that many 
factors other than development status contribute to the 
fertility rate in children and adolescents. Some countries 
have been able to reduce adolescent fertility rates faster 
than expected. A detailed analysis of the determinants of 
the variation in fertility rate among children and 
adolescents across SDI bands, including policy factors, is 
beyond the scope of this study, but this finding suggests 
that such research is urgently needed.
The population decline that we found in Syria indicates 
the potentially important role of conflict on both fertility 
and migration rates. Conflict in some settings, such as in 
Kuwait during the first Persian Gulf War, can reduce 
fertility rates, but other examples have been found where 
conflict has led to younger marriage and increased 
fertility rates.73 We explored adding the death rate from 
conflict as a covariate to the fertility estimation model 
but we found that this variable, on average, did not 
predict changes in fertility; this finding is consistent with 
1950
1955
1960
1965
1970
1975
1980
1985
1990
1995
2000
2005
2010
2015 2017
0
50
55
75
65
Proportion of the population who are working-age (%)
Year
60
70
GBD super-region
Central Europe, eastern Europe, and central Asia
High income
Latin America and Caribbean
North Africa and Middle East
South Asia
Southeast Asia, east Asia, and Oceania
Sub-Saharan Africa
Global
Figure 10: Proportion of the population that is of working age, globally and for GBD super-regions, 1950–2017
Working age is defined as 15–64 years. Data are for both sexes combined from 1950 to 2017. GBD= Global Burden of Diseases, Injuries, and Risk Factors Study.
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2035
examples of increases and decreases in fertility in 
individual countries. Conflict is also associated with large 
migration flows; many of these are captured in the 
UNHCR migrant stock and derived flow data. Given the 
large-scale migration seen during the conflict in Syria, a 
deeper understanding of what determines the magnitude 
of migration before, during, and after conflict would be 
useful in planning public health, social, and policy 
interventions to ameliorate the effects of migration on 
individuals and families.
Sex ratios in most countries remain in the narrow band 
of 1·03–1·07 male livebirths for every female livebirth. 
We found in some countries, most notably India and 
China, that since the availability of ultrasonography in the 
early 1980s, the ratio of males to females has increased. In 
China, the sex ratios in 2017 were in excess of 1·16 males 
for every female. These ratios imply very substantial 
sex-selective abortion and even the possibility of female 
infanticide. The effect of such pronounced sex ratios 
on patterns of social interaction might be substantial in 
future gener 
ations. From the perspective of demographic 
growth, high sex ratios at birth reduce the net reproductive 
rate to below that predicted from the TFR alone. In China, 
low TFR and high sex ratios led to a net reproductive rate 
of 0·69 female livebirths expected per woman.
Cross-cutting themes
An important debate in the medical literature about the 
decreases in fertility has been regarding the relative 
contribution of declines in the under-5 mortality rate, 
women’s educational attainment, and the availability 
of reproductive health services, particularly modern 
contraception methods.74–79 There is a strong correlation 
between 
estimated 
TFR 
and 
maternal 
education 
(r=–0·886), the met contraceptive need (r=–0·799), and the 
under-5 mortality rate (r=0·800), which are consistent over 
decades and across SDI quintiles. Nevertheless, use of 
time series of cross-sectional data to estimate causal 
relationships is particularly challenging given that all 
three of these measures are highly correlated. Under-
standing the magnitude of these different drivers and their 
complex interconnections is important to understand the 
future trajectory of ASFR. Fertility over the next few 
decades is hard to forecast in regions such as western 
sub-Saharan Africa, where fertility rates remain high, 
progress on educational attainment has been relatively 
modest, met need for contraception remains low (despite 
some recent improvements), and under-5 mortality has 
considerably decreased. Our more detailed time series of 
these drivers could provide opportunities for future studies 
to disentangle the contribution of these different factors.
Many factors other than maternal education, repro-
ductive health services, and under-5 mortality rates 
influence annual fertility rates. The data compiled for 
our study show that there has been marked variation 
in fertility rates annually or over shorter durations in 
response to events with cultural significance or policy 
change. For example, the TFR in Singapore increased 
from 2·01 livebirths in 1999 to 2·39 livebirths in 2000, 
whereas in Japan in 1966—the year of the Fire Horse, 
during which giving birth to females was deemed 
unlucky80—the TFR decreased by 13% in a single year. 
Local legislation can also lead to an abrupt increase in the 
TFR: the introduction of a ban on abortion in Romania in 
1966 increased TFR from 2·72 livebirths to 3·53 livebirths 
in the year following the ban. This ban on abortion also 
led to increases in the maternal mortality rate. The recent 
change from the one-child policy in China to a policy 
that allows second births was associated with an 
11·7% increase in total livebirths from 2014 to 2017
. 
These abrupt variations in fertility rates highlight the 
importance of understanding the magnitude of policy 
changes on fertility rates, especially in settings where 
fertility rates might have decreased far below the 
replacement value.
Over the past 25 years, annual livebirths globally have 
remained between 133·5 million and 141·7 million 
livebirths per year. This comparative stability has occurred 
even during marked changes in the population of women 
of repro 
ductive age and highly heterogeneous trends in 
fertility rates. With each year, a larger proportion of the 
birth cohort is represented in regions with lower incomes 
and lower educational attainment because of different 
speeds of changing fertility in different locations, creating 
a phenomenon known as demographic headwinds.61,64,65 
As more births occur in increasingly difficult circum-
stances, the challenge of meeting the ambitious SDG 
targets will become more difficult. We would expect the 
pace of reductions in the global under-5 mortality rate to 
slow due to the changes in the birth cohort, and similar 
global slowing might be expected for other indicators 
such as childhood vaccination. Other changes, such as 
the slower rates of decrease in neonatal mortality than in 
mortality in post-neonatal infants (age 28–365 days) and 
children aged 1–4 years, might slow the decrease in 
overall child mortality. Evaluating global progress will 
need to take into account these important compositional 
shifts in the global birth cohort in terms of income and 
educational attainment.
Estimation challenges
The biggest challenge in creating population estimates 
that are consistent with observed population counts and 
with data on ASFR and age-specific mortality is the poor 
data available in many countries regarding net migration. 
We used the GBD Bayesian demographic balancing model 
to effectively infer net migration from the difference 
between the population expected from fertility and 
mortality rates and that observed in census or registry data. 
For some countries, the model has been informed with 
reported data on documented migration and UNHCR data 
on stocks and flows of refugees. Nevertheless, the only 
data that are increasingly available for many low-income 
and middle-income countries are stocks of migrants 
 Global Health Metrics
2036 
www.thelancet.com   Vol 392   November 10, 2018
reported at the time of the census. Although these data are 
clearly useful, different assumptions about mortality rates 
and the timing of migration can lead to very different 
estimates of past migration flows, leading to the same 
observed stock of migrants in each country being estimated 
for. Even within these data, some temporary migrants who 
move for employment opportunities might not be 
recorded. More transparent estimates of population with 
standardised methods, such as the methods that we have 
presented, will hopefully drive a more extensive debate on 
data sources for assessing migration and how to improve 
them in the future.
We identified and extracted results from national PESs 
in only 165 censuses, although it is likely that many more 
have been done but their results have not been publicly 
released. PESs use direct or indirect methods: direct 
PESs match the records of individuals with actual census 
records to estimate census completeness, whereas 
indirect methods ask PES respondents if they participated 
in the census. Direct matching is more reliable but much 
harder to conduct. Censuses and PESs can miss certain 
populations such as homeless people in some countries 
or excluded minorities. The absence of PESs for most 
censuses in most countries means that the actual 
population count in many countries is uncertain. To 
avoid systematic bias, we estimated census completeness 
in all countries. The issue of census completeness 
remains a major challenge and one that cannot easily be 
addressed for past censuses. It is unlikely, for example, 
that we will empirically resolve debates on census 
completeness for many censuses in the 1950s–2000s. 
At best, we can adequately represent this uncertainty in 
our results. Moving forward, standardising the reporting 
of PES results so that some form of systematic analysis 
can be done will aid in future assessments.
Age misreporting, including age heaping, is a sub 
stantial 
challenge in use of data from many censuses, particularly 
in locations where numeracy of the res 
pondents is 
relatively low.35,37 In fact, some education research has used 
age heaping as a proxy measure of the quality of 
mathematics education in a country.81 We detected age 
misreporting in many earlier censuses in many countries, 
often manifested by implausible immigration rates 
required to match census counts in the oldest age groups. 
We mitigated the effect of age misreporting by excluding 
some data in the oldest age groups so that the estimates 
are driven by census data at younger age groups and 
mortality estimates, and by increasing the variance of 
population counts at older ages, but this approach does not 
remove all the effects of systematic age misreporting. For 
age heaping, we used the Feeney, Arriaga, and Arriaga 
strong corrections, dependent on the details of age group 
available and the degree of age heaping. These approaches 
have helped to mitigate age misreporting and age-heaping 
issues, but further work on how to analyse these complex 
error patterns in the data will be helpful to improve future 
estimates.
Demographers have long recognised that population 
estimates are necessary for planning, regardless of the 
availability and quality of the data. The challenge for 
demographers is to produce the most plausible estimates 
of population that can be used, rather than simply 
cataloguing all the limitations of the available data or the 
potential for error. This approach was part of the original 
inspiration for GBD. However, demographic estimation 
has also remained quite operator dependent: analytical 
choices by different demographers can lead to con-
siderable differences in estimates for the same country. 
The differences between UNPOP estimates, US Census 
Bureau estimates, and national government estimates for 
many countries is one illustration of this analyst 
dependence. Demographic estimation has only recently 
started to examine statistical methods that generate 
uncertainty intervals,47–49,82–85 but these have not been 
widely used by UNPOP, the US Census Bureau, or by 
most national authorities for population estimation, and 
these methods remain primarily a research interest. To 
our knowledge, we have generated the first complete time 
series of the population size (with uncertainty intervals) 
for all countries by use of such methods; however, there 
are still many analytical choices that have been made that 
could arguably be changed in future efforts. These might 
include the choice of age-heaping smoother, the decision 
to exclude some census counts as outliers, or inclusion of 
documented migration estimates from various sources. 
We hope that this effort will stimulate vigorous debate on 
the analysis of population size for different countries.
Limitations
This study has many limitations, some of which—
including the paucity of direct measurement of net 
migration—have already been identified, whereas others 
need to be articulated. First, the GBD Bayesian demo-
graphic balancing model for population and migration 
estimation includes a number of hyperpriors. The results 
of the estimation are sensitive to the choice of these 
hyperpriors, such as the correlation of migration over 
time. We have largely used the same hyperpriors for all 
locations, but we have modified the hyperpriors in some 
locations to improve the fit of the model. Second, we 
sought to estimate de-facto population counts, but in 
some low-income and middle-income locations, only de-
jure counts were available as inputs. De-jure counts could, 
in some countries, exclude temporary migrants; we 
identified and included migration data in locations where 
large labour migration is known to occur, but the use of 
de-jure counts in other settings could overestimate or 
underestimate de-facto counts. Third, we assume that the 
estimates of age-specific mortality from the GBD study 
and ASFR from this study are accurate. Any systematic 
errors in either would affect our estimates of migration 
and of population in years that are further from a census. 
Fourth, the estimation method requires a baseline 
estimate of the population in 1950 for detailed age groups, 
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2037
and any errors in this baseline based on a backwards 
cohort-component method of population projection will 
have a sustained effect on the population estimates from 
the baseline until at least the first census after 1950. Major 
errors in the baseline can also have an effect after the first 
census. Fifth, we were unable to obtain census counts by 
sex from ten known censuses and could not obtain age-
specific population data in 62 censuses. Inclusion of this 
unpublished information could substantially change the 
results for those locations. Sixth, uncertainty in our 
current results is based on the uncertainty in population 
counts and the time since the last population count and, 
implicitly, errors in fertility and mortality estimation. We 
used an out-of-sample approach to estimate uncertainty in 
the population size in years without a census count, and 
we used uncertainty in the PES model prediction of 
completeness to estimate uncertainty in the years with 
and without a census count. The out-of-sample method 
provides a robust approach to estimating uncertainty but 
does not provide draws of migration, fertility, and mortality 
associated with each draw of population. We also assumed 
that years where registry counts are available only have 
uncertainty in the PES model prediction of completeness 
and zero uncertainty from the out-of-sample approach. 
This approach to estimating population uncertainty also 
does not incorporate any spatial correlation of uncertainty 
across countries and assumes complete correlation of 
uncertainty by age. Uncertainty at the country level could 
be exaggerated by this approach. Seventh, age-specific 
migration estimates can be affected by age-specific 
variation in census completeness. In our analysis, we have 
included the average age pattern of enumeration 
completeness, as detected in our analysis of PESs, 
but country-specific variation in the age pattern of 
enumeration is possible. Eighth, refugee flows might be 
misenumerated by UNHCR in some settings, leading to 
underestimates of migrants. Ninth, alternative hyper-
parameters could be selected and could change the results, 
although we believe that our selection of hyperparameters, 
which were based on several rounds of testing, provide 
sensible results. Tenth, we analysed each location 
independently, without imposing global constraints on 
global net migration. As a con 
sequence, in some years, 
our estimates imply global net migration, which is not 
possible. For example, in 2015, our estimate of global net 
migration was 14 709 people. Finally, our model for fertility 
in girls aged 10–14 years is based on a simple linear 
regression of the ratio of fertility in those aged 10–14 years 
versus those aged 15–19 years, on the fertility rate in those 
aged 15–19 years and 50–54 years was estimated as a fixed 
fraction of the fertility rate in women aged 45–49 years 
because, even in the linear regression, the coefficient was 
not significant. This regression is based on locations with 
complete vital registration data, which tend to be high-SDI 
and middle-SDI countries. Other factors might drive 
fertility at these extreme ages that are not captured in our 
models or the available data.
Future directions
There are many ways in which our estimation of population 
by age, sex, location, and year can be improved and made 
more useful for diverse applications. We currently use the 
GBD Bayesian demographic balancing model to estimate 
age-sex-year-specific migration, consistent with our 
estimated fertility and mortality rates and observed 
population numbers. In settings where direct measure-
ment of migration is possible, it could be useful to use a 
version of the same model that allows the posterior values 
for fertility, mortality, and migration to change relative to 
the prior. This approach is conceptually appealing, 
allowing incon 
sistencies between fertility, mortality, and 
migration to be resolved through shifts in some or all of 
these inputs. However, our early testing of this approach 
showed considerable instability given that the same 
observed population count can be exactly explained by an 
infinite set of combinations of deaths and migration. This 
instability in the full Bayesian model led to estimates of 
implausible shifts in the age and time pattern of mortality. 
In some settings, it might be possible to provide more 
information on the credible age structure of death and 
migration to stabilise such a version of the model. A second 
improvement in the modelling approach would be to 
address how to ensure that the global net migration in any 
age-sex-year group is zero. Joint estimation of all locations 
simultaneously is unlikely to be computationally feasible 
given the complexity of the model for just one location at a 
time. Two-stage processes can be explored that might 
accommodate the logical requirement for global net 
migration to be zero. Another avenue that warrants 
investigation is the inclusion in the analysis of household 
age structure from household surveys; there is a very wide 
array of these surveys, and methods to use this information 
with appropriately wider data variance than a census could 
improve estimation in census-poor locations. We currently 
adjust data for age heaping with the three correction 
methods (Feeney, Arriaga, and Arriaga strong), but there 
could be other ways to incorporate age-heaping corrections 
directly into the GBD Bayesian demographic balancing 
model likelihood. In future analyses of fertility and 
population, the im 
portant role of urbanisation should be 
explored. Given the drive in many GBD-related analyses 
toward 5 × 5 km estimation,86,87 the logical extension of our 
analysis will be to generate population estimates at a 
detailed local level. Such efforts will need to leverage 
similarly fine-grained assessments of fertility, mortality, 
and available population counts, supplemented with 
satellite imagery where feasible.
Conclusion
Population size and age structure have substantial 
consequences on every aspect of social and economic life 
in every location. Over the past 70 years, there have 
been huge changes in ASFR, mortality, and migration 
that have reshaped popu 
lation structures. Trends have 
not been homogeneous across and within countries and, 
 Global Health Metrics
2038 
www.thelancet.com   Vol 392   November 10, 2018
although global population growth rates have decreased, 
the absolute increase in global population every year 
has remained notably constant for many decades. 
Linear growth in the global population is occurring 
despite population decreases in some parts of the world, 
particularly eastern Europe, and large population 
increases in sub-Saharan Africa. Demographic changes 
will continue to have substantial social and economic 
effects, highlighting the impor 
tance of close monitoring 
and analysis of fertility and population at the local level. 
The statistical methods for estimation that we present 
will hopefully facilitate this need, providing the essential 
demographic intelligence for countries to reliably inform 
their health and social development strategies.
GBD 2017 Population and Fertility Collaborators
Christopher J L Murray, Charlton S K H Callender, Xie Rachel Kulikoff, 
Vinay Srinivasan, Degu Abate, Kalkidan Hassen Abate, Solomon M Abay, 
Nooshin Abbasi, Hedayat Abbastabar, Jemal Abdela, Ahmed Abdelalim, 
Omar Abdel-Rahman, Alireza Abdi, Nasrin Abdoli, Ibrahim Abdollahpour, 
Rizwan Suliankatchi Abdulkader, Haftom Temesgen Abebe, Molla Abebe, 
Zegeye Abebe, Teshome Abuka Abebo, Ayenew Negesse Abejie, 
Victor Aboyans, Haftom Niguse Abraha, Daisy Maria Xavier Abreu, 
Aklilu Roba Abrham, Laith Jamal Abu-Raddad, Niveen M E Abu-Rmeileh, 
Manfred Mario Kokou Accrombessi, Pawan Acharya, Abdu A Adamu, 
Oladimeji M Adebayo, Isaac Akinkunmi Adedeji, Victor Adekanmbi, 
Olatunji O Adetokunboh, Beyene Meressa Adhena, Tara Ballav Adhikari, 
Mina G Adib, Arsène Kouablan Adou, Jose C Adsuar, Mohsen Afarideh, 
Ashkan Afshin, Gina Agarwal, Kareha M Agesa, Sargis Aghasi Aghayan, 
Sutapa Agrawal, Alireza Ahmadi, Mehdi Ahmadi, Muktar Beshir Ahmed, 
Sayem Ahmed, Amani Nidhal Aichour, Ibtihel Aichour, 
Miloud Taki Eddine Aichour, Ali S Akanda, Mohammad Esmaeil Akbari, 
Mohammed Akibu, Rufus Olusola Akinyemi, Tomi Akinyemiju, 
Nadia Akseer, Fares Alahdab, Ziyad Al-Aly, Khurshid Alam, 
Animut Alebel, Alicia V Aleman, Kefyalew Addis Alene, 
Ayman Al-Eyadhy, Raghib Ali, Mehran Alijanzadeh, 
Reza Alizadeh-Navaei, Syed Mohamed Aljunid, Ala’a Alkerwi, 
François Alla, Peter Allebeck, Ali Almasi, Jordi Alonso, 
Rajaa M Al-Raddadi, Ubai Alsharif, Khalid Altirkawi, 
Nelson Alvis-Guzman, Azmeraw T Amare, Walid Ammar, 
Nahla Hamed Anber, Catalina Liliana Andrei, Sofia Androudi, 
Megbaru Debalkie Animut, Hossein Ansari, Mustafa Geleto Ansha, 
Carl Abelardo T Antonio, Seth Christopher Yaw Appiah, Olatunde Aremu, 
Habtamu Abera Areri, Nicholas Arian, Johan Ärnlöv, Al Artaman, 
Krishna K Aryal, Hamid Asayesh, Ephrem Tsegay Asfaw, 
Solomon Weldegebreal Asgedom, Reza Assadi, 
Tesfay Mehari Mehari Atey, Suleman Atique, Madhu Sudhan Atteraya, 
Marcel Ausloos, Euripide F G A Avokpaho, Ashish Awasthi, 
Beatriz Paulina Ayala Quintanilla, Yohanes Ayele, Rakesh Ayer, 
Tambe B Ayuk, Peter S Azzopardi, Tesleem Kayode Babalola, 
Arefeh Babazadeh, Hamid Badali, Alaa Badawi, Ayele Geleto Bali, 
Maciej Banach, Suzanne Lyn Barker-Collo, Till Winfried Bärnighausen, 
Lope H Barrero, Huda Basaleem, Quique Bassat, Arindam Basu, 
Bernhard T Baune, Habtamu Wondifraw Baynes, Ettore Beghi, 
Masoud Behzadifar, Meysam Behzadifar, Bayu Begashaw Bekele, 
Abate Bekele Belachew, Aregawi Gebreyesus Belay, Ezra Belay, 
Saba Abraham Belay, Yihalem Abebe Belay, Michelle L Bell, 
Aminu K Bello, Derrick A Bennett, Isabela M Bensenor, Gilles Bergeron, 
Adugnaw Berhane, Adam E Berman, Eduardo Bernabe, 
Robert S Bernstein, Gregory J Bertolacci, Mircea Beuran, Suraj Bhattarai, 
Soumyadeep Bhaumik, Zulfiqar A Bhutta, Belete Biadgo, Ali Bijani, 
Boris Bikbov, Nigus Bililign, Muhammad Shahdaat Bin Sayeed, 
Sait Mentes Birlik, Charles Birungi, Tuhin Biswas, Hailemichael Bizuneh, 
Archie Bleyer, Berrak Bora Basara, Cristina Bosetti, Soufiane Boufous, 
Oliver J Brady, Nicola Luigi Bragazzi, Michael Brainin, 
Alexandra Brazinova, Nicholas J K Breitborde, Hermann Brenner, 
Jerry D Brewer, Paul Svitil Briant, Gabrielle Britton, Roy Burstein, 
Reinhard Busse, Zahid A Butt, Lucero Cahuana-Hurtado, 
Ismael R Campos-Nonato, Julio Cesar Campuzano Rincon, Jorge Cano, 
Mate Car, Rosario Cárdenas, Juan J Carrero, Félix Carvalho, 
Carlos A Castañeda-Orjuela, Jacqueline Castillo Rivas, Franz Castro, 
Ferrán Catalá-López, Alanur Çavlin, Ester Cerin, Julian Chalek, 
Hsing-Yi Chang, Jung-Chen Chang, Aparajita Chattopadhyay, 
Pankaj Chaturvedi, Peggy Pei-Chia Chiang, Ken Lee Chin, 
Vesper Hichilombwe Chisumpa, Abdulaal Chitheer, Jee-Young J Choi, 
Rajiv Chowdhury, Devasahayam J Christopher, Flavia M Cicuttini, 
Liliana G Ciobanu, Massimo Cirillo, Rafael M Claro, 
Daniel Collado-Mateo, Maria-Magdalena Constantin, Sara Conti, 
Cyrus Cooper, Leslie Trumbull Cooper, Leslie Cornaby, 
Paolo Angelo Cortesi, Monica Cortinovis, Megan Costa, 
Elizabeth A Cromwell, Christopher Stephen Crowe, Petra Cukelj, 
Matthew Cunningham, Alemneh Kabeta Daba, Berihun Assefa Dachew, 
Lalit Dandona, Rakhi Dandona, Paul I Dargan, Ahmad Daryani, 
Rajat Das Gupta, José Das Neves, Tamirat Tesfaye Dasa, 
Aditya Prasad Dash, Nicole Davis Weaver, Dragos Virgil Davitoiu, 
Kairat Davletov, Diego De Leo, Jan-Walter De Neve, Meaza Girma Degefa, 
Louisa Degenhardt, Tizta Tilahun Degfie, Selina Deiparine, 
Gebre Teklemariam Demoz, Balem Demtsu, Edgar Denova-Gutiérrez, 
Kebede Deribe, Nikolaos Dervenis, Don C Des Jarlais, 
Getenet Ayalew Dessie, Samath D Dharmaratne, Meghnath Dhimal, 
Daniel Dicker, Eric L Ding, Girmaye Deye Dinsa, Shirin Djalalinia, 
Huyen Phuc Do, Klara Dokova, David Teye Doku, Kate A Dolan, 
Kerrie E Doyle, Tim R Driscoll, Manisha Dubey, Eleonora Dubljanin, 
Eyasu Ejeta Duken, Andre R Duraes, Soheil Ebrahimpour, 
David Edvardsson, Charbel El Bcheraoui, Ziad El-Khatib, Iqbal Rf Elyazar, 
Ahmadali Enayati, Aman Yesuf Endries, Sergey Petrovich Ermakov, 
Babak Eshrati, Sharareh Eskandarieh, Reza Esmaeili, Alireza Esteghamati, 
Sadaf Esteghamati, Kara Estep, Hamed Fakhim, Tamer Farag, 
Mahbobeh Faramarzi, Mohammad Fareed, Carla Sofia E Sá Farinha, 
Andre Faro, Maryam S Farvid, Farshad Farzadfar, 
Mohammad Hosein Farzaei, Kairsten A Fay, Mir Sohail Fazeli, 
Valery L Feigin, Andrea B Feigl, Fariba Feizy, Ama P Fenny, 
Netsanet Fentahun, Seyed-Mohammad Fereshtehnejad, 
Eduarda Fernandes, Garumma Tolu Feyissa, Irina Filip, Samuel Finegold, 
Florian Fischer, Luisa Sorio Flor, Nataliya A Foigt, Kyle J Foreman, 
Carla Fornari, Thomas Fürst, Takeshi Fukumoto, John E Fuller, 
Nancy Fullman, Emmanuela Gakidou, Silvano Gallus, 
Amiran Gamkrelidze, Morsaleh Ganji, Fortune Gbetoho Gankpe, 
Gregory M Garcia, Miguel Á Garcia-Gordillo, Abadi Kahsu Gebre, 
Teshome Gebre, Gebremedhin Berhe Gebregergs, 
Tsegaye Tewelde Gebrehiwot, Amanuel Tesfay Gebremedhin, 
Tilayie Feto Gelano, Yalemzewod Assefa Gelaw, Johanna M Geleijnse, 
Ricard Genova-Maleras, Peter Gething, Kebede Embaye Gezae, 
Mohammad Rasoul Ghadami, Reza Ghadimi, Keyghobad Ghadiri, 
Khalil Ghasemi Falavarjani, Maryam Ghasemi-Kasman, 
Hesam Ghiasvand, Mamata Ghimire, Aloke Gopal Ghoshal, 
Paramjit Singh Gill, Tiffany K Gill, Giorgia Giussani, 
Elena V Gnedovskaya, Srinivas Goli, Ricardo Santiago Gomez, 
Hector Gómez-Dantés, Philimon N Gona, Amador Goodridge, 
Sameer Vali Gopalani, Alessandra C Goulart, 
Bárbara Niegia Garcia Goulart, Ayman Grada, Giuseppe Grosso, 
Harish Chander C Gugnani, Jingwen Guo, Yuming Guo, 
Prakash C Gupta, Rahul Gupta, Rajeev Gupta, Tanush Gupta, 
Juanita A Haagsma, Vladimir Hachinski, Nima Hafezi-Nejad, 
Tekleberhan B Hagos, Tewodros Tesfa Hailegiyorgis, 
Gessessew Bugssa Hailu, Arvin Haj-Mirzaian, Arya Haj-Mirzaian, 
Randah R Hamadeh, Samer Hamidi, Alexis J Handal, Graeme J Hankey, 
Yuantao Hao, Hilda L Harb, Hamidreza Haririan, Josep Maria Haro, 
Mehedi Hasan, Hadi Hassankhani, Hamid Yimam Hassen, 
Rasmus Havmoeller, Simon I Hay, Yihua He, 
Akbar Hedayatizadeh-Omran, Mohamed I Hegazy, Behzad Heibati, 
Behnam Heidari, Delia Hendrie, Andualem Henok, Nathaniel J Henry, 
Claudiu Herteliu, Fatemeh Heydarpour, Desalegn T Hibstu, 
Michael K Hole, Enayatollah Homaie Rad, Praveen Hoogar, 
H Dean Hosgood, Seyed Mostafa Hosseini, 
Meimanat M Hosseini Chavoshi, Mehdi Hosseinzadeh, Mihaela Hostiuc, 
Sorin Hostiuc, Mohamed Hsairi, Thomas Hsiao, Guoqing Hu, 
John J Huang, Kim Moesgaard Iburg, Ehimario U Igumbor, 
Chad Thomas Ikeda, Olayinka Stephen Ilesanmi, Usman Iqbal, 
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2039
Asnake Ararsa Irenso, Seyed Sina Naghibi Irvani, 
Oluwaseyi Oluwakemi Isehunwa, Sheikh Mohammed Shariful Islam, 
Leila Jahangiry, Nader Jahanmehr, Sudhir Kumar Jain, Mihajlo Jakovljevic, 
Moti Tolera Jalu, Spencer L James, Simerjot K Jassal, Mehdi Javanbakht, 
Achala Upendra Jayatilleke, Panniyammakal Jeemon, Ravi Prakash Jha, 
Vivekanand Jha, John S Ji, Jost B Jonas, Jacek Jerzy Jozwiak, 
Suresh Banayya Jungari, Mikk Jürisson, Zubair Kabir, Rajendra Kadel, 
Amaha Kahsay, Rizwan Kalani, Umesh Kapil, Manoochehr Karami, 
Behzad Karami Matin, André Karch, Corine Karema, Seyed M Karimi, 
Amir Kasaeian, Dessalegn H Kassa, Getachew Mullu Kassa, 
Tesfaye Dessale Kassa, Zemenu Yohannes Kassa, Nicholas J Kassebaum, 
Anshul Kastor, Srinivasa Vittal Katikireddi, Anil Kaul, Norito Kawakami, 
Ali Kazemi Karyani, Seifu Kebede, Peter Njenga Keiyoro, 
Grant Rodgers Kemp, Andre Pascal Kengne, Andre Keren, 
Maia Kereselidze, Yousef Saleh Khader, Morteza Abdullatif Khafaie, 
Alireza Khajavi, Nauman Khalid, Ibrahim A Khalil, Ejaz Ahmad Khan, 
Muhammad Shahzeb Khan, Young-Ho Khang, Tripti Khanna, 
Mona M Khater, Alireza Khatony, Zahra Khazaeipour, Habibolah Khazaie, 
Abdullah T Khoja, Ardeshir Khosravi, Mohammad Hossein Khosravi, 
Getiye D Kibret, Zelalem Teklemariam Kidanemariam, Daniel N Kiirithio, 
Paul Evan Kilgore, Daniel Kim, Jun Y Kim, Young-Eun Kim, Yun Jin Kim, 
Ruth W Kimokoti, Yohannes Kinfu, Sanjay Kinra, Adnan Kisa, 
Mika Kivimäki, Sonali Kochhar, Yoshihiro Kokubo, Tufa Kolola, 
Jacek A Kopec, Margaret N Kosek, Soewarta Kosen, Parvaiz A Koul, 
Ai Koyanagi, Kewal Krishan, Sanjay Krishnaswami, Kristopher J Krohn, 
Barthelemy Kuate Defo, Burcu Kucuk Bicer, G Anil Kumar, 
Manasi Kumar, Pushpendra Kumar, Fekede Asefa Kumsa, Michael J Kutz, 
Sheetal D Lad, Alessandra Lafranconi, Dharmesh Kumar Lal, 
Ratilal Lalloo, Hilton Lam, Faris Hasan Lami, Justin J Lang, Sonia Lansky, 
Van C Lansingh, Dennis Odai Laryea, Zohra S Lassi, Arman Latifi, 
Avula Laxmaiah, Jeffrey V Lazarus, James B Lee, Paul H Lee, James Leigh, 
Cheru Tesema Leshargie, Samson Leta, Miriam Levi, Shanshan Li, 
Xiaohong Li, Yichong Li, Juan Liang, Xiaofeng Liang, 
Misgan Legesse Liben, Lee-Ling Lim, Miteku Andualem Limenih, 
Shai Linn, Shiwei Liu, Stefan Lorkowski, Paulo A Lotufo, Rafael Lozano, 
Raimundas Lunevicius, Crispin Mabika Mabika, 
Erlyn Rachelle King Macarayan, Mark T Mackay, Fabiana Madotto, 
Tarek Abd Elaziz Mahmood, Narayan Bahadur Mahotra, Marek Majdan, 
Reza Majdzadeh, Azeem Majeed, Reza Malekzadeh, 
Manzoor Ahmad Malik, Abdullah A Mamun, Wondimu Ayele Manamo, 
Ana-Laura Manda, Srikanth Mangalam, Mohammad Ali Mansournia, 
Lorenzo Giovanni Mantovani, Chabila Christopher Mapoma, 
Dadi Marami, Joemer C Maravilla, Wagner Marcenes, 
Shakhnazarova Marina, Francisco Rogerlândio Martins-Melo, 
Winfried März, Melvin B Marzan, Tivani Phosa Mashamba-Thompson, 
Felix Masiye, Amanda J Mason-Jones, Benjamin Ballard Massenburg, 
Manu Raj Mathur, Pallab K Maulik, Mohsen Mazidi, John J McGrath, 
Suresh Mehata, Sanjay Madhav Mehendale, Man Mohan Mehndiratta, 
Ravi Mehrotra, Saeed Mehrzadi, Kala M Mehta, Varshil Mehta, 
Tefera C Mekonnen, Hagazi Gebre Meles, Kidanu Gebremariam Meles, 
Addisu Melese, Mulugeta Melku, Peter T N Memiah, Ziad A Memish, 
Walter Mendoza, Melkamu Merid Mengesha, Desalegn Tadese Mengistu, 
Getnet Mengistu, George A Mensah, Seid Tiku Mereta, Atte Meretoja, 
Tuomo J Meretoja, Tomislav Mestrovic, Haftay Berhane Mezgebe, 
Yode Miangotar, Bartosz Miazgowski, Tomasz Miazgowski, Ted R Miller, 
Molly Katherine Miller-Petrie, G K Mini, Parvaneh Mirabi, 
Andreea Mirica, Erkin M Mirrakhimov, Awoke Temesgen Misganaw, 
Babak Moazen, Karzan Abdulmuhsin Mohammad, Moslem Mohammadi, 
Noushin Mohammadifard, Maryam Mohammadi-Khanaposhtani, 
Mohammed A Mohammed, Shafiu Mohammed, Ali H Mokdad, 
Glen Dl Mola, Mariam Molokhia, Lorenzo Monasta, 
Julio Cesar Montañez, Ghobad Moradi, Mahmoudreza Moradi, 
Maziar Moradi-Lakeh, Mehdi Moradinazar, Paula Moraga, 
Joana Morgado-Da-Costa, Rintaro Mori, Shane Douglas Morrison, 
Abbas Mosapour, Marilita M Moschos, Seyyed Meysam Mousavi, 
Achenef Asmamaw Muche, Kindie Fentahun Muchie, 
Ulrich Otto Mueller, Satinath Mukhopadhyay, Tasha B Murphy, 
Kate Muller, G V S Murthy, Jonah Musa, Kamarul Imran Musa, 
Ghulam Mustafa, Saravanan Muthupandian, Jean B Nachega, 
Gabriele Nagel, Mohsen Naghavi, Aliya Naheed, Azin Nahvijou, 
Gurudatta Naik, Paulami Naik, Farid Najafi, Luigi Naldi, Vinay Nangia, 
Jobert Richie Nansseu, Bruno Ramos Nascimento, Haseeb Nawaz, 
Busisiwe P Ncama, Nahid Neamati, Ionut Negoi, Ruxandra Irina Negoi, 
Subas Neupane, Charles Richard James Newton, Frida N Ngalesoni, 
Josephine W Ngunjiri, Grant Nguyen, Long Hoang Nguyen, 
Trang Huyen Nguyen, Dina Nur Anggraini Ningrum, 
Yirga Legesse Nirayo, Muhammad Imran Nisar, Molly R Nixon, 
Shuhei Nomura, Mehdi Noroozi, Jean Jacques Noubiap, 
Hamid Reza Nouri, Malihe Nourollahpour Shiadeh, 
Mohammad Reza Nowroozi, Alypio Nyandwi, Peter S Nyasulu, 
Christopher M Odell, Richard Ofori-Asenso, Okechukwu Samuel Ogah, 
Felix Akpojene Ogbo, In-Hwan Oh, Anselm Okoro, 
Olanrewaju Oladimeji, Andrew T Olagunju, Tinuke O Olagunju, 
Pedro R Olivares, Bolajoko Olubukunola Olusanya, 
Jacob Olusegun Olusanya, Sok King Ong, Alberto Ortiz, 
Aaron Osgood-Zimmerman, Erika Ota, Brenda Achieng Otieno, 
Stanislav S Otstavnov, Mayowa Ojo Owolabi, Abayomi Samuel Oyekale, 
Mahesh P A, Smita Pakhale, Abhijit P Pakhare, Adrian Pana, 
Basant Kumar Panda, Songhomitra Panda-Jonas, Achyut Raj Pandey, 
Eun-Kee Park, Hadi Parsian, Shanti Patel, Snehal T Patil, Ajay Patle, 
George C Patton, Vishnupriya Rao Paturi, Deepak Paudel, 
Marcel Moraes Pedroso, Emmanuel K Peprah, David M Pereira, 
Norberto Perico, Konrad Pesudovs, William A Petri, Max Petzold, 
Maxwell Pierce, David M Pigott, Julian David Pillay, Meghdad Pirsaheb, 
Guilherme V Polanczyk, Maarten J Postma, Farshad Pourmalek, 
Akram Pourshams, Hossein Poustchi, Swayam Prakash, Narayan Prasad, 
Caroline A Purcell, Manorama B Purwar, Mostafa Qorbani, 
Reginald Quansah, Amir Radfar, Anwar Rafay, Alireza Rafiei, 
Fakher Rahim, Afarin Rahimi-Movaghar, Vafa Rahimi-Movaghar, 
Mahfuzar Rahman, Md Shafiur Rahman, Mohammad Hifz Ur Rahman, 
Muhammad Aziz Rahman, Sajjad Ur Rahman, Rajesh Kumar Rai, 
Fatemeh Rajati, Sasa Rajsic, Usha Ram, Chhabi Lal Ranabhat, 
Prabhat Ranjan, David Laith Rawaf, Salman Rawaf, Sarah E Ray, 
Christian Razo-García, Robert C Reiner, Cesar Reis, Giuseppe Remuzzi, 
Andre M N Renzaho, Serge Resnikoff, Satar Rezaei, Shahab Rezaeian, 
Mohammad Sadegh Rezai, Seyed Mohammad Riahi, 
Maria Jesus Rios-Blancas, Kedir Teji Roba, Nicholas L S Roberts, 
Leonardo Roever, Luca Ronfani, Gholamreza Roshandel, Ali Rostami, 
Enrico Rubagotti, George Mugambage Ruhago, Yogesh Damodar Sabde, 
Perminder S Sachdev, Basema Saddik, Sahar Saeedi Moghaddam, 
Hosein Safari, Yahya Safari, Roya Safari-Faramani, Mahdi Safdarian, 
Sare Safi, Saeid Safiri, Rajesh Sagar, Amirhossein Sahebkar, 
Mohammad Ali Sahraian, Haniye Sadat Sajadi, Mohamadreza Salahshoor, 
Nasir Salam, Joseph S Salama, Payman Salamati, 
Raphael De Freitas Saldanha, Zikria Saleem, Yahya Salimi, 
Hamideh Salimzadeh, Joshua A Salomon, Sundeep Santosh Salvi, 
Inbal Salz, Evanson Zondani Sambala, Abdallah M Samy, Juan Sanabria, 
Maria Dolores Sanchez-Niño, Itamar S Santos, 
Milena M Santric Milicevic, Bruno Piassi Sao Jose, Mayank Sardana, 
Abdur Razzaque Sarker, Rodrigo Sarmiento-Suárez, Satish Saroshe, 
Nizal Sarrafzadegan, Benn Sartorius, Shahabeddin Sarvi, Brijesh Sathian, 
Maheswar Satpathy, Arundhati R Sawant, Monika Sawhney, Sonia Saxena, 
Elke Schaeffner, Kathryn Schelonka, Ione J C Schneider, 
David C Schwebel, Falk Schwendicke, Soraya Seedat, Mario Sekerija, 
Sadaf G Sepanlou, Edson Serván-Mori, Hosein Shabaninejad, 
Katya Anne Shackelford, Azadeh Shafieesabet, Amira A Shaheen, 
Masood Ali Shaikh, Raad A Shakir, Mehran Shams-Beyranvand, 
Mohammadbagher Shamsi, Morteza Shamsizadeh, Heidar Sharafi, 
Kiomars Sharafi, Mehdi Sharif, Mahdi Sharif-Alhoseini, Jayendra Sharma, 
Rajesh Sharma, Jun She, Aziz Sheikh, Peilin Shi, Kenji Shibuya, 
Mika Shigematsu, Rahman Shiri, Reza Shirkoohi, Ivy Shiue, 
Farhad Shokraneh, Sharvari Rahul Shukla, Si Si, Soraya Siabani, 
Abla Mehio Sibai, Tariq J Siddiqi, Inga Dora Sigfusdottir, 
Rannveig Sigurvinsdottir, Naris Silpakit, Diego Augusto Santos Silva, 
João Pedro Silva, Dayane Gabriele Alves Silveira, 
Narayana Sarma Venkata Singam, Jasvinder A Singh, Narinder Pal Singh, 
Virendra Singh, Dhirendra Narain Sinha, Karen Sliwa, 
Adauto Martins Soares Filho, Badr Hasan Sobaih, Soheila Sobhani, 
Moslem Soofi, Joan B Soriano, Ireneous N Soyiri, 
Chandrashekhar T Sreeramareddy, Vladimir I Starodubov, Caitlyn Steiner, 
Leo G Stewart, Mark A Stokes, Mark Strong, Michelle L Subart, 
Mu’awiyyah Babale Sufiyan, Gerhard Sulo, Bruno F Sunguya, 
 Global Health Metrics
2040 
www.thelancet.com   Vol 392   November 10, 2018
Patrick John Sur, Ipsita Sutradhar, Bryan L Sykes, P N Sylaja, 
Dillon O Sylte, Cassandra E I Szoeke, Rafael Tabarés-Seisdedos, 
Karen M Tabb, Santosh Kumar Tadakamadla, Nikhil Tandon, 
Aberash Abay Tassew, Segen Gebremeskel Tassew, Nuno Taveira, 
Nega Yimer Tawye, Arash Tehrani-Banihashemi, Tigist Gashaw Tekalign, 
Merhawi Gebremedhin Tekle, Mohamad-Hani Temsah, 
Abdullah Sulieman Terkawi, Manaye Yihune Teshale, Belay Tessema, 
Mebrahtu Teweldemedhin, Jarnail Singh Thakur, 
Kavumpurathu Raman Thankappan, Sathish Thirunavukkarasu, 
Nihal Thomas, Alan J Thomson, Binyam Tilahun, Quyen G To, 
Marcello Tonelli, Roman Topor-Madry, Anna E Torre, 
Miguel Tortajada-Girbés, Marcos Roberto Tovani-Palone, 
Hideaki Toyoshima, Bach Xuan Tran, Khanh Bao Tran, 
Srikanth Prasad Tripathy, Thomas Clement Truelsen, Nu Thi Truong, 
Afewerki Gebremeskel Tsadik, Amanuel Tsegay, Nikolaos Tsilimparis, 
Lorainne Tudor Car, Kingsley N Ukwaja, Irfan Ullah, 
Muhammad Shariq Usman, Olalekan A Uthman, Selen Begüm Uzun, 
Muthiah Vaduganathan, Afsane Vaezi, Gaurang Vaidya, Pascual R Valdez, 
Elena Varavikova, Santosh Varughese, Tommi Juhani Vasankari, 
Ana Maria Nogales Vasconcelos, Narayanaswamy Venketasubramanian, 
Santos Villafaina, Francesco S Violante, 
Sergey Konstantinovitch Vladimirov, Vasily Vlassov, Stein Emil Vollset, 
Theo Vos, Kia Vosoughi, Isidora S Vujcic, Fasil Shiferaw Wagnew, 
Yasir Waheed, Judd L Walson, Yanping Wang, Yuan-Pang Wang, 
Elisabete Weiderpass, Robert G Weintraub, Kidu Gidey Weldegwergs, 
Andrea Werdecker, Ronny Westerman, Harvey Whiteford, 
Justyna Widecka, Katarzyna Widecka, Tissa Wijeratne, 
Andrea Sylvia Winkler, Charles Shey Wiysonge, Charles D A Wolfe, 
Shouling Wu, Grant M A Wyper, Gelin Xu, Tomohide Yamada, 
Yuichiro Yano, Mehdi Yaseri, Yasin Jemal Yasin, Pengpeng Ye, 
Gökalp Kadri Yentür, Alex Yeshaneh, Ebrahim M Yimer, Paul Yip, 
Engida Yisma, Naohiro Yonemoto, Seok-Jun Yoon, Marcel Yotebieng, 
Mustafa Z Younis, Mahmoud Yousefifard, Chuanhua Yu, Vesna Zadnik, 
Zoubida Zaidi, Sojib Bin Zaman, Mohammad Zamani, Zohreh Zare, 
Mulugeta Molla Zeleke, Zerihun Menlkalew Zenebe, 
Taddese Alemu Zerfu, Xueying Zhang, Xiu-Ju Zhao, Maigeng Zhou, 
Jun Zhu, Stephanie R M Zimsen, Sanjay Zodpey, Leo Zoeckler, 
Alan D Lopez, Stephen S Lim.
Affiliations
Institute for Health Metrics and Evaluation (Prof C J L Murray DPhil, 
C S Callender BS, X R Kulikoff BA, V Srinivasan BA, A Afshin MD, 
K M Agesa BA, N Arian BA, G J Bertolacci BS, P S Briant BS, 
R Burstein BA, J Chalek BS, L Cornaby BS, E A Cromwell PhD, 
M Cunningham MSc, Prof L Dandona MD, Prof R Dandona PhD, 
N Davis Weaver MPH, L Degenhardt PhD, S Deiparine BA, 
S D Dharmaratne MD, D Dicker BS, C El Bcheraoui PhD, K Estep MPA, 
T Farag PhD, K A Fay BS, Prof V L Feigin PhD, S Finegold BS, 
K J Foreman PhD, J E Fuller MLIS, N Fullman MPH, 
Prof E Gakidou PhD, G M Garcia BS, J Guo BS, Prof S I Hay FMedSci, 
Y He MS, N J Henry BS, T Hsiao BS, C T Ikeda BS, S L James MD, 
N J Kassebaum MD, G R Kemp BA, I A Khalil MD, J Y Kim BS, 
K J Krohn MPH, M J Kutz BS, J B Lee BS, Prof R Lozano MD, 
F Masiye PhD, M K Miller-Petrie MSc, A T Misganaw PhD, 
Prof A H Mokdad PhD, K Muller MPH, Prof M Naghavi MD, 
P Naik MSPH, G Nguyen MPH, M R Nixon PhD, C M Odell MPP, 
A Osgood-Zimmerman MS, M Pierce, D M Pigott DPhil, 
C A Purcell BA, S E Ray BA, R C Reiner PhD, N L S Roberts BS, 
J S Salama MSc, K Schelonka BA, K A Shackelford BA, N Silpakit BS, 
C Steiner MPH, L G Stewart BS, M L Subart BA, P J Sur MPH, 
D O Sylte BA, A E Torre BS, Prof S E Vollset DrPH, Prof T Vos PhD, 
H A Whiteford PhD, S R M Zimsen MA, L Zoeckler BA, 
Prof A D Lopez PhD, Prof S S Lim PhD), Department of Health Metrics 
Sciences (Prof C J L Murray DPhil, A Afshin MD, 
E A Cromwell PhD, C El Bcheraoui PhD, Prof E Gakidou PhD, 
Prof S I Hay FMedSci, I A Khalil MD, Prof R Lozano MD, 
A T Misganaw PhD, Prof A H Mokdad PhD, Prof M Naghavi MD, 
D M Pigott DPhil, R C Reiner PhD, Prof S E Vollset DrPH, 
Prof T Vos PhD, Prof S S Lim PhD), Department of Neurology 
(R Kalani MD), Department of Global Health (S Kochhar MD, 
Prof J L Walson MD), Department of Surgery (S D Morrison MD), 
Division of Plastic Surgery (C S Crowe MD, B B Massenburg MD), 
School of Social Work (T B Murphy PhD), University of Washington, 
Seattle, WA, USA; College of Health and Medical Sciences 
(Z T Kidanemariam MSc), Department of Epidemiology and Biostatistics 
(M Mengesha MPH), Department of Medical Laboratory Science 
(D Marami MSc), Department of Pediatrics (A R Abrham MSc), School 
of Nursing and Midwifery (T T Dasa MSc, K T Roba PhD), School of 
Pharmacy (J Abdela MSc, Y Ayele MSc, G Mengistu MSc, 
M M Zeleke MSc), School of Public Health (A G Bali MPH, 
A Irenso MPH, F A Kumsa MPH, M G Tekle MPH), Haramaya 
University, Harar, Ethiopia (D Abate MSc, T F Gelano MSc, 
T Hailegiyorgis MSc, M T Jalu MPH, T G Tekalign MS); Department of 
Environmental Health Sciences and Technology (S Mereta PhD), 
Department of Epidemiology (M B Ahmed MPH, 
T T Gebrehiwot MPH), Department of Health Education & Behavioral 
Sciences (G T Feyissa MPH), Department of Population and Family 
Health (K H Abate PhD, A T Gebremedhin MPH), Mycobacteriology 
Research Center (E Duken MSc), Jimma University, Jimma, Ethiopia; 
Department of Pharmacology and Clinical Pharmacy (S M Abay PhD), 
School of Allied Health Sciences (E Yisma MPH), School of Nursing and 
Midwifery (H A Areri MSc), School of Public Health (A Berhane PhD, 
K Deribe PhD, W A Manamo MS, Y J Yasin MPH), Addis Ababa 
University, Addis Ababa, Ethiopia (G T Demoz MSc, S Leta MSc); Brain 
and Spinal Cord Injury Research Center (Z Khazaeipour MD), Cancer 
Biology Research Center (R Shirkoohi PhD), Cancer Research Center 
(A Nahvijou PhD, R Shirkoohi PhD), Community-Based Participatory 
Research Center (Prof R Majdzadeh PhD), Department of Anatomy 
(S Sobhani MD), Department of Epidemiology and Biostatistics 
(Prof S Hosseini PhD, M Mansournia PhD, M Yaseri PhD), Department 
of Health (H Abbastabar PhD), Department of Health Management and 
Economics (S Mousavi PhD), Department of Pharmacology 
(A Haj-Mirzaian MD, A Haj-Mirzaian MD), Digestive Diseases Research 
Institute (Prof R Malekzadeh MD, Prof A Pourshams MD, 
H Poustchi PhD, G Roshandel PhD, H Salimzadeh PhD, 
S G Sepanlou MD), Endocrine Research Center (S Esteghamati MD), 
Endocrinology and Metabolism Research Center (M Afarideh MD, 
Prof A Esteghamati MD, M Ganji MD), Hematologic Malignancies 
Research Center (A Kasaeian PhD), Hematology-Oncology and Stem 
Cell Transplantation Research Center (A Kasaeian PhD), Iran National 
Institute of Health Research (H S Sajadi PhD), Iranian National Center 
for Addiction Studies (Prof A Rahimi-Movaghar MD), Knowledge 
Utilization Research Center (Prof R Majdzadeh PhD), Multiple Sclerosis 
Research Center (S Eskandarieh PhD, Prof M Sahraian MD), Non-
communicable Diseases Research Center (N Abbasi MD, 
F Farzadfar MD, S N Irvani MD, S Saeedi Moghaddam MSc, 
M Shams-Beyranvand MSc), School of Medicine (N Hafezi-Nejad MD), 
Sina Trauma and Surgery Research Center 
(Prof V Rahimi-Movaghar MD, M Safdarian MD, Prof P Salamati MD, 
M Sharif-Alhoseini PhD), Uro-Oncology Research Center 
(M Nowroozi MD), Tehran University of Medical Sciences, Tehran, Iran; 
Montreal Neuroimaging Center (N Abbasi MD), Montreal Neurological 
Institute (S Fereshtehnejad PhD), McGill University, Montreal, QC, 
Canada; Department of Medical Parasitology (M M Khater MD), 
Department of Neurology (Prof A Abdelalim MD, M I Hegazy PhD), 
Cairo University, Cairo, Egypt; Department of Oncology 
(O Abdel-Rahman MD), Department of Medicine (Prof M Tonelli MD), 
University of Calgary, Calgary, AB, Canada; Department of Entomology 
(A M Samy PhD), Department of Oncology (O Abdel-Rahman MD), 
Ain Shams University, Cairo, Egypt; Department of Anesthesiology 
(A Ahmadi PhD), Department of Environmental Health Engineering 
(Prof A Almasi PhD), Department of Epidemiology & Biostatistics 
(Prof F Najafi PhD, Y Salimi PhD), Department of Health Education & 
Promotion (F Rajati PhD), Department of Psychiatry 
(Prof H Khazaie MD), Department of Traditional and Complementary 
Medicine (M Farzaei PhD), Department of Urology (Prof M Moradi MD), 
Environmental Determinants of Health Research Center (S Rezaei PhD, 
M Soofi PhD), Faculty of Nursing and Midwifery (A Abdi PhD), Faculty 
of Nutrition and Food Sciences (F Heydarpour PhD), Faculty of Public 
Health (B Karami Matin PhD, A Kazemi Karyani PhD, 
R Safari-Faramani PhD), Imam Ali Cardiovascular Research Center 
(S Siabani PhD), Pharmaceutical Sciences Research Center 
(M Farzaei PhD), Research Center for Environmental Determinants of 
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2041
Health (M Moradinazar PhD), Sleep Disorders Research Center 
(M Ghadami MD), Sports Medicine & Rehabilitation (M Shamsi PhD), 
Kermanshah University of Medical Sciences, Kermanshah, Iran 
(N Abdoli PsyD, K Ghadiri BEP, A Khatony PhD, Prof M Pirsaheb PhD, 
S Rezaeian PhD, Y Safari PhD, K Sharafi PhD); Department of 
Epidemiology (I Abdollahpour PhD), Arak University of Medical 
Sciences, Arak, Iran; Multiple Sclerosis Research Center, Tehran, Iran 
(I Abdollahpour PhD); Department of Statistics (R S Abdulkader MD), 
Manonmaniam Sundaranar University, Tirunelveli, India; Anatomy Unit 
(T B Hagos MSc), Biomedical Sciences Division (G B Hailu MSc), 
Clinical Pharmacy Unit (H N Abraha MSc, T D Kassa MSc, 
Y L Nirayo MS, K G Weldegwergs MSc), College of Health Sciences 
(H T Abebe PhD, A Tsegay MSc), Department of Biostatistics 
(K Gezae MSc), Department of Epidemiology (A G Belay MPH), 
Department of Microbiology and Immunology (S Muthupandian PhD), 
Department of Midwifery (Z M Zenebe MSc), Department of Nutrition 
and Dietetics (M G Degefa BSc, A Kahsay MPH), Institute of Biomedical 
Science (E T Asfaw MSc), School of Medicine (D T Mengistu MSc), 
School of Pharmacy (S W Asgedom MSc, T M Atey MS, A K Gebre MSc, 
A G Tsadik MSc, E M Yimer MSc), School of Public Health 
(B M Adhena MPH, A B Belachew MSc, G B Gebregergs MPH), Mekelle 
University, Mekelle, Ethiopia (E Belay MSc, B D Demtsu MSc, 
H G Meles MPH, K G Meles MPH, S G Tassew MSc); Department of 
Clinical Chemistry (M Abebe MSc, B Biadgo MSc), Department of 
Medical Microbiology (B Tessema PhD), Human Nutrition Department 
(Z Abebe MSc), Institute of Public Health (K A Alene MPH, 
B Bekele MPH, B A Dachew MPH, Y A Gelaw MPH, M A Limenih MSc, 
M Melku MSc, A A Muche MPH, K Muchie MSc, A A Tassew MPH, 
B Tilahun PhD), University of Gondar, Gondar, Ethiopia 
(H W Baynes MSc); College of Medicine and Health Sciences 
(T A Abebo MPH, A K Daba MSc), Department of Reproductive Health 
(D T Hibstu MPH), School of Nursing and Midwifery (Z Y Kassa MSc), 
Hawassa University, Hawassa, Ethiopia; College of Health Sciences 
(G M Kassa MSc), Department of Nursing (A Alebel MSc, 
G A Dessie MSc, D H Kassa MSc, F S Wagnew MSc), Department of 
Public Health (Y A Belay MPH, G D Kibret MPH, C T Leshargie MPH), 
Debre Markos University, Debre Markos, Ethiopia (A N Abejie MPH); 
Department of Cardiology (Prof V Aboyans MD), Dupuytren University 
Hospital, Limoges, France; Institute of Epidemiology 
(Prof V Aboyans MD), University of Limoges, Limoges, France; 
Department of Surgery (Prof R S Gomez PhD), Education Center in 
Public Health (D M Abreu DSc), Hospital of the Federal University of 
Minas Gerais (B R Nascimento PhD), Nutrition Department 
(Prof R M Claro PhD), Post-Graduate Program in Infectious Diseases 
and Tropical Medicine (B P Sao Jose PhD), Federal University of Minas 
Gerais, Belo Horizonte, Brazil; Department of Healthcare Policy and 
Research (Prof L J Abu-Raddad PhD), Weill Cornell Medical College in 
Qatar, Doha, Qatar; Institute of Community and Public Health 
(N M Abu-Rmeileh PhD), Birzeit University, Birzeit, Palestine; Bénin 
Clinical Research Institute (IRCB), Cotonou, Benin 
(M M K Accrombessi PhD, E F A Avokpaho MD); Nepal Development 
Society, Pokhara, Nepal (P Acharya MPH); Department of Global Health 
(A A Adamu MSc, O O Adetokunboh MD, Prof C S Wiysonge MD), 
Department of Psychiatry (Prof S Seedat PhD), Faculty of Medicine & 
Health Sciences (Prof P S Nyasulu PhD), Stellenbosch University, Cape 
Town, South Africa; Cochrane South Africa (A A Adamu MSc, 
O O Adetokunboh MD), South African Medical Research Council, Cape 
Town, South Africa; Department of Medicine (O M Adebayo MD, 
O S Ogah PhD), University College Hospital, Ibadan, Nigeria; 
Department of Sociology (I A Adedeji PhD), Olabisi Onabanjo 
University, Ago-Iwoye, Nigeria; School of Medicine (V Adekanmbi PhD), 
Cardiff University, Cardiff, UK; Nepal Health Research Environment 
(T B Adhikari MPH), Center for Social Science and Public Health 
Research Nepal, Lalitpur, Nepal; Unit for Health Promotion Research 
(T B Adhikari MPH), University of Southern Denmark, Esbjerg, 
Denmark; Emergency Department (M G Adib MD), Saint Mark 
Hospital, Alexandria, Egypt; Ivorian Association for Family Welfare, 
Abidjan, Côte d’Ivoire (A K Adou MD); Sport Science Department 
(J C Adsuar PhD, S Villafaina MSc), University of Extremadura, Cáceres, 
Spain (D Collado-Mateo MSc); Department of Family Medicine 
(G Agarwal MD), Department of Pathology and Molecular Medicine 
(T O Olagunju MD), McMaster University, Hamilton, ON, Canada; 
Department of Zoology (S A Aghayan PhD), Yerevan State University, 
Yerevan, Armenia; Research Group of Molecular Parasitology 
(S A Aghayan PhD), Scientific Center of Zoology and Hydroecology, 
Yerevan, Armenia; Indian Institute of Public Health 
(Prof S Zodpey PhD), Indian Institute of Public Health – Hyderabad 
(Prof G Murthy MD), Public Health Foundation of India, Gurugram, 
India (S Agrawal PhD, A Awasthi PhD, Prof L Dandona MD, 
Prof R Dandona PhD, G Kumar PhD, D K Lal MD, M R Mathur PhD); 
Vital Strategies, Gurugram, India (S Agrawal PhD); Department of 
Neurosurgery (H Safari MD), Department of Public Health 
(M A Khafaie PhD), Environmental Technologies Research Center 
(M Ahmadi PhD), Thalassemia and Hemoglobinopathy Research Center 
(F Rahim PhD), Ahvaz Jundishapur University of Medical Sciences, 
Ahvaz, Iran; Health Economics and Financing Research Group 
(A R Sarker MHE), Health Systems and Population Studies Division 
(S Ahmed MSc), Initiative for Non Communicable Diseases 
(A Naheed PhD), Maternal and Child Health Division (S Zaman MPH), 
International Centre for Diarrhoeal Disease Research, Bangladesh, 
Dhaka, Bangladesh; Department of Learning, Informatics, Management, 
and Ethics (S Ahmed MSc), Department of Medical Epidemiology and 
Biostatistics (J J Carrero PhD, Prof E Weiderpass PhD), Department of 
Neurobiology (Prof J Ärnlöv PhD), Department of Neurobiology, Care 
Sciences and Society (S Fereshtehnejad PhD), Department of Public 
Health Sciences (Prof P Allebeck MD, Z El-Khatib PhD), Karolinska 
Institute, Stockholm, Sweden; University Ferhat Abbas of Setif, Setif, 
Algeria (A Aichour BMedSc, I Aichour BPharm); Higher National 
School of Veterinary Medicine, Algiers, Algeria (M Aichour MA); 
Department of Civil and Environmental Engineering (A S Akanda PhD), 
University of Rhode Island, Kingston, RI, USA; Cancer Research Center 
(Prof M Akbari MD), Department of Biostatistics (A Khajavi MSc), 
Department of Epidemiology (S Riahi PhD), Ophthalmic Epidemiology 
Research Center (S Safi PhD), Ophthalmic Research Center (S Safi PhD, 
M Yaseri PhD), Research Institute for Endocrine Sciences 
(A Haj-Mirzaian MD, S N Irvani MD), Safety Promotion and Injury 
Prevention Research Center (N Jahanmehr PhD), School of Public 
Health (N Jahanmehr PhD), Shahid Beheshti University of Medical 
Sciences, Tehran, Iran; Department of Midwifery (M Akibu MSc), 
Department of Public Health (M G Ansha MPH, T Kolola MPH), Debre 
Berhan University, Debre Berhan, Ethiopia; Institute for Advanced 
Medical Research and Training (R O Akinyemi PhD, 
Prof M O Owolabi DrM), University of Ibadan, Ibadan, Nigeria; 
Department of Epidemiology (T Akinyemiju PhD), University of 
Kentucky, Lexington, KY, USA; Department of Nutritional Sciences 
(A Badawi PhD), The Hospital for Sick Children (N Akseer PhD, 
Prof Z A Bhutta PhD), University of Toronto, Toronto, ON, Canada; 
Evidence Based Practice Center (F Alahdab MD), Mayo Clinic 
Foundation for Medical Education and Research, Rochester, MN, USA; 
Research Committee (F Alahdab MD), Syrian American Medical Society, 
Washington, DC, USA; Internal Medicine Department (Z Al-Aly MD), 
Washington University in St Louis, St Louis, MO, USA; Clinical 
Epidemiology Center, VA St Louis Health Care System (Z Al-Aly MD), 
Department of Internal Medicine (S K Jassal MD), Department of 
Veterans Affairs, St Louis, MO, USA; School of Medicine 
(Prof G J Hankey MD), School of Population and Global Health 
(K Alam PhD), University of Western Australia, Perth, WA, Australia; 
Department of Preventive Medicine (A V Aleman MD), University of the 
Republic, Montevideo, Uruguay; National Centre for Epidemiology and 
Population Health (M Bin Sayeed MSPS), Research School of Population 
Health (K A Alene MPH), Australian National University, Canberra, 
ACT, Australia; Department of Pediatrics (B H Sobaih MD, 
M Temsah MD), Pediatric Intensive Care Unit (A Al-Eyadhy MD), 
King Saud University, Riyadh, Saudi Arabia (K Altirkawi MD); Public 
Health Research Center (R Ali MPH), New York University Abu Dhabi, 
Abu Dhabi, United Arab Emirates; Big Data Institute 
(Prof P W Gething PhD), Department of Psychiatry 
(Prof C R J Newton MD), Nuffield Department of Population Health 
(R Ali MPH, D A Bennett PhD), University of Oxford, Oxford, UK 
(Prof V Jha MD); Qazvin University of Medical Sciences, Qazvin, Iran 
(M Alijanzadeh PhD); Department of Immunology (Prof A Rafiei PhD), 
Department of Medical Mycology (H Badali PhD), Department of 
 Global Health Metrics
2042 
www.thelancet.com   Vol 392   November 10, 2018
Medical Mycology and Parasitology (A Vaezi PhD), Department of 
Pediatrics (M Rezai MD), Department of Physiology and Pharmacology 
(M Mohammadi PhD), Gastrointestinal Cancer Research Center 
(R Alizadeh-Navaei PhD), Molecular and Cell Biology Research Center 
(Prof A Rafiei PhD), School of Public Health (Prof A Enayati PhD), 
Toxoplasmosis Research Center (Prof A Daryani PhD, S Sarvi PhD), 
Mazandaran University of Medical Sciences, Sari, Iran 
(A Hedayatizadeh-Omran PhD, M Nourollahpour Shiadeh PhD, 
Z Zare PhD); Department of Health Policy and Management 
(Prof S M Aljunid PhD), Kuwait University, Safat, Kuwait; International 
Centre for Casemix and Clinical Coding (Prof S M Aljunid PhD), 
National University of Malaysia, Bandar Tun Razak, Malaysia; 
Department of Population Health (A Alkerwi PhD), Luxembourg 
Institute of Health, Strassen, Luxembourg; University of Bordeaux, 
Bordeaux, France (Prof F Alla PhD); Swedish Research Council for 
Health, Working Life, and Welfare, Stockholm, Sweden 
(Prof P Allebeck MD); Research Program in Epidemiology & Public 
Health (Prof J Alonso MD), Hospital del Mar Medical Research Institute, 
Barcelona, Spain; Department of Experimental and Health Sciences 
(Prof J Alonso MD), Pompeu Fabra University, Barcelona, Spain; 
Department of Family and Community Medicine 
(Prof R M Al-Raddadi PhD), King Abdulaziz University, Jeddah, Saudi 
Arabia; Department of Operative and Preventive Dentistry 
(Prof F Schwendicke MPH), Institute of Public Health 
(Prof R Busse PhD, Prof E Schaeffner MD), Charité University Medical 
Center Berlin, Berlin, Germany (U Alsharif MD); Research Group on 
Health Economics (Prof N Alvis-Guzman PhD), University of Cartagena, 
Cartagena, Colombia; Research Group in Hospital Management and 
Health Policies (Prof N Alvis-Guzman PhD), University of the Coast, 
Barranquilla, Colombia; Sansom Institute (A Amare PhD), 
Wardliparingga Aboriginal Research Unit (P S Azzopardi PhD), 
South Australian Health and Medical Research Institute, Adelaide, SA, 
Australia; Department of Public Health Nutrition (N Fentahun PhD), 
Bahir Dar University, Bahir Dar, Ethiopia (A Amare PhD); Federal 
Ministry of Health, Beirut, Lebanon (Prof W Ammar PhD); Department 
of Epidemiology and Population Health (Prof A M Sibai PhD), Faculty of 
Health Sciences (Prof W Ammar PhD), American University of Beirut, 
Beirut, Lebanon; Faculty of Medicine (N H Anber PhD), Mansoura 
University, Mansoura, Egypt (N H Anber PhD); Anatomy and 
Embryology Department (R I Negoi PhD), Department of General 
Surgery (D V Davitoiu PhD, M Hostiuc PhD), Department of Legal 
Medicine and Bioethics (S Hostiuc PhD), Emergency Hospital of 
Bucharest (Prof M Beuran PhD, I Negoi PhD), 2nd Department of 
Dermatology (M Constantin MD), Carol Davila University of Medicine 
and Pharmacy, Bucharest, Romania (C Andrei PhD); Department of 
Medicine (S Androudi PhD), University of Thessaly, Volos, Greece; 
Department of Public Health (M Y Teshale MPH), Arba Minch 
University, Arba Minch, Ethiopia (M D Animut MPH); Zahedan 
University of Medical Sciences, Zahedan, Iran (H Ansari PhD); 
Department of Health Policy and Administration (C T Antonio MD), 
Development and Communication Studies (E K Macarayan PhD), 
University of the Philippines Manila, Manila, Philippines; Department 
of Applied Social Sciences (C T Antonio MD), School of Nursing 
(P H Lee PhD), Hong Kong Polytechnic University, Hong Kong, China; 
Department of Sociology and Social Work (S Appiah MD), Kwame 
Nkrumah University of Science and Technology, Kumasi, Ghana; Center 
for International Health (S Appiah MD, D Paudel PhD), Ludwig 
Maximilians University, Munich, Germany; School of Health Sciences 
(O Aremu PhD), Birmingham City University, Birmingham, UK; School 
of Health and Social Studies (Prof J Ärnlöv PhD), Dalarna University, 
Falun, Sweden; Department of Community Health Sciences 
(A Artaman PhD), University of Manitoba, Winnipeg, MB, Canada; 
Monitoring Evaluation and Operational Research Project 
(K K Aryal PhD), Abt Associates Nepal, Lalitpur, Nepal; Qom University 
of Medical Sciences, Qom, Iran (H Asayesh MSc); Department of 
Medical Biotechnology (A Sahebkar PhD), Education Development 
Center (R Assadi PhD), Mashhad University of Medical Sciences, 
Mashhad, Iran; University Institute of Public Health (S Atique PhD), 
The University of Lahore, Lahore, Pakistan; Public Health Department 
(S Atique PhD), University of Hail, Hail, Saudi Arabia; Department of 
Social Welfare (M S Atteraya PhD), Keimyung University, Daegu, South 
Korea; School of Business (Prof M Ausloos PhD), University of Leicester, 
Leicester, UK; Contrôle des Maladies Infectieuses (E F A Avokpaho MD), 
Non Communicable Disease Department (F G Gankpe MD), Laboratory 
of Studies and Research-Action in Health, Porto Novo, Benin; Indian 
Institute of Public Health, Gandhinagar, India (A Awasthi PhD); Austin 
Clinical School of Nursing (M Rahman PhD), Department of Psychology 
and Counselling (Prof T Wijeratne MD), School of Nursing and 
Midwifery (Prof D Edvardsson PhD), The Judith Lumley Centre 
(B Ayala Quintanilla PhD), La Trobe University, Melbourne, VIC, 
Australia; General Office for Research and Technological Transfer 
(B Ayala Quintanilla PhD), Peruvian National Institute of Health, Lima, 
Peru; Department of Community and Global Health (R Ayer MHSc), 
Department of Diabetes and Metabolic Diseases (T Yamada MD), 
Department of Global Health Policy (S Nomura MSc, M Rahman MHS, 
Prof K Shibuya MD), Department of Mental Health 
(Prof N Kawakami PhD), University of Tokyo, Tokyo, Japan; Centre for 
Food and Nutrition Research (T B Ayuk PhD), Institute of Medical 
Research and Medicinal Plant Studies, Yaounde, Cameroon; Department 
of Health studies (T B Ayuk PhD), University of South Africa, Pretoria, 
South Africa; Global Adolescent Health Group (P S Azzopardi PhD), 
Burnet Institute, Melbourne, VIC, Australia; Department of Public 
Health Medicine (T K Babalola MSc, T P Mashamba-Thompson PhD, 
Prof B P Ncama PhD, Prof B Sartorius PhD), University of KwaZulu-
Natal, Durban, South Africa; Department of Community Health and 
Primary Care (T K Babalola MSc), Department of Psychiatry 
(A T Olagunju MD), University of Lagos, Lagos, Nigeria; Center for 
Infectious Diseases Research, Babol, Iran (A Babazadeh MD, 
S Ebrahimpour PhD); Health Promotion and Chronic Disease 
Prevention Branch (J J Lang PhD), Public Health Risk Sciences Division 
(A Badawi PhD), Public Health Agency of Canada, Toronto, ON, Canada; 
Department of Hypertension (Prof M Banach PhD), Medical University 
of Lodz, Lodz, Poland; Polish Mothers’ Memorial Hospital Research 
Institute, Lodz, Poland (Prof M Banach PhD); Molecular Medicine and 
Pathology (K B Tran MD), School of Psychology 
(Prof S L Barker-Collo PhD), University of Auckland, Auckland, 
New Zealand; Augenpraxis Jonas (S Panda-Jonas MD), Department of 
Ophthalmology (Prof J B Jonas MD), Institute of Public Health 
(Prof T W Bärnighausen MD, Prof J De Neve MD, B Moazen MSc, 
S Mohammed PhD), Medical Clinic V (Prof W März MD), Heidelberg 
University, Heidelberg, Germany; Ariadne Labs (E K Macarayan PhD), 
Department of Global Health and Population 
(Prof T W Bärnighausen MD, A B Feigl PhD), Department of Nutrition 
(E L Ding DSc, M S Farvid PhD), Division of General Internal Medicine 
and Primary Care (Prof A Sheikh MD), Fenot Project (G D Dinsa PhD), 
Heart and Vascular Center (M Vaduganathan MD), T H Chan School of 
Public Health (G D Dinsa PhD, P C Gupta DSc), Harvard University, 
Boston, MA, USA; Department of Industrial Engineering 
(Prof L H Barrero DSc), Pontifical Javeriana University, Bogota, 
Colombia; University of Aden, Aden, Yemen (H Basaleem PhD); 
Barcelona Institute for Global Health, Barcelona, Spain 
(Prof Q Bassat MD, Prof J V Lazarus PhD); Manhiça Health Research 
Center, Manhiça, Mozambique (Prof Q Bassat MD); School of Health 
Sciences (A Basu PhD), University of Canterbury, Christchurch, New 
Zealand; Melbourne Medical School, Melbourne, VIC, Australia 
(Prof B T Baune PhD); Department of Environmental Health Science 
(S Gallus DSc), Department of Neuroscience (E Beghi MD, 
G Giussani PhD), Department of Oncology (C Bosetti PhD, 
M Cortinovis PhD), Department of Renal Medicine (B Bikbov MD, 
N Perico MD), Mario Negri Institute for Pharmacological Research, 
Milan, Italy (Prof G Remuzzi MD); Air Pollution Research Center 
(B Heibati PhD), Department of Community Medicine 
(A Tehrani-Banihashemi PhD), Department of Health Policy 
(H Shabaninejad PhD), Department of Neuroscience (M Safdarian MD), 
Department of Ophthalmology (K Ghasemi Falavarjani MD), Health 
Management and Economics Research Center (M Behzadifar PhD), 
Pharmacology Department (S Mehrzadi PhD), Physiology Research 
Center (M Yousefifard PhD), Preventive Medicine and Public Health 
Research Center (M Moradi-Lakeh MD, A Tehrani-Banihashemi PhD, 
K Vosoughi MD), Iran University of Medical Sciences, Tehran, Iran 
(M Hosseinzadeh PhD); Social Determinants of Health Research Center 
(M Behzadifar PhD), Lorestan University of Medical Sciences, 
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2043
Khorramabad, Iran (M Behzadifar MS); Public Health Department 
(B Bekele MPH, H Y Hassen MPH), Mizan-Tepi University, Teppi, 
Ethiopia (A Henok MPH); Dr Tewelde Legesse Health Sciences College, 
Mekelle, Ethiopia (S A Belay MPH); Department of Ophthalmology and 
Visual Science (Prof J J Huang MD), School of Forestry and 
Environmental Studies (Prof M L Bell PhD), Yale University, New 
Haven, CT, USA; Department of Medicine (A K Bello PhD), University 
of Alberta, Edmonton, AB, Canada; Center for Clinical and 
Epidemiological Research (A C Goulart PhD), Department of Internal 
Medicine (I M Bensenor PhD, Prof I S Santos PhD), Department of 
Medicine (Prof P A Lotufo DrPH), Department of Pathology and Legal 
Medicine (M R Tovani-Palone MSc), Department of Psychiatry 
(G V Polanczyk MD, Y Wang PhD), University Hospital, Internal 
Medicine Department (A C Goulart PhD), University of São Paulo, São 
Paulo, Brazil; Sackler Institute for Nutrition Science (G Bergeron PhD), 
New York Academy of Sciences, New York, NY, USA; Division of 
Cardiology (Prof A E Berman MD), Medical College of Georgia at 
Augusta University, Augusta, GA, USA; Department of Health Policy 
(Prof A E Berman MD), Personal Social Services Research Unit 
(R Kadel MPH), London School of Economics and Political Science, 
London, UK; Dental Institute (E Bernabe PhD), Division of Patient and 
Population (Prof W Marcenes PhD), Faculty of Life Sciences and 
Medicine (Prof P I Dargan MB, M Molokhia PhD), School of Population 
Health & Environmental Sciences (Prof C D A Wolfe MD), King’s 
College London, London, UK; Hubert Department of Global Health 
(R S Bernstein MD), Emory University, Atlanta, GA, USA; Department 
of Global Health (R S Bernstein MD), University of South Florida, 
Tampa, FL, USA; Department of Disease Control (J Cano PhD), 
Department of Infectious Disease Epidemiology (O J Brady PhD), 
Department of Non-communicable Disease Epidemiology 
(Prof S Kinra PhD), London School of Hygiene & Tropical Medicine, 
London, UK (S Bhattarai MD); Nepal Academy of Science & Technology, 
Patan, Nepal (S Bhattarai MD); The George Institute for Global Health, 
New Delhi, India (S Bhaumik MBBS, Prof V Jha MD, P K Maulik PhD); 
Center of Excellence in Women and Child Health 
(Prof Z A Bhutta PhD), Department of Pediatrics & Child Health 
(M Nisar MSc), Aga Khan University, Karachi, Pakistan; Cellular and 
Molecular Biology Research Center (H Nouri PhD), Department of 
Clinical Biochemistry (A Mosapour PhD, N Neamati MSc, 
H Parsian PhD), Department of Pharmacology 
(M Mohammadi-Khanaposhtani PhD), Fatemeh Zahra Infertility and 
Reproductive Health Center (P Mirabi PhD), Health Research Institute 
(R Ghadimi PhD, M Ghasemi-Kasman PhD), Infectious Diseases and 
Tropical Medicine Research Center (A Rostami PhD), Social 
Determinants of Health Research Center (A Bijani PhD), Student 
Research Committee (M Zamani MD), Babol University of Medical 
Sciences, Babol, Iran (M Faramarzi PhD); Woldia University, Woldia, 
Ethiopia (N Bililign BHlthSci); Department of Clinical Pharmacy and 
Pharmacology (M Bin Sayeed MSPS), University of Dhaka, Ramna, 
Bangladesh; Department of Medical and Surgical Sciences 
(Prof F S Violante MPH), University of Bologna, Bologna, Italy 
(S M Birlik MBA); Liaison of Turkey (S M Birlik MBA), Guillain-Barré 
Syndrome/Chronic Inflammatory Demyelinating Polyneuropathy 
Foundation International, Conshohocken, PA, USA; Department of 
Epidemiology and Public Health (Prof M Kivimäki PhD, 
M R Mathur PhD), Department of Psychology (M Kumar PhD), The 
UCL Centre for Global Health Economics (C Birungi MSc), University 
College London, London, UK; Fast-Track Implementation Department 
(C Birungi MSc), United Nations Programme on HIV
/AIDS (UNAIDS), 
Gaborone, Botswana; Department of Health Sciences (I Filip MD), 
A T Still University, Brisbane, QLD, Australia (T Biswas MPH, 
A Radfar MD); Department of Public Health (H Bizuneh MPH), 
St Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia; 
Department of Surgery (S Krishnaswami MD), Radiation Medicine 
(A Bleyer MD), Oregon Health and Science University, Portland, OR, 
USA; Department of Pediatrics (A Bleyer MD), University of Texas, 
Houston, TX, USA (X Zhang PhD); General Directorate of Health 
Information Systems (B Bora Basara PhD), Department of Health 
Statistics (G K Yentür MSc), Ministry of Health, Ankara, Turkey 
(M Car PhD, A Chitheer MD); National Drug and Alcohol Research 
Centre (Prof L Degenhardt PhD), School of Medicine (P K Maulik PhD), 
School of Psychiatry (Prof P S Sachdev MD), Transport and Road Safety 
Research (S Boufous PhD), University of New South Wales, Sydney, 
NSW, Australia (Prof K A Dolan PhD); University of Genoa, Genoa, Italy 
(N L Bragazzi PhD); Department for Clinical Neurosciences and 
Preventive Medicine (Prof M Brainin MD), Danube University Krems, 
Krems, Austria; Institute of Epidemiology (A Brazinova MD), Comenius 
University, Bratislava, Slovakia; College of Public Health 
(M Yotebieng PhD), Department of Psychology 
(Prof N J K Breitborde PhD), Psychiatry and Behavioral Health 
Department (Prof N J K Breitborde PhD), The Ohio State University, 
Columbus, OH, USA; Division of Clinical Epidemiology and Aging 
Research (Prof H Brenner MD), German Cancer Research Center, 
Heidelberg, Germany; Department of Cardiovascular Medicine 
(L T Cooper MD), Department of Dermatology (J D Brewer MD), Mayo 
Clinic, Rochester, MN, USA; Tuberculosis Biomarker Research Unit 
(A Goodridge PhD), Institute for Scientific Research and High 
Technology Services, City of Knowledge, Panama (G Britton PhD); 
Department of Research and Health Technology Assessment 
(F Castro MD), Gorgas Memorial Institute for Health Studies, Panama, 
Panama (G Britton PhD); School of Population and Public Health 
(Z A Butt PhD, F Pourmalek PhD, Prof N Sarrafzadegan MD), 
University of British Columbia, Vancouver, BC, Canada (J A Kopec PhD); 
Al Shifa School of Public Health (Z A Butt PhD), Al Shifa Trust Eye 
Hospital, Rawalpindi, Pakistan; Center for Health Systems Research 
(L Cahuana-Hurtado PhD, H Gómez-Dantés MSc, M Rios-Blancas MPH, 
Prof E Serván-Mori DSc), Center for Nutrition and Health Research 
(E Denova-Gutiérrez DSc), Center for Population Health Research 
(C Razo-García MSc), National Institute of Public Health, Cuernavaca, 
Mexico (I R Campos-Nonato PhD, J Campuzano Rincon PhD); School of 
Medicine (J Campuzano Rincon PhD), University of the Valley of 
Cuernavaca, Cuernavaca, Mexico; Department of Primary Care and 
Public Health (M Car PhD, Prof A Majeed MD, Prof S Rawaf PhD), 
Division of Brain Sciences (Prof R A Shakir MD), School of Public 
Health (Prof S Saxena MD), WHO Collaborating Centre for Public 
Health Education and Training (D L Rawaf MD), Imperial College 
London, London, UK; Department of Population and Health 
(Prof R Cárdenas DSc), Metropolitan Autonomous University, Mexico 
City, Mexico; Applied Molecular Biosciences Unit (Prof F Carvalho PhD), 
Institute for Research and Innovation in Health (i3S) (J das Neves PhD), 
Institute of Biomedical Engineering (J das Neves PhD), Institute of 
Public Health (Prof F Carvalho PhD), REQUIMTE/LAQV 
(Prof E Fernandes PhD, Prof D M Pereira PhD), UCIBIO 
(J P Silva PhD), University of Porto, Porto, Portugal; Colombian National 
Health Observatory (C A Castañeda-Orjuela MD), National Institute of 
Health, Bogota, Colombia; Epidemiology and Public Health Evaluation 
Group (C A Castañeda-Orjuela MD), National University of Colombia, 
Bogota, Colombia; Area de Estadística, Dirección Actuarial 
(Prof J Castillo Rivas MSc), Costa Rican Department of Social Security, 
San Jose, Costa Rica; School of Dentistry (Prof J Castillo Rivas MSc), 
University of Costa Rica, San Pedro, Costa Rica; Department of Health 
Planning and Economics (F Catalá-López PhD), Institute of Health 
Carlos III, Madrid, Spain; Department of Public Health 
(B Kucuk Bicer BEP), Institute of Population Studies (A Çavlin PhD), 
Hacettepe University, Ankara, Turkey; Mary MacKillop Institute for 
Health Research (Prof E Cerin PhD), The Brain Institute 
(Prof C E I Szoeke PhD), Australian Catholic University, Melbourne, 
VIC, Australia; Centre for Suicide Research and Prevention 
(Prof P Yip PhD), School of Public Health (Prof E Cerin PhD), 
University of Hong Kong, Hong Kong, China (Prof P Yip PhD); Health 
Systems Research Center (Prof J C Montañez MSc), Institute of 
Population Health Sciences (Prof H Chang DrPH), National Health 
Research Institutes, Zhunan Township, Taiwan; College of Medicine 
(J Chang PhD), National Taiwan University, Taipei, Taiwan; Department 
of Development Studies (A Chattopadhyay PhD, M A Malik MPhil), 
Department of Fertility Studies (A Kastor MPhil, B K Panda MA), 
Department of Population Studies (A Patle MPH), Department of Public 
Health & Mortality Studies (M H Rahman MPhil, Prof U Ram PhD), 
International Institute for Population Sciences, Mumbai, India 
(S Goli PhD, P Kumar PhD); Surgical Oncology (Prof P Chaturvedi MD), 
Tata Memorial Hospital, Mumbai, India; Clinical Governance 
(P P Chiang PhD), Gold Coast Health, Gold Coast, QLD, Australia; 
 Global Health Metrics
2044 
www.thelancet.com   Vol 392   November 10, 2018
Centre of Cardiovascular Research and Education in Therapeutics 
(R Ofori-Asenso MSc), Department of Epidemiology and Preventive 
Medicine (K L Chin PhD), School of Public Health and Preventive 
Medicine (Prof F M Cicuttini PhD, Prof Y Guo PhD, S Li PhD, 
S Si PhD), Monash University, Melbourne, VIC, Australia; Department 
of Economics (F Masiye PhD), Department of Population Studies 
(V H Chisumpa PhD, C Mapoma PhD), University of Zambia, Lusaka, 
Zambia; Demography and Population Studies (V H Chisumpa PhD), 
University of the Witwatersrand, Johannesburg, South Africa; 
Biochemistry, Biomedical Science (J J Choi PhD), Seoul National 
University Hospital, Seoul, South Korea; Department of Public Health 
and Primary Care (R Chowdhury PhD), University of Cambridge, 
Cambridge, UK; Department of Endocrinology (Prof N Thomas PhD), 
Department of Pulmonary Medicine (Prof D J Christopher MD), 
Christian Medical College and Hospital (CMC), Vellore, India 
(Prof S Varughese MD); Adelaide Medical School (L G Ciobanu PhD, 
T K Gill PhD), Robinson Research Institute (Z S Lassi PhD), University 
of Adelaide, Adelaide, SA, Australia (A T Olagunju MD); Scuola Medica 
Salernitana (M Cirillo MD), University of Salerno, Baronissi, Italy; 
Faculty of Business and Management (M Á Garcia-Gordillo PhD), 
Faculty of Education (D Collado-Mateo MSc), Institute of Physical 
Activity and Health (Prof P R Olivares PhD), Autonomous University of 
Chile, Talca, Chile; School of Medicine and Surgery (S Conti PhD, 
P A Cortesi PhD, A Lafranconi MD, F Madotto PhD, 
Prof L G Mantovani DSc), University of Milan Bicocca, Monza, Italy; 
NIHR Oxford Biomedical Research Centre (Prof C Cooper MEd), 
University of Southampton, Southampton, UK (Prof C Cooper MEd); 
T Denny Sanford School of Social and Family Dynamics (M Costa PhD), 
Arizona State University, Tempe, AZ, USA; Division of Reproductive 
Health (M Costa PhD), Centers for Disease Control and Prevention 
(CDC), Atlanta, GA, USA; Division of Epidemiology and Prevention of 
Chronic Noncommunicable Diseases (P Cukelj MA, M Sekerija PhD), 
Croatian Institute of Public Health, Zagreb, Croatia; Division of 
Epidemiology and Biostatistics, School of Public Health 
(Y A Gelaw MPH), Institute for Social Science Research 
(A A Mamun PhD, J C Maravilla PhD), Queensland Brain Institute 
(Prof J J McGrath MD), School of Dentistry (R Lalloo PhD), School of 
Public health (B A Dachew MPH), The University of Queensland, 
Brisbane, QLD, Australia (Prof H A Whiteford PhD); Biomedical 
Research Council (Prof C D A Wolfe MD), Clinical Toxicology Service 
(Prof P I Dargan MB), Guy’s and St. Thomas’ NHS Foundation Trust, 
London, UK; James P Grant School of Public Health 
(R Das Gupta MPH, M Hasan MPH, I Sutradhar MPH), Research and 
Evaluation Division (M Rahman PhD), BRAC University, Dhaka, 
Bangladesh; Central University of Tamil Nadu (Prof A P Dash DSc), 
Thiruvarur, India; Department of Surgery (D V Davitoiu PhD), Clinical 
Emergency Hospital Sf Pantelimon, Bucharest, Romania; Kazakh 
National Medical University, Almaty, Kazakhstan (K Davletov PhD); 
Australian Institute for Suicide Research and Prevention 
(Prof D De Leo DSc), Menzies Health Institute Queensland 
(S K Tadakamadla PhD), Griffith University, Mount Gravatt, QLD, 
Australia; Maternal and Child Wellbeing Unit (T A Zerfu PhD), 
Population Dynamics and Reproductive Health Unit (T T Degfie PhD), 
African Population Health Research Centre, Nairobi, Kenya; Department 
of Clinical Pharmacy (G T Demoz MSc), Department of Medical 
Laboratory Sciences (M Teweldemedhin MSc), Aksum University, 
Aksum, Ethiopia; Department of Global Health and Infection 
(K Deribe PhD), Brighton and Sussex Medical School, Brighton, UK; 
Information Services Division (G M A Wyper MSc), National Health 
Service Scotland, Edinburgh, UK (N Dervenis MD); Aristotle University 
of Thessaloniki, Thessaloniki, Greece (N Dervenis MD); Department of 
Psychiatry (Prof D C Des Jarlais PhD), Icahn School of Medicine at 
Mount Sinai, New York, NY, USA; Department of Community Medicine 
(S D Dharmaratne MD), University of Peradeniya, Peradeniya, 
Sri Lanka; Health Research Section (M Dhimal PhD), Research Section 
(A R Pandey MPH), Nepal Health Research Council, Kathmandu, Nepal; 
Center of Communicable Disease Control (B Eshrati PhD), Deputy of 
Research and Technology (S Djalalinia PhD), Ministry of Health and 
Medical Education, Tehran, Iran (A Khosravi PhD); Institute for Global 
Health Innovations (H P Do PhD, L H Nguyen PhD, 
T H Nguyen BMedSc), Nguyen Tat Thanh University, Hanoi, Vietnam; 
Department of Social Medicine and Health Care Organisation 
(K Dokova PhD), Medical University of Varna, Varna, Bulgaria; 
Department of Population and Health (D T Doku PhD), University of 
Cape Coast, Cape Coast, Ghana; Faculty of Social Sciences 
(D T Doku PhD), Faculty of Health Sciences (S Neupane PhD), 
University of Tampere, Tampere, Finland; School of Health and 
Biomedical Sciences (Prof K E Doyle PhD), Royal Melbourne Institute of 
Technology University, Bundoora, VIC, Australia; Asbestos Diseases 
Research Institute (J Leigh MD), Sydney Medical School (S Islam PhD), 
Sydney School of Public Health (Prof T R Driscoll PhD), University of 
Sydney, Sydney, NSW, Australia (M A Mohammed PhD); United Nations 
World Food Programme, New Delhi, India (M Dubey PhD); Centre 
School of Public Health and Health Management 
(Prof M M Santric Milicevic PhD), Faculty of Medicine 
(E Dubljanin PhD), Faculty of Medicine Institute of Epidemiology 
(I S Vujcic PhD), University of Belgrade, Belgrade, Serbia; Department 
of Health Sciences (E Duken MSc), Wollega University, Nekemte, 
Ethiopia; School of Medicine (Prof A R Duraes PhD), Federal University 
of Bahia, Salvador, Brazil; Diretoria Médica (Prof A R Duraes PhD), 
Roberto Santos General Hospital, Salvador, Brazil; Department of 
Nursing (Prof D Edvardsson PhD), Umeå University, Umeå, Sweden; 
Eijkman-Oxford Clinical Research Unit (I R Elyazar PhD), Eijkman 
Institute for Molecular Biology, Jakarta, Indonesia; Public Health 
Department (A Y Y Endries MPH), Saint Paul’s Hospital Millennium 
Medical College, Addis Ababa, Ethiopia; Laboratory for Socio-economic 
Issues of Human Development and Quality of Life 
(Prof S P Ermakov DSc), Russian Academy of Sciences, Moscow, Russia; 
Central Research Institute of Cytology and Genetics (E Varavikova PhD), 
Department of Medical Statistics and Documentary 
(Prof S P Ermakov DSc), Federal Research Institute for Health 
Organization and Informatics of the Ministry of Health, Moscow, Russia 
(Prof V I Starodubov DSc, S K Vladimirov PhD); Department of Public 
Health (R Esmaeili PhD), Gonabad University of Medical Sciences, 
Gonabad, Iran; Department of Medical Parasitology and Mycology 
(H Fakhim PhD), Urmia University of Medical Science, Urmia, Iran; 
College of Medicine (M Fareed PhD), Department of Public Health 
(A T Khoja MD), Imam Muhammad Ibn Saud Islamic University, 
Riyadh, Saudi Arabia; National Statistical Office, Lisbon, Portugal 
(C S e Farinha MSc); Department of Psychology (Prof A Faro PhD), 
Federal University of Sergipe, Sao Cristovao, Brazil; Doctor Evidence, 
Santa Monica, CA, USA (M Fazeli PhD); National Institute for Stroke 
and Applied Neurosciences (Prof V L Feigin PhD), Auckland University 
of Technology, Auckland, New Zealand; Health Division (A B Feigl PhD), 
Organisation for Economic Co-operation and Development, Paris, 
France; Fertility & Infertility, Sarem Fertility & Infertility Research 
Center, Tehran, Iran (Prof F Feizy MD); Institute of Statistical, Social and 
Economic Research (A P Fenny PhD), School of Public Health 
(R Quansah PhD), University of Ghana, Legon, Ghana; Psychiatry 
(I Filip MD), Kaiser Permanente, Fontana, CA, USA; Department of 
Public Health Medicine (F Fischer PhD), Bielefeld University, Bielefeld, 
Germany; Sergio Arouca National School of Public Health, Rio de 
Janeiro, Brazil (L S Flor MPH); Federal University of Espírito Santo, 
Vitoria, Brazil (L S Flor MPH); Institute of Gerontology (N A Foigt PhD), 
National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine; 
Department of Medicine and Surgery (C Fornari PhD), University of 
Milano – Bicocca, Monza, Italy; Epidemiology and Public Health 
(T Fürst PhD); Malaria Vaccines (C Karema MPH), Swiss Tropical and 
Public Health Institute, Basel, Switzerland; University of Basel, Basel, 
Switzerland (T Fürst PhD); Gene Expression & Regulation Program 
(T Fukumoto PhD), Cancer Institute, Philadelphia, PA, USA; 
Department of Dermatology (T Fukumoto PhD), Kobe University, Kobe, 
Japan; Medical Statistics (S Marina MS), National Centre for Disease 
Control, Tbilisi, Georgia (Prof A Gamkrelidze PhD, M Kereselidze MD); 
Faculty of Medicine and Pharmacy of Fez (F G Gankpe MD), University 
Sidi Mohammed Ben Abdellah, Fez, Morocco; International Trachoma 
Initiative (T Gebre PhD), Task Force for Global Health, Decatur, GA, 
USA; School of Public Health (A T Gebremedhin MPH, D Hendrie PhD, 
T R Miller PhD), Curtin University, Perth, WA, Australia; Division of 
Human Nutrition and Health (Prof J M Geleijnse PhD), Wageningen 
University & Research, Wageningen, Netherlands; Directorate General 
for Public Health (R Genova-Maleras MSc), Regional Health Council, 
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2045
Madrid, Spain; Social Determinants of Health Research Center 
(H Ghiasvand PhD), University of Social Welfare and Rehabilitation 
Sciences, Tehran, Iran (M Noroozi PhD); Department of Health Care 
Policy and Management (M Ghimire MA), University of Tsukuba, 
Tsukuba, Japan; Department of Respiratory Medicine 
(Prof A G Ghoshal MD), National Allergy, Asthma, and Bronchitis 
Institute, Kolkota, India; Department of Respiratory Medicine 
(Prof A G Ghoshal MD), Fortis Hospital, Kolkata, India; Division of 
Health Sciences (O A Uthman PhD), Unit of Academic Primary Care 
(Prof P S Gill DM), University of Warwick, Coventry, UK; Research 
Center of Neurology, Moscow, Russia (E V Gnedovskaya PhD); Center 
for the Study of Regional Development (S Goli PhD), Centre for Ethics 
(T Khanna PhD), Jawahar Lal Nehru University, New Delhi, India; 
Nursing and Health Sciences Department (P N Gona PhD), University 
of Massachusetts Boston, Boston, MA, USA; Department of Biostatistics 
and Epidemiology (S V Gopalani MPH), University of Oklahoma, 
Oklahoma City, OK, USA; Department of Health and Social Affairs 
(S V Gopalani MPH), Government of the Federated States of Micronesia, 
Palikir, Federated States of Micronesia; Postgraduate Program in 
Epidemiology (Prof B N G Goulart DSc), Federal University of Rio 
Grande do Sul, Porto Alegre, Brazil; School of Medicine (A Grada MD), 
School of Public Health (O O Isehunwa MD), Boston University, Boston, 
MA, USA; Registro Tumori Integrato (G Grosso PhD), Vittorio 
Emanuele University Hospital Polyclinic, Catania, Italy; Department of 
Epidemiology (Prof H C C Gugnani PhD), Department of Microbiology 
(Prof H C C Gugnani PhD), Saint James School of Medicine, The Valley, 
Anguilla; Department of Epidemiology (P C Gupta DSc, 
D N Sinha PhD), Healis Sekhsaria Institute for Public Health, Mumbai, 
India; Commissioner of Public Health (Prof R Gupta MD), West Virginia 
Bureau for Public Health, Charleston, WV, USA; Department of Health 
Policy, Management & Leadership (Prof R Gupta MD), West Virginia 
University School of Public Health, Morgantown, WV, USA; Academics 
and Research (Prof R Gupta MD), Rajasthan University of Health 
Sciences, Jaipur, India; Department of Preventive Cardiology 
(Prof R Gupta MD), Eternal Heart Care Centre & Research Institute, 
Jaipur, India; Department of Cardiology (T Gupta MD), Montefiore 
Medical Center, Bronx, NY, USA; Department of Epidemiology and 
Population Health (H Hosgood PhD), Albert Einstein College of 
Medicine, Bronx, NY, USA (T Gupta MD); Department of Public Health 
(J A Haagsma PhD, S Kochhar MD), Erasmus University Medical 
Center, Rotterdam, Netherlands; Department of Clinical Neurological 
Sciences (V Hachinski DSc), The University of Western Ontario, 
London, ON, Canada; Lawson Health Research Institute, London, ON, 
Canada (V Hachinski DSc); Department of Epidemiology 
(Prof J B Nachega PhD), Department of Gastroenterology and 
Hepatology (K Vosoughi MD), Department of Health Policy and 
Management (A T Khoja MD), Department of International Health 
(M N Kosek MD), Department of Radiology (N Hafezi-Nejad MD, 
A Haj-Mirzaian MD), Johns Hopkins University, Baltimore, MD, USA; 
Department of Family and Community Medicine 
(Prof R R Hamadeh DPhil), Arabian Gulf University, Manama, Bahrain; 
School of Health and Environmental Studies (Prof S Hamidi DrPH), 
Hamdan Bin Mohammed Smart University, Dubai, United Arab 
Emirates; Population Health Department (A J Handal PhD), University 
of New Mexico, Albuquerque, NM, USA; Neurology Department 
(Prof G J Hankey MD), Sir Charles Gairdner Hospital, Perth, WA, 
Australia; Department of Medical Statistics and Epidemiology 
(Prof Y Hao PhD), Sun Yat-sen Global Health Institute 
(Prof Y Hao PhD), Sun Yat-sen University, China; Department of 
Disease, Epidemics, and Pandemics Control (J Nansseu MD), 
Department of Vital and Health Statistics (H L Harb MPH), Ministry of 
Public Health, Beirut, Lebanon; Health Education and Health Promotion 
Department (L Jahangiry PhD), Tabriz University of Medical Sciences, 
Tabriz, Iran (H Haririan PhD, H Hassankhani PhD); Research and 
Development Unit (Prof J M Haro MD, A Koyanagi MD), San Juan de 
Dios Sanitary Park, Sant Boi de Llobregat, Spain; Department of 
Medicine (Prof J M Haro MD), University of Barcelona, Barcelona, 
Spain; Independent Consultant, Tabriz, Iran (H Hassankhani PhD); 
Unit of Epidemiology and Social Medicine (H Y Hassen MPH), 
University Hospital Antwerp, Wilrijk, Belgium; Clinical Sciences 
(R Havmoeller PhD), Karolinska University Hospital, Stockholm, 
Sweden; Endocrinology and Metabolism Research Center 
(B Heidari MD), Teikyo University School of Medicine, Tehran, Iran; 
Department of Statistics and Econometrics (Prof C Herteliu PhD, 
A Mirica PhD, A Pana MD), Bucharest University of Economic Studies, 
Bucharest, Romania; University of Texas Austin, Austin, TX, USA 
(M K Hole MD); Guilan Road Trauma Research Center 
(E Homaie Rad PhD), School of Health (E Homaie Rad PhD), Guilan 
University of Medical Sciences, Rasht, Iran; Transdisciplinary Centre for 
Qualitative Methods (P Hoogar PhD), Manipal University, Manipal, 
India; Department of Medicine (Prof T Wijeratne MD), Department of 
Paediatrics (M T Mackay PhD, Prof G C Patton MD), School of Health 
Sciences (A Meretoja MD, Prof C E I Szoeke PhD), School of Population 
and Global Health (M M Hosseini Chavoshi PhD), University of 
Melbourne, Melbourne, VIC, Australia (Prof A D Lopez PhD); 
Department of Computer Science (M Hosseinzadeh PhD), University of 
Human Development, Sulaimaniyah, Iraq; Department of Internal 
Medicine (M Hostiuc PhD), Bucharest Emergency Hospital, Bucharest, 
Romania; Clinical Legal Medicine (S Hostiuc PhD), National Institute of 
Legal Medicine Mina Minovici, Bucharest, Romania; Faculty of Medicine 
Tunis (Prof M Hsairi MPH), Medicine School of Tunis, Baab Saadoun, 
Tunisia; Department of Epidemiology and Health Statistics 
(Prof G Hu PhD), Central South University, Changsha, China; 
Department of Public Health (K M Iburg PhD), National Centre for 
Register-based Research (Prof J J McGrath MD), Aarhus University, 
Aarhus, Denmark; School of Public Health (Prof E U Igumbor PhD), 
University of the Western Cape, Bellville, Cape Town, South Africa; 
Department of Public Health (Prof E U Igumbor PhD), Walter Sisulu 
University, Mthatha, South Africa; Department of Public Health and 
Community Medicine (O S Ilesanmi PhD), University of Liberia, 
Monrovia, Liberia; Global Health and Development Department 
(Prof U Iqbal PhD), Graduate Institute of Biomedical Informatics 
(D N A Ningrum MPH), Taipei Medical University, Taipei City, Taiwan, 
Taiwan; School of Public Health (O O Isehunwa MD), University of 
Memphis, Memphis, TN, USA; Department of Psychology 
(M A Stokes PhD), Institute for Physical Activity and Nutrition 
(S Islam PhD), School of Medicine (M Rahman PhD), Deakin 
University, Burwood, VIC, Australia; Department of Parasitic Diseases 
(S K Jain MD), National Centre for Disease Control Delhi, Delhi, India; 
Medical Sciences Department (Prof M Jakovljevic PhD), University of 
Kragujevac, Kragujevac, Serbia; Department of Internal Medicine 
(S K Jassal MD), University of California San Diego, San Diego, CA, 
USA; Newcastle University, Tyne, UK (M Javanbakht PhD); Faculty of 
Graduate Studies (A U Jayatilleke PhD), Institute of Medicine 
(A U Jayatilleke PhD), University of Colombo, Colombo, Sri Lanka; 
Achutha Menon Centre for Health Science Studies (P Jeemon PhD, 
G K Mini PhD, Prof K R Thankappan MD), Neurology Department 
(Prof P Sylaja MD), Sree Chitra Tirunal Institute for Medical Sciences 
and Technology, Trivandrum, India (Prof P Sylaja MD); Department of 
Community Medicine (R P Jha MSc), Banaras Hindu University, 
Varanasi, India; Environmental Research Center (J S Ji DSc), Duke 
Kunshan University, Kunshan, China; Beijing Institute of 
Ophthalmology (Prof J B Jonas MD), Beijing Tongren Hospital, Beijing, 
China; Institution of Health and Nutrition Sciences (J J Jozwiak PhD), 
Czestochowa University of Technology, Czestochowa, Poland; Faculty of 
Medicine and Health Sciences (J J Jozwiak PhD), University of Opole, 
Opole, Poland; School of Health Sciences (S B Jungari MA), Savitribai 
Phule Pune University, Pune, India; Institute of Family Medicine and 
Public Health (M Jürisson PhD), University of Tartu, Tartu, Estonia; 
School of Public Health (Z Kabir PhD), University College Cork, Cork, 
UK; A C S Medical College and Hospital, New Delhi, India 
(Prof U Kapil MD, M Salahshoor PhD); Chronic Diseases (Home Care) 
Research Center (M Shamsizadeh MSc), Department of Epidemiology 
(M Karami PhD), Hamadan University of Medical Sciences, Hamadan, 
Iran; Department for Epidemiology (A Karch MD), Helmholtz Centre 
for Infection Research, Braunschweig, Germany; Quality and Equity 
Health Care, Kigali, Rwanda (C Karema MPH); School of 
Interdisciplinary Arts and Sciences (S Karimi PhD), University of 
Washington Tacoma, Tacoma, WA, USA; Department of Anesthesiology 
& Pain Medicine (N J Kassebaum MD), Seattle Children’s Hospital, 
Seattle, WA, USA (T B Murphy PhD); MRC/CSO Social and Public 
Health Sciences Unit (S V Katikireddi PhD), University of Glasgow, 
 Global Health Metrics
2046 
www.thelancet.com   Vol 392   November 10, 2018
Glasgow, UK; School of Health Care Administration (Prof A Kaul MD), 
Oklahoma State University, Tulsa, OK, USA; Health Care Delivery 
Sciences (Prof A Kaul MD), University of Tulsa, Tulsa, OK, USA; 
Midwifery Program (S Kebede MSc), Salale University, Fiche, Ethiopia; 
ODeL campus (Prof P N Keiyoro PhD), University of Nairobi 
(M Kumar PhD), Nairobi, Kenya; Department of Linguistics and 
Germanic, Slavic, Asian, and African Languages (G R Kemp BA), 
Michigan State University, East Lansing, MI, USA; Cochrane South 
Africa (E Z Sambala PhD, Prof C S Wiysonge MD), Non-Communicable 
Diseases Research Unit (Prof A P Kengne PhD), Medical Research 
Council South Africa, Cape Town, South Africa; Department of Medicine 
(Prof A P Kengne PhD, G A Mensah MD, J Noubiap MD, 
Prof K Sliwa MD), University of Cape Town, Cape Town, South Africa; 
Institute of Cardiology (Prof A Keren MD), Assuta Hospital, Tel Aviv 
Yaffo, Israel; Heart Failure and Cardiomyopathies Center 
(Prof A Keren MD), Hadassah Hebrew University Hospital, Jerusalem, 
Israel; Department of Public Health and Community Medicine 
(Prof Y S Khader PhD), Jordan University of Science and Technology, 
Ramtha, Jordan; School of Food and Agricultural Sciences 
(N Khalid PhD), University of Management and Technology, Lahore, 
Pakistan; Epidemiology and Biostatistics Department (E A Khan MPH), 
Health Services Academy, Islamabad, Pakistan; Department of Internal 
Medicine (M S Khan MD), John H Stroger, Jr Hospital of Cook County, 
Chicago, IL, USA; Department of Internal Medicine (M S Khan MD, 
T J Siddiqi MB, M S Usman MB), Dow University of Health Sciences, 
Karachi, Pakistan; Department of Health Policy and Management 
(Prof Y Khang MD), Institute of Health Policy and Management 
(Prof Y Khang MD), Seoul National University, Seoul, South Korea; 
Department of Health Research (T Khanna PhD), National Institute for 
Research in Environmental Health (Y D Sabde MD), National Institute 
of Nutrition (Prof A Laxmaiah PhD), Indian Council of Medical 
Research, New Delhi, India (S M Mehendale MD); Student Research 
Committee (M Khosravi MD), Baqiyatallah University of Medical 
Sciences, Tehran, Iran; International Otorhinolaryngology Research 
Association, Tehran, Iran (M Khosravi MD); Research Department 
(D N Kiirithio MSc), Kenya Revenue Authority, Nairobi, Kenya; Research 
and Data Solutions (D N Kiirithio MSc), Synotech Consultant, Nairobi, 
Kenya; Departments of Pharmacy Practice and Public Health Sciences 
(P E Kilgore MD), Wayne State University, Detroit, MI, USA; 
Department of Health Sciences (Prof D Kim DrPH), Northeastern 
University, Boston, MA, USA; Department of Preventive Medicine 
(Y Kim PhD, Prof S Yoon PhD), Korea University, Seoul, South Korea; 
School of Medicine (Y Kim PhD), Xiamen University Malaysia, Sepang, 
Malaysia; Department of Nutrition (R W Kimokoti MD), Simmons 
College, Boston, MA, USA; Faculty of Health (Y Kinfu PhD), University 
of Canberra, Canberra, ACT, Australia; Department of Health 
Management and Health Economics (Prof A Kisa PhD), Institute of 
Health and Society (A S Winkler PhD), University of Oslo, Oslo, Norway; 
Department of Global Community Health and Behavioral Sciences 
(Prof A Kisa PhD), Tulane University, New Orleans, LA, USA; 
Department of Public Health (Prof M Kivimäki PhD), University of 
Helsinki, Helsinki, Finland (T J Meretoja MD); Department of 
Preventive Cardiology (Prof Y Kokubo PhD), National Cerebral and 
Cardiovascular Center, Suita, Japan; Arthritis Research Canada, 
Richmond, BC, Canada (J A Kopec PhD); Independent Consultant, 
Jakarta, Indonesia (S Kosen MD); Department of Internal and 
Pulmonary Medicine (Prof P A Koul MD), Sheri Kashmir Institute of 
Medical Sciences, Srinagar, India; Department of Anthropology 
(K Krishan PhD), Panjab University, Chandigarh, India; Department of 
Demography (Prof B Kuate Defo PhD), Department of Social and 
Preventive Medicine (Prof B Kuate Defo PhD), University of Montreal, 
Montreal, QC, Canada; Department of Public Health 
(B Kucuk Bicer BEP), Yuksek Ihtisas University, Ankara, Turkey; Center 
for Midwifery, Child and Family Health (F A Kumsa MPH), School of 
Health (S Siabani PhD), University of Technology Sydney, Sydney, NSW, 
Australia; Department of Pediatrics (S D Lad MD), School of Public 
Health (Prof J S Thakur MD, Prof J S Thakur MD), Post Graduate 
Institute of Medical Education and Research, Chandigarh, India; Center 
for Translation Research and Implementation Science 
(G A Mensah MD), Institute of Health Policy and Development Studies 
(Prof H Lam PhD), National Heart, Lung, and Blood Institute 
(E K Peprah PhD), National Institutes of Health, Manila, Philippines; 
Department of Community and Family Medicine (F H Lami PhD), 
Academy of Medical Science, Baghdad, Iraq; HelpMeSee, New York, NY, 
USA (Prof V C Lansingh PhD); International Relations 
(Prof V C Lansingh PhD), Mexican Institute of Ophthalmology, 
Queretaro, Mexico; Belo Horizonte City Hall, Municipal Health 
Department of Belo Horizonte, Belo Horizonte, Brazil 
(Prof S Lansky PhD); Disease Control Department (D O Laryea MD), 
Ghana Health Service, Accra, Ghana; Department of Public Health 
(A Latifi PhD), Managerial Epidemiology Research Center (S Safiri PhD), 
Maragheh University of Medical Sciences, Maragheh, Iran; Regional 
Centre for the Analysis of Data on Occupational and Work-related 
Injuries and Diseases (M Levi PhD), Local Health Unit Tuscany Centre, 
Florence, Italy; Department of Health Sciences (M Levi PhD), University 
of Florence, Florence, Italy; West China Second University Hospital of 
Sichuan University, Chengdu, China (X Li PhD); Department of Clinical 
Research and Epidemiology (Y Li PhD, Y Li PhD), Shenzhen Sun 
Yat-sen Cardiovascular Hospital, Shenzhen, China; National Office for 
Maternal and Child Health Surveillance, Chengdu, China 
(Prof J Liang MD, Prof Y Wang MD, Prof J Zhu MD); National Center of 
Birth Defects Monitoring of China, Chengdu, China (Prof J Liang MD, 
Prof Y Wang MD); Division of Injury Prevention and Mental Health 
Improvement (P Ye MPH), Non-communicable Disease Control and 
Prevention Center (M Zhou PhD), Chinese Center for Disease Control 
and Prevention, Beijing, China (Prof X Liang MD); Department of 
Public Health (M L Liben MPH), Samara University, Samara, Ethiopia; 
Department of Medicine (L Lim MD), University of Malaya, Kuala 
Lumpur, Malaysia; Department of Medicine and Therapeutics 
(L Lim MD), The Chinese University of Hong Kong, Shatin, China; 
School of Public Health (Prof S Linn DrPH), University of Haifa, Haifa, 
Israel; Centre for Chronic Disease Control, Beijing, China 
(Prof S Liu PhD); Institute of Nutrition (Prof S Lorkowski PhD), 
Friedrich Schiller University Jena, Jena, Germany; Competence Cluster 
for Nutrition and Cardiovascular Health (nutriCARD), Jena, Germany 
(Prof S Lorkowski PhD); General Surgery Department 
(R Lunevicius PhD), Aintree University Hospital National Health Service 
(NHS) Foundation Trust, LIverpool, UK; Surgery Department 
(R Lunevicius PhD), University of Liverpool, LIverpool, UK; School of 
Public Health (M Yotebieng PhD), University of Kinshasa, Kinshasa, 
Democratic Republic of the Congo (Prof C Mabika Mabika PhD); 
Cardiology Department (R G Weintraub MB), Neurology Department 
(M T Mackay PhD), Royal Children’s Hospital, Melbourne, VIC, 
Australia; Preventive Department (T A Mahmood MBBCH), Ministry of 
Health and Population, Cairo, Egypt; Institute of Medicine 
(N B Mahotra MD), Tribhuvan University, Kathmandu, Nepal; 
Department of Public Health (M Majdan PhD), Trnava University, 
Trnava, Slovakia; Non-Communicable Diseases Research Center 
(Prof R Malekzadeh MD, S G Sepanlou MD), Shiraz University of 
Medical Sciences, Shiraz, Iran; Department of Humanities and Social 
Sciences (M A Malik MPhil), Indian Institute of Technology, Roorkee, 
Haridwar, India; Surgery Department (A Manda MD), Emergency 
University Hospital Bucharest, Bucharest, Romania; Public Risk 
Management Institute, Mississauga, ON, Canada (S Mangalam MS); 
Trade and Competitiveness (S Mangalam MS), World Bank, New York, 
NY, USA; Campus Caucaia (F R Martins-Melo PhD), Federal Institute of 
Education, Science and Technology of Ceará, Caucaia, Brazil; Clinical 
Institute of Medical and Chemical Laboratory Diagnostics 
(Prof W März MD), Medical University of Graz, Graz, Austria; Graduate 
School (M B Marzan MSc), University of the East Ramon Magsaysay 
Memorial Medical Center, Quezon City, Philippines; Department of 
Health Sciences (A J Mason-Jones PhD), University of York, York, UK; 
Department of Biology and Biological Engineering (M Mazidi PhD), 
Chalmers University of Technology, Gothenburg, Sweden; Research, 
Monitoring and Evaluation (S Mehata PhD), Ipas Nepal, Kathmandu, 
Nepal; Neurology Department (Prof M Mehndiratta MD), Janakpuri 
Super Specialty Hospital Society, New Delhi, India; Preventive Oncology 
(Prof R Mehrotra PhD), National Institute of Cancer Prevention and 
Research, Noida, India; Department of Epidemiology and Biostatistics 
(K M Mehta DSc), University of California San Francisco, San Francisco, 
CA, USA; Department of Internal Medicine (V Mehta MD), SevenHills 
Hospital, Mumbai, India; Department of Adult Health Nursing 
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2047
(N Y Tawye MSc), Department of Pharmacy (G Mengistu MSc), 
Department of Public Health (T C Mekonnen MPH), Wollo University, 
Dessie, Ethiopia; College of Health Sciences (A Melese MSc), 
Department of Pharmacy (M M Zeleke MSc), Debre Tabor University, 
Debre Tabor, Ethiopia; Department of Public Health 
(P T N Memiah DrPH), University of West Florida, Pensacola, FL, USA; 
Research Department Prince Mohammed Bin Abdulaziz Hospital 
(Prof Z A Memish MD), Ministry of Health, Riyadh, Saudi Arabia; 
College of Medicine (Prof Z A Memish MD, M Temsah MD), Alfaisal 
University, Riyadh, Saudi Arabia; Peru Country Office (W Mendoza MD), 
United Nations Population Fund (UNFPA), Lima, Peru; Breast Surgery 
Unit (T J Meretoja MD), Neurocenter (A Meretoja MD), Helsinki 
University Hospital, Helsinki, Finland; Clinical Microbiology and 
Parasitology Unit (T Mestrovic PhD), Dr Zora Profozic Polyclinic, 
Zagreb, Croatia; University Centre Varazdin (T Mestrovic PhD), 
University North, Varazdin, Croatia; Pharmacy (H B Mezgebe MSc), 
Ethiopian Academy of Medical Science, Ethiopia; Faculty of Humanities 
and Social Sciences (Y Miangotar PhD), University of N’Djaména, 
N’Djaména, Chad; Department of Hypertension 
(Prof T Miazgowski MD), Emergency Department (B Miazgowski MD), 
Zdroje Hospital (J Widecka PhD), Pomeranian Medical University, 
Szczecin, Poland (B Miazgowski MD, K Widecka PhD); Pacific Institute 
for Research & Evaluation, Calverton, MD, USA (T R Miller PhD); 
President’s Office (A Mirica PhD), National Institute of Statistics, 
Bucharest, Romania; Faculty of General Medicine 
(Prof E M Mirrakhimov MD), Kyrgyz State Medical Academy, Bishkek, 
Kyrgyzstan; Department of Atherosclerosis and Coronary Heart Disease 
(Prof E M Mirrakhimov MD), National Center of Cardiology and Internal 
Disease, Bishkek, Kyrgyzstan; Institute of Addiction Research (ISFF) 
(B Moazen MSc), Frankfurt University of Applied Sciences, Frankfurt, 
Germany; Department of Biology (K A Mohammad PhD), Salahaddin 
University, Erbil, Iraq; Erbil (K A Mohammad PhD), ISHIK University, 
Erbil, Iraq; Cardiovascular Research Institute (N Mohammadifard PhD, 
Prof N Sarrafzadegan MD), Isfahan University of Medical Sciences, 
Isfahan, Iran; Department of Public Health (M A Mohammed PhD), 
Jigjiga University, Jigjiga, Ethiopia (A A Tassew MPH); Department of 
Community Medicine (M B Sufiyan MD), Health Systems and Policy 
Research Unit (S Mohammed PhD), Ahmadu Bello University, Zaria, 
Nigeria; School of Medicine and Health Sciences, Obstetrics & 
Gynecology Department (Prof G D Mola MB), University of Papua New 
Guinea, Boroko, Papua New Guinea; Department of Obstetrics and 
Gynaecology (Prof G D Mola MB), Port Moresby General Hospital, 
Boroko, Port Moresby, Papua New Guinea; Clinical Epidemiology and 
Public Health Research Unit (L Monasta DSc, L Ronfani PhD), Burlo 
Garofolo Institute for Maternal and Child Health, Trieste, Italy; 
Department of Epidemiology and Biostatistics (G Moradi PhD), Social 
Determinants of Health Research Center (G Moradi PhD), Kurdistan 
University of Medical Sciences, Sanandaj, Iran; Lancaster University, 
Lancaster, UK (P Moraga PhD); Hospital de Sto António 
(J Morgado-da-Costa MSc), Hospital Center of Porto, Porto, Portugal; 
Department of Health Policy (Prof R Mori PhD), National Center for 
Child Health and Development, Setagaya, Japan; Department of Clinical 
Biochemistry (A Mosapour PhD), Tarbiat Modares University, Tehran, 
Iran; 1st Department of Ophthalmology (M M Moschos PhD), University 
of Athens, Athens, Greece; Biomedical Research Foundation 
(M M Moschos PhD), Academy of Athens, Athens, Greece; Competence 
Center Mortality-Follow-Up (R Westerman PhD), Demographic Change 
and Ageing Research Area (A Werdecker PhD), Federal Institute for 
Population Research, Wiesbaden, Germany (Prof U O Mueller MD); 
Center for Population and Health, Wiesbaden, Germany 
(Prof U O Mueller MD); Department of Endocrinology & Metabolism 
(Prof S Mukhopadhyay MD), Institute of Post Graduate Medical 
Education & Research, Kolkata, India; Department of Obstetrics and 
Gynecology (J Musa MD), University of Jos, Jos, Nigeria; Center for 
Global Health (J Musa MD), Department of Preventive Medicine 
(Y Yano MD), Northwestern University, Chicago, IL, USA; School of 
Medical Sciences (K Musa PhD), Science University of Malaysia, Kubang 
Kerian, Malaysia; Pediatrics Department (Prof G Mustafa MD), Nishtar 
Medical University, Multan, Pakistan; Pediatrics & Pediatric 
Pulmonology (Prof G Mustafa MD), Institute of Mother & Child Care, 
Multan, Pakistan; Department of Epidemiology (Prof J B Nachega PhD), 
University of Pittsburgh, Pittsburgh, PA, USA; Institute of Epidemiology 
and Medical Biometry (Prof G Nagel PhD), Ulm University, Ulm, 
Germany; Department of Epidemiology (G Naik MPH, J A Singh MD), 
Department of Medicine (P Ranjan PhD, J A Singh MD), Department of 
Psychology (D C Schwebel PhD), University of Alabama at Birmingham, 
Birmingham, AL, USA (A R Sawant MD); Department of Dermatology 
(Prof L Naldi MD), San Bortolo Hospital, Vicenza, Italy; Direction 
(Prof L Naldi MD), GISED Study Center, Bergamo, Italy; Suraj Eye 
Institute, Nagpur, India (V Nangia MD); Department of Public Heath 
(J Nansseu MD), University of Yaoundé I, Yaoundé, Cameroon; Mercy 
Saint Vincent Medical Center, Toledo, OH, USA (H Nawaz MD); 
Department of Cardiology (R I Negoi PhD), Cardio-Aid, Bucharest, 
Romania; Kenya Medical Research Institute/Wellcome Trust Research 
Programme, Kilifi, Kenya (Prof C R J Newton MD); Ministry of Health, 
Community Development, Gender, Elderly and Children, Dar es Salaam, 
Tanzania (F N Ngalesoni PhD); Department of Biological Sciences 
(J W Ngunjiri DrPH), University of Embu, Embu, Kenya; Public Health 
Science Department (D N A Ningrum MPH), State University of 
Semarang, Kota Semarang, Indonesia; Institute for Global Health Policy 
Research (S Nomura MSc), National Center for Global Health and 
Medicine, Shinjuku-ku, Japan; Directorate General of Planning, 
Monitoring and Evolution (A Nyandwi MPH), Rwanda Ministry of 
Health, Kigali, Rwanda; College of Medicine and Health Sciences 
(A Nyandwi MPH), University of Rwanda, Kigali, Rwanda; Independent 
Consultant, Accra, Ghana (R Ofori-Asenso MSc); Department of 
Medicine (O S Ogah PhD), Abia State University, Uturu, Nigeria; School 
of Social Sciences and Psychology (Prof A M N Renzaho PhD), Western 
Sydney University, Penrith, NSW, Australia (F A Ogbo PhD); 
Department of Preventive Medicine (I Oh PhD), Kyung Hee University, 
Dongdaemun-gu, South Korea; Research, Measurement, and Results 
(A Okoro MPH), Society for Family Health, Nigeria, Abuja, Nigeria; 
Department of HIV/AIDS, STIs & TB (O Oladimeji MD), Human 
Sciences Research Council, Durban, South Africa; School of Public 
Health (O Oladimeji MD), University of Namibia, Oshakati Campus, 
Namibia; Centre for Healthy Start Initiative, Ikoyi, Nigeria 
(B O Olusanya PhD, J O Olusanya MBA); NCD Prevention & Control 
Unit (S Ong MBBS), Ministry of Health, Bandar Seri Begawan, Brunei; 
Institute of Health Science (S Ong MBBS), University of Brunei 
Darussalam, Gadong, Brunei; Pneumology Service 
(Prof J B Soriano MD), School of Medicine (Prof A Ortiz MD), 
Autonomous University of Madrid, Madrid, Spain; Department of 
Nephrology and Hypertension (Prof A Ortiz MD), The Institute for 
Health Research Foundation Jiménez Díaz University Hospital, Madrid, 
Spain; Department of Global Health Nursing (Prof E Ota PhD), St. 
Luke’s International University, Chuo-ku, Japan; Research, Monitoring 
and Evaluation (B A Otieno MPH), Kisumu Medical and Education 
Trust, Kisumu, Kenya; Ministry of Health of the Russian Federation, 
Moscow, Russia; Moscow Institute of Physics and Technology 
(S S Otstavnov PhD), Moscow State University, Dolgoprudny, Russia; 
Agricultural Economics Group (Prof A S Oyekale PhD), Department of 
Pediatrics (Prof S u Rahman MBBS), North-West University, Mafikeng, 
South Africa; Department of TB & Respiratory Medicine 
(Prof M P A DNB), Jagadguru Sri Shivarathreeswara University, Mysore, 
India; Department of Medicine (S Pakhale MD), University of Ottawa, 
Ottawa, ON, Canada; Centre for Community Medicine 
(A P Pakhare MD), Department of Endocrinology, Metabolism, & 
Diabetes (Prof N Tandon PhD), Department of Psychiatry 
(Prof R Sagar MD), All India Institute of Medical Sciences, New Delhi, 
India; Health Outcomes (A Pana MD), Center for Health Outcomes & 
Evaluation, Bucharest, Romania; Department of Medical Humanities 
and Social Medicine (Prof E Park PhD), Kosin University, Busan, South 
Korea; Department of Medicine (S Patel MD), Maimonides Medical 
Center, Brooklyn, NY, USA; Krishna Institute of Medical Sciences 
(S T Patil MBA), Deemed University, Karad, India; International 
Institute of Health Management Research, New Delhi, India 
(A Patle MPH); Population Health Group (Prof G C Patton MD), 
Murdoch Childrens Research Institute, Melbourne, VIC, Australia 
(R G Weintraub MB); Clinical Research Department 
(Prof V R Paturi MD), Diabetes Research Society, Hyderabad, India; 
Clinical Research Department (Prof V R Paturi MD), DiabetOmics, 
Portland, OR, USA; Health, Nutrition, and HIV/AIDS Program 
 Global Health Metrics
2048 
www.thelancet.com   Vol 392   November 10, 2018
(D Paudel PhD), Save the Children, Kathmandu, Nepal; Institute of 
Scientific and Technological Communication and Information in Health 
(M M Pedroso PhD, R d Saldanha MPH), Oswaldo Cruz Foundation, 
Rio de Janeiro, Brazil; Cartagena University, Cartagena, Colombia 
(Prof D M Pereira PhD); Independent Consultant, Glenelg, SA, Australia 
(Prof K Pesudovs PhD); Anesthesiology Department (A S Terkawi MD), 
School of Medicine (W A Petri MD), University of Virginia, 
Charlottesville, VA, USA; Institute of Medicine (Prof M Petzold PhD), 
University of Gothenburg, Gothenburg, Sweden; School of Public 
Health (Prof M Petzold PhD), University of Witwatersrand, 
Johannesburg, South Africa; Basic Medical Sciences Department 
(J D Pillay PhD), Durban University of Technology, Durban, South 
Africa; University Medical Center Groningen (Prof M J Postma PhD), 
University of Groningen, Groningen, Netherlands; Department of 
Nephrology (S Prakash PhD, Prof N Prasad MD), Sanjay Gandhi 
Postgraduate Institute of Medical Sciences, Lucknow, India; Government 
Medical College, Nagpur, India (Prof M B Purwar MD); 
Non-communicable Diseases Research Center (M Qorbani PhD), Alborz 
University of Medical Sciences, Karaj, Iran; Medichem, Barcelona, Spain 
(A Radfar MD); Department of Epidemiology & Biostatistics 
(A Rafay MS), Contech School of Public Health, Lahore, Pakistan; 
Research Division (M Rahman MHS), Global Public Health Research 
Foundation, Dhaka, Bangladesh; Department of Clinical Pediatrics 
(Prof S u Rahman MBBS), Sweidi Hospital, Riyadh, Saudi Arabia; 
Society for Health and Demographic Surveillance, Suri, India 
(R Rai MPH); Department of Economics (R Rai MPH), University of 
Göttingen, Göttingen, Germany; Medical University Innsbruck, 
Innsbruck, Austria (S Rajsic MD); Institute for Poverty Alleviation and 
International Development (C L Ranabhat PhD), Yonsei University, 
Seoul, Korea; University College London Hospitals, London, UK 
(D L Rawaf MD); Public Health England, London, UK 
(Prof S Rawaf PhD); Department of Preventive Medicine and 
Occupational Medicine (C Reis MD), Loma Linda University Medical 
Center, Loma Linda, CA, USA; Brien Holden Vision Institute, Sydney, 
NSW, Australia (Prof S Resnikoff MD); Organization for the Prevention 
of Blindness, Paris, France (Prof S Resnikoff MD); Department of 
Epidemiology (S Riahi PhD), Birjand University of Medical Sciences, 
Birjand, Iran; Department of Clinical Research (L Roever PhD), Federal 
University of Uberlândia, Uberlândia, Brazil; Golestan Research Center 
of Gastroenterology and Hepatology (G Roshandel PhD), Golestan 
University of Medical Sciences, Gorgan, Iran; Biotechnology 
(E Rubagotti PhD), IKIAM Amazon Regional University, Ciudad de 
Tena, Ecuador; Department of Ocean Science and Engineering 
(E Rubagotti PhD), Southern University of Science and Technology, 
Shenzhen, China; Department of Community Health 
(B F Sunguya PhD), School of Public Health (G M Ruhago PhD), 
Muhimbili University of Health and Allied Sciences, Dar es Salaam, 
Tanzania (B F Sunguya PhD); Neuropsychiatric Institute 
(Prof P S Sachdev MD), Prince of Wales Hospital, Randwick, NSW, 
Australia; Medical Department (B Saddik PhD), University of Sharjah, 
Sharjah, United Arab Emirates; College of Medicine (N Salam PhD), Al-
Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia; 
School of Health and Policy Management, Faculty of Health 
(Prof P Salamati MD), York University, Toronto, ON, Canada; Punjab 
University College of Pharmacy, Anarkali, Pakistan (Z Saleem PharmD); 
Center for Health Policy & Center for Primary Care and Outcomes 
Research (Prof J A Salomon PhD), Stanford University, Stanford, CA, 
USA; Clinical Research Division (Prof S S Salvi MD), Chest Research 
Foundation, Pune, India; Department of Surgery (Prof J Sanabria MD), 
Marshall University, Huntington, WV, USA; Health and Disability 
Intelligence Group (I Salz MD), Ministry of Health, Wellington, New 
Zealand; Department of Nutrition and Preventive Medicine 
(Prof J Sanabria MD), Case Western Reserve University, Cleveland, OH, 
USA; Nephrology Group (M Sanchez-Niño PhD), Jimenez Diaz 
Foundation University Hospital Institute for Health Research, Madrid, 
Spain; Department of Medicine (M Sardana MD), University of 
Massachusetts Medical School, Worcester, MA, USA; Department of 
Health and Society, Faculty of Medicine (Prof R Sarmiento-Suárez MPH), 
University of Applied and Environmental Sciences, Bogotá, Colombia; 
Department of Community Medicine (S Saroshe MD), Mahatma Gandhi 
Memorial Medical College, Indore, India; Surgery Department 
(B Sathian PhD), Hamad Medical Corporation, Doha, Qatar; Faculty of 
Health & Social Sciences (B Sathian PhD), Bournemouth University, 
Bournemouth, UK; UGC Centre of Advanced Study in Psychology 
(M Satpathy PhD), Utkal University, Bhubaneswar, India; Udyam-Global 
Association for Sustainable Development, Bhubaneswar, India 
(M Satpathy PhD); Dr D Y Patil Vidyapeeth, Pune, India 
(A R Sawant MD); Department of Public Health Sciences 
(M Sawhney PhD), University of North Carolina at Charlotte, Charlotte, 
NC, USA; School of Health Sciences (Prof I J C Schneider PhD, 
Prof D A S Silva PhD), Federal University of Santa Catarina, Ararangua, 
Brazil; Department of Medical Statistics, Epidemiology and Medical 
Informatics (M Sekerija PhD), University of Zagreb, Zagreb, Croatia; 
Langone Medical Center (A Shafieesabet MD), New York University, 
New York, NY, USA; Public Health Division (A A Shaheen PhD), An-
Najah National University, Nablus, Palestine; Department of Molecular 
Hepatology (H Sharafi PhD), Middle East Liver Disease Center, Tehran, 
Iran; Independent Consultant, Karachi, Pakistan (M A Shaikh MD); 
Department of Basic Sciences (Prof M Sharif PhD), Department of 
Laboratory Sciences (Prof M Sharif PhD), Islamic Azad University, Sari, 
Iran; Policy and Planning Division (J Sharma MPH), Ministry of Health, 
Thimphi, Bhutan; University School of Management and 
Entrepreneurship (R Sharma PhD), Delhi Technological University, 
New Delhi, India; Department of Pulmonary Medicine (J She MD), 
Fudan University, Shanghai, China; Usher Institute of Population 
Health Sciences and Informatics (Prof A Sheikh MD, I N Soyiri PhD), 
University of Edinburgh, Edinburgh, UK; Friedman School of Nutrition 
Science and Policy (P Shi PhD), Tufts University, Boston, MA, USA; 
National Institute of Infectious Diseases, Tokyo, Japan 
(M Shigematsu PhD); Finnish Institute of Occupational Health, 
Helsinki, Finland (R Shiri PhD); Institute of Medical Epidemiology 
(I Shiue PhD), Martin Luther University Halle-Wittenberg, Halle, 
Germany; School of Medicine (F Shokraneh MS), University of 
Nottingham, Nottingham, UK; Symbiosis Institute of Health Sciences 
(Prof S R Shukla PhD), Symbiosis International University, Pune, India; 
Department of Psychology (Prof I D Sigfusdottir PhD, 
R Sigurvinsdottir PhD), Reykjavik University, Reykjavik, Iceland; 
Department of Health and Behavior Studies (Prof I D Sigfusdottir PhD), 
Columbia University, New York, NY, USA; Brasília University, Brasília, 
Brazil (Prof D A Silveira MD); Department of the Health Industrial 
Complex and Innovation in Health (Prof D A Silveira MD), Department 
of Diseases and Non-communicable Diseases and Health Promotion 
(A M Soares Filho DSc), Federal Ministry of Health, Brasilia, Brazil; 
Division of Cardiovascular Medicine (N V Singam MD, G Vaidya MD), 
University of Louisville, Louisville, KY, USA; Max Hospital, Ghaziabad, 
India (Prof N P Singh MD); Department of Pulmonary Medicine 
(Prof V Singh MD), Asthma Bhawan, Jaipur, India; Department of 
Epidemiology (D N Sinha PhD), School of Preventive Oncology, Patna, 
India; Pediatric Department (B H Sobaih MD), King Khalid University 
Hospital, Riyadh, Saudi Arabia; Service of Pulmonology 
(Prof J B Soriano MD), Health Research Institute of the University 
Hospital “de la Princesa”, Madrid, Spain; Hull York Medical School 
(I N Soyiri PhD), University of Hull, Hull City, UK; Division of 
Community Medicine (C T Sreeramareddy MD), International Medical 
University, Kuala Lumpur, Malaysia; School of Health and Related 
Research (M Strong PhD), University of Sheffield, Sheffield, UK; 
Norwegian Institute of Public Health, Bergen, Norway (G Sulo PhD); 
School of Medicine (P J Sur MPH), University of California Riverside, 
Riverside, CA, USA; Department of Criminology, Law and Society 
(Prof B L Sykes PhD), University of California Irvine, Irvine, CA, USA; 
Department of Medicine (Prof R Tabarés-Seisdedos PhD), Department 
of Pediatrics, Obstetrics and Gynecology (Prof M Tortajada-Girbés PhD), 
University of Valencia, Valencia, Spain; Carlos III Health Institute 
(Prof R Tabarés-Seisdedos PhD), Biomedical Research Networking 
Center for Mental Health Network (CiberSAM), MADRID, Spain; School 
of Social Work (Prof K M Tabb PhD), University of Illinois, Urbana, IL, 
USA; University Institute “Egas Moniz”, Monte da Caparica, Portugal 
(Prof N Taveira PhD); Research Institute for Medicines, Faculty of 
Pharmacy of Lisbon (Prof N Taveira PhD), University of Lisbon, Lisbon, 
Portugal; Selihom School of Nursing (N Y Tawye MSc), Alkan Health 
Science, Business and Technology College, Dessie, Ethiopia; Syrian 
Expatriate Medical Association, Charlottesville, VA, USA 
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2049
(A S Terkawi MD); Lee Kong Chian School of Medicine 
(L Tudor Car PhD), Nanyang Technological University, Singapore, 
Singapore (S Thirunavukkarasu PhD); Department of Global Health 
Research (A J Thomson PhD), Adaptive Knowledge Management, 
Victoria, BC, Canada; School of Exercise and Nutrition Sciences 
(Q G To PhD), Queensland University of Technology, Brisbane, QLD, 
Australia; Institute of Public Health (R Topor-Madry PhD), Jagiellonian 
University Medical College, Krakow, Poland; Agency for Health 
Technology Assessment and Tariff System, Warszawa, Poland 
(R Topor-Madry PhD); Pediatric Department 
(Prof M Tortajada-Girbés PhD), University Hospital Doctor Peset, 
Valencia, Spain; Nagoya University, Nagoya, Japan 
(Prof H Toyoshima PhD); Department of Health Economics 
(B X Tran PhD), Hanoi Medical University, Hanoi, Vietnam; Clinical 
Hematology and Toxicology (K B Tran MD), Military Medical University, 
Hanoi, Vietnam; National Institute for Research in Tuberculosis, Chennai, 
India (S P Tripathy MD); Department of Neurology (T C Truelsen PhD), 
University of Copenhagen, Copenhagen, Denmark; Institute for Global 
Health Innovations (N T Truong BHlthSci), Duy Tan University, Hanoi, 
Vietnam; Department of Vascular Medicine (N Tsilimparis PhD), 
University Heart Center of Hamburg, Hamburg, Germany; Department 
of Internal Medicine (K N Ukwaja MD), Federal Teaching Hospital, 
Abakaliki, Nigeria; Gomal Center of Biochemistry and Biotechnology 
(I Ullah PhD), Gomal University, Dera Ismail Khan, Pakistan; TB Culture 
Laboratory (I Ullah PhD), Mufti Mehmood Memorial Teaching Hospital, 
Dera Ismail Khan, Pakistan; Ankara University, Ankara, Turkey 
(S B Uzun MSc); Argentine Society of Medicine, Ciudad de Buenos Aires, 
Argentina (Prof P R Valdez MEd); Velez Sarsfield Hospital, Buenos Aires, 
Argentina (Prof P R Valdez MEd); UKK Institute, Tampere, Finland 
(Prof T J Vasankari MD); Department of Statistics 
(Prof A N Vasconcelos PhD), University of Brasilia, Brasília, Brazil; 
Directorate of Social Studies and Policies (Prof A N Vasconcelos PhD), 
Federal District Planning Company, Brasília, Brazil; Raffles Neuroscience 
Centre (Prof N Venketasubramanian MBBS), Raffles Hospital, Singapore, 
Singapore; Yong Loo Lin School of Medicine 
(Prof N Venketasubramanian MBBS), National University of Singapore, 
Singapore, Singapore; Occupational Health Unit (Prof F S Violante MPH), 
Sant’Orsola Malpighi Hospital, Bologna, Italy; Department of Information 
and Internet Technologies (S K Vladimirov PhD), I M Sechenov First 
Moscow State Medical University, Moscow, Russia; Department of Health 
Care Administration and Economy (Prof V Vlassov MD), National Research 
University Higher School of Economics, Moscow, Russia; Foundation 
University Medical College (Y Waheed PhD), Foundation University, 
Rawalpindi, Pakistan; Department of Research (Prof E Weiderpass PhD), 
Cancer Registry of Norway, Oslo, Norway; Independent Consultant, 
Staufenberg, Germany (A Werdecker PhD); Department of Neurology 
(A S Winkler PhD), Technical University of Munich, Munich, Germany; 
Kailuan General Hospital (Prof S Wu PhD), Kailuan General Hospital, 
Tangshan, China; University of Strathclyde, Glasgow, UK 
(G M A Wyper MSc); School of Medicine (Prof G Xu MD), Nanjing 
University, Nanjing, China; Department of Earth Science (Y J Yasin MPH), 
King Fahd University of Petroleum and Minerals, Dhahran, Saudi Arabia; 
Wolkite University, Wolkite, Ethiopia (A Yeshaneh BHlthSci); Department 
of Biostatistics (N Yonemoto MPH), Kyoto University, Kyoto, Japan; 
Department of Health Policy and Management (Prof M Z Younis DrPH), 
Jackson State University, Jackson, MS, USA; Tsinghua University 
(Prof M Z Younis DrPH), Tsinghua University, Beijing, China; Department 
of Epidemiology and Biostatistics (Prof C Yu PhD), Global Health Institute 
(Prof C Yu PhD), Wuhan University, Wuhan, China; Epidemiology and 
Cancer Registry Sector (Prof V Zadnik PhD), Institute of Oncology 
Ljubljana, Ljubljana, Slovenia; Department of Epidemiology 
(Prof Z Zaidi PhD), University Hospital of Setif, Setif, Algeria; Public 
Health Department (T A Zerfu PhD), Dilla University, Dilla, Ethiopia; 
Wuhan Polytechnic University, Wuhan, China (X Zhao PhD)
Contributors
Please see appendix 1 for more detailed information about individual 
authors’ contributions to the research, divided into the following 
categories: managing the estimation process; writing the first draft of the 
manuscript; providing data or critical feedback on data sources; 
developing methods or computational machinery; applying analytical 
methods to produce estimates; providing critical feedback on methods or 
results; drafting the work or revising it critically for important intellectual 
content; extracting, cleaning, or cataloguing data; designing or coding 
figures and tables; and managing the overall research enterprise. 
Declaration of interests
Adam Berman reports personal fees from Philips. Cyrus Cooper reports 
personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, 
GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda, and 
UCB. Mir Sohail Fazeli reports personal fees from Doctor Evidence LLC. 
Panniyammakal Jeemon reports a Clinical and Public Health 
Intermediate Fellowship from the Wellcome Trust-DBT India Alliance 
(2015–20). Jacek Jóźwiak reports a grant from Valeant, personal fees 
from Valeant, ALAB Laboratoria and Amgen, and non-financial support 
from Microlife and Servier. Nicholas Kassebaum reports personal fees 
and other support from Vifor Pharmaceuticals, LLC. Srinivasa Vittal 
Katikireddi reports grants from NHS Research Scotland (no. 
SCAF/15/02), the Medical Research Council (MC_UU_12017/13 and 
MC_UU_12017/15), and Scottish Government Chief Scientist Office 
(SPHSU13 and SPHSU15). Jeffrey Lazarus reports personal fees from 
Janssen and CEPHEID and grants and personal fees from AbbVie, 
Gilead Sciences, and MSD. Winfried März reports grants and personal 
fees from Siemens Diagnostics, Aegerion Pharmaceuticals, Amgen, 
AstraZeneca, Danone Research, Pfizer, BASF, Numares AG, and 
Berline-Chemie; personal fees from Hoffmann LaRoche, MSD, Sanofi, 
and Synageva; grants from Abbott Diagnostics; and other support from 
Synlab Holding Deutschland GmbH. Walter Mendoza is currently a 
Program Analyst for Population and Development at the Peru Country 
Office of the United Nations Population Fund (UNFPA), which does not 
necessarily endorse this study. Ted Miller reports an evaluation contract 
from AB InBev Foundation. Guilherme Polanczyk reports personal fees 
from Shire, Teva, Medice, and Editora Manole. Maarten Postma reports 
grants from Mundipharma, Bayer, BMS, AstraZeneca, ARTEG, 
and AscA; grants and personal fees from Sigma Tau, MSD, GSK, Pfizer, 
Boehringer-Ingelheim, Novavax, Ingress Health, AbbVie, and Sanofi; 
personal fees from Quintiles, Astellas, Mapi, OptumInsight, Novartis, 
Swedish Orphan, Innoval, Jansen, Intercept, and Pharmerit, and stock 
ownership in Ingress Health and Pharmacoeconomics Advice 
Groningen. Kenji Shibuya reports grants from Ministry of Health, 
Labour, and Welfare and from Ministry of Education, Culture, Sports, 
Science, and Technology. Cassandra Szoeke reports a grant from the 
National Medical Health Research Council, Lundbeck, Alzheimer’s 
Association, and the Royal Australasian College of Practitioners; 
she holds patent PCT/AU2008/001556. Muthiah Vaduganathan receives 
research support from the NIH/NHLBI and serves as a consultant for 
Bayer AG and Baxter Healthcare. Marcel Yotebieng reports grants from 
the US National Institutes of Health. All remaining authors declare no 
competing interests.
Data sharing
To download the data used in these analyses, please visit the Global
Health Data Exchange at http://ghdx.healthdata.org/gbd−2017
.
Acknowledgments
Research reported in this publication was supported by the 
Bill & Melinda Gates Foundation, the University of Melbourne, Public 
Health England, the Norwegian Institute of Public Health, St Jude 
Children’s Research Hospital, the National Institute on Ageing of the 
National Institutes of Health (award no. P30AG047845), and the National 
Institute of Mental Health of the National Institutes of Health 
(R01MH110163). The content is solely the responsibility of the authors 
and does not necessarily represent the official views of the funders. 
Data for this research was provided by the Russia Longitudinal 
Monitoring survey, conducted by the National Research University 
Higher School of Economics, ZAO Demoscope, Carolina Population 
Center, University of North Carolina at Chapel Hill, and the Institute of 
Sociology RAS. This analysis uses data or information from the LASI 
Pilot micro data and documentation. The development and release of the 
LASI Pilot Study was funded by the National Institute on Ageing and 
National Institutes of Health (R21AG032572, R03AG043052, and 
R01AG030153). The Palestinian Central Bureau of Statistics granted the 
researchers access to relevant data in accordance with license number 
SLN2014-3-170, after subjecting data to processing aiming to preserve the 
confidentiality of individual data in accordance with the General 
 Global Health Metrics
2050 
www.thelancet.com   Vol 392   November 10, 2018
Statistics Law, 2000. The researchers are solely responsible for the 
conclusions and inferences drawn upon available data.
References
1 
Thomas RK. Concepts, methods and practical applications in 
applied demography: an introductory textbook. Cham, 
Switzerland: Springer International Publishing, 2018.
2 
WHO. World health statistics 2018: monitoring health for the SDGs. 
May 2, 2018. http://apps.who.int/iris/bitstream/handle/10665/ 
272596/9789241565585-eng.pdf?ua=1 (accessed May 18, 2018).
3 
WHO. Health in 2015: from MDGs to SDGs. December, 2015. 
http://www.who.int/gho/publications/mdgs-sdgs/en/ (accessed 
Oct 15, 2018). 
4 
UN Department of Economic and Social Affairs, Population Division. 
World population prospects: the 2017 revision, key findings and 
advance tables. June 21, 2017
. https://esa.un.org/unpd/wpp/
Publications/Files/WPP2017_KeyFindings.pdf (accessed Feb 22, 2018).
5 
UN Department of Economic and Social Affairs, 
Population Division. World population prospects: the 2017 revision, 
methodology of the united nations population estimates and 
projections. 2017
. https://esa.un.org/unpd/wpp/publications/Files/
WPP2017_Methodology.pdf (accessed March 19, 2018).
6 
Consejo Nacional de Población CONAPO. Proyecciones de la 
población 2010–2050. https://www.gob.mx/conapo/acciones-y-
programas/conciliacion-demografica-de-mexico-1950-2015-y-
proyecciones-de-la-poblacion-de-mexico-y-de-las-entidades-federativas- 
2016-2050 Proyecciones (accessed March 14, 2018). 
7 
US Census Bureau. International data base. Dec 5, 2017
. 
https://www.census.gov/programs-surveys/international-programs/
about/idb.html (accessed March 14, 2018).
8 
Population Reference Bureau. 2017 World population data sheet 
with a special focus on youth. 2017
. https://www.prb.org/wp-
content/uploads/2017/08/WPDS-2017
.pdf (accessed June 21, 2018).
9 
World Bank Group. Population estimates and projections. 
Sept 20, 2018. https://datacatalog.worldbank.org/dataset/
population-estimates-and-projections (accessed Oct 15, 2018). 
10 
European Comission Joint Research Centre. Demographic and 
human capital scenarios for the 21st century: 2018 assessment for 
201 countries. April 19, 2018. http://pure.iiasa.ac.at/id/eprint/15226/1/
lutz_et_al_2018_demographic_and_human_capital.pdf (accessed 
Oct 15, 2018). 
11 
Gapminder. Gapminder tools. https://www.gapminder.org/
tools/#$chart-type=bubbles (accessed June 21, 2018). 
12 
Stevens GA, Alkema L, Black RE, et al. Guidelines for accurate and 
transparent health estimates reporting: the GATHER statement. 
PLoS Med 2016; 13: e1002056.
13 
GBD 2017 Mortality collaborators. Global, regional, and national 
age-specific mortality and life expectancy, 1950–2017: a systematic 
analysis for the Global Burden of Disease Study 2017
. Lancet 2018; 
392: 1684–735.
14 
UN Population Division. World mortality report 2017
. 2017
. 
http://www.un.org/en/development/desa/population/publications/
mortality/world-mortality-cdrom-2017
.shtml (accessed June 26, 2018). 
15 
GBD 2016 Mortality Collaborators. Global, regional, and national 
under-5 mortality, adult mortality, age-specific mortality, and life 
expectancy, 1970–2016: a systematic analysis for the Global Burden 
of Disease Study 2016. Lancet 2017; 390: 1084–150.
16 
Preston SH, Heuveline P, Guillot M. Demography: measuring and 
modelling population processes. Hoboken, NJ, USA: 
Wiley-Blackwell, 2000. 
17 
US Census Bureau. History: 1890. https://www.census.gov/history/
www/through_the_decades/index_of_questions/1890_1.html 
(accessed March 14, 2018).
18 
UN. United Nations demographic yearbook 2016. 2017
. 
https://unstats.un.org/unsd/demographic-social/products/dyb/
dybsets/2016.pdf (accessed Oct 15, 2018).
19 
GBD 2016 Risk Factors Collaborators. Global, regional, and national 
comparative risk assessment of 84 behavioural, environmental and 
occupational, and metabolic risks or clusters of risks, 1990–2016: 
a systematic analysis for the Global Burden of Disease Study 2016. 
Lancet 2017; 390: 1345–422.
20 GBD 2016 Causes of Death Collaborators. Global, regional, and 
national age-sex specific mortality for 264 causes of death, 
1980–2016: a systematic analysis for the Global Burden of Disease 
Study 2016. Lancet 2017; 390: 1151–210.
21 
UN. Transforming our world: the 2030 agenda for sustainable 
development. 2015. https://sustainabledevelopment.un.org/
content/documents/21252030%20Agenda%20for%20
Sustainable%20Development%20web.pdf (accessed Oct 15, 2018). 
22 Goyer DS. The international population census bibliography, 
revision and update, 1945–1977
. New York: Academic Press, 1980.
23 Ruggles S, Alexander JT, Genadek K, Goeken R, Schroeder MB, 
Sobek M. Integrated public use microdata series: version 5.0. 
Minneapolis, MN, USA: Minnesota Population Center, 2010.
24 
UN Department of Economic and Social Affairs, Statistics Division. 
Population censuses’ datasets (1995–present). https://unstats.un.
org/unsd/demographic-social/products/dyb/dybcensusdata.cshtml 
(accessed March 30, 2018). 
25 UN Department of Economic and Social Affairs, Statistics Division. 
The census program, census dates from 1990 onward. May 27, 2016.
https://unstats.un.org/unsd/demographic/sources/census/
censusdates.htm (accessed March 30, 2018).
26 UN. Member states. http://www.un.org/en/member-states/ 
(accessed June 21, 2018).
27 
Zarkovich SS. The overcount in censuses of population. 
Jahrbucher Natl Stat 1989; 206: 606–09.
28 Ahonsi BA. Deliberate falsification and census data in Nigeria. 
Afr Aff 1988; 87: 553–62.
29 Kotzamanis B, Cantisani G, Dekker A, Logiadu-Didika D, 
Duquenne MN, Castori A. Documentation of the 2000 round of 
population and housing censures in the EU, EFTA and candidate 
countries: part III and annexes. Sept 21, 2004. https://ec.europa.eu/
eurostat/documents/3888793/5831893/KS-CC-04-003-EN.
PDF/7264ad74-4719-404f-af3a-d2bf4cc3f71d?version=1.0 
(accessed Oct 15, 2018). 
30 Centro Centroamericano de Población. Evaluación demográfica del 
X Censo Nacional de Población de Costa Rica 2011 y de otras 
fuentes de información. March, 2013. https://ccp.ucr.ac.cr/observa/
CRnacional/pdf/Evaluacion%20censal%20FINAL%20marzo%20
2013.pdf (accessed Oct 15, 2018). 
31 
Cabella W, Filgueira F, Giusti A, Macadar D. Informe de la 
comisión técnica honoraria para la evaluacion del censo Uruguay 
2011. Aug 7, 2012. http://www.ine.gub.uy/documents/10181/ 
63830/Informe+de+la+Comisi%C3%B3n+T%C3%A9cnica+Honor
aria/0624ef71-f00e-44ab-a69c-3eede9d127d5 (accessed Oct 15, 2018).
32 El Instituto Nacional de Estadística y Geografía. Resultados de la 
encuesta de posenumeración del Censo de Población y Vivienda 
2010. 2012. https://celade.cepal.org/censosinfo/manuales/MX_
ResultEncPosEnumeracion_2010.pdf (accessed Oct 15, 2018). 
33 de la Mora F. Paraguay: proyección de la población nacional, áreas 
urbana y rural por sexo y edad, 2000–2025: revisión 2015. 
October, 2015. http://www.dgeec.gov.py/Publicaciones/Biblioteca/
proyeccion%20nacional/Estimacion%20y%20proyeccion%20
Nacional.pdf (accessed Oct 15, 2018). 
34 
Bravo D, Larrañaga O, Millán I, Ruiz M, Zamorano F. Informe final, 
comisión externa, revisora del Censo 2012. Aug 7, 2013. 
http://www.cl.undp.org/content/chile/es/home/library/poverty/
informes_de_comisiones/informe-final--comision-externa-revisora-
del-censo-2012.html (accessed Oct 15, 2018). 
35 Lyons-Amos M, Stones T. Trends in Demographic and Health 
Survey data quality: an analysis of age heaping over time in 
34 countries in Sub Saharan Africa between 1987 and 2015. 
BMC Res Notes 2017; 10: 760.
36 Pardeshi GS. Age heaping and accuracy of age data collected during 
a community survey in the Yavatmal district, Maharashtra. 
Indian J Community Med 2010; 35: 391–95.
37 
Borkotoky K, Unisa S. Indicators to examine quality of large scale 
survey data: an example through District Level Household and 
Facility Survey. PLoS One 2014; 9: e90113.
38 National Research Council. Age misreporting and age-selective 
underenumeration: sources, patterns, and consequences for 
demographic analysis. 1981. https://www.nap.edu/catalog/19649/
age-misreporting-and-age-selective-underenumeration-sources-
patterns-and-consequences (accessed March 16, 2018).
39 Shryock HS, Siegel JS, Larmon EA. The methods and materials of 
demography, volume 2. Suitland, MD, USA: US Bureau of the 
Census, 1973.
40 
Feeney G. A technique for correcting age distributions for heaping 
on multiples of five. Asian Pac Census Forum 1979; 5: 12–14.
 Global Health Metrics
www.thelancet.com   Vol 392   November 10, 2018 
2051
41 
Organisation for Economic Co-operation and Development. 
OECD data: working age population. July 2, 2018. http://data.oecd.
org/pop/working-age-population.htm (accessed July 2, 2018).
42 
World Bank. Population ages 15–64 (% of total). July 2, 2018. 
https://data.worldbank.org/indicator/SP.POP.1564.TO.
ZS?view=chart (accessed July 2, 2018).
43 
Hyman J. Accurate monotonicity preserving cubic interpolation. 
SIAM J Sci Stat Comput 1983; 4: 645–54.
44 
Dougherty RL, Edelman AS, Hyman JM. 
Nonnegativity-, monotonicity-, or convexity-preserving cubic and 
quintic Hermite interpolation. Math Comput 1989; 52: 471–94.
45 
UN Department of Economic and Social Affairs, Population 
Division. International migration flows to and from selected 
countries: the 2015 revision. December, 2015. http://www.un.org/
en/development/desa/population/migration/data/empirical2/docs/
migflows2015documentation.pdf (accessed Feb 28, 2018).
46 
Abel GJ. Estimates of global bilateral migration flows by gender 
between 1960 and 2015. Int Migr Rev 2017; published online Nov 24. 
DOI:10.1111/imre.12327
.
47 
Wheldon MC, Raftery AE, Clark SJ, Gerland P. Reconstructing past 
populations with uncertainty from fragmentary data. 
J Am Stat Assoc 2013; 108: 96–110.
48 
Wheldon MC, Raftery AE, Clark SJ, Gerland P. Bayesian 
reconstruction of two-sex populations by age: estimating sex ratios 
at birth and sex ratios of mortality. J R Stat Soc Ser A Stat Soc 2015; 
178: 977–1007
.
49 
Wheldon MC, Raftery AE, Clark SJ, Gerland P. Bayesian population 
reconstruction of female populations for less developed and more 
developed countries. Popul Stud 2016; 70: 21–37
.
50 Kristensen K, Bell B, Skaug H, et al. TMB: template model builder: 
a general random effect tool inspired by ‘ADMB’. June 23, 2018. 
https://CRAN.R-project.org/package=TMB (accessed June 26, 2018).
51 
Smallwood S, Chamberlain J. Replacement fertility, what has it 
been and what does it mean? Popul Trends 2005; 119: 16–27
.
52 Keyfitz N. On the momentum of population growth. 
Demography 1971; 8: 71–80.
53 Bloom D, Canning D, Sevilla J. The demographic dividend: 
a new perspective on the economic consequences of population 
change. Santa Monica, CA, USA: RAND Corporation, 2003.
54 
GBD 2016 SDG Collaborators. Measuring progress and projecting 
attainment on the basis of past trends of the health-related 
Sustainable Development Goals in 188 countries: an analysis from 
the Global Burden of Disease Study 2016. Lancet 2017; 390: 1423–59.
55 Gauthier AH. The impact of family policies on fertility in 
industrialized countries: a review of the literature. Popul Res Policy Rev 
2007; 26: 323–46.
56 Mcdonald P. Low fertility and the state: the efficacy of policy. 
Popul Dev Rev 2006; 32: 485–510.
57 
Gauthier AH, Hatzius J. Family benefits and fertility: 
an econometric analysis. Popul Stud 1997; 51: 295–306.
58 Gavrilova NS, Gavrilov LA. Rapidly aging populations: 
Russia/eastern Europe. In: Uhlenberg P, ed. International 
handbook of population aging. New York: Springer, 2009: 113–31.
59 Woo J, Kwok T, Sze FKH, Yuan HJ. Ageing in China: health and 
social consequences and responses. Int J Epidemiol 2002; 31: 772–75.
60 Carone G, Costello D, Diez Guardia N, Mourre G, Przywara B, 
Salomäki A. The economic impact of ageing populations in the 
EU25 member states. Jan 5, 2006. https://papers.ssrn.com/
abstract=873872 (accessed March 28, 2018).
61 
Morrow KM, Röger W. Economic and financial market 
consequences of ageing populations. 2003. https://ideas.repec.
org/p/euf/ecopap/0182.html (accessed March 28, 2018).
62 Poterba JM. Retirement security in an aging population. 
Am Econ Rev 2014; 104: 1–30.
63 Beard JR, Bloom DE. Towards a comprehensive public health 
response to population ageing. Lancet 2015; 385: 658–61.
64 
Bloom DE, Chatterji S, Kowal P, et al. Macroeconomic implications 
of population ageing and selected policy responses. Lancet 2015; 
385: 649–57
.
65 Christensen K, Doblhammer G, Rau R, Vaupel JW. 
Ageing populations: the challenges ahead. Lancet 2009; 374: 1196–208.
66 McCurry J. Japan will be model for future super-ageing societies. 
Lancet 2015; 386: 1523.
67 
Ekerdt DJ. Population retirement patterns. In: Uhlenberg P, ed. 
International handbook of population aging. New York: Springer, 
2009: 471–91.
68 Aaron HJ, Burtless G. Closing the deficit: how much can later 
retirement help? Washington, DC, USA: Brookings Institution 
Press, 2013.
69 Clark RL, Ogawa N, Lee SH, Matsukura R. Older workers and 
national productivity in Japan. Popul Dev Rev 2008; 34: 257–74.
70 
Humpel N, O’Loughlin K, Wells Y, Kendig H. Ageing baby boomers 
in Australia: evidence informing actions for better retirement. 
Aust J Soc Issues 2016; 44: 399–415.
71 
Cobb-Clark DA, Stillman S. The retirement expectations of 
middle-aged Australians. Econ Rec 2009; 85: 146–63.
72 
Hess M. Rising preferred retirement age in Europe: are Europe’s 
future pensioners adapting to pension system reforms? 
J Aging Soc Policy 2017; 29: 245–61.
73 
Cetorelli V. The effect on fertility of the 2003–2011 war in Iraq. 
Popul Dev Rev 2014; 40: 581–604.
74 
Cochrane SH. Fertility and education: what do we really know? 1979.
http://documents.worldbank.org/curated/en/550621468765918708/
pdf/multi0page.pdf (accessed Oct 15, 2018). 
75 
McCrary J, Royer H. The effect of female education on fertility and 
infant health: evidence from school entry policies using exact date 
of birth. Am Econ Rev 2011; 101: 158–95.
76 
Bongaarts J, Sinding S. Population policy in transition in the 
developing world. Science 2011; 333: 574–76.
77 
Canning D, Schultz TP. The economic consequences of 
reproductive health and family planning. Lancet 2012; 380: 165–71.
78 
Cleland J. The effects of improved survival on fertility: 
a reassessment. Popul Dev Rev 2001; 27: 60–92.
79 
Angeles L. Demographic transitions: analyzing the effects of 
mortality on fertility. J Popul Econ 2010; 23: 99–120.
80 Azumi K. The mysterious drop in Japan’s birth rate. Trans-Action 
1968; 5: 46–48.
81 
Diebolt C, Haupert M. Handbook of cliometrics. New York: 
Springer, 2016.
82 Raftery AE, Alkema L, Gerland P. Bayesian population projections 
for the United Nations. Stat Sci Rev J Inst Math Stat 2014; 29: 58–68.
83 Raftery AE, Li N, Ševčíková H, Gerland P, Heilig GK. 
Bayesian probabilistic population projections for all countries. 
Proc Natl Acad Sci USA 2012; 109: 13915–21.
84 
Azose JJ, Ševčíková H, Raftery AE. Probabilistic population 
projections with migration uncertainty. Proc Natl Acad Sci USA 
2016; 113: 6460–65.
85 Ševčíková H, Raftery AE. bayesPop: probabilistic population 
projections. J Stat Softw 2016; 75.
86 Golding N, Burstein R, Longbottom J, et al. Mapping under-5 and 
neonatal mortality in Africa, 2000–15: a baseline analysis for the 
Sustainable Development Goals. Lancet 2017; 390: 2171–82.
87 
Osgood-Zimmerman A, Millear AI, Stubbs RW, et al. Mapping child 
growth failure in Africa between 2000 and 2015. Nature 2018; 
555: 41–47
.
